Query 014849
Match_columns 417
No_of_seqs 360 out of 2242
Neff 8.0
Searched_HMMs 46136
Date Fri Mar 29 09:06:45 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/014849.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/014849hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0583 Serine/threonine prote 100.0 4.5E-66 9.7E-71 515.3 29.1 322 12-339 13-367 (370)
2 KOG0575 Polo-like serine/threo 100.0 2.2E-64 4.8E-69 506.1 26.4 264 16-282 18-282 (592)
3 KOG0588 Serine/threonine prote 100.0 4.7E-65 1E-69 512.8 21.2 264 11-277 7-271 (786)
4 KOG0615 Serine/threonine prote 100.0 3.8E-65 8.3E-70 490.2 17.0 264 10-276 166-444 (475)
5 KOG0598 Ribosomal protein S6 k 100.0 5E-62 1.1E-66 465.1 24.4 261 12-275 21-287 (357)
6 KOG0616 cAMP-dependent protein 100.0 2.1E-61 4.5E-66 447.6 20.8 258 13-276 41-304 (355)
7 KOG0592 3-phosphoinositide-dep 100.0 4.6E-59 1E-63 461.2 24.4 263 12-275 69-344 (604)
8 KOG0611 Predicted serine/threo 100.0 5.5E-59 1.2E-63 445.9 15.1 262 12-277 49-311 (668)
9 KOG0595 Serine/threonine-prote 100.0 2.1E-57 4.5E-62 437.2 24.3 261 12-277 6-276 (429)
10 KOG0605 NDR and related serine 100.0 4.2E-57 9.2E-62 447.4 22.2 262 14-277 139-453 (550)
11 KOG0581 Mitogen-activated prot 100.0 2.1E-56 4.6E-61 426.6 21.1 257 14-277 77-343 (364)
12 KOG0033 Ca2+/calmodulin-depend 100.0 8.8E-58 1.9E-62 413.4 7.8 260 11-275 6-273 (355)
13 KOG0694 Serine/threonine prote 100.0 2.2E-55 4.8E-60 445.8 22.9 260 13-275 365-630 (694)
14 KOG0580 Serine/threonine prote 100.0 5.8E-56 1.3E-60 400.7 14.9 262 9-275 15-279 (281)
15 KOG0585 Ca2+/calmodulin-depend 100.0 3.5E-55 7.6E-60 427.4 20.6 267 12-278 93-381 (576)
16 KOG4717 Serine/threonine prote 100.0 1.7E-55 3.7E-60 431.9 18.0 263 11-277 13-278 (864)
17 KOG0591 NIMA (never in mitosis 100.0 8.8E-56 1.9E-60 407.4 8.1 255 12-275 15-282 (375)
18 KOG0597 Serine-threonine prote 100.0 1.1E-54 2.4E-59 430.5 15.5 258 15-277 1-259 (808)
19 PTZ00263 protein kinase A cata 100.0 6.6E-53 1.4E-57 416.0 27.2 257 13-275 15-277 (329)
20 KOG0032 Ca2+/calmodulin-depend 100.0 7.6E-53 1.6E-57 420.5 27.3 262 11-276 30-300 (382)
21 KOG0593 Predicted protein kina 100.0 3.3E-54 7.1E-59 400.6 13.5 256 15-273 1-288 (396)
22 KOG0198 MEKK and related serin 100.0 4.1E-53 8.8E-58 408.6 19.6 260 15-277 16-284 (313)
23 KOG0600 Cdc2-related protein k 100.0 4.5E-53 9.7E-58 415.6 20.2 259 13-274 114-405 (560)
24 cd05612 STKc_PRKX_like Catalyt 100.0 1.8E-52 3.9E-57 405.5 24.2 253 16-274 1-259 (291)
25 KOG0661 MAPK related serine/th 100.0 9.3E-54 2E-58 417.8 13.4 262 10-277 4-299 (538)
26 KOG0599 Phosphorylase kinase g 100.0 8.5E-54 1.9E-58 392.7 11.5 268 6-277 7-291 (411)
27 cd05571 STKc_PKB Catalytic dom 100.0 6.4E-52 1.4E-56 407.9 24.6 251 22-275 1-257 (323)
28 KOG0586 Serine/threonine prote 100.0 8.7E-53 1.9E-57 422.8 18.2 265 10-278 50-315 (596)
29 KOG0659 Cdk activating kinase 100.0 3.4E-52 7.3E-57 381.2 20.2 256 16-275 2-287 (318)
30 PTZ00426 cAMP-dependent protei 100.0 2E-51 4.3E-56 407.7 26.8 257 12-274 26-289 (340)
31 KOG0610 Putative serine/threon 100.0 3.3E-52 7.1E-57 401.4 20.3 262 15-277 76-400 (459)
32 KOG0582 Ste20-like serine/thre 100.0 3.2E-51 6.9E-56 397.4 25.8 261 13-276 23-300 (516)
33 cd05628 STKc_NDR1 Catalytic do 100.0 7.1E-51 1.5E-55 406.9 27.8 258 16-275 1-299 (363)
34 cd05585 STKc_YPK1_like Catalyt 100.0 4E-51 8.8E-56 400.1 24.4 249 24-275 1-253 (312)
35 cd05589 STKc_PKN Catalytic dom 100.0 1.2E-50 2.6E-55 398.7 26.8 255 18-275 1-263 (324)
36 cd05593 STKc_PKB_gamma Catalyt 100.0 9.8E-51 2.1E-55 400.5 25.3 250 22-274 1-256 (328)
37 cd05595 STKc_PKB_beta Catalyti 100.0 1.3E-50 2.8E-55 398.8 25.5 251 22-275 1-257 (323)
38 cd05590 STKc_nPKC_eta Catalyti 100.0 1.5E-50 3.2E-55 397.8 25.4 251 22-275 1-259 (320)
39 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 1.7E-50 3.7E-55 399.0 25.8 254 16-275 1-263 (333)
40 cd05599 STKc_NDR_like Catalyti 100.0 1.6E-50 3.6E-55 403.7 25.6 258 16-275 1-302 (364)
41 cd05587 STKc_cPKC Catalytic do 100.0 3.4E-50 7.4E-55 395.6 27.4 256 17-275 1-263 (324)
42 KOG0690 Serine/threonine prote 100.0 3.3E-52 7E-57 390.1 11.8 263 10-275 162-430 (516)
43 cd05591 STKc_nPKC_epsilon Cata 100.0 2E-50 4.2E-55 396.8 24.8 250 22-274 1-259 (321)
44 cd05631 STKc_GRK4 Catalytic do 100.0 3.5E-50 7.5E-55 388.2 25.7 255 17-275 1-267 (285)
45 cd05626 STKc_LATS2 Catalytic d 100.0 3.9E-50 8.5E-55 404.2 26.8 259 16-275 1-311 (381)
46 cd07871 STKc_PCTAIRE3 Catalyti 100.0 7.9E-50 1.7E-54 386.3 27.2 253 15-272 4-288 (288)
47 KOG0578 p21-activated serine/t 100.0 4.5E-51 9.8E-56 407.2 18.9 257 12-274 269-528 (550)
48 cd05625 STKc_LATS1 Catalytic d 100.0 3.6E-50 7.9E-55 404.3 25.3 258 16-275 1-311 (382)
49 cd05620 STKc_nPKC_delta Cataly 100.0 5.6E-50 1.2E-54 393.0 25.9 251 22-275 1-254 (316)
50 cd05594 STKc_PKB_alpha Catalyt 100.0 2.1E-50 4.5E-55 397.2 22.9 251 22-275 1-258 (325)
51 cd05596 STKc_ROCK Catalytic do 100.0 5.8E-50 1.3E-54 401.7 26.2 262 13-275 40-310 (370)
52 cd05573 STKc_ROCK_NDR_like Cat 100.0 2.8E-50 6.1E-55 399.2 23.3 258 16-275 1-291 (350)
53 cd05616 STKc_cPKC_beta Catalyt 100.0 9.5E-50 2.1E-54 392.3 26.5 255 17-274 1-262 (323)
54 cd05629 STKc_NDR_like_fungal C 100.0 5.2E-50 1.1E-54 402.4 24.8 257 16-274 1-310 (377)
55 cd05588 STKc_aPKC Catalytic do 100.0 7.8E-50 1.7E-54 394.1 25.3 250 22-274 1-267 (329)
56 cd05621 STKc_ROCK2 Catalytic d 100.0 6.5E-50 1.4E-54 401.4 25.1 263 12-275 39-310 (370)
57 cd07848 STKc_CDKL5 Catalytic d 100.0 1.4E-49 3E-54 383.1 25.8 254 16-272 1-287 (287)
58 cd07869 STKc_PFTAIRE1 Catalyti 100.0 1.8E-49 3.8E-54 386.3 26.7 256 15-275 4-294 (303)
59 KOG0660 Mitogen-activated prot 100.0 1.9E-50 4.2E-55 384.3 19.3 264 13-278 19-319 (359)
60 cd05598 STKc_LATS Catalytic do 100.0 5.4E-50 1.2E-54 402.1 23.6 257 16-274 1-306 (376)
61 cd05592 STKc_nPKC_theta_delta 100.0 1.3E-49 2.8E-54 390.5 25.7 251 22-275 1-254 (316)
62 cd05570 STKc_PKC Catalytic dom 100.0 1.5E-49 3.2E-54 390.2 25.7 251 22-275 1-258 (318)
63 cd05619 STKc_nPKC_theta Cataly 100.0 2.2E-49 4.8E-54 388.9 26.5 251 22-275 1-254 (316)
64 cd05584 STKc_p70S6K Catalytic 100.0 1.5E-49 3.4E-54 390.9 25.4 252 21-275 1-262 (323)
65 cd05627 STKc_NDR2 Catalytic do 100.0 1.1E-49 2.3E-54 397.8 24.2 258 16-275 1-299 (360)
66 cd05575 STKc_SGK Catalytic dom 100.0 1.5E-49 3.2E-54 390.8 24.3 251 22-275 1-257 (323)
67 cd05615 STKc_cPKC_alpha Cataly 100.0 4.1E-49 8.8E-54 388.1 27.0 256 17-275 1-263 (323)
68 cd05618 STKc_aPKC_iota Catalyt 100.0 2.5E-49 5.4E-54 390.7 25.2 251 22-275 1-268 (329)
69 cd05614 STKc_MSK2_N N-terminal 100.0 5.2E-49 1.1E-53 388.1 26.4 258 17-275 1-273 (332)
70 cd05622 STKc_ROCK1 Catalytic d 100.0 5.9E-49 1.3E-53 394.5 26.5 263 12-275 39-310 (371)
71 cd05601 STKc_CRIK Catalytic do 100.0 2.6E-49 5.7E-54 389.9 22.8 258 16-275 1-269 (330)
72 cd05604 STKc_SGK3 Catalytic do 100.0 4.5E-49 9.8E-54 387.8 22.9 250 22-274 1-256 (325)
73 cd05617 STKc_aPKC_zeta Catalyt 100.0 1.1E-48 2.4E-53 385.6 25.5 251 22-275 1-266 (327)
74 cd05603 STKc_SGK2 Catalytic do 100.0 7.5E-49 1.6E-53 385.4 24.0 250 22-274 1-256 (321)
75 KOG0663 Protein kinase PITSLRE 100.0 1.6E-49 3.4E-54 373.6 18.2 260 14-277 74-369 (419)
76 cd05586 STKc_Sck1_like Catalyt 100.0 2.3E-49 4.9E-54 390.5 20.2 250 24-275 1-259 (330)
77 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1.8E-48 4E-53 383.9 26.7 256 17-275 1-296 (338)
78 KOG0594 Protein kinase PCTAIRE 100.0 3.9E-49 8.5E-54 376.0 20.8 259 15-277 10-310 (323)
79 cd05582 STKc_RSK_N N-terminal 100.0 4.8E-49 1E-53 386.3 21.2 250 22-275 2-260 (318)
80 cd05602 STKc_SGK1 Catalytic do 100.0 1.2E-48 2.7E-53 384.7 24.0 250 22-274 1-256 (325)
81 cd05608 STKc_GRK1 Catalytic do 100.0 1.8E-48 4E-53 375.2 24.6 248 24-274 1-262 (280)
82 cd05605 STKc_GRK4_like Catalyt 100.0 2.9E-48 6.3E-53 374.8 26.0 254 17-274 1-266 (285)
83 cd06649 PKc_MEK2 Catalytic dom 100.0 9.2E-48 2E-52 379.6 28.5 255 15-276 4-308 (331)
84 cd05597 STKc_DMPK_like Catalyt 100.0 7.8E-48 1.7E-52 380.2 27.5 259 16-275 1-272 (331)
85 KOG0201 Serine/threonine prote 100.0 2.4E-50 5.2E-55 391.0 9.0 261 11-276 8-270 (467)
86 PTZ00036 glycogen synthase kin 100.0 5.1E-48 1.1E-52 396.1 25.8 251 15-276 65-358 (440)
87 KOG0986 G protein-coupled rece 100.0 3.9E-49 8.5E-54 382.9 15.5 329 13-349 182-526 (591)
88 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.9E-47 4.1E-52 373.1 27.0 257 15-276 5-293 (309)
89 PTZ00283 serine/threonine prot 100.0 1.4E-47 3E-52 398.2 27.4 261 13-275 29-303 (496)
90 cd07862 STKc_CDK6 Catalytic do 100.0 1.9E-47 4.2E-52 368.7 26.5 251 16-272 1-290 (290)
91 PTZ00267 NIMA-related protein 100.0 3.4E-47 7.4E-52 393.9 29.2 258 13-274 64-328 (478)
92 KOG0192 Tyrosine kinase specif 100.0 1.1E-47 2.5E-52 380.4 24.4 249 15-269 40-299 (362)
93 cd07876 STKc_JNK2 Catalytic do 100.0 2.4E-47 5.2E-52 380.5 26.4 258 13-277 18-323 (359)
94 cd05580 STKc_PKA Catalytic dom 100.0 5E-47 1.1E-51 366.6 27.5 255 16-276 1-261 (290)
95 PLN00034 mitogen-activated pro 100.0 1.7E-47 3.7E-52 380.9 24.8 257 13-276 71-335 (353)
96 cd05623 STKc_MRCK_alpha Cataly 100.0 3E-47 6.5E-52 376.0 26.0 258 16-274 1-271 (332)
97 cd07878 STKc_p38beta_MAPK11 Ca 100.0 1.5E-47 3.4E-52 379.2 23.9 258 12-276 11-305 (343)
98 PHA03212 serine/threonine kina 100.0 4E-47 8.7E-52 383.8 27.3 250 15-276 91-383 (391)
99 PF00069 Pkinase: Protein kina 100.0 1.6E-47 3.5E-52 361.8 22.5 252 18-272 1-260 (260)
100 cd05624 STKc_MRCK_beta Catalyt 100.0 2.9E-47 6.2E-52 376.2 24.9 258 16-274 1-271 (331)
101 KOG0589 Serine/threonine prote 100.0 2.1E-48 4.6E-53 385.4 16.1 258 15-276 3-265 (426)
102 cd06625 STKc_MEKK3_like Cataly 100.0 1.2E-46 2.7E-51 357.1 27.2 256 16-272 2-263 (263)
103 KOG0612 Rho-associated, coiled 100.0 7E-49 1.5E-53 414.3 12.8 261 15-277 74-346 (1317)
104 KOG0696 Serine/threonine prote 100.0 1.6E-48 3.5E-53 374.6 14.0 263 12-277 345-614 (683)
105 cd07875 STKc_JNK1 Catalytic do 100.0 8.7E-47 1.9E-51 377.2 27.1 258 13-277 21-326 (364)
106 cd07863 STKc_CDK4 Catalytic do 100.0 7E-47 1.5E-51 364.2 25.4 250 17-272 1-288 (288)
107 cd07874 STKc_JNK3 Catalytic do 100.0 7.2E-47 1.6E-51 376.4 26.2 258 13-277 14-319 (355)
108 cd06650 PKc_MEK1 Catalytic dom 100.0 8.3E-47 1.8E-51 373.3 26.3 255 15-276 4-306 (333)
109 KOG0658 Glycogen synthase kina 100.0 6.2E-48 1.3E-52 367.8 17.4 252 15-277 23-314 (364)
110 cd05630 STKc_GRK6 Catalytic do 100.0 7.9E-47 1.7E-51 364.9 25.4 254 17-274 1-266 (285)
111 cd07853 STKc_NLK Catalytic dom 100.0 5.1E-47 1.1E-51 380.1 24.8 257 17-276 1-295 (372)
112 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.7E-46 3.6E-51 364.8 27.2 258 14-276 4-293 (301)
113 cd05607 STKc_GRK7 Catalytic do 100.0 1.1E-46 2.4E-51 362.2 25.3 247 24-274 1-259 (277)
114 cd05632 STKc_GRK5 Catalytic do 100.0 2.4E-46 5.3E-51 361.3 27.0 255 17-275 1-267 (285)
115 KOG0604 MAP kinase-activated p 100.0 1.7E-48 3.8E-53 361.8 11.3 254 10-275 55-328 (400)
116 PTZ00284 protein kinase; Provi 100.0 1.6E-46 3.4E-51 387.9 27.0 252 15-277 128-446 (467)
117 cd08223 STKc_Nek4 Catalytic do 100.0 9.7E-46 2.1E-50 349.8 28.3 252 17-272 1-257 (257)
118 cd05102 PTKc_VEGFR3 Catalytic 100.0 1.2E-46 2.7E-51 371.9 23.0 251 15-268 6-329 (338)
119 KOG0607 MAP kinase-interacting 100.0 7.2E-48 1.6E-52 360.2 12.6 268 13-283 74-375 (463)
120 cd06654 STKc_PAK1 Catalytic do 100.0 8.6E-46 1.9E-50 359.6 27.5 261 9-275 13-276 (296)
121 KOG0667 Dual-specificity tyros 100.0 9E-47 2E-51 382.6 20.4 253 12-275 182-508 (586)
122 cd07861 STKc_CDK1_euk Catalyti 100.0 1.2E-45 2.6E-50 354.8 27.1 252 17-272 1-285 (285)
123 cd07868 STKc_CDK8 Catalytic do 100.0 4.3E-46 9.4E-51 364.3 24.5 246 21-272 6-317 (317)
124 cd06655 STKc_PAK2 Catalytic do 100.0 1.7E-45 3.6E-50 357.8 28.0 259 12-276 15-276 (296)
125 cd06628 STKc_MAPKKK_Byr2_like 100.0 1.4E-45 3E-50 351.0 26.5 255 17-272 1-267 (267)
126 cd05574 STKc_phototropin_like 100.0 1.5E-45 3.2E-50 360.4 27.3 259 16-275 1-295 (316)
127 cd06615 PKc_MEK Catalytic doma 100.0 1.4E-45 2.9E-50 360.2 26.9 253 16-275 1-293 (308)
128 cd06644 STKc_STK10_LOK Catalyt 100.0 1.9E-45 4E-50 355.7 27.0 263 7-275 3-275 (292)
129 KOG0579 Ste20-like serine/thre 100.0 6.8E-48 1.5E-52 385.4 10.1 259 13-277 29-297 (1187)
130 cd06656 STKc_PAK3 Catalytic do 100.0 1.3E-45 2.9E-50 358.4 25.6 262 10-277 13-277 (297)
131 PHA03207 serine/threonine kina 100.0 1.1E-45 2.4E-50 373.3 25.9 254 12-275 88-381 (392)
132 cd06609 STKc_MST3_like Catalyt 100.0 1.8E-45 3.9E-50 352.1 25.4 257 16-277 1-259 (274)
133 cd07839 STKc_CDK5 Catalytic do 100.0 6.4E-46 1.4E-50 356.8 22.3 252 17-272 1-284 (284)
134 cd06611 STKc_SLK_like Catalyti 100.0 9.3E-46 2E-50 355.2 23.2 256 15-276 4-269 (280)
135 cd06646 STKc_MAP4K5 Catalytic 100.0 1.7E-45 3.7E-50 350.6 24.8 252 14-271 7-267 (267)
136 cd05609 STKc_MAST Catalytic do 100.0 3.9E-45 8.5E-50 356.1 27.8 259 16-275 1-279 (305)
137 cd08529 STKc_FA2-like Catalyti 100.0 5.7E-45 1.2E-49 344.0 27.9 252 17-272 1-256 (256)
138 cd05578 STKc_Yank1 Catalytic d 100.0 9E-46 2E-50 350.8 22.4 252 17-272 1-258 (258)
139 PHA03211 serine/threonine kina 100.0 2.8E-45 6E-50 376.6 27.6 250 14-274 167-460 (461)
140 cd07832 STKc_CCRK Catalytic do 100.0 4.2E-45 9.2E-50 350.8 27.0 254 17-273 1-286 (286)
141 cd07847 STKc_CDKL1_4 Catalytic 100.0 5.7E-45 1.2E-49 349.9 27.8 254 16-272 1-286 (286)
142 cd07841 STKc_CDK7 Catalytic do 100.0 4.7E-45 1E-49 353.4 26.8 261 17-280 1-293 (298)
143 cd08218 STKc_Nek1 Catalytic do 100.0 5.3E-45 1.2E-49 344.8 26.5 252 17-272 1-256 (256)
144 cd06610 STKc_OSR1_SPAK Catalyt 100.0 5.5E-45 1.2E-49 345.9 26.5 255 16-272 1-267 (267)
145 cd06645 STKc_MAP4K3 Catalytic 100.0 1.8E-45 3.9E-50 350.5 23.2 251 15-271 8-267 (267)
146 cd08227 PK_STRAD_alpha Pseudok 100.0 2.3E-45 5E-50 361.6 24.4 255 19-275 1-313 (327)
147 cd06637 STKc_TNIK Catalytic do 100.0 4.2E-45 9.2E-50 348.6 25.5 252 14-272 4-272 (272)
148 cd06643 STKc_SLK Catalytic dom 100.0 4.1E-45 8.8E-50 351.4 25.5 254 17-276 6-269 (282)
149 KOG0614 cGMP-dependent protein 100.0 2.2E-47 4.7E-52 374.6 9.7 257 14-274 418-682 (732)
150 cd06631 STKc_YSK4 Catalytic do 100.0 5.4E-45 1.2E-49 346.8 25.9 254 17-272 1-265 (265)
151 cd06619 PKc_MKK5 Catalytic dom 100.0 7.1E-45 1.5E-49 349.6 26.9 250 16-275 1-259 (279)
152 cd05572 STKc_cGK_PKG Catalytic 100.0 4.5E-45 9.8E-50 346.8 24.6 247 24-274 1-257 (262)
153 cd06629 STKc_MAPKKK_Bck1_like 100.0 8.1E-45 1.7E-49 346.9 26.4 256 17-272 2-272 (272)
154 cd05633 STKc_GRK3 Catalytic do 100.0 6.3E-45 1.4E-49 350.6 25.3 249 23-275 1-261 (279)
155 cd07845 STKc_CDK10 Catalytic d 100.0 1E-44 2.2E-49 353.6 27.1 260 14-277 5-298 (309)
156 cd07846 STKc_CDKL2_3 Catalytic 100.0 4.2E-45 9.2E-50 351.1 24.0 254 16-272 1-286 (286)
157 PHA02988 hypothetical protein; 100.0 6.8E-45 1.5E-49 351.5 25.3 240 22-269 26-275 (283)
158 PTZ00266 NIMA-related protein 100.0 6E-45 1.3E-49 393.8 27.4 265 8-276 5-302 (1021)
159 cd07849 STKc_ERK1_2_like Catal 100.0 1E-44 2.2E-49 358.2 26.9 261 14-277 3-300 (336)
160 cd05581 STKc_PDK1 Catalytic do 100.0 3.7E-45 8.1E-50 349.4 22.8 256 16-272 1-280 (280)
161 cd06630 STKc_MEKK1 Catalytic d 100.0 5E-45 1.1E-49 347.0 23.3 256 17-273 1-268 (268)
162 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 4.9E-45 1.1E-49 351.2 23.4 256 16-277 1-270 (286)
163 cd07844 STKc_PCTAIRE_like Cata 100.0 1.6E-44 3.6E-49 348.4 26.8 253 15-272 4-291 (291)
164 cd08219 STKc_Nek3 Catalytic do 100.0 2E-44 4.2E-49 341.1 26.8 248 17-269 1-252 (255)
165 cd06651 STKc_MEKK3 Catalytic d 100.0 1.5E-44 3.2E-49 344.5 26.0 255 17-273 3-265 (266)
166 cd08221 STKc_Nek9 Catalytic do 100.0 3.5E-44 7.5E-49 339.3 28.1 252 17-272 1-256 (256)
167 cd05106 PTKc_CSF-1R Catalytic 100.0 4.3E-45 9.3E-50 366.9 23.1 251 15-268 37-367 (374)
168 PHA03209 serine/threonine kina 100.0 6.1E-45 1.3E-49 363.4 24.1 246 15-274 65-356 (357)
169 cd07850 STKc_JNK Catalytic dom 100.0 1.5E-44 3.3E-49 359.6 26.7 260 13-279 13-321 (353)
170 cd06652 STKc_MEKK2 Catalytic d 100.0 2.7E-44 5.9E-49 342.3 27.3 256 16-273 2-265 (265)
171 cd06613 STKc_MAP4K3_like Catal 100.0 3E-44 6.5E-49 340.2 27.4 251 15-271 2-262 (262)
172 cd05606 STKc_beta_ARK Catalyti 100.0 1.3E-44 2.8E-49 348.1 25.0 250 23-276 1-262 (278)
173 cd05048 PTKc_Ror Catalytic Dom 100.0 9.4E-45 2E-49 348.5 23.8 252 15-269 4-279 (283)
174 cd05096 PTKc_DDR1 Catalytic do 100.0 1.5E-44 3.3E-49 351.5 25.4 251 14-267 3-299 (304)
175 cd06639 STKc_myosinIIIB Cataly 100.0 5E-44 1.1E-48 345.3 28.6 255 13-273 19-291 (291)
176 cd07867 STKc_CDC2L6 Catalytic 100.0 1.5E-44 3.2E-49 353.0 25.1 247 20-272 5-317 (317)
177 cd08220 STKc_Nek8 Catalytic do 100.0 3.6E-44 7.7E-49 338.6 26.9 251 17-272 1-256 (256)
178 cd06917 STKc_NAK1_like Catalyt 100.0 1.8E-44 3.8E-49 345.5 25.0 257 17-277 2-263 (277)
179 cd05577 STKc_GRK Catalytic dom 100.0 1.1E-44 2.4E-49 347.7 23.5 248 24-275 1-260 (277)
180 cd07833 STKc_CDKL Catalytic do 100.0 2.5E-44 5.4E-49 345.8 25.9 255 16-272 1-288 (288)
181 cd05579 STKc_MAST_like Catalyt 100.0 9.9E-45 2.1E-49 343.0 22.7 250 24-274 1-262 (265)
182 cd07865 STKc_CDK9 Catalytic do 100.0 2.6E-44 5.7E-49 349.2 26.2 259 12-272 8-310 (310)
183 cd06640 STKc_MST4 Catalytic do 100.0 1.5E-44 3.3E-49 346.7 24.2 258 15-277 3-261 (277)
184 KOG4236 Serine/threonine prote 100.0 2.4E-46 5.3E-51 368.3 11.9 257 12-275 558-825 (888)
185 cd06608 STKc_myosinIII_like Ca 100.0 2.3E-44 4.9E-49 342.8 25.1 253 14-272 4-275 (275)
186 cd07860 STKc_CDK2_3 Catalytic 100.0 1.9E-44 4E-49 346.6 24.6 252 17-272 1-284 (284)
187 cd06612 STKc_MST1_2 Catalytic 100.0 2E-44 4.4E-49 340.3 24.4 249 16-272 3-256 (256)
188 cd06632 STKc_MEKK1_plant Catal 100.0 4.4E-44 9.5E-49 338.0 26.6 253 17-272 1-258 (258)
189 cd06658 STKc_PAK5 Catalytic do 100.0 7.1E-45 1.5E-49 352.7 21.6 260 13-278 19-281 (292)
190 cd05064 PTKc_EphR_A10 Catalyti 100.0 3E-44 6.5E-49 342.9 25.6 250 15-268 4-260 (266)
191 cd07831 STKc_MOK Catalytic dom 100.0 3.5E-44 7.6E-49 343.7 25.9 248 18-272 1-282 (282)
192 cd08217 STKc_Nek2 Catalytic do 100.0 5.1E-44 1.1E-48 338.2 26.4 252 17-272 1-265 (265)
193 cd06636 STKc_MAP4K4_6 Catalyti 100.0 2.4E-44 5.2E-49 345.7 24.4 253 13-272 13-282 (282)
194 cd07870 STKc_PFTAIRE2 Catalyti 100.0 7.3E-44 1.6E-48 344.2 27.8 253 15-272 4-291 (291)
195 cd05104 PTKc_Kit Catalytic dom 100.0 1.2E-44 2.5E-49 363.9 22.8 252 15-269 34-370 (375)
196 cd06626 STKc_MEKK4 Catalytic d 100.0 9.4E-44 2E-48 337.2 27.4 255 17-272 1-264 (264)
197 cd06641 STKc_MST3 Catalytic do 100.0 5.8E-44 1.3E-48 342.7 26.3 256 17-277 5-261 (277)
198 cd07837 STKc_CdkB_plant Cataly 100.0 7E-44 1.5E-48 344.4 26.8 254 16-273 1-295 (295)
199 cd06638 STKc_myosinIIIA Cataly 100.0 6.2E-44 1.3E-48 343.3 26.2 256 10-272 12-286 (286)
200 KOG0197 Tyrosine kinases [Sign 100.0 4.8E-45 1E-49 362.9 18.8 243 18-267 208-455 (468)
201 cd07843 STKc_CDC2L1 Catalytic 100.0 3E-44 6.5E-49 347.2 23.9 254 15-272 4-293 (293)
202 cd07880 STKc_p38gamma_MAPK12 C 100.0 8E-44 1.7E-48 353.3 27.5 258 13-277 12-306 (343)
203 cd08228 STKc_Nek6 Catalytic do 100.0 8.9E-44 1.9E-48 338.5 26.6 252 15-269 1-261 (267)
204 cd06647 STKc_PAK_I Catalytic d 100.0 3.6E-44 7.8E-49 347.7 24.2 260 12-277 15-277 (293)
205 KOG0574 STE20-like serine/thre 100.0 1.9E-47 4.1E-52 354.9 1.1 254 15-276 32-290 (502)
206 cd07854 STKc_MAPK4_6 Catalytic 100.0 5E-44 1.1E-48 354.5 25.7 258 14-275 3-306 (342)
207 cd07836 STKc_Pho85 Catalytic d 100.0 6.9E-44 1.5E-48 342.3 25.8 251 17-272 1-284 (284)
208 cd06642 STKc_STK25-YSK1 Cataly 100.0 7.6E-45 1.6E-49 348.6 18.8 256 15-275 3-259 (277)
209 cd06648 STKc_PAK_II Catalytic 100.0 1.1E-43 2.4E-48 342.7 26.9 257 15-277 18-277 (285)
210 cd08225 STKc_Nek5 Catalytic do 100.0 8.3E-44 1.8E-48 336.2 25.2 252 17-272 1-257 (257)
211 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 4.9E-44 1.1E-48 344.4 23.7 257 16-279 5-276 (284)
212 cd05611 STKc_Rim15_like Cataly 100.0 7.8E-44 1.7E-48 337.9 24.1 247 22-275 2-257 (260)
213 cd05061 PTKc_InsR Catalytic do 100.0 1.3E-43 2.9E-48 342.3 26.1 257 15-274 5-285 (288)
214 cd05049 PTKc_Trk Catalytic dom 100.0 5.7E-44 1.2E-48 342.2 23.3 251 15-268 4-276 (280)
215 cd06659 STKc_PAK6 Catalytic do 100.0 5.1E-44 1.1E-48 347.5 23.2 256 16-277 21-279 (297)
216 cd06605 PKc_MAPKK Catalytic do 100.0 4.1E-44 8.8E-49 340.2 21.8 253 16-275 1-263 (265)
217 cd08215 STKc_Nek Catalytic dom 100.0 3.4E-43 7.3E-48 330.8 27.3 252 17-272 1-258 (258)
218 cd07842 STKc_CDK8_like Catalyt 100.0 1.1E-43 2.3E-48 346.2 24.6 255 17-272 1-316 (316)
219 cd05062 PTKc_IGF-1R Catalytic 100.0 1.4E-43 2.9E-48 339.9 24.7 253 14-269 4-274 (277)
220 cd05093 PTKc_TrkB Catalytic do 100.0 1.6E-43 3.5E-48 341.7 25.3 250 15-268 4-274 (288)
221 cd07851 STKc_p38 Catalytic dom 100.0 8.5E-44 1.8E-48 353.0 24.0 259 12-277 11-306 (343)
222 cd07855 STKc_ERK5 Catalytic do 100.0 8.3E-44 1.8E-48 351.5 23.7 263 14-278 3-303 (334)
223 KOG0695 Serine/threonine prote 100.0 8.1E-45 1.7E-49 341.5 15.4 258 15-275 249-522 (593)
224 cd06607 STKc_TAO Catalytic dom 100.0 2.5E-43 5.4E-48 343.7 26.6 258 12-276 11-274 (307)
225 cd06623 PKc_MAPKK_plant_like C 100.0 3.2E-43 7E-48 333.2 26.6 254 16-274 1-261 (264)
226 cd05084 PTKc_Fes Catalytic dom 100.0 1.8E-43 3.9E-48 333.9 24.5 244 22-268 1-248 (252)
227 cd06606 STKc_MAPKKK Catalytic 100.0 5.7E-43 1.2E-47 328.9 27.7 254 17-272 1-260 (260)
228 cd05090 PTKc_Ror1 Catalytic do 100.0 2E-43 4.4E-48 339.7 25.2 252 15-269 4-279 (283)
229 cd06627 STKc_Cdc7_like Catalyt 100.0 5.9E-43 1.3E-47 329.2 27.8 252 17-272 1-254 (254)
230 cd07877 STKc_p38alpha_MAPK14 C 100.0 2.2E-43 4.8E-48 350.4 26.2 258 13-277 14-308 (345)
231 cd07835 STKc_CDK1_like Catalyt 100.0 2E-43 4.3E-48 339.3 24.9 251 18-272 1-283 (283)
232 PHA03390 pk1 serine/threonine- 100.0 1E-43 2.3E-48 340.0 22.8 249 11-274 9-267 (267)
233 cd05033 PTKc_EphR Catalytic do 100.0 3.4E-43 7.3E-48 334.9 26.0 251 16-269 4-261 (266)
234 cd05108 PTKc_EGFR Catalytic do 100.0 1.8E-43 4E-48 346.2 24.8 251 15-269 6-264 (316)
235 PTZ00024 cyclin-dependent prot 100.0 2.6E-43 5.5E-48 347.8 25.8 265 13-278 5-322 (335)
236 KOG0662 Cyclin-dependent kinas 100.0 1.5E-44 3.3E-49 314.2 15.0 256 16-275 2-289 (292)
237 cd06617 PKc_MKK3_6 Catalytic d 100.0 2.9E-43 6.2E-48 337.9 25.4 255 16-277 1-269 (283)
238 PLN00009 cyclin-dependent kina 100.0 4.5E-43 9.7E-48 339.2 26.6 257 15-275 1-290 (294)
239 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 7.1E-43 1.5E-47 331.7 27.5 250 16-268 2-260 (267)
240 cd07858 STKc_TEY_MAPK_plant Ca 100.0 2.5E-43 5.5E-48 348.6 24.7 258 14-275 3-297 (337)
241 cd05123 STKc_AGC Catalytic dom 100.0 3.2E-43 6.9E-48 330.9 24.2 246 24-272 1-250 (250)
242 cd00192 PTKc Catalytic domain 100.0 4.2E-43 9.1E-48 330.9 25.0 245 22-269 1-260 (262)
243 cd06624 STKc_ASK Catalytic dom 100.0 5.6E-43 1.2E-47 333.8 25.7 247 21-272 13-268 (268)
244 cd05035 PTKc_Axl_like Catalyti 100.0 3.6E-43 7.7E-48 334.8 24.3 250 18-269 1-268 (273)
245 cd05091 PTKc_Ror2 Catalytic do 100.0 1.4E-43 3E-48 340.6 21.7 252 15-269 4-279 (283)
246 cd08229 STKc_Nek7 Catalytic do 100.0 2.5E-43 5.5E-48 335.4 23.2 250 16-268 2-260 (267)
247 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 1E-42 2.3E-47 335.9 27.8 256 16-278 1-275 (287)
248 cd07852 STKc_MAPK15 Catalytic 100.0 3.3E-43 7.1E-48 347.5 24.7 264 12-277 3-303 (337)
249 cd05032 PTKc_InsR_like Catalyt 100.0 5E-43 1.1E-47 335.2 25.0 253 14-269 4-274 (277)
250 cd05075 PTKc_Axl Catalytic dom 100.0 4.1E-43 9E-48 334.8 24.3 250 18-269 1-267 (272)
251 cd07840 STKc_CDK9_like Catalyt 100.0 6.7E-43 1.5E-47 335.0 25.9 252 18-272 1-287 (287)
252 cd05036 PTKc_ALK_LTK Catalytic 100.0 4.2E-43 9.1E-48 336.7 24.4 252 15-269 5-274 (277)
253 cd05114 PTKc_Tec_Rlk Catalytic 100.0 7.4E-43 1.6E-47 330.7 25.8 246 16-268 4-253 (256)
254 cd05052 PTKc_Abl Catalytic dom 100.0 7.7E-43 1.7E-47 332.2 26.0 248 16-269 6-258 (263)
255 cd05088 PTKc_Tie2 Catalytic do 100.0 2.7E-43 6E-48 343.1 23.4 250 14-269 5-276 (303)
256 cd06653 STKc_MEKK3_like_1 Cata 100.0 1.5E-42 3.2E-47 330.4 27.8 255 16-272 2-264 (264)
257 cd05098 PTKc_FGFR1 Catalytic d 100.0 6.1E-43 1.3E-47 341.0 25.6 255 12-269 14-295 (307)
258 KOG0603 Ribosomal protein S6 k 100.0 2.7E-44 5.8E-49 363.3 15.9 245 13-272 319-566 (612)
259 cd05054 PTKc_VEGFR Catalytic d 100.0 1.7E-43 3.6E-48 350.5 21.3 251 16-269 7-329 (337)
260 cd07866 STKc_BUR1 Catalytic do 100.0 5.5E-43 1.2E-47 340.1 24.5 256 15-272 7-311 (311)
261 cd07864 STKc_CDK12 Catalytic d 100.0 6.8E-43 1.5E-47 338.7 24.9 257 13-272 4-302 (302)
262 cd05613 STKc_MSK1_N N-terminal 100.0 1.1E-42 2.4E-47 335.7 26.3 259 17-276 1-275 (290)
263 cd05053 PTKc_FGFR Catalytic do 100.0 4.9E-43 1.1E-47 338.5 23.8 252 15-269 11-287 (293)
264 KOG1989 ARK protein kinase fam 100.0 7.5E-44 1.6E-48 371.4 19.2 246 16-269 37-307 (738)
265 cd06657 STKc_PAK4 Catalytic do 100.0 6.5E-43 1.4E-47 339.1 24.3 255 18-278 22-279 (292)
266 cd05105 PTKc_PDGFR_alpha Catal 100.0 4.6E-43 9.9E-48 355.1 24.2 251 15-268 36-392 (400)
267 cd05101 PTKc_FGFR2 Catalytic d 100.0 1.3E-42 2.9E-47 337.9 26.5 257 10-269 9-292 (304)
268 cd07834 STKc_MAPK Catalytic do 100.0 5.9E-43 1.3E-47 344.0 24.0 259 17-277 1-297 (330)
269 cd05089 PTKc_Tie1 Catalytic do 100.0 1.1E-42 2.4E-47 337.6 25.5 248 16-269 2-271 (297)
270 cd05148 PTKc_Srm_Brk Catalytic 100.0 4.3E-43 9.2E-48 332.8 22.0 247 15-268 5-256 (261)
271 KOG0596 Dual specificity; seri 100.0 5.5E-44 1.2E-48 354.2 16.4 256 15-274 360-632 (677)
272 KOG0577 Serine/threonine prote 100.0 1.1E-44 2.4E-49 360.6 11.4 255 16-277 26-286 (948)
273 cd05094 PTKc_TrkC Catalytic do 100.0 1E-42 2.2E-47 336.6 24.8 251 15-269 4-278 (291)
274 cd05051 PTKc_DDR Catalytic dom 100.0 8.8E-43 1.9E-47 336.9 24.3 251 15-268 4-292 (296)
275 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.8E-42 6E-47 340.3 28.1 259 13-278 7-297 (328)
276 PRK13184 pknD serine/threonine 100.0 1.3E-42 2.9E-47 374.1 27.9 252 15-267 1-283 (932)
277 PHA03210 serine/threonine kina 100.0 3.9E-43 8.6E-48 365.4 23.0 262 12-276 144-461 (501)
278 KOG0608 Warts/lats-like serine 100.0 6E-44 1.3E-48 357.5 15.8 258 15-274 628-933 (1034)
279 cd06633 STKc_TAO3 Catalytic do 100.0 2.4E-42 5.2E-47 338.2 26.8 258 12-276 17-280 (313)
280 cd05122 PKc_STE Catalytic doma 100.0 3.5E-42 7.6E-47 322.2 26.7 248 17-271 1-253 (253)
281 cd05068 PTKc_Frk_like Catalyti 100.0 3.5E-42 7.7E-47 327.0 26.9 247 15-268 5-256 (261)
282 KOG4645 MAPKKK (MAP kinase kin 100.0 2.9E-45 6.3E-50 391.2 6.3 262 12-274 1231-1499(1509)
283 cd06614 STKc_PAK Catalytic dom 100.0 1.5E-42 3.3E-47 334.1 24.7 258 12-276 15-277 (286)
284 cd05109 PTKc_HER2 Catalytic do 100.0 2.5E-42 5.4E-47 331.5 26.0 251 15-269 6-264 (279)
285 cd07879 STKc_p38delta_MAPK13 C 100.0 1.7E-42 3.7E-47 343.5 25.6 255 13-275 12-303 (342)
286 cd05099 PTKc_FGFR4 Catalytic d 100.0 2.1E-42 4.6E-47 338.4 25.8 252 15-269 11-289 (314)
287 cd05059 PTKc_Tec_like Catalyti 100.0 1.7E-42 3.7E-47 328.5 24.2 247 16-269 4-254 (256)
288 cd05045 PTKc_RET Catalytic dom 100.0 1.6E-42 3.5E-47 334.9 24.4 249 17-268 1-281 (290)
289 cd05055 PTKc_PDGFR Catalytic d 100.0 2.1E-42 4.5E-47 337.0 25.3 253 13-268 32-296 (302)
290 cd08226 PK_STRAD_beta Pseudoki 100.0 6.5E-43 1.4E-47 344.3 22.0 256 22-278 4-317 (328)
291 cd06635 STKc_TAO1 Catalytic do 100.0 3.8E-42 8.3E-47 337.2 27.2 257 14-277 23-285 (317)
292 cd05092 PTKc_TrkA Catalytic do 100.0 2E-42 4.3E-47 332.8 24.6 250 15-268 4-276 (280)
293 cd05610 STKc_MASTL Catalytic d 100.0 2.8E-42 6E-47 370.2 28.5 149 15-163 3-152 (669)
294 KOG4279 Serine/threonine prote 100.0 9.6E-44 2.1E-48 358.8 16.0 247 23-275 582-838 (1226)
295 cd05113 PTKc_Btk_Bmx Catalytic 100.0 2.8E-42 6.1E-47 327.5 25.2 247 16-269 4-254 (256)
296 cd05072 PTKc_Lyn Catalytic dom 100.0 2.8E-42 6.1E-47 327.4 25.1 247 15-268 5-256 (261)
297 cd08530 STKc_CNK2-like Catalyt 100.0 2.6E-42 5.6E-47 325.5 24.7 250 17-272 1-256 (256)
298 cd05116 PTKc_Syk Catalytic dom 100.0 2.2E-42 4.8E-47 327.9 24.3 244 23-269 2-251 (257)
299 cd05065 PTKc_EphR_B Catalytic 100.0 3.1E-42 6.7E-47 328.8 25.2 252 15-269 3-264 (269)
300 cd05050 PTKc_Musk Catalytic do 100.0 2.4E-42 5.3E-47 333.1 24.5 251 15-268 4-284 (288)
301 cd05103 PTKc_VEGFR2 Catalytic 100.0 1.1E-42 2.4E-47 345.1 22.4 252 15-269 6-335 (343)
302 cd05071 PTKc_Src Catalytic dom 100.0 4.6E-42 1E-46 327.1 25.7 247 14-268 4-255 (262)
303 cd05066 PTKc_EphR_A Catalytic 100.0 3.7E-42 8.1E-47 328.2 25.1 251 15-268 3-261 (267)
304 cd05111 PTK_HER3 Pseudokinase 100.0 4.4E-42 9.4E-47 330.5 25.6 251 15-269 6-264 (279)
305 cd05100 PTKc_FGFR3 Catalytic d 100.0 3.6E-42 7.8E-47 339.8 25.6 253 14-269 10-289 (334)
306 cd06616 PKc_MKK4 Catalytic dom 100.0 1.4E-42 3E-47 334.5 22.0 255 16-276 4-274 (288)
307 cd05097 PTKc_DDR_like Catalyti 100.0 2.5E-42 5.4E-47 334.6 23.7 251 15-268 4-291 (295)
308 PF07714 Pkinase_Tyr: Protein 100.0 1.2E-42 2.7E-47 331.1 21.2 247 19-268 2-257 (259)
309 cd05583 STKc_MSK_N N-terminal 100.0 4.4E-42 9.4E-47 331.3 25.1 259 17-276 1-273 (288)
310 cd08222 STKc_Nek11 Catalytic d 100.0 1.9E-42 4E-47 328.5 22.0 252 17-272 1-260 (260)
311 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 4.7E-42 1E-46 325.9 24.7 247 14-268 4-255 (260)
312 cd07857 STKc_MPK1 Catalytic do 100.0 9.7E-42 2.1E-46 336.4 27.7 259 17-277 1-300 (332)
313 cd05057 PTKc_EGFR_like Catalyt 100.0 7.6E-42 1.7E-46 328.1 26.1 250 15-268 6-263 (279)
314 cd05118 STKc_CMGC Catalytic do 100.0 2.6E-42 5.7E-47 330.6 22.8 251 18-272 1-283 (283)
315 cd07838 STKc_CDK4_6_like Catal 100.0 6.6E-42 1.4E-46 328.5 25.2 249 18-272 1-287 (287)
316 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 5.9E-42 1.3E-46 329.5 24.5 251 15-268 2-276 (283)
317 cd05095 PTKc_DDR2 Catalytic do 100.0 5.3E-42 1.1E-46 332.4 24.3 251 15-268 4-292 (296)
318 cd05067 PTKc_Lck_Blk Catalytic 100.0 9.2E-42 2E-46 324.0 25.3 247 14-268 4-255 (260)
319 cd05034 PTKc_Src_like Catalyti 100.0 1.6E-41 3.5E-46 321.9 26.5 248 14-268 4-256 (261)
320 cd07829 STKc_CDK_like Catalyti 100.0 4.5E-42 9.8E-47 328.8 22.7 251 18-272 1-282 (282)
321 cd05060 PTKc_Syk_like Catalyti 100.0 1.4E-41 3E-46 322.2 25.5 243 22-268 1-250 (257)
322 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.7E-41 3.6E-46 323.3 26.0 251 15-268 4-262 (268)
323 cd05107 PTKc_PDGFR_beta Cataly 100.0 5.1E-42 1.1E-46 347.5 23.7 252 15-269 36-395 (401)
324 cd05069 PTKc_Yes Catalytic dom 100.0 1.8E-41 4E-46 322.2 26.2 246 15-268 5-255 (260)
325 cd05082 PTKc_Csk Catalytic dom 100.0 1.4E-41 3E-46 322.0 25.3 241 15-268 5-251 (256)
326 cd08216 PK_STRAD Pseudokinase 100.0 4.5E-42 9.8E-47 335.2 22.5 254 19-276 5-302 (314)
327 cd06634 STKc_TAO2 Catalytic do 100.0 9.1E-42 2E-46 333.2 24.6 256 13-275 12-273 (308)
328 cd05039 PTKc_Csk_like Catalyti 100.0 1.9E-41 4.1E-46 320.8 25.8 242 15-268 5-251 (256)
329 KOG0666 Cyclin C-dependent kin 100.0 9.1E-44 2E-48 331.8 9.7 265 12-278 20-346 (438)
330 cd05115 PTKc_Zap-70 Catalytic 100.0 1.7E-41 3.7E-46 322.5 25.0 243 23-269 2-251 (257)
331 cd07830 STKc_MAK_like Catalyti 100.0 9.9E-42 2.1E-46 327.2 23.6 249 18-272 1-283 (283)
332 cd05112 PTKc_Itk Catalytic dom 100.0 3.1E-41 6.7E-46 319.1 26.5 247 16-269 4-254 (256)
333 smart00219 TyrKc Tyrosine kina 100.0 2E-41 4.4E-46 319.4 25.2 247 18-268 1-256 (258)
334 cd05047 PTKc_Tie Catalytic dom 100.0 1.3E-41 2.8E-46 325.2 24.2 242 22-269 1-264 (270)
335 cd05041 PTKc_Fes_like Catalyti 100.0 1.6E-41 3.5E-46 320.1 24.4 244 22-269 1-248 (251)
336 cd05043 PTK_Ryk Pseudokinase d 100.0 1.9E-41 4E-46 325.3 25.0 251 15-268 5-271 (280)
337 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 3.6E-42 7.9E-47 326.9 19.8 238 22-269 1-256 (258)
338 KOG0584 Serine/threonine prote 100.0 7.1E-43 1.5E-47 351.7 15.5 258 11-275 34-302 (632)
339 cd05046 PTK_CCK4 Pseudokinase 100.0 2.2E-41 4.7E-46 323.7 24.4 250 16-269 5-272 (275)
340 cd05085 PTKc_Fer Catalytic dom 100.0 4.2E-41 9.2E-46 317.0 26.0 243 22-269 1-247 (250)
341 cd05040 PTKc_Ack_like Catalyti 100.0 2.6E-41 5.7E-46 319.7 24.5 243 22-268 1-253 (257)
342 cd06618 PKc_MKK7 Catalytic dom 100.0 2.6E-41 5.7E-46 327.6 25.0 258 13-276 12-280 (296)
343 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 2.6E-41 5.7E-46 322.3 23.8 238 22-269 1-260 (262)
344 cd05576 STKc_RPK118_like Catal 100.0 9E-42 2E-46 320.7 20.2 228 27-272 4-237 (237)
345 cd05056 PTKc_FAK Catalytic dom 100.0 5.3E-41 1.1E-45 320.5 25.4 250 15-269 5-261 (270)
346 KOG0193 Serine/threonine prote 100.0 1.1E-42 2.3E-47 348.6 13.6 250 13-268 389-648 (678)
347 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 3.1E-41 6.6E-46 324.1 23.1 237 23-269 2-272 (274)
348 cd05073 PTKc_Hck Catalytic dom 100.0 1E-40 2.2E-45 317.0 26.3 248 13-268 3-255 (260)
349 cd05110 PTKc_HER4 Catalytic do 100.0 4.9E-41 1.1E-45 327.1 24.6 251 15-269 6-264 (303)
350 cd05042 PTKc_Aatyk Catalytic d 100.0 4.6E-41 9.9E-46 320.8 23.7 245 22-269 1-266 (269)
351 cd05044 PTKc_c-ros Catalytic d 100.0 3.2E-41 6.9E-46 321.3 22.0 244 22-268 1-265 (269)
352 cd05058 PTKc_Met_Ron Catalytic 100.0 8.9E-41 1.9E-45 317.0 24.8 245 22-269 1-255 (262)
353 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 6.6E-41 1.4E-45 319.9 23.8 244 22-268 1-265 (269)
354 KOG0194 Protein tyrosine kinas 100.0 8.5E-42 1.9E-46 344.0 18.4 249 16-268 157-415 (474)
355 KOG1035 eIF-2alpha kinase GCN2 100.0 3.4E-42 7.3E-47 366.3 16.0 256 12-273 475-875 (1351)
356 cd05083 PTKc_Chk Catalytic dom 100.0 1.1E-40 2.5E-45 315.4 24.4 241 15-269 5-250 (254)
357 KOG2345 Serine/threonine prote 100.0 1.8E-42 4E-47 314.4 11.4 252 15-269 20-296 (302)
358 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 7.4E-41 1.6E-45 322.3 23.1 249 18-269 6-279 (284)
359 cd05074 PTKc_Tyro3 Catalytic d 100.0 7E-41 1.5E-45 319.6 22.7 250 18-269 1-268 (273)
360 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 1.6E-40 3.5E-45 319.5 24.5 250 16-269 4-279 (284)
361 KOG1026 Nerve growth factor re 100.0 8.5E-42 1.9E-46 354.8 16.6 249 15-266 485-755 (774)
362 KOG0983 Mitogen-activated prot 100.0 1.5E-41 3.2E-46 312.3 15.5 252 17-275 93-355 (391)
363 cd08528 STKc_Nek10 Catalytic d 100.0 3E-40 6.6E-45 314.8 24.5 249 17-269 1-266 (269)
364 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1.9E-40 4.1E-45 313.6 22.6 236 22-269 1-257 (259)
365 PHA02882 putative serine/threo 100.0 4.5E-40 9.8E-45 319.3 25.7 254 12-268 8-291 (294)
366 KOG4721 Serine/threonine prote 100.0 7E-42 1.5E-46 339.4 12.6 235 19-269 127-364 (904)
367 KOG0669 Cyclin T-dependent kin 100.0 9.3E-43 2E-47 316.9 3.8 266 11-278 12-324 (376)
368 cd05086 PTKc_Aatyk2 Catalytic 100.0 8E-40 1.7E-44 312.7 24.1 244 22-268 1-264 (268)
369 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 6E-40 1.3E-44 314.4 22.5 250 16-268 4-278 (284)
370 KOG4250 TANK binding protein k 100.0 9.5E-41 2.1E-45 340.1 14.0 242 15-261 12-296 (732)
371 KOG1095 Protein tyrosine kinas 100.0 7E-40 1.5E-44 351.3 21.3 250 16-268 692-956 (1025)
372 KOG0671 LAMMER dual specificit 100.0 4.9E-41 1.1E-45 321.3 10.2 253 12-275 85-412 (415)
373 KOG1187 Serine/threonine prote 100.0 2.8E-39 6E-44 321.9 20.9 248 15-269 74-348 (361)
374 KOG0587 Traf2- and Nck-interac 100.0 2.6E-39 5.7E-44 335.2 20.6 257 12-275 15-288 (953)
375 PLN03225 Serine/threonine-prot 100.0 3.3E-39 7.1E-44 339.3 21.2 253 14-275 130-456 (566)
376 smart00220 S_TKc Serine/Threon 100.0 4.4E-38 9.6E-43 292.0 24.0 239 28-272 1-244 (244)
377 KOG0665 Jun-N-terminal kinase 100.0 4.5E-39 9.7E-44 301.7 12.9 258 13-278 14-319 (369)
378 KOG0668 Casein kinase II, alph 100.0 3.8E-39 8.3E-44 289.8 10.2 251 15-276 37-329 (338)
379 KOG1151 Tousled-like protein k 100.0 5.8E-39 1.2E-43 311.0 9.8 265 11-275 458-747 (775)
380 KOG0670 U4/U6-associated splic 100.0 6.7E-39 1.5E-43 315.7 9.9 253 12-274 428-751 (752)
381 KOG4257 Focal adhesion tyrosin 100.0 5.4E-38 1.2E-42 314.5 15.8 245 18-267 391-643 (974)
382 KOG0199 ACK and related non-re 100.0 4.4E-38 9.6E-43 318.5 13.6 257 13-273 107-372 (1039)
383 PLN03224 probable serine/threo 100.0 1.7E-36 3.7E-41 312.6 24.9 260 14-274 143-505 (507)
384 KOG0664 Nemo-like MAPK-related 100.0 2.7E-38 5.8E-43 290.7 4.2 256 17-275 54-349 (449)
385 KOG1006 Mitogen-activated prot 100.0 6.2E-38 1.4E-42 287.4 6.2 251 20-277 68-335 (361)
386 KOG4278 Protein tyrosine kinas 100.0 1.9E-36 4E-41 303.1 17.1 240 19-267 270-517 (1157)
387 KOG1094 Discoidin domain recep 100.0 1.8E-36 4E-41 302.0 16.0 249 15-267 537-798 (807)
388 KOG0196 Tyrosine kinase, EPH ( 100.0 5.1E-37 1.1E-41 314.4 12.4 250 16-269 629-887 (996)
389 PLN00113 leucine-rich repeat r 100.0 2.6E-36 5.6E-41 337.3 18.0 238 15-269 689-947 (968)
390 KOG1027 Serine/threonine prote 100.0 5E-37 1.1E-41 317.0 10.5 247 20-278 513-776 (903)
391 KOG1152 Signal transduction se 100.0 1.3E-36 2.8E-41 302.8 10.9 206 10-219 555-770 (772)
392 KOG0576 Mitogen-activated prot 100.0 5.6E-37 1.2E-41 309.7 7.1 266 3-275 3-277 (829)
393 KOG1290 Serine/threonine prote 100.0 3.4E-35 7.3E-40 288.2 19.3 132 13-149 74-222 (590)
394 KOG0200 Fibroblast/platelet-de 100.0 1.2E-33 2.5E-38 299.9 22.6 246 19-268 299-574 (609)
395 cd00180 PKc Catalytic domain o 100.0 1.2E-32 2.5E-37 248.8 22.6 212 24-270 1-215 (215)
396 KOG2052 Activin A type IB rece 100.0 2.4E-33 5.3E-38 272.8 18.9 248 13-268 208-498 (513)
397 KOG3653 Transforming growth fa 100.0 1E-33 2.2E-38 277.1 16.1 244 15-266 209-496 (534)
398 KOG1345 Serine/threonine kinas 100.0 1.5E-34 3.2E-39 265.9 8.8 257 12-277 20-295 (378)
399 KOG1025 Epidermal growth facto 100.0 1.5E-33 3.2E-38 289.9 15.4 247 18-268 698-952 (1177)
400 smart00221 STYKc Protein kinas 100.0 3.1E-32 6.7E-37 250.9 22.7 219 18-240 1-224 (225)
401 KOG1167 Serine/threonine prote 100.0 1.1E-33 2.5E-38 274.0 10.1 255 13-274 33-386 (418)
402 KOG0984 Mitogen-activated prot 100.0 5E-33 1.1E-37 247.0 12.5 210 16-233 46-268 (282)
403 PLN00181 protein SPA1-RELATED; 100.0 2.3E-32 4.9E-37 299.4 10.6 200 72-275 28-271 (793)
404 KOG0590 Checkpoint kinase and 100.0 3.5E-33 7.7E-38 293.6 3.6 263 14-277 315-593 (601)
405 COG0515 SPS1 Serine/threonine 100.0 1.3E-28 2.9E-33 234.7 25.9 255 18-275 2-281 (384)
406 KOG0603 Ribosomal protein S6 k 100.0 3E-31 6.5E-36 268.7 3.1 240 23-276 1-250 (612)
407 smart00750 KIND kinase non-cat 100.0 1.4E-29 3E-34 226.6 12.6 158 101-274 1-170 (176)
408 KOG1024 Receptor-like protein 100.0 6.7E-29 1.5E-33 238.3 15.1 251 15-268 283-550 (563)
409 PRK09188 serine/threonine prot 100.0 1.1E-28 2.4E-33 244.9 17.1 172 10-191 12-194 (365)
410 KOG1164 Casein kinase (serine/ 99.9 6.9E-26 1.5E-30 223.2 21.8 248 17-269 19-293 (322)
411 KOG0606 Microtubule-associated 99.9 9.5E-27 2.1E-31 246.4 11.1 226 9-275 76-321 (1205)
412 KOG1240 Protein kinase contain 99.9 1.2E-26 2.6E-31 245.7 7.9 255 1-269 1-291 (1431)
413 KOG1163 Casein kinase (serine/ 99.9 6.2E-25 1.3E-29 199.6 16.3 244 12-262 11-273 (341)
414 PRK10359 lipopolysaccharide co 99.9 3.3E-25 7.2E-30 206.0 11.4 174 13-211 28-215 (232)
415 KOG1165 Casein kinase (serine/ 99.9 6.9E-24 1.5E-28 200.5 18.8 241 14-261 26-287 (449)
416 cd05147 RIO1_euk RIO kinase fa 99.9 8.2E-25 1.8E-29 199.5 12.2 141 21-165 2-167 (190)
417 PF14531 Kinase-like: Kinase-l 99.9 2.1E-24 4.6E-29 206.4 14.8 232 17-260 13-288 (288)
418 KOG0590 Checkpoint kinase and 99.9 2.8E-26 6E-31 241.5 -1.0 259 15-274 19-291 (601)
419 cd05145 RIO1_like RIO kinase f 99.9 1E-23 2.2E-28 192.2 15.0 143 20-166 1-168 (190)
420 KOG4158 BRPK/PTEN-induced prot 99.9 4.9E-24 1.1E-28 205.5 10.7 188 74-263 274-504 (598)
421 PRK10345 hypothetical protein; 99.9 1.4E-22 3.1E-27 187.1 15.0 135 20-162 6-156 (210)
422 PRK12274 serine/threonine prot 99.9 2.4E-22 5.2E-27 183.6 15.5 192 18-221 4-210 (218)
423 smart00090 RIO RIO-like kinase 99.9 3.8E-21 8.1E-26 181.3 12.3 143 17-164 29-197 (237)
424 PRK14879 serine/threonine prot 99.8 2E-20 4.3E-25 172.6 14.9 137 22-164 2-143 (211)
425 KOG0195 Integrin-linked kinase 99.8 5.5E-21 1.2E-25 176.6 7.2 241 15-267 189-440 (448)
426 TIGR03724 arch_bud32 Kae1-asso 99.8 1.6E-19 3.4E-24 165.1 13.5 133 23-164 1-138 (199)
427 KOG1166 Mitotic checkpoint ser 99.8 8.5E-20 1.9E-24 197.0 13.2 234 15-267 697-947 (974)
428 cd05144 RIO2_C RIO kinase fami 99.8 1.6E-19 3.5E-24 165.4 11.6 138 18-165 17-175 (198)
429 KOG1033 eIF-2alpha kinase PEK/ 99.8 2.4E-20 5.1E-25 186.5 4.2 250 13-272 241-515 (516)
430 PRK09605 bifunctional UGMP fam 99.8 6.8E-19 1.5E-23 185.0 14.5 140 15-164 332-476 (535)
431 KOG1023 Natriuretic peptide re 99.8 1.3E-18 2.8E-23 176.7 12.2 200 70-269 1-220 (484)
432 cd05119 RIO RIO kinase family, 99.8 1.5E-18 3.2E-23 156.9 11.3 139 20-165 1-164 (187)
433 PRK01723 3-deoxy-D-manno-octul 99.8 1.1E-17 2.4E-22 157.9 14.4 138 21-164 36-191 (239)
434 KOG0606 Microtubule-associated 99.7 1.3E-18 2.9E-23 185.1 6.0 262 15-277 803-1100(1205)
435 cd05120 APH_ChoK_like Aminogly 99.7 2E-17 4.3E-22 142.2 10.2 132 20-164 2-138 (155)
436 PF03822 NAF: NAF domain; Int 99.7 8.2E-17 1.8E-21 117.6 4.5 62 299-365 2-63 (63)
437 PRK04750 ubiB putative ubiquin 99.6 6.8E-16 1.5E-20 160.3 5.6 146 13-166 117-315 (537)
438 TIGR01982 UbiB 2-polyprenylphe 99.6 5.4E-15 1.2E-19 151.3 12.1 140 22-166 123-308 (437)
439 KOG0601 Cyclin-dependent kinas 99.6 2E-15 4.3E-20 153.8 5.3 255 15-274 113-384 (524)
440 KOG1243 Protein kinase [Genera 99.6 6.8E-14 1.5E-18 144.1 16.3 171 34-216 30-201 (690)
441 cd05146 RIO3_euk RIO kinase fa 99.5 4E-13 8.8E-18 122.4 13.5 140 22-166 3-175 (197)
442 cd05151 ChoK Choline Kinase (C 99.5 1.9E-13 4.1E-18 121.2 9.7 127 21-163 3-135 (170)
443 KOG0601 Cyclin-dependent kinas 99.4 9.8E-14 2.1E-18 141.5 4.3 254 11-274 260-519 (524)
444 KOG1266 Protein kinase [Signal 99.4 4.3E-13 9.4E-18 127.6 6.8 201 70-274 121-336 (458)
445 COG3642 Mn2+-dependent serine/ 99.3 1.7E-11 3.6E-16 109.1 11.9 135 22-165 2-141 (204)
446 cd05154 ACAD10_11_like Acyl-Co 99.3 2.2E-11 4.8E-16 112.3 11.3 139 22-163 4-205 (223)
447 KOG3087 Serine/threonine prote 99.2 1.6E-10 3.5E-15 102.5 12.5 143 20-164 11-165 (229)
448 KOG3741 Poly(A) ribonuclease s 99.2 6.4E-10 1.4E-14 112.0 16.6 210 29-269 289-521 (655)
449 PF01163 RIO1: RIO1 family; I 99.1 6.1E-10 1.3E-14 101.1 12.0 127 31-164 1-155 (188)
450 PRK15123 lipopolysaccharide co 99.1 3E-09 6.6E-14 102.0 15.1 140 23-164 29-194 (268)
451 KOG2137 Protein kinase [Signal 99.0 9.4E-11 2E-15 121.6 2.6 155 122-277 106-273 (700)
452 COG4248 Uncharacterized protei 99.0 1.3E-08 2.8E-13 100.5 14.9 233 19-266 14-293 (637)
453 COG0478 RIO-like serine/threon 98.9 6.3E-09 1.4E-13 97.9 10.5 137 18-163 93-250 (304)
454 PF06293 Kdo: Lipopolysacchari 98.8 5.5E-08 1.2E-12 89.8 12.9 105 60-164 55-170 (206)
455 PF06176 WaaY: Lipopolysacchar 98.8 1.8E-07 3.9E-12 86.3 14.4 140 13-162 28-181 (229)
456 PRK09902 hypothetical protein; 98.7 4.6E-07 1E-11 83.3 13.3 137 25-163 27-178 (216)
457 COG1718 RIO1 Serine/threonine 98.6 4.7E-07 1E-11 84.5 12.1 148 13-166 42-217 (268)
458 KOG0576 Mitogen-activated prot 98.6 1.9E-09 4.2E-14 111.0 -4.3 239 16-274 242-489 (829)
459 TIGR02172 Fb_sc_TIGR02172 Fibr 98.5 1.1E-06 2.4E-11 82.3 13.0 132 22-163 7-181 (226)
460 COG0661 AarF Predicted unusual 98.5 4.1E-07 9E-12 94.5 10.4 142 22-166 131-316 (517)
461 PF01636 APH: Phosphotransfera 98.4 3.7E-06 8E-11 77.7 12.9 136 21-163 2-196 (239)
462 KOG1035 eIF-2alpha kinase GCN2 98.4 2.8E-06 6E-11 93.3 13.3 202 64-277 230-442 (1351)
463 KOG1826 Ras GTPase activating 98.3 3.6E-08 7.8E-13 109.6 -2.9 207 65-274 1278-1497(2724)
464 cd05150 APH Aminoglycoside 3'- 98.3 4.7E-06 1E-10 78.6 11.5 130 26-163 8-192 (244)
465 PF10707 YrbL-PhoP_reg: PhoP r 98.3 1.4E-05 3E-10 73.2 13.7 131 21-158 6-165 (199)
466 KOG1235 Predicted unusual prot 98.3 4.4E-06 9.5E-11 86.8 10.8 138 22-165 167-355 (538)
467 PLN02876 acyl-CoA dehydrogenas 98.2 1.4E-05 3.1E-10 88.6 14.5 81 20-102 42-130 (822)
468 COG2112 Predicted Ser/Thr prot 98.2 1.5E-05 3.3E-10 70.9 9.8 138 11-165 15-156 (201)
469 PF13095 FTA2: Kinetochore Sim 98.1 7.2E-05 1.6E-09 68.4 13.0 130 14-162 35-206 (207)
470 cd05155 APH_ChoK_like_1 Unchar 98.0 3E-05 6.6E-10 72.8 9.3 73 22-104 3-82 (235)
471 PF12260 PIP49_C: Protein-kina 97.8 0.00011 2.4E-09 66.8 8.3 97 65-165 8-112 (188)
472 PRK09550 mtnK methylthioribose 97.7 0.00056 1.2E-08 69.3 14.0 80 21-102 31-117 (401)
473 cd05157 ETNK_euk Ethanolamine 97.7 0.00038 8.3E-09 65.0 11.9 75 21-103 3-79 (235)
474 cd05153 HomoserineK_II Homoser 97.7 0.00036 7.7E-09 67.7 11.0 135 21-163 19-204 (296)
475 PRK10593 hypothetical protein; 97.6 0.00092 2E-08 65.2 13.5 79 18-103 16-100 (297)
476 TIGR02721 ycfN_thiK thiamine k 97.6 0.00032 6.8E-09 66.7 9.3 132 23-164 3-175 (256)
477 KOG2270 Serine/threonine prote 97.4 0.0011 2.5E-08 65.4 10.9 139 23-165 151-314 (520)
478 TIGR00938 thrB_alt homoserine 97.4 0.00096 2.1E-08 65.2 10.7 136 21-163 27-216 (307)
479 PRK05231 homoserine kinase; Pr 97.4 0.0021 4.5E-08 63.1 12.0 135 21-163 27-216 (319)
480 KOG2268 Serine/threonine prote 97.4 0.00015 3.3E-09 70.4 3.7 136 17-162 93-249 (465)
481 cd05156 ChoK_euk Choline Kinas 97.4 0.0017 3.6E-08 63.2 11.1 76 21-104 3-85 (302)
482 KOG1093 Predicted protein kina 97.2 0.0013 2.8E-08 67.6 8.6 164 60-277 26-202 (725)
483 TIGR01767 MTRK 5-methylthiorib 97.1 0.0038 8.2E-08 62.2 11.0 85 23-109 2-94 (370)
484 COG3173 Predicted aminoglycosi 96.8 0.0094 2E-07 58.5 10.6 141 20-164 29-228 (321)
485 PF02149 KA1: Kinase associate 96.8 0.0016 3.4E-08 45.1 3.8 34 377-410 3-40 (47)
486 TIGR02906 spore_CotS spore coa 96.8 0.014 2.9E-07 56.9 11.7 29 134-163 187-215 (313)
487 cd05152 MPH2' Macrolide 2'-Pho 96.8 0.0095 2E-07 57.5 10.3 30 135-164 186-216 (276)
488 PLN02756 S-methyl-5-thioribose 96.8 0.02 4.3E-07 58.1 12.9 77 20-100 36-119 (418)
489 PLN02236 choline kinase 96.6 0.023 5.1E-07 56.6 11.7 135 21-163 41-230 (344)
490 PRK12396 5-methylribose kinase 96.5 0.016 3.4E-07 58.6 9.9 78 21-100 34-117 (409)
491 KOG1236 Predicted unusual prot 96.5 0.0084 1.8E-07 60.2 7.6 124 22-151 195-381 (565)
492 PLN02421 phosphotransferase, a 96.2 0.042 9.1E-07 54.4 11.0 134 22-163 20-212 (330)
493 TIGR02904 spore_ysxE spore coa 96.1 0.054 1.2E-06 53.0 11.2 29 135-163 197-225 (309)
494 PF01633 Choline_kinase: Choli 95.9 0.024 5.3E-07 52.1 7.1 30 135-164 144-174 (211)
495 PF03881 Fructosamin_kin: Fruc 95.9 0.063 1.4E-06 52.1 10.2 76 18-101 19-97 (288)
496 PTZ00384 choline kinase; Provi 95.4 0.12 2.6E-06 52.3 10.5 76 20-103 54-136 (383)
497 COG2334 Putative homoserine ki 95.4 0.19 4.2E-06 49.7 11.7 129 28-163 37-227 (331)
498 PRK11768 serine/threonine prot 94.8 0.74 1.6E-05 45.4 14.1 70 28-102 37-113 (325)
499 PRK06148 hypothetical protein; 94.6 0.63 1.4E-05 53.1 14.5 135 22-163 31-235 (1013)
500 COG5072 ALK1 Serine/threonine 93.5 0.31 6.8E-06 48.6 8.1 87 74-165 283-371 (488)
No 1
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-66 Score=515.33 Aligned_cols=322 Identities=49% Similarity=0.831 Sum_probs=276.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc--chHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG--GLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
....++|++++.||+|+||+|++|.+..+|..||+|+++++..... ....++.+|+.+|++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4678999999999999999999999999999999999888644322 45678889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~ 166 (417)
+.+|+|||||.||+|++++.. +++.|.+++.+|+||++|++|||++||+||||||||||++.+ +++||+|||+|....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccCCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCC-ChH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT-SPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 244 (417)
..+..+++.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3567899999999999999999998 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc-ccccCC-CCC----C----CCC--c-ccccC--CCC-------C-CCCc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK-DYKERK-FPH----E----DFD--L-KDSVG--CNV-------G-SEKY 301 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~-~~~~~~-~~~----~----~~~--~-~~~~~--~~~-------~-~~~~ 301 (417)
+++|+++||.+||.+|+|+.+|+.||||+. ...... .+. . ... . ..... +.. . ....
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLS 330 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999998 432210 000 0 000 0 00000 000 0 1347
Q ss_pred cCcchhhc-cCCCC--CCCCCCccCCCCCCCccccceeecC
Q 014849 302 LNAFDIIS-LSSGF--NLSGLFDDFNNNDAPFCNERFLSNE 339 (417)
Q Consensus 302 ~~~~~~is-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (417)
++++++++ ++++. +++++|+.... ....+|.+..
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 367 (370)
T KOG0583|consen 331 LNAYDLGSSLSTGINEALSGLFENEKE----KEEPRFASLT 367 (370)
T ss_pred cChhhhccccccccccccccccccccc----chhhhhhhcc
Confidence 88999887 78888 89998886653 1445555543
No 2
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.2e-64 Score=506.06 Aligned_cols=264 Identities=38% Similarity=0.712 Sum_probs=252.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|+.++.||+|+|++||.+++..+|+.||+|++.+..+.+....+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+|..++|..++++ +.++|.+|+.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||+.... .+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999986 7899999999999999999999999999999999999999999999999999997653 34667
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.|.||||+|+||||+.+.++. ..+||||+|||||.||.|++||...+..+.|.+|...++..|...|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 899999999999999999985 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccccccCCCC
Q 014849 255 TDPATRITVDEILRDPWFKKDYKERKFP 282 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f~~~~~~~~~~ 282 (417)
+||.+|||+++||.|+||++++.+...+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999998888776654
No 3
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.7e-65 Score=512.84 Aligned_cols=264 Identities=40% Similarity=0.770 Sum_probs=250.2
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.....|-|+++++||.|+-|.|.+|++..||+.+|||++.+..-........|.+||-||+.+.||||+++|++++++++
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 34578999999999999999999999999999999999998754455556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+|+||++||+||+++.. |+++|.+|+++|.||+.|+.|||..+||||||||+|+|||..+++||+|||+|.+-.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--- 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--- 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---
Confidence 9999999999999998875 999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
++.++.|.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.|...++.++.+|.|..|..+|+++++||
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 57799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++||+.||.+|+|.+||++|||++....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999999986544
No 4
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.8e-65 Score=490.18 Aligned_cols=264 Identities=41% Similarity=0.720 Sum_probs=237.0
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc----hHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG----LTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
....+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+..... -...+.+|++||++|+|||||+++++|
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 3455889999999999999999999999999999999999988765422 234577999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeEEeeeec
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLKISDFGL 161 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vkl~DFGl 161 (417)
..+...||||||+.||+|++++.. +.+.|+..+.+|+||+.|+.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999999999876 789999999999999999999999999999999999999876 7799999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p 238 (417)
|.+.. ......|.||||.|+||||+.++++. +.++||||+|||||.+|+|++||.+.... .+.++|.+|.+.+.
T Consensus 326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 98765 46678999999999999999877643 45889999999999999999999886544 49999999998753
Q ss_pred --CC--CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 239 --KW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 239 --~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.| +|.++++||.+||..||++|||++|+|+||||+...
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 34 589999999999999999999999999999998644
No 5
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=5e-62 Score=465.09 Aligned_cols=261 Identities=41% Similarity=0.714 Sum_probs=244.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-.+.|++.++||+|+||+|+.++.++|++.+|+|++++.++.+....+++++|..||..++||.||+++..|++++++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34578899999999999999999999999999999999999998888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+.||+|+..|.+ |.++|+.|+.|+.+|+.||.|||++||+||||||+|||||.+|+++|+||||+...- ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cC
Confidence 999999999999999985 899999999999999999999999999999999999999999999999999997432 23
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 249 (417)
+...++.|||+.|||||++.+.+|+ ..+|+|||||++|+|++|.+||.+.+...++++|.+++. ..|...|.++++|+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4566788999999999999999997 999999999999999999999999999999999999994 45555999999999
Q ss_pred HHhccCCCCCCC----CHHHHhcCcccccc
Q 014849 250 GRLLDTDPATRI----TVDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~----t~~eil~h~~f~~~ 275 (417)
+++|+.||++|. ++.+|.+||||+..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999996 79999999999864
No 6
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-61 Score=447.57 Aligned_cols=258 Identities=40% Similarity=0.718 Sum_probs=246.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.++|+..++||.|+||+|.+++++.+|..+|+|+++++.+.+....++..+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34678999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||||++||+|+.++.+ ++++|..|+.|+.||+.||+|||+++|++|||||||||||.+|++||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 99999999999999987 899999999999999999999999999999999999999999999999999997543
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
+...|.||||.|+|||++..++|. .++|+|||||++|||++|++||.+.+...+|++|..++..+|..+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 457899999999999999999996 9999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCC-----CHHHHhcCccccccc
Q 014849 252 LLDTDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 252 ~L~~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
+|+.|-.+|. ...+|+.||||+.-.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccccc
Confidence 9999999995 688999999998643
No 7
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-59 Score=461.16 Aligned_cols=263 Identities=35% Similarity=0.622 Sum_probs=244.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
..-..+|..++.||+|+|++|++|+++.+++.|||||+++..+.++...+-+.+|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567899999999999999999999999999999999999998888888899999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+|+||+++|+|.++|.+ |.|+|..++.|+.||++||+|||++|||||||||||||||.|+++||+|||.|.......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999998 999999999999999999999999999999999999999999999999999987654321
Q ss_pred C-----------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 014849 170 P-----------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238 (417)
Q Consensus 170 ~-----------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 238 (417)
. .....+.+||-.|++||++..... +..+|||+||||||.|++|.+||.+.|.--.+++|..-++.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 1 112256899999999999987665 5999999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+++.+++||+++|..||.+|+|+++|++||||..-
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 9999999999999999999999999999999999864
No 8
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=5.5e-59 Score=445.86 Aligned_cols=262 Identities=43% Similarity=0.765 Sum_probs=248.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+..||++.++||+|+||+|.+|++...|+.||||.|.++++.+....-+|+|||+||+.|+||||+++|++|+.++++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 46788999999999999999999999999999999999999998887888999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
.+||||..||+|.+++.. +.|+|.+++.+|+||++|+.|||.++|+|||||.+|||||.|+++||+|||+|.++. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999987 899999999999999999999999999999999999999999999999999998765 4
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
...+.|.||+|.|.+||++++.+|.|+.+|-|||||+||.|..|..||++.+...+.++|.+|.+.-|.. +.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHH
Confidence 5688999999999999999999999999999999999999999999999999999999999999988874 557899999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.||-.||.+|.|+++|-.|=|..=.+.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeecccc
Confidence 999999999999999999988764444
No 9
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-57 Score=437.16 Aligned_cols=261 Identities=38% Similarity=0.696 Sum_probs=240.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|+++.++..||||.+.+.+. .....+.+..||.+|+.++|||||+++++..+.+.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4568999999999999999999999999999999999998865 344577888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC------CCeEEeeeeccee
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN------WDLKISDFGLSAV 164 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~------~~vkl~DFGls~~ 164 (417)
|+|||||+||+|.++|.+ ++++|..++.++.||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999987 799999999999999999999999999999999999999865 4589999999987
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCC
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWT 241 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 241 (417)
.. +.....+.||+|.|||||++....|+ +|+|+||+|+|||++++|+.||+..+..+++..+.++.. ..|.+.
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 65 56788999999999999999999998 999999999999999999999999999999998888764 345677
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++...+|+...|+.+|..|.+..+-+.|++......
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 888999999999999999999999999999986654
No 10
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=4.2e-57 Score=447.39 Aligned_cols=262 Identities=35% Similarity=0.600 Sum_probs=237.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.+.|++++.||+|+||.||+|+.+.||+.+|+|++.++...+.+..++++.|-.+|....+|+||+||..|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 36789999999999999999999999999999999999998888889999999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc-----
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ----- 167 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~----- 167 (417)
||||++||++..+|.+ +.|+|+.++.|+.+++.|++-+|+.|++||||||+|+|||..|++||+|||||.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999999986 8999999999999999999999999999999999999999999999999999864211
Q ss_pred ---------------cCCCC-------------------------cccccccCccccccccccccCCCCChhhHHHHHHH
Q 014849 168 ---------------IRPDG-------------------------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVV 207 (417)
Q Consensus 168 ---------------~~~~~-------------------------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvi 207 (417)
...+. .....+|||.||||||+.+++|. ...|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHH
Confidence 00000 11246899999999999999985 99999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccccc
Q 014849 208 LFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKDYK 277 (417)
Q Consensus 208 l~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~~~ 277 (417)
+||||.|++||.+.++.+.+++|..-+ +..|. ..++++.+||.+||+ ||.+|. +++||++||||+.--.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 999999999999999999999998765 45554 468999999999999 999999 5999999999997443
No 11
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-56 Score=426.58 Aligned_cols=257 Identities=29% Similarity=0.550 Sum_probs=234.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK-IY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 92 (417)
..+..+.+..||+|+.|+||+|+++.|++.+|+|++... .+.....|+.+|+++++.++||+||.+|+.|.++.. ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 345788899999999999999999999999999999443 355567899999999999999999999999999995 99
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+||+|.+.+.. |+++|....+++.+++.||.|||. ++|+||||||.|||++..|.|||||||.|....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv---- 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV---- 230 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh----
Confidence 99999999999999986 899999999999999999999995 999999999999999999999999999997653
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCC-CCCCCC-CCh
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGE-YRCPKW-TSP 243 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~ 243 (417)
+....+.+||..|||||.+.+..|. .++||||||+.++|+..|+.||... +..+++..|..+. +..|.. +|+
T Consensus 231 nS~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 231 NSIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred hhhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 2367889999999999999999885 8899999999999999999999875 6778899998865 456776 999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++||..||++||.+|||+.|+++|||+++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999999999987543
No 12
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=8.8e-58 Score=413.44 Aligned_cols=260 Identities=38% Similarity=0.709 Sum_probs=237.3
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.+.+.+.|++.+.||+|.|+.||.+.+..||+.+|+|+++..+.... ..+.+.+|++|-+.|+|||||+|++.+.+...
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 35678899999999999999999999999999999999998876554 57889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DFGls~~~~ 166 (417)
.|+|+|++.|++|+.-|.+ --++|..+..+.+||++||+|||.+||+|||+||+|+||.+ ...+||+|||++....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999877765 46899999999999999999999999999999999999954 3459999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--C--CC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--W--TS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s 242 (417)
.+.......|||.|||||++...+|. .++|||+||||||.||.|++||.+.+...+|++|..+.+..|. | ++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 44566778999999999999999885 8999999999999999999999999999999999999887654 3 58
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+++++|+++||..||.+|+|+.|.|+|||+++.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999864
No 13
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-55 Score=445.81 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=245.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.-...|.+.++||+|+||+|++|..+.+++.+|||+++|..+...+..+..+.|.+|+.... ||.+++++..|++++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34678999999999999999999999999999999999999999999999999999999886 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||+.||++...+..+.++|..|+.|+..++.||.|||++||||||||.+|||||.+|++||+|||++.- ....+
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~~g 522 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMGQG 522 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCCCC
Confidence 9999999999977666679999999999999999999999999999999999999999999999999999863 33355
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
....|.||||.|||||++.+..|. .++|+|||||+||+||.|..||.+.+.++++..|...+..+|.|+|.++.+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence 678899999999999999999995 9999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCcccccc
Q 014849 252 LLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 252 ~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
+|..||++|.. +++|+.||||+..
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999994 6999999999964
No 14
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.8e-56 Score=400.69 Aligned_cols=262 Identities=37% Similarity=0.677 Sum_probs=248.1
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
....--.++|++++.||+|-||.||+|+.+.++-.||+|++.++.+.+.+...+++||++|.+.|+||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34455678999999999999999999999999999999999999988888899999999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
..+|+++||.++|+|+..+.. .+++|..+..|..|++.|+.|||.++|+||||||+|+|++.+|.+||+|||.|...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999999999983 57999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHH
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
+.+...|.|||..|.|||...+.++| ..+|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|..++.++
T Consensus 175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 175 ----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred ----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence 35677899999999999999999998 9999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++||.+||..+|.+|.+..|++.|||+...
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999998753
No 15
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-55 Score=427.39 Aligned_cols=267 Identities=38% Similarity=0.622 Sum_probs=237.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----------chHHHHHHHHHHHHhCCCCCcce
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----------GLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
....++|++++.||+|.||+|.+|++..+++.||||++++....+. .-.+++++||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3457889999999999999999999999999999999987554321 12468999999999999999999
Q ss_pred EEEEEEeC--CEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 81 LYEVLATK--AKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 81 l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
|+++..++ +++|||+|||..|.+...-..+. +++++|++|++.++.||.|||.+||+||||||.|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999765 58999999999999877665566 9999999999999999999999999999999999999999999999
Q ss_pred eeecceeeccc---CCCCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q 014849 158 DFGLSAVKEQI---RPDGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 158 DFGls~~~~~~---~~~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 231 (417)
|||.+..+... ..+..+....|||.|+|||.+.. ..|+|.+.||||+||+||.|+.|++||-+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999765322 12234455899999999999877 5688999999999999999999999999999999999999
Q ss_pred cCCCCCCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 232 KGEYRCPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 232 ~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.....+|.. ..+++++||.+||++||++|+++.+|..|||.......
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 998888866 58999999999999999999999999999999876443
No 16
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-55 Score=431.88 Aligned_cols=263 Identities=38% Similarity=0.685 Sum_probs=247.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.|-|.+.++||+|-|+.|.+|++.-||..||||++++.+.. .....++..|++.|+.++|||||+||++..+.++
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 356889999999999999999999999999999999999998864 3457789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe-cCCCCeEEeeeecceeecc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL-DENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl-~~~~~vkl~DFGls~~~~~ 167 (417)
+|+|+|+-+||+|+++|.+ ..+.|+.+++||.||+.|+.|||+..||||||||+|+.+ ..-|-|||+|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 9999999999999999986 689999999999999999999999999999999999876 567899999999997554
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (417)
++..+.+.||+..|-|||++.+..|+.+++||||||||||-|.+|++||...|..+.+..|+..+|..|...|.++++
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrd 248 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRD 248 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHH
Confidence 677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||.+||..||++|.|.+||..++|++..-.
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999999999986543
No 17
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=8.8e-56 Score=407.44 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=227.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-E-EeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV-L-ATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~-~-~~~~ 89 (417)
..-...|++.+.||+|+||.||++++..+|..+|.|.+..... +......+..|+.+|++|+|||||+++++ + +++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3445569999999999999999999999999999999986544 34456788899999999999999999983 3 4555
Q ss_pred EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHS--RG--VFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~--~g--ivHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.+++|||||.+|+|...|+. +.++|..++++|.||+.||.+||+ .. |.||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 59999999999999998853 579999999999999999999999 55 9999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP- 238 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p- 238 (417)
|++++.. .....++.+|||.||+||++...+|+ ++|||||+||++|||++-+.||.+.+..++.++|..++++ +|
T Consensus 174 L~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 9998764 33466789999999999999999997 9999999999999999999999999999999999999986 77
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...|.++..||..|+.+||.+||+. +|++++.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 6789999999999999999999987 5555543
No 18
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.1e-54 Score=430.46 Aligned_cols=258 Identities=35% Similarity=0.620 Sum_probs=240.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|-+.+.+|+|+||.||+|+.+.|.+.||||.+++.... ......+.+|++|++.++|||||.+++.|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46899999999999999999999999999999999987643 23467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|||.| +|+.++.. +.++|+.++.++.|+++||.|||+++|.|||+||+|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999986 8999999999999999999999999999999999999999999999999999986554 3446
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
+....|||.|||||++.+.+|+ ..+|.||+|||+||+++|++||......++.+.|.......|...|.++..|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6778899999999999999997 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+||.+|+|+.+++.|||++....
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhh
Confidence 999999999999999999986544
No 19
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=6.6e-53 Score=416.04 Aligned_cols=257 Identities=37% Similarity=0.702 Sum_probs=235.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+.|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34688999999999999999999999999999999998765544445677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----
Confidence 99999999999998876 7899999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+.++..+....|.+.++.+++||++
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 23456899999999999888875 8999999999999999999999999988999999999999999999999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCcccccc
Q 014849 252 LLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 252 ~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
||+.||.+||+ +++++.||||++.
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999997 7999999999863
No 20
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=7.6e-53 Score=420.52 Aligned_cols=262 Identities=40% Similarity=0.710 Sum_probs=240.0
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~ 89 (417)
...+...|++++.||+|.||.||.|+++.||+.+|+|++.+...........+.+|+++|+++. |||||++++++++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3556778999999999999999999999999999999999988765556788999999999998 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC----CCeEEeeeecceee
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN----WDLKISDFGLSAVK 165 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~----~~vkl~DFGls~~~ 165 (417)
.+|+|||+|.||+|++.|.+..++|..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999987559999999999999999999999999999999999999543 47999999999875
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--CC--C
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP--KW--T 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~ 241 (417)
.. ....++.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+......+|..+++.++ .| .
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 53 5678999999999999999988885 999999999999999999999999999999999999987553 34 4
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|..+++||++||..||.+|+|+.++|+|||++...
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 89999999999999999999999999999998653
No 21
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=3.3e-54 Score=400.56 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=219.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|+..-.+|+|+||.||+|++++||+.||||.+.-+. .++....-..|||++|++++|||+|.++++|..+.++++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 478999999999999999999999999999999985432 2333445567999999999999999999999999999999
Q ss_pred EeccCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|||+..-|.++-. ..+++++.+++|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... ++..
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99998854444433 27899999999999999999999999999999999999999999999999999986653 4556
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------C-----
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------------E----- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------~----- 234 (417)
.+.++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|++.+..+..-.|.+. .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 777899999999999999766689999999999999999999999998766655444321 0
Q ss_pred --CCCC----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 235 --YRCP----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 235 --~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
++-| +..+.-+.+|+++||..||.+|++.+|++.||||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 12366788999999999999999999999999994
No 22
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-53 Score=408.60 Aligned_cols=260 Identities=33% Similarity=0.575 Sum_probs=224.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--KIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 92 (417)
..+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 567999999999999999999999999999999998763211 677899999999999999999999854444 699
Q ss_pred EEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecc-c
Q 014849 93 FVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQ-I 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~-~ 168 (417)
+.|||++||+|.+++.. + +|+|..++.|.+|+++||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 4 7999999999999999999999999999999999999999 79999999999876553 1
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGE--YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~ 245 (417)
..........|||.|||||++......+.++||||+||++.||+||+.||.. ....+..-.+.... +.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1223345678999999999998733333599999999999999999999988 44445444554443 57889999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++||.+||..||++|||++++|+|||.+....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987544
No 23
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=4.5e-53 Score=415.65 Aligned_cols=259 Identities=34% Similarity=0.534 Sum_probs=230.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AK 90 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 90 (417)
...+.|+.++.||+|+||.||+|++..||+.||+|.+..+.. +.++..-..|||.||++|+||||++|.+.+.++ ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456789999999999999999999999999999999987753 456677778999999999999999999999877 78
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
+|+|+|||+. +|.-++... +|++.+++.|++||+.||+|||++||.|||||..|||||.+|.+||+|||||++....
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999987 898888874 7999999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------CCCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------YRCP 238 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------~~~p 238 (417)
. ...++..+-|.+|+|||.+.+..-+|.++|+||+||||.||++|++.|.+.+..+...+|.+-. ..+|
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3 3346777889999999999998877899999999999999999999999999998888886421 1111
Q ss_pred -------------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 -------------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+++.+.+|+..||..||.+|.|+.++|+|+||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 123788899999999999999999999999999954
No 24
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.8e-52 Score=405.49 Aligned_cols=253 Identities=34% Similarity=0.621 Sum_probs=231.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998754433334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999875 6899999999999999999999999999999999999999999999999999865432 22
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+..+...+|...++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 356899999999999888775 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.||.+||+ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
No 25
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.3e-54 Score=417.81 Aligned_cols=262 Identities=33% Similarity=0.511 Sum_probs=229.5
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
..+.++.||.+.+.||.|+||.||+|+..++|..||||.+.+....-+ ..--.||+..|++++ |||||+|.+++.++
T Consensus 4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 346788999999999999999999999999999999999977653311 222358999999999 99999999999888
Q ss_pred C-EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 A-KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~-~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
. .+|+|||||+. .|+.+++. ..|+|..++.|+.||+.||+|+|.+|+.|||+||||||+..+..+||+|||+|+-.
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 99999999976 89999976 57999999999999999999999999999999999999998889999999999865
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------ 233 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 233 (417)
. .....+.++.|.+|+|||++...++++.++|+|++|||++|+++-++.|.+.+..+.+-+|+.-
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 4 3456677889999999999999999999999999999999999999999999888877777531
Q ss_pred -------CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 -------EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 -------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+.+| +..++++.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 12222 125889999999999999999999999999999986443
No 26
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=8.5e-54 Score=392.73 Aligned_cols=268 Identities=38% Similarity=0.687 Sum_probs=238.8
Q ss_pred CCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----cchHHHHHHHHHHHHhC-CCCCcc
Q 014849 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----GGLTAHVKREISIMSRL-RHPNIV 79 (417)
Q Consensus 6 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l-~HpnIv 79 (417)
+.......+..+|+-.+.||.|..+.|..|.++.||+.+|+|+++...-.. ..+.+.-.+|+.||+++ .||+|+
T Consensus 7 pd~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II 86 (411)
T KOG0599|consen 7 PDKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII 86 (411)
T ss_pred cchhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence 444555678899999999999999999999999999999999997532211 22445667899999998 599999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 80 KLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 80 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+++++++++..+++|+|.|+.|+|+|++.. -.++|.+++++++||++|+.|||.++|+||||||+|||+++|-++||+|
T Consensus 87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred EeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEec
Confidence 999999999999999999999999999987 5799999999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccc------cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK------KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~------~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 232 (417)
||+|+... ++..+...||||.|.|||.+.. .|| +..+|+|+||||+|.||+|.+||.....+-|.+.|..
T Consensus 167 FGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 167 FGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred cceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 99998654 5678889999999999999853 355 4889999999999999999999999998999999999
Q ss_pred CCCC--CCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 GEYR--CPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 ~~~~--~p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|++. .|.| +|..+++||++||+.||.+|+|++|+|.||||.....
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 9875 4777 4788999999999999999999999999999975443
No 27
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=6.4e-52 Score=407.86 Aligned_cols=251 Identities=38% Similarity=0.640 Sum_probs=227.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||+||+|++..+|+.||+|++.+..........++.+|+.+|+.++||||+++++++.+.+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99998876 6899999999999999999999999999999999999999999999999999864221 22334567899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..|+ .++||||+||++|+|++|..||...+.......+..+...+|...++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999888775 8999999999999999999999999988888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014849 261 I-----TVDEILRDPWFKKD 275 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~~ 275 (417)
| ++.++++||||+..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999864
No 28
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=8.7e-53 Score=422.81 Aligned_cols=265 Identities=45% Similarity=0.787 Sum_probs=249.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...+-++-|.+.++||+|.|++|.+|++..||..||||++++..... .....+.+|+++|+.++|||||++++++.++.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34567899999999999999999999999999999999999876433 33456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+.+|++++++.+ ++..+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||+|.++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999999999987 899999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (417)
....+.+.||+|.|.|||++.+..|+|+.+|+||+|++||.|+.|.+||++.+..++......+.+.+|-..+.+..+|
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 5678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
|+++|.++|.+|++.++|+.|.|....+..
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999866554
No 29
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=3.4e-52 Score=381.22 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=227.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.||...+.||+|+||.||+|++..||+.||||.+..... +.+......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 589999999999999999999999999999999987653 4455667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++. +|...|+. ..++...++.|+.+++.||+|||++.|.||||||.|+|++++|.+||+|||+|+.+.. ++..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~--p~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS--PNRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC--CCcc
Confidence 99976 89999986 5799999999999999999999999999999999999999999999999999998765 3344
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 234 (417)
....+-|.+|+|||.+.+...+|..+|+||.|||+.||+.|.+-|.+.+..+....|.+.-
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 4555889999999999988777899999999999999999999999998888777776420
Q ss_pred ---CCCC------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ---YRCP------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ---~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.| ...++++.+|+.+||..||.+|+|+.|+++|+||+..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 0111 1237888999999999999999999999999999874
No 30
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=2e-51 Score=407.75 Aligned_cols=257 Identities=32% Similarity=0.590 Sum_probs=233.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..-.++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 344678999999999999999999976655 6899999987655445556778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
.|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 9999999999999999976 6899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
...+.+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+....+.++..+...+|...+++++++|
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 23467899999999999887774 89999999999999999999999999888999999998889999999999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 250 GRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
++||+.||.+|+ |++++++||||++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999996 8999999999986
No 31
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=3.3e-52 Score=401.38 Aligned_cols=262 Identities=31% Similarity=0.488 Sum_probs=235.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++.+.||+|.-|+||+|+.+.++..+|+|+++++......-..++..|-.||+.++||.++.||..+++....|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 56799999999999999999999999999999999999887766678888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc----
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ---- 167 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~---- 167 (417)
||||+||+|..+..+ +.++++.|+.|+.+++.||+|||..|||+||||||||||.++|++.|+||.||.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999998875 5799999999999999999999999999999999999999999999999998753100
Q ss_pred -----------------------------c-C--------------------CCCcccccccCccccccccccccCCCCC
Q 014849 168 -----------------------------I-R--------------------PDGMLHTLCGTPAYVAPEILAKKGYDGA 197 (417)
Q Consensus 168 -----------------------------~-~--------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~ 197 (417)
. . .+......+||-.|+|||++.+.|+. .
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-s 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-S 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-c
Confidence 0 0 00122346899999999999999985 9
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CChHHHHHHHHhccCCCCCCCC----HHHHhcCcc
Q 014849 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW--TSPDLKWFIGRLLDTDPATRIT----VDEILRDPW 271 (417)
Q Consensus 198 ~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~h~~ 271 (417)
++|+|+|||.+||||.|..||.+.+..+.+.+|......+|.. .+..+++||+++|.+||++|+. +.||++|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 9999999999999999999999999999999999888877754 5789999999999999999998 999999999
Q ss_pred cccccc
Q 014849 272 FKKDYK 277 (417)
Q Consensus 272 f~~~~~ 277 (417)
|+.-..
T Consensus 395 F~gVnW 400 (459)
T KOG0610|consen 395 FEGVNW 400 (459)
T ss_pred ccCCCh
Confidence 986433
No 32
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-51 Score=397.42 Aligned_cols=261 Identities=31% Similarity=0.492 Sum_probs=231.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.+.|++...||.|.-+.||+|+.+.+++.||||+++.+++... .+.+++|++.|+.++||||++++..|.....+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 346789999999999999999999999999999999999987554 788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||.||.+|++.+.+.. ..++|..+..++++++.||.|||.+|-||||||+.||||+++|.|||+|||.+.......
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999975 579999999999999999999999999999999999999999999999999987543322
Q ss_pred CC-C-cccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC------
Q 014849 170 PD-G-MLHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK------ 239 (417)
Q Consensus 170 ~~-~-~~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~------ 239 (417)
.. . ...+..|||+|||||++. ..||+ .|+||||+|+...||.+|..||..-.++.+...-.++.++.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 11 1 226789999999999954 45786 9999999999999999999999998888877766666665432
Q ss_pred ----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 ----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.++..++.+|..||+.||.+|||++++|+|+||++..
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3467889999999999999999999999999998643
No 33
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=7.1e-51 Score=406.86 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=224.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP---- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~---- 170 (417)
||++||+|.+++.+ +.+++.+++.++.|++.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999875 7899999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 171 -----------------------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 171 -----------------------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
.....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112356899999999999888886 8999999999999999999999999
Q ss_pred CHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCC---CCCCHHHHhcCcccccc
Q 014849 222 NLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPA---TRITVDEILRDPWFKKD 275 (417)
Q Consensus 222 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~---~R~t~~eil~h~~f~~~ 275 (417)
+..+.+.++... ...+|+ ..++++++||.+|+. +|. .||+++||++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 988888888763 344454 368999999999875 444 46899999999999864
No 34
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=4e-51 Score=400.10 Aligned_cols=249 Identities=37% Similarity=0.621 Sum_probs=226.1
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999876544444466788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 7899999999999999999999999999999999999999999999999999875322 1223456789999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCC-
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRI- 261 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~- 261 (417)
|+|||++.+..|+ .++||||+||++|+|++|..||.+.+....+..+......+|...++++++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999888875 89999999999999999999999999999999999998899999999999999999999999997
Q ss_pred --CHHHHhcCcccccc
Q 014849 262 --TVDEILRDPWFKKD 275 (417)
Q Consensus 262 --t~~eil~h~~f~~~ 275 (417)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999864
No 35
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.2e-50 Score=398.75 Aligned_cols=255 Identities=32% Similarity=0.573 Sum_probs=229.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM---SRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++ +.++||||+++++++.+...+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444456777777665 456799999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|||+.|++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864221 22334
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..+....|...++++.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999887774 8999999999999999999999999988999999888888899999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
.||.+|| ++.++++||||++.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 79999999999863
No 36
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=9.8e-51 Score=400.55 Aligned_cols=250 Identities=37% Similarity=0.641 Sum_probs=226.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544445677889999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99988875 6799999999999999999999999999999999999999999999999999864221 12234457899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+......+|...++++.+||++||++||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999887774 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 014849 261 I-----TVDEILRDPWFKK 274 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~ 274 (417)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
No 37
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.3e-50 Score=398.77 Aligned_cols=251 Identities=37% Similarity=0.652 Sum_probs=226.7
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444667788999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988875 6799999999999999999999999999999999999999999999999999864221 22233456899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999887775 8999999999999999999999999988888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014849 261 I-----TVDEILRDPWFKKD 275 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~~ 275 (417)
+ ++.++++||||.+.
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999864
No 38
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1.5e-50 Score=397.76 Aligned_cols=251 Identities=35% Similarity=0.625 Sum_probs=226.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566777888888876 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998875 6899999999999999999999999999999999999999999999999999864321 2223455789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..+++..+..+....|.+.++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 899999999999999999999999999999999999988999999999999999999999999
Q ss_pred CCCH------HHHhcCcccccc
Q 014849 260 RITV------DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~------~eil~h~~f~~~ 275 (417)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 999999999763
No 39
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=1.7e-50 Score=399.04 Aligned_cols=254 Identities=29% Similarity=0.518 Sum_probs=226.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6899999999999999999999999999999999999999999999999999875432 34
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC------CCChHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK------WTSPDLK 246 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 246 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.... ...|. ..++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 567899999999999888775 89999999999999999999999988888777765432 22233 3489999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+||.+||..+|.+|||++++++||||++.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999864
No 40
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=1.6e-50 Score=403.70 Aligned_cols=258 Identities=35% Similarity=0.601 Sum_probs=225.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC---
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD--- 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 171 (417)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999875 68999999999999999999999999999999999999999999999999998643211100
Q ss_pred ---------------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC
Q 014849 172 ---------------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218 (417)
Q Consensus 172 ---------------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf 218 (417)
....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999888875 9999999999999999999999
Q ss_pred CCCCHHHHHHHHhcCC--CCCCC--CCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 219 NDPNLMAMYRKIYKGE--YRCPK--WTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 219 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
.+.+..+.+.++.... +..|. ..++++++||.+||. +|.+|++ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988888887776543 33343 358999999999997 9999998 9999999999863
No 41
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=3.4e-50 Score=395.59 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=230.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP-NIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 95 (417)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.+++.++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999876554444566788899999999765 5888999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999998875 6899999999999999999999999999999999999999999999999999864221 22334
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+.......|...++++.+++++||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999888775 8999999999999999999999999989999999988888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCcccccc
Q 014849 255 TDPATRITV-----DEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~t~-----~eil~h~~f~~~ 275 (417)
+||.+|++. +++++||||+..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999863
No 42
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-52 Score=390.09 Aligned_cols=263 Identities=38% Similarity=0.656 Sum_probs=246.4
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+...-++.|+..++||+|+||+|-+|+.+.||+.+|||+++++-+......++-..|-++|+.++||.+..|...|++..
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 33557889999999999999999999999999999999999998887777888889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+++||||+.||+|+..+.+ ..++|+.++.|-.+|++||.|||+++|++||||.+|+|||.+|++||+|||++. ...
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK--E~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK--EEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch--hcc
Confidence 99999999999999999987 789999999999999999999999999999999999999999999999999985 333
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (417)
..+....+.||||.|.|||++....| |.++|+|.+||++|||++|++||...+...++.-|..++..+|..+|++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 45567789999999999999999988 59999999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 249 IGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 249 i~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+..+|..||.+|. .+.||++|+||...
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999998 58999999999864
No 43
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=2e-50 Score=396.80 Aligned_cols=250 Identities=33% Similarity=0.586 Sum_probs=226.4
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|+.+++.+ +||||+++++++.++..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554444556777899999866 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999988865 6899999999999999999999999999999999999999999999999999864322 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..|+ .++|||||||++|+|++|+.||...+....+..+..+....|.+.++++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887775 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 014849 260 RI-------TVDEILRDPWFKK 274 (417)
Q Consensus 260 R~-------t~~eil~h~~f~~ 274 (417)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999975
No 44
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=3.5e-50 Score=388.19 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=221.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+|+.++||||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655443344567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999887753 3689999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||...+. ......+.......+...++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999888775 899999999999999999999987543 23334444455566777899999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
++||+.||.+||| ++++++||||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999864
No 45
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=3.9e-50 Score=404.15 Aligned_cols=259 Identities=33% Similarity=0.553 Sum_probs=222.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998766555555678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999876 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 170 ----------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 170 ----------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 00012346899999999999888875 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCChHHHHHHHHhc--cCCCCCCCCHHHHhcCcccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYK--GEYRCPK--WTSPDLKWFIGRLL--DTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+|++|..||...+..+...++.. .....|. ..++++.+||.+|+ ..+|..|+|+++++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999998887766666653 2344444 46899999999965 4555569999999999999863
No 46
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=7.9e-50 Score=386.27 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=214.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4689999999999999999999999999999999975432 22345677999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999976 89888864 4589999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------ 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 234 (417)
.....+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 33456789999999998765444589999999999999999999999877666554443210
Q ss_pred -CCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 -YRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 -~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+..| ...++++.+||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2357889999999999999999999999999998
No 47
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-51 Score=407.21 Aligned_cols=257 Identities=33% Similarity=0.568 Sum_probs=231.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-..+|.....+|+|+.|.||.|....+++.||||.++.....+ .+-+.+|+.+|+..+|+|||++++.|.-.+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 445678999999999999999999999999999999999876544 56688999999999999999999999888999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+++......
T Consensus 346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-- 423 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-- 423 (550)
T ss_pred EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence 999999999999999999899999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCC--CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA-MYRKIYKGE--YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~--~~~p~~~s~~~~~l 248 (417)
....+.+|||+|||||++..+.| |+++||||||++++||.-|.+||-..++.. +|.--..|. +..|...|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 36678899999999999999998 599999999999999999999998666554 444333443 45678899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+.+||+.||.+|+|+.|+|+||||+.
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999954
No 48
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=3.6e-50 Score=404.28 Aligned_cols=258 Identities=34% Similarity=0.582 Sum_probs=223.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.++..+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
|||+||+|.+.+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999876 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 170 ----------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 170 ----------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00112345899999999999988886 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYKG--EYRCP--KWTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
+|++|++||.+.+..+...++... ....| ...++++.+||.+|+ .+|.+|++ ++++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999998877777666543 23334 346999999999986 59999997 9999999999864
No 49
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=5.6e-50 Score=393.04 Aligned_cols=251 Identities=33% Similarity=0.608 Sum_probs=223.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876543333455667788888754 899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998875 6899999999999999999999999999999999999999999999999999863221 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+...+...+.......|.+.+.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 899999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccc
Q 014849 260 RITV-DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-~eil~h~~f~~~ 275 (417)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9997 689999999764
No 50
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=2.1e-50 Score=397.25 Aligned_cols=251 Identities=37% Similarity=0.647 Sum_probs=226.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544444567788999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|...+.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998875 679999999999999999999998 7999999999999999999999999999864321 1223345689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|...++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887775 899999999999999999999999988888888888888889999999999999999999999
Q ss_pred CC-----CHHHHhcCcccccc
Q 014849 260 RI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 260 R~-----t~~eil~h~~f~~~ 275 (417)
|+ ++.++++||||+..
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 99999999999864
No 51
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=5.8e-50 Score=401.65 Aligned_cols=262 Identities=33% Similarity=0.500 Sum_probs=229.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999998755444444566789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||++||+|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 245 (417)
...+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+|. ..|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 234568999999999987543 34589999999999999999999999999888888887643 44454 468999
Q ss_pred HHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
.+||++||+.+|.+ |+|++++++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999988 9999999999999863
No 52
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=2.8e-50 Score=399.23 Aligned_cols=258 Identities=36% Similarity=0.621 Sum_probs=229.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765545455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999876 689999999999999999999999999999999999999999999999999987543321
Q ss_pred ----------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 014849 170 ----------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY 227 (417)
Q Consensus 170 ----------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~ 227 (417)
........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 01123456799999999999888775 9999999999999999999999999888888
Q ss_pred HHHhc--CCCCCCCC--CChHHHHHHHHhccCCCCCCCC-HHHHhcCcccccc
Q 014849 228 RKIYK--GEYRCPKW--TSPDLKWFIGRLLDTDPATRIT-VDEILRDPWFKKD 275 (417)
Q Consensus 228 ~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t-~~eil~h~~f~~~ 275 (417)
.++.. .....|.. .++++.+||.+||. ||.+||+ ++++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88876 44555544 49999999999997 9999999 9999999999863
No 53
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=9.5e-50 Score=392.26 Aligned_cols=255 Identities=29% Similarity=0.535 Sum_probs=229.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.|++.+.||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544444455677788888877 5899999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999998875 7899999999999999999999999999999999999999999999999999864321 12234
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...++..+.......|...++++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 467899999999999988875 8999999999999999999999999999999999988888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.||.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999998 489999999985
No 54
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=5.2e-50 Score=402.44 Aligned_cols=257 Identities=33% Similarity=0.566 Sum_probs=222.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP---- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~---- 170 (417)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999853211000
Q ss_pred ---------C--------------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 171 ---------D--------------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 171 ---------~--------------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
. ......+||+.|+|||++.+..|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 0 001135799999999999888875 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCCCC---CCHHHHhcCccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPATR---ITVDEILRDPWFKK 274 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R---~t~~eil~h~~f~~ 274 (417)
+|++|.+||.+.+..+.+.++... ....|. ..++++++||.+||. +|.+| +|+.|++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999998888877777653 344454 368999999999998 77765 59999999999985
No 55
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=7.8e-50 Score=394.15 Aligned_cols=250 Identities=31% Similarity=0.586 Sum_probs=220.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444566788999999988 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999988865 789999999999999999999999999999999999999999999999999986321 12334456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---------NLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||... .....+..+.......|...++++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 8999999999999999999999631 22235566777778889999999999999
Q ss_pred HhccCCCCCCCC------HHHHhcCccccc
Q 014849 251 RLLDTDPATRIT------VDEILRDPWFKK 274 (417)
Q Consensus 251 ~~L~~dP~~R~t------~~eil~h~~f~~ 274 (417)
+||+.||.+|+| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 799999999975
No 56
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=6.5e-50 Score=401.36 Aligned_cols=263 Identities=33% Similarity=0.522 Sum_probs=228.5
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34467899999999999999999999999999999999875544444456688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987643211 1
Q ss_pred CcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPD 244 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 244 (417)
....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++.... +..|. ..++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1234678999999999997653 34589999999999999999999999998888888887643 44454 45899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++++.+||+.+|.+ |+|++|+++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865544 8999999999999864
No 57
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=1.4e-49 Score=383.06 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.+...... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877665543 579999999999999999999999999999999999999999999999999987643211 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 356799999999999887775 89999999999999999999998876544333222110 0
Q ss_pred CCC-------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RCP-------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~p-------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..| ...|+++.+||++||++||++|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1257789999999999999999999999999998
No 58
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=1.8e-49 Score=386.32 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=211.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999976532 22244677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 577777754 5799999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhc--CCC---------C----
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYK--GEY---------R---- 236 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 236 (417)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655445899999999999999999999987532 222222211 000 0
Q ss_pred --------CCC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 --------CPK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 --------~p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|. ..++++.+|+++||+.||++|||+.|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 010 134678999999999999999999999999999864
No 59
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-50 Score=384.31 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=224.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----- 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----- 87 (417)
.+..+|...+.||+|+||.|+.|.++.||+.||||.+.... ...-...+..||+.+|+.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34567777899999999999999999999999999987432 344457888999999999999999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
-+.+|+|+|+| +.+|...|+.++ |+++.++.++.||+.||.|+|+.||+||||||.|+|++.++.+||+|||+|+...
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 35799999999 569999999876 9999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
.....+..+.++.|.+|+|||++....-++.++||||+|||+.||++|++.|.+.+....+..|..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 443455667788999999999987654446999999999999999999999988766555444421
Q ss_pred ---------CCCCCC--------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 ---------GEYRCP--------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 ---------~~~~~p--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 011111 2468999999999999999999999999999999876544
No 60
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=5.4e-50 Score=402.06 Aligned_cols=257 Identities=35% Similarity=0.566 Sum_probs=222.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 678999999999999999999999999999999999999999999999999974221000
Q ss_pred ------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc
Q 014849 170 ------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 170 ------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~ 213 (417)
......+.+||+.|+|||++.+.+++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011245899999999999888875 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChHHHHHHHHhccCCCCCCC---CHHHHhcCccccc
Q 014849 214 GYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKK 274 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~ 274 (417)
|+.||.+.+..+....+.... ...| ...++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999988777766665432 2333 346899999999977 5999999 9999999999986
No 61
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.3e-49 Score=390.46 Aligned_cols=251 Identities=34% Similarity=0.656 Sum_probs=222.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+..............|..++.. .+||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987654444445556677777765 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999998875 7899999999999999999999999999999999999999999999999999875322 1234456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+++..+.......|.+.++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccc
Q 014849 260 RITV-DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-~eil~h~~f~~~ 275 (417)
||++ .++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 9986 589999999863
No 62
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=1.5e-49 Score=390.23 Aligned_cols=251 Identities=33% Similarity=0.636 Sum_probs=226.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999888 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 2223445689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+....+..+.......|...++++.+||++||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999888875 899999999999999999999999998889899988888889899999999999999999999
Q ss_pred CCCH-----HHHhcCcccccc
Q 014849 260 RITV-----DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-----~eil~h~~f~~~ 275 (417)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999863
No 63
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=2.2e-49 Score=388.93 Aligned_cols=251 Identities=33% Similarity=0.611 Sum_probs=223.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987654333334566678888876 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+.......|.+.+.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887775 899999999999999999999999998888888887777888899999999999999999999
Q ss_pred CCCHH-HHhcCcccccc
Q 014849 260 RITVD-EILRDPWFKKD 275 (417)
Q Consensus 260 R~t~~-eil~h~~f~~~ 275 (417)
||++. ++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 99999999874
No 64
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=1.5e-49 Score=390.91 Aligned_cols=252 Identities=36% Similarity=0.645 Sum_probs=224.9
Q ss_pred eeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 21 GKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.+.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 578999999998754322 2334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|++|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999875 6789999999999999999999999999999999999999999999999999864321 223345
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+.......+..+....|...++++.+||.+||+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 57899999999999887775 89999999999999999999999999888889999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~ 275 (417)
||++|| +++++++||||+..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999863
No 65
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=1.1e-49 Score=397.77 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=225.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765444555678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999875 789999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 170 ----------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 170 ----------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 00112346899999999999988886 8999999999999999999999999
Q ss_pred CHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccc
Q 014849 222 NLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 222 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~ 275 (417)
+....+.++... ...+|. ..++++++||.+|+ .||.+|+ +++++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 888888887753 234444 36899999999987 4999998 58999999999863
No 66
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=1.5e-49 Score=390.85 Aligned_cols=251 Identities=34% Similarity=0.575 Sum_probs=222.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
++||+|+||+||+|++..+|+.||+|++.+..........++.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333455556655 46789999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998875 6899999999999999999999999999999999999999999999999999864221 2233445689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++.++.......+...++++.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999888775 899999999999999999999999999999999988888888888999999999999999999
Q ss_pred CCCH----HHHhcCcccccc
Q 014849 260 RITV----DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~----~eil~h~~f~~~ 275 (417)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9987 699999999763
No 67
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=4.1e-49 Score=388.08 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=228.8
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.|+..+.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.+++.+. ||+|+++++++.+...+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444444567778999998886 577889999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999864321 12233
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+....+..+.......|...++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887775 8999999999999999999999999988899999988888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCcccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
.||.+|++ .+++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 5799999999863
No 68
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=2.5e-49 Score=390.65 Aligned_cols=251 Identities=31% Similarity=0.588 Sum_probs=219.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 5799999999999999999999999999876554444566788899998776 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---------PNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.. .........+.......|...+..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 899999999999999999999952 122345566777778889999999999999
Q ss_pred HhccCCCCCCCC------HHHHhcCcccccc
Q 014849 251 RLLDTDPATRIT------VDEILRDPWFKKD 275 (417)
Q Consensus 251 ~~L~~dP~~R~t------~~eil~h~~f~~~ 275 (417)
+||+.||.+||| ++++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5899999999763
No 69
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=5.2e-49 Score=388.06 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=222.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.|++++.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 58899999999865432 2233567889999999995 89999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999998865 67999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHhcCCCCCCCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND----PNLMAMYRKIYKGEYRCPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~----~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (417)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.. .........+.......|...++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 22334568999999999998765456899999999999999999999964 23445566677777778888999999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+||.+||+.||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88999999999863
No 70
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=5.9e-49 Score=394.50 Aligned_cols=263 Identities=33% Similarity=0.508 Sum_probs=227.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 33458999999999999999999999999999999999875544444456678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...... ..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Cc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998754321 11
Q ss_pred CcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPD 244 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 244 (417)
....+.+||+.|+|||++...+ +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+| ...++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1234678999999999987543 34589999999999999999999999999888888887643 3334 357999
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++||.+||..+|.+ |++++++++||||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999844443 7899999999999864
No 71
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2.6e-49 Score=389.90 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=224.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999987543221 112
Q ss_pred ccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 244 (417)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ...| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2223589999999999999999999999988888888776543 2233 357899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+||.+||+ ||.+|||+++++.||||+..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999863
No 72
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=4.5e-49 Score=387.76 Aligned_cols=250 Identities=34% Similarity=0.572 Sum_probs=221.0
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433334455566655 46779999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988875 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++.++.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999888875 899999999999999999999999998899999988887777788999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014849 260 RITV----DEILRDPWFKK 274 (417)
Q Consensus 260 R~t~----~eil~h~~f~~ 274 (417)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999985
No 73
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=1.1e-48 Score=385.58 Aligned_cols=251 Identities=30% Similarity=0.568 Sum_probs=220.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 5799999999999999999999999999887654445567788999999888 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988875 7899999999999999999999999999999999999999999999999999864221 2234456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-------PNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
|+.|+|||++.+..|+ .++|||||||++|+|++|..||.. ......+..+.......|...++.+.++|++|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999888775 899999999999999999999953 22334566666677788888999999999999
Q ss_pred ccCCCCCCCC------HHHHhcCcccccc
Q 014849 253 LDTDPATRIT------VDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~t------~~eil~h~~f~~~ 275 (417)
|+.||.+|++ ++++++||||+..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999997 5799999999864
No 74
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=7.5e-49 Score=385.37 Aligned_cols=250 Identities=34% Similarity=0.582 Sum_probs=221.4
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765444333445555654 67889999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988875 6799999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+.......|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 889999999999999999999999998899999988888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014849 260 RITV----DEILRDPWFKK 274 (417)
Q Consensus 260 R~t~----~eil~h~~f~~ 274 (417)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999975
No 75
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.6e-49 Score=373.59 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=225.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 91 (417)
-.+.|+.+..|++|+||.||+|+++.|++.||+|.++.++ .+.++.-.-.|||.+|.+++|||||.+-++.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3567999999999999999999999999999999998776 45566666779999999999999999999975 44579
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|||||+. +|..++.. .++...+++.+..|+++|++|||.+.|+||||||.|+|++..|.+||+|||+|+....
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-- 229 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-- 229 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC--
Confidence 999999977 89999976 5899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------- 233 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 233 (417)
+-...+..+-|.+|+|||.+.+..-++.++|+||+|||+.||+++++.|.+....+...+|.+-
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3344566788999999999998776679999999999999999999999998888777777531
Q ss_pred ---CCCCCC-----------C--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---EYRCPK-----------W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---~~~~p~-----------~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...+++ + .|....+|+..+|..||.+|.|++|.|+|+||.+...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 011111 1 3588899999999999999999999999999997544
No 76
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=2.3e-49 Score=390.53 Aligned_cols=250 Identities=36% Similarity=0.595 Sum_probs=219.3
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
||+|+||+||+|++..+|+.||+|++.+..........+..+|..++..+ +||||+++++++.+...+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999876544333345556677777665 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988875 7899999999999999999999999999999999999999999999999999864321 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC-CChHHHHHHHHhccCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW-TSPDLKWFIGRLLDTDPA 258 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~li~~~L~~dP~ 258 (417)
|+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+++.++..+....|.. .++++.+||++||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765544589999999999999999999999999999999998888777754 689999999999999999
Q ss_pred CCC----CHHHHhcCcccccc
Q 014849 259 TRI----TVDEILRDPWFKKD 275 (417)
Q Consensus 259 ~R~----t~~eil~h~~f~~~ 275 (417)
+|| ++.++++||||+..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HCCCCCCCHHHHhcCccccCC
Confidence 998 79999999999853
No 77
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1.8e-48 Score=383.90 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=209.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK-----AKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 91 (417)
||++.+.||+|+||.||+|++..+|+.||||.+..... ......++.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999875322 222345688999999999999999999987543 358
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888875 6799999999999999999999999999999999999999999999999999875322111
Q ss_pred -CCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Q 014849 171 -DGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--------------- 232 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 232 (417)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122245689999999999865 445 5899999999999999999999987664432221110
Q ss_pred -----------CCCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 233 -----------GEYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 233 -----------~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...+. .+..++++.++|.+||+.||++|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 02357788999999999999999999999999999753
No 78
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=3.9e-49 Score=376.00 Aligned_cols=259 Identities=32% Similarity=0.511 Sum_probs=223.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKA---- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 89 (417)
+..|+..+.||+|+||+||+|+++.+|+.||+|.+..+... ++......||+.+|+.++|+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688888999999999999999999999999999877532 455667789999999999999 999999998887
Q ss_pred --EEEEEEeccCCCChHHHHhc-C----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 --KIYFVMEFAKGGELFAKISK-G----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 --~~~lV~E~~~gg~L~~~i~~-~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.+|+|+||++- +|..++.. + .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89998875 2 5888899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------- 233 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 233 (417)
+...- +.....+.++|.+|+|||++.+..+++..+||||+|||++||++++..|.+....+....|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85432 3344677889999999999998866679999999999999999999999998877776666431
Q ss_pred ---------CCCCCCCC------------ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---------EYRCPKWT------------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---------~~~~p~~~------------s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...+|.|. +++..+++.+||+.+|.+|+|+..++.||||+....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11223332 358899999999999999999999999999987543
No 79
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=4.8e-49 Score=386.29 Aligned_cols=250 Identities=35% Similarity=0.623 Sum_probs=223.4
Q ss_pred eEEeeeCceEEEEEEE---ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRN---VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||+||++++ ..+|+.||+|++.+.... .....++.+|+.+|+.++||||+++++++.+...+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 368899999999875432 222456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999875 6799999999999999999999999999999999999999999999999999865332 22334567
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+||+.|+|||++.+.+++ .++|||||||++|+|++|+.||...+.......+.......|...++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999887774 8999999999999999999999999988888889888888899999999999999999999
Q ss_pred CCCCC-----HHHHhcCcccccc
Q 014849 258 ATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 258 ~~R~t-----~~eil~h~~f~~~ 275 (417)
.+||| +++++.||||+..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7889999999863
No 80
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.2e-48 Score=384.68 Aligned_cols=250 Identities=34% Similarity=0.584 Sum_probs=220.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998765433333344555544 56789999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 6799999999999999999999999999999999999999999999999999864321 2334456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+..+++..+.......++..++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 899999999999999999999999998899999888877778888999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 014849 260 RITVD----EILRDPWFKK 274 (417)
Q Consensus 260 R~t~~----eil~h~~f~~ 274 (417)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99865 8999999975
No 81
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=1.8e-48 Score=375.21 Aligned_cols=248 Identities=31% Similarity=0.456 Sum_probs=214.8
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||+||+|.+..+|+.||+|.+.+...........+..|+.+|+.++||||+++++++.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999876544333346678899999999999999999999999999999999999999
Q ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 104 FAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 104 ~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
.+.+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 88773 246999999999999999999999999999999999999999999999999998654321 12234567
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|...++++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999988775 899999999999999999999976532 3344455555566677789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~ 274 (417)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999976
No 82
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=2.9e-48 Score=374.76 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=220.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999987654433334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999888753 4699999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+... ....+.......|...++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 3456899999999999877765 88999999999999999999998765533 233344444556677899999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 250 GRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
.+||+.||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999986
No 83
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=9.2e-48 Score=379.57 Aligned_cols=255 Identities=23% Similarity=0.413 Sum_probs=218.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+|..+|+|++.... ......++.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997642 233456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 999999999999976 6799999999999999999999986 699999999999999999999999999865422 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..++...+...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 33456799999999999887775 8999999999999999999999876655443322110
Q ss_pred ---------------------------C-CCC-CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 ---------------------------E-YRC-PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ---------------------------~-~~~-p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
. ... ....++++++||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 000 113578899999999999999999999999999998643
No 84
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=7.8e-48 Score=380.19 Aligned_cols=259 Identities=31% Similarity=0.509 Sum_probs=221.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++.+....+......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC---CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP---KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 244 (417)
....+||+.|+|||++.. .+..+.++||||+||++|+|++|+.||.+.+..+.+.++.... +..| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233579999999999873 2334589999999999999999999999988888887776533 3333 346899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++||++||..++++ |++++++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999664444 8899999999999753
No 85
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-50 Score=391.02 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=231.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...-...|...+.||+|+||.||+|.+..|++.||||+++.+... ...+.+.+|+.+|..+++|||.++|+.+.....
T Consensus 8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 344456788889999999999999999999999999999987643 347789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISKGRF-SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l-~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|++||||.||++.+.++.+.+ +|.++..++++++.|+.|+|+++.+|||||+.|||+..+|.+|++|||.+......
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech-
Confidence 9999999999999999998665 99999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
.....+.+|||.||||||+...+|+ .++||||||++.+||++|.+|+.+..++...--|-+..+ ..-..+|+.+++|
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred -hhccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence 2334899999999999999988997 999999999999999999999999887655544444333 2334679999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|..||+.||+.|||+.++|+|+|++...
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999999999999999999998633
No 86
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=5.1e-48 Score=396.07 Aligned_cols=251 Identities=31% Similarity=0.435 Sum_probs=207.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK------ 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------ 88 (417)
.++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999885432 2335799999999999999999887432
Q ss_pred --CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeee
Q 014849 89 --AKIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFG 160 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFG 160 (417)
..+++||||+++ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 257799999976 6766553 25799999999999999999999999999999999999999765 69999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------- 233 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 233 (417)
+|..... .....+.+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+.+.++...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9975432 223345678999999999876544459999999999999999999999987766555444321
Q ss_pred ----------CC------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 ----------EY------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ----------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. .+|...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 12345678999999999999999999999999999998643
No 87
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-49 Score=382.90 Aligned_cols=329 Identities=28% Similarity=0.376 Sum_probs=260.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-...|+..|+||+|+||.||.|+-+.||+.+|+|.+++.++.+..-..-..+|-.||++++.|.||.+-..|++++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567899999999999999999999999999999999988877666677789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||..|+||+|..+|.+ | .++|+.++.|+.+|+.||.+||+++||+||+||+|||||+.|+++|+|.|||.-..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--- 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP--- 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC---
Confidence 99999999999888865 4 89999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCCCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
........+||..|||||++.+..|+ .++|+|||||+||+|+.|+-||.... .+++-+.+......+|..+|+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 23344555999999999999999986 89999999999999999999997643 23555566666777889999999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCcccccccccC-CCCCCCCCcccccCCCCCCCCccCcchhhccC--CCCCCC
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKKDYKER-KFPHEDFDLKDSVGCNVGSEKYLNAFDIISLS--SGFNLS 317 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~is~~--~~~~~~ 317 (417)
++|.+.+|+.||.+|. +++++.+||||++.-... .......++-.. ......-.++||-+|| .|..|.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd----p~aVyakDv~DIeqFs~VKGV~ld 493 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD----PGAVYAKDVLDIEQFSTVKGVKLD 493 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC----ccccchhhhhhhhhcccccceecc
Confidence 9999999999999998 688999999999732221 111111111100 0111123456666665 366665
Q ss_pred CCCccCCCCCCCccccceeecCCHHH-HHHHHH
Q 014849 318 GLFDDFNNNDAPFCNERFLSNETPEK-ILEKVE 349 (417)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~ 349 (417)
.-.+++..+.+..+-+.-|+++-+++ +.+.++
T Consensus 494 ~~D~~fy~~F~tg~vsipWQnE~~ET~~f~eln 526 (591)
T KOG0986|consen 494 DTDTDFYKNFATGSVSIPWQNEMIETECFEELN 526 (591)
T ss_pred cccHHHHHhccCCcccchHHHHHHHhhhHHHhh
Confidence 55555544332223344445555555 555554
No 88
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.9e-47 Score=373.06 Aligned_cols=257 Identities=26% Similarity=0.483 Sum_probs=215.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||.||+|++..+++.||+|.+..... ........+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999976542 22244677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Ccc
Confidence 999976 78777754 4589999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
.....++|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2334578999999999876554468999999999999999999999887765544443221
Q ss_pred CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
....| ...++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23578899999999999999999999999999998653
No 89
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.4e-47 Score=398.16 Aligned_cols=261 Identities=32% Similarity=0.490 Sum_probs=228.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 4568999999999999999999999999999999999876432 233566789999999999999999998775432
Q ss_pred -----EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 90 -----KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 90 -----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
.+++||||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998853 46899999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCP 238 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p 238 (417)
|++.............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999765433333344567899999999999888775 999999999999999999999999998888888776654 467
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++++.+++.+||+.||.+|||+.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7789999999999999999999999999999998753
No 90
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.9e-47 Score=368.72 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=209.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLA----- 86 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~----- 86 (417)
.+|++.+.||+|+||+||+|++.. +|+.||+|++..... .........+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 468899999876542 222344566788887766 6999999999875
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
....+++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999997 588888864 458999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-C------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-R------ 236 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~------ 236 (417)
.... .......+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+..+.+.++..... +
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2334566799999999999877775 899999999999999999999999887777666643210 0
Q ss_pred --------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 --------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 --------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+..++.+++|+.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012357788999999999999999999999999998
No 91
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=3.4e-47 Score=393.95 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=226.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC-CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+++|+.+|+.++|||||++++++.+.+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3455699999999999999999998877 7889999775432 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 92 YFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|+||||++||+|.+.+.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887642 468999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDL 245 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~ 245 (417)
.........+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+...++..+... .|...++++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 33222334567899999999999887775 8999999999999999999999998888888888776653 566789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+++|.+||..||++|||+++++.|||++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999874
No 92
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-47 Score=380.38 Aligned_cols=249 Identities=33% Similarity=0.554 Sum_probs=215.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS-VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-KIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 92 (417)
.....+.+.||+|+||+||+|..+ |+. ||+|++......... ...+.+|+.+|++++|||||++++++.++. ...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 445667777999999999999994 445 999999876544333 678999999999999999999999999887 799
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCC-CeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRG-VFHRDLKLENLLLDENW-DLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~g-ivHrDlkp~NILl~~~~-~vkl~DFGls~~~~~ 167 (417)
+||||+++|+|.+++.. +.++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999954 78999999999999999999999999 99999999999999998 999999999987543
Q ss_pred cCCCCcccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cC-CCCCCCCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KG-EYRCPKWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~ 243 (417)
.. .......||+.|||||++. ...|+ .++||||+|++||||+||..||.+.........+. .+ ....|...++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2233368999999999999 55776 99999999999999999999999988766555554 33 3455777899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..|+.+||..||.+||++.+|+.-
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~~ 299 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVSR 299 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence 99999999999999999999999754
No 93
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.4e-47 Score=380.54 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=212.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 578999999999999999999999999999999999976532 2233567789999999999999999999986543
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666553 458999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
.........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+.++..
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 22233456789999999999888875 889999999999999999999987765433322211
Q ss_pred --------CCCC---------CCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 --------GEYR---------CPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 --------~~~~---------~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.... .|. ..++++++||.+||+.||++|||+.|+++||||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 111 13577899999999999999999999999999986544
No 94
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=5e-47 Score=366.61 Aligned_cols=255 Identities=42% Similarity=0.724 Sum_probs=232.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||.|.+..+++.||+|++.............+.+|+.+|++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 77999999999999999999999999999999999999999999999999998754321 3
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+......++..+....|...++.++++|.+||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 456799999999998877664 8899999999999999999999988888888888888888898899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
.||.+|+ +++|+++||||+...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 999999999997643
No 95
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=1.7e-47 Score=380.87 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=215.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+.|+.++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999996543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||+.+|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MD 223 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cc
Confidence 99999999998653 34678888999999999999999999999999999999999999999999998764321 12
Q ss_pred cccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhc-CCCCCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL---MAMYRKIYK-GEYRCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~-~~~~~p~~~s~~ 244 (417)
.....+||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+.. .....+...+++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345679999999999753 34556799999999999999999999974332 222222322 233456677899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+++||.+||..||++|||+.|+++||||.+..
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998753
No 96
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=3e-47 Score=376.03 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=221.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999975 67999999999999999999999999999999999999999999999999998643211 1112
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC---CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP---KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 244 (417)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+.++.... +..| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999862 2333589999999999999999999999998888888887653 2333 246899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~ 274 (417)
+++||++||..+|.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999985
No 97
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=1.5e-47 Score=379.24 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=216.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--- 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--- 88 (417)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3567899999999999999999999999999999999976432 122345677899999999999999999987543
Q ss_pred ---CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 ---AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
...|++++++ |++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 779998888788999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC----------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---------- 235 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 235 (417)
.. ...+.+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 169 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred CC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 32 234567999999999998755456899999999999999999999988766554444322100
Q ss_pred -------------CC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 -------------RC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 -------------~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. ....++.+.+||.+||+.||.+|||+.|+++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 00 113466789999999999999999999999999998643
No 98
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=4e-47 Score=383.81 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=206.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||+++++++..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 4689999999999999999999999999999996532 3457899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~ 239 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANK 239 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccc
Confidence 99995 588888765 67999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHh---------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-------LMAMYRKIY--------------- 231 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~--------------- 231 (417)
....+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.... .......+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 4456899999999999887774 99999999999999999998874321 111111111
Q ss_pred -----------cCCCC----CCC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 232 -----------KGEYR----CPK-----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 232 -----------~~~~~----~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..... .|. ..+.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11011 111 1356789999999999999999999999999998743
No 99
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.6e-47 Score=361.85 Aligned_cols=252 Identities=37% Similarity=0.669 Sum_probs=214.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887543322 23345699999999999999999999999999999999
Q ss_pred cCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccc
Q 014849 98 AKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176 (417)
Q Consensus 98 ~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 176 (417)
+.+++|.+++. .+.+++.++..++.||+.||.+||++||+||||||+||+++.++.++|+|||++... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999998 589999999999999999999999999999999999999999999999999998753 123345556
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCC----CChHHHHHH
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKW----TSPDLKWFI 249 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~----~s~~~~~li 249 (417)
.++|+.|+|||++......+.++||||||+++|+|++|..||...+ ......+........+.. .++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7899999999998833344699999999999999999999999873 333333333322221111 237999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
No 100
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=2.9e-47 Score=376.18 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=221.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998754444444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccccccCcccccccccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC---CCChH
Q 014849 174 LHTLCGTPAYVAPEILAKK----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK---WTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~----~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 244 (417)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+..+.+.++.... ++.|. ..+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2346799999999998752 223589999999999999999999999988888888877643 33343 35889
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~ 274 (417)
+++||.+||..+|++ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 569999999999985
No 101
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.1e-48 Score=385.36 Aligned_cols=258 Identities=30% Similarity=0.537 Sum_probs=238.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK-IYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~l 93 (417)
++.|++++.+|+|+||.+++++++..++.+++|.+...+..... .....+|+.++++++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999887754433 4467899999999999999999999988888 999
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+||+||+|.+.|.. .-++|+.+..||.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|..... .
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--E 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--c
Confidence 9999999999999975 3589999999999999999999999999999999999999999999999999987654 3
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.....+..|||.||+||++.+.+|. .++|||||||++|||++-+++|...+...+..+|.++. .+.|...+.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 3477889999999999999999996 99999999999999999999999999999999999988 678899999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.||..+|..||++.++|.+|..+...
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999999887443
No 102
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=1.2e-46 Score=357.08 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=220.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+.|++++.||+|+||.||.|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1124578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD- 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~- 171 (417)
|+||++|++|.+.+.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998875 67999999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 249 (417)
......+|++.|+|||++.+..++ .++||||+||++|+|++|+.||...+......++... ....|...++.+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 111345788999999999887764 9999999999999999999999887666655555443 3456677899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999998
No 103
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-49 Score=414.29 Aligned_cols=261 Identities=32% Similarity=0.490 Sum_probs=237.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|+++++||+|+||.|.+++++.|++.||+|++++-...+....+.++.|-.+|.-.+.+.|++++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 46899999999999999999999999999999999997777777788999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||++||+|..++.+ +++||+-|+.|+..|+.||+-+|+.|+|||||||+|||||.+|++||+|||.+..... +..-.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGTVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CCcEE
Confidence 999999999999988 6899999999999999999999999999999999999999999999999997754432 12234
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCChHH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCP--KWTSPDL 245 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~ 245 (417)
..+.+|||.|++||++.. ++.+|...|+||+||++|||+.|..||...+..+.|.+|..- .+.+| ...|+++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 567899999999999863 355689999999999999999999999999999999999876 56777 5679999
Q ss_pred HHHHHHhccCCCCCCCC---HHHHhcCcccccccc
Q 014849 246 KWFIGRLLDTDPATRIT---VDEILRDPWFKKDYK 277 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t---~~eil~h~~f~~~~~ 277 (417)
++||.++|. +|..|.. ++++..||||....+
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 999999996 8889998 999999999987544
No 104
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-48 Score=374.57 Aligned_cols=263 Identities=31% Similarity=0.537 Sum_probs=242.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
......|..+.+||+|+||+|.+|..+.|.+.+|||++.++-+.+....+.-..|-++|... +-|.+++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34567899999999999999999999999999999999999887777777777888888877 46899999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+.||+|...|.+ |++.|..|..|+.+|+-||-|||++||++||||.+|||||.+|++||+|||++. +..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK--Eni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc--cccc
Confidence 9999999999999999988 999999999999999999999999999999999999999999999999999985 2333
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
.+....|.||||.|+|||++..++| |.++|+||+||+|||||+|++||++.+..++++.|......+|+.+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4556788999999999999999998 599999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~~~ 277 (417)
+..|...|.+|.. -.+|..||||+..-.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 9999999999984 478999999986433
No 105
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=8.7e-47 Score=377.19 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=214.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||.|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 467899999999999999999999999999999999976432 223356678899999999999999999987543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 6766664 358899999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+.++...-.
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456799999999999888875 899999999999999999999998776665555432100
Q ss_pred -----------C--------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 -----------R--------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 -----------~--------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .+...++++++||.+||+.||.+|||+.|+++||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 0 00112467899999999999999999999999999986544
No 106
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=7e-47 Score=364.17 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=207.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLAT-----K 88 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 88 (417)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 69999999999999999999999999999999976432 222334566777777766 69999999998764 3
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
..+++|+||+.+ +|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 88888764 35899999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------- 234 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 234 (417)
.. ........||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+......++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 2223446789999999999887775 89999999999999999999998877665555543210
Q ss_pred C----------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 Y----------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+.+..+..+.+||.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112346778999999999999999999999999998
No 107
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=7.2e-47 Score=376.36 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=212.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 567899999999999999999999999999999999976432 223356777899999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+||||+++ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5666654 358999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2233456899999999999888875 8999999999999999999999887655443322110
Q ss_pred ---------C-----CC---------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---------E-----YR---------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---------~-----~~---------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .. .+...+.++++||.+||+.||++|||+.|+++||||+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01123567899999999999999999999999999986543
No 108
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=8.3e-47 Score=373.29 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=216.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+|..+|+|++.... ......++.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999987642 233456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence 999999999999876 6799999999999999999999985 799999999999999999999999999864422 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI---------------------- 230 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---------------------- 230 (417)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 23445799999999999877764 8999999999999999999999866543332111
Q ss_pred ----------------------hcCC-CCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 231 ----------------------YKGE-YRCP-KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 231 ----------------------~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.... ...+ ...++++++||.+||+.||++|||+.|++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0100 0111 13578899999999999999999999999999998654
No 109
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=6.2e-48 Score=367.82 Aligned_cols=252 Identities=31% Similarity=0.466 Sum_probs=213.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
.=+|+..+++|+|+||.||.|...++++.||||....++-.+ -+|+.+|+.++|||||++.-+|.+..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 346999999999999999999999999999999887654322 27999999999999999998885432
Q ss_pred EEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecce
Q 014849 90 KIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSA 163 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~ 163 (417)
...+||||++. +|...+. +.+++.-.++-|..||++||.|||+.|||||||||+|||+|.+ |.+||||||.|.
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 34579999976 8988887 3689999999999999999999999999999999999999977 899999999998
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------- 233 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------- 233 (417)
..... ....++..|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+..+....|.+-
T Consensus 175 ~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 76543 33355666999999999998776679999999999999999999999998877766665431
Q ss_pred -------CCC------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 -------EYR------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.. .....++++.+|+.++|..+|.+|.|+.|++.||||.....
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111 12234899999999999999999999999999999986544
No 110
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=7.9e-47 Score=364.93 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=216.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+.+++.+.+...+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987654444445567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3699999999999999999999999999999999999999999999999999865432 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-hcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---AMYRKI-YKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..++ .++||||+||++|+|++|.+||...... .....+ .......+...++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999887775 8999999999999999999999864321 112221 1222345566889999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.+||+.||.+||| ++|+++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 999999999975
No 111
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=5.1e-47 Score=380.10 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=215.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
.|++++.||+|+||.||+|.+..+|+.||||.+.... .......++.+|+.+|+.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986532 12223567889999999999999999999998876 89
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 478777765 679999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------------ 232 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 232 (417)
........+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233457899999999998765446899999999999999999999988776655544422
Q ss_pred -----CCC---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 233 -----GEY---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 233 -----~~~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
... ......++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234578899999999999999999999999999998753
No 112
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.7e-46 Score=364.82 Aligned_cols=258 Identities=28% Similarity=0.493 Sum_probs=216.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875532 2234567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+.+ +|...+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 9999975 88887764 5689999999999999999999999999999999999999999999999999865332 12
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------ 233 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 233 (417)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567999999999876655568999999999999999999999887765544433221
Q ss_pred -CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 -EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+..| ...++++++||.+||+.||.+|||++|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01111 23578899999999999999999999999999997643
No 113
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=1.1e-46 Score=362.21 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=209.8
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||+|++..+|+.||+|.+.............+..|+.+|+.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765543333345566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 888753 3589999999999999999999999999999999999999999999999999875432 1223446799
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCC-CCCChHHHHHHHHhccC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCP-KWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~ 255 (417)
+.|+|||++.+..++ .++||||+||++|+|++|..||.+.. .......+.......+ ..+++++++||++||+.
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999999887764 89999999999999999999997643 2334444444443332 35789999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 014849 256 DPATRITV----DEILRDPWFKK 274 (417)
Q Consensus 256 dP~~R~t~----~eil~h~~f~~ 274 (417)
||++|||+ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 77889999976
No 114
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=2.4e-46 Score=361.32 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=221.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|+..+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+|+.++|+||+.+++.+.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987655444445567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999865432 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM----YRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+|++.|+|||++.+..++ .++|+||+||++|+|++|..||........ ...+.......+...++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 3455799999999999887775 899999999999999999999987655433 33334444556667889999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
.+||+.||++||| +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8999999999864
No 115
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-48 Score=361.77 Aligned_cols=254 Identities=37% Similarity=0.669 Sum_probs=221.7
Q ss_pred ccccccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE-
Q 014849 10 REVNLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA- 86 (417)
Q Consensus 10 ~~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~- 86 (417)
++..+.+.|.+ -++||-|-.|+|..|.++.||+.+|+|++.- ....+||++..-+. .|||||+++++++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 44567888988 5679999999999999999999999998743 34566888876555 5999999999974
Q ss_pred ---eCCEEEEEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEe
Q 014849 87 ---TKAKIYFVMEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKIS 157 (417)
Q Consensus 87 ---~~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~ 157 (417)
....+.+|||.++||+|+..|.. | .++|.+|..|.+||..|+.|||+.+|.||||||||+|... |..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 45679999999999999999986 3 5999999999999999999999999999999999999964 4569999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcC
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKG 233 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~ 233 (417)
|||+|.... ..+.+.+.|-||.|+|||++....|+ ...|+||+|||+|.||+|++||.... ...|..+|..|
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999997543 35678899999999999999999987 88999999999999999999997642 34688899999
Q ss_pred CCCCC--CC--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 234 EYRCP--KW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 234 ~~~~p--~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+.+| .| .|.+++++|+++|..+|.+|.|+++++.|||+...
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 87776 45 48999999999999999999999999999999753
No 116
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1.6e-46 Score=387.93 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=204.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH------PNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H------pnIv~l~~~~~~~ 88 (417)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123445677888777765 4588899988764
Q ss_pred -CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCC-------------
Q 014849 89 -AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENW------------- 152 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~------------- 152 (417)
..+|+|||++ |++|.+++.+ +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 6788888765 789999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 014849 153 ---DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229 (417)
Q Consensus 153 ---~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 229 (417)
.+||+|||++.... ......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 223457899999999999988885 899999999999999999999988776544433
Q ss_pred HhcCCCCCC----------------------------C--------------CCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 230 IYKGEYRCP----------------------------K--------------WTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 230 i~~~~~~~p----------------------------~--------------~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+.......| . ..++.+.+||.+||+.||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 321100000 0 0145577999999999999999999999
Q ss_pred cCcccccccc
Q 014849 268 RDPWFKKDYK 277 (417)
Q Consensus 268 ~h~~f~~~~~ 277 (417)
+||||++.+.
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987544
No 117
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=9.7e-46 Score=349.77 Aligned_cols=252 Identities=30% Similarity=0.555 Sum_probs=220.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~ 95 (417)
.|++.+.||.|++|.||.|.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999765432 2235568899999999999999999998764 45789999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+++++|.+.+.. ..+++.++..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999998864 3589999999999999999999999999999999999999999999999999876533 223
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
...+..|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+..+.. ..+...++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 34556789999999999887765 889999999999999999999998887777666666554 4556788999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
No 118
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=1.2e-46 Score=371.87 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=205.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 368999999999999999999853 456789999987542 222356788999999999 899999999988654
Q ss_pred -CEEEEEEeccCCCChHHHHhc----------------------------------------------------------
Q 014849 89 -AKIYFVMEFAKGGELFAKISK---------------------------------------------------------- 109 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~~---------------------------------------------------------- 109 (417)
..+|+||||++||+|.+++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 468999999999999988863
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccc
Q 014849 110 -----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184 (417)
Q Consensus 110 -----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~ 184 (417)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+..+|+.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 137778889999999999999999999999999999999999999999999987543211111223345678899
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCC
Q 014849 185 APEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA-MYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRI 261 (417)
Q Consensus 185 APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 261 (417)
|||++.+..|+ .++|||||||++|+|++ |..||.+....+ ....+..+. ...|...++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999887775 89999999999999996 999998765433 333343332 345667789999999999999999999
Q ss_pred CHHHHhc
Q 014849 262 TVDEILR 268 (417)
Q Consensus 262 t~~eil~ 268 (417)
|+.|+++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999976
No 119
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.2e-48 Score=360.25 Aligned_cols=268 Identities=31% Similarity=0.595 Sum_probs=229.7
Q ss_pred cccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 014849 13 NLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAK 90 (417)
Q Consensus 13 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 90 (417)
.+.+-|++ .++||+|++|.|--|.+..||..+|||+++++ ......++.||++++.+++ |+||++|+++|++.++
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 45566766 67899999999999999999999999999987 3345788999999999995 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~~~ 166 (417)
+|+|||-+.||.|...|.+ ..++|.+|.++.++|++||+|||.+||.||||||+|||..... .+|||||.+..-..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999999876 6799999999999999999999999999999999999996654 48999999875322
Q ss_pred c-----cCCCCcccccccCcccccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------------C
Q 014849 167 Q-----IRPDGMLHTLCGTPAYVAPEILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---------------N 222 (417)
Q Consensus 167 ~-----~~~~~~~~~~~Gt~~y~APEvl~----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---------------~ 222 (417)
. ......+.++||+-.|||||+.. ...++..+.|.||||||||.||+|++||.+. -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 1 11234567889999999999963 2233348999999999999999999999542 1
Q ss_pred HHHHHHHHhcCCCCCCC--C--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccCCCCC
Q 014849 223 LMAMYRKIYKGEYRCPK--W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283 (417)
Q Consensus 223 ~~~~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~~~ 283 (417)
...++..|..|.+.+|. | +|.++++||+.+|..||.+|.++.++++|||++....+..++.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 34578889999999985 3 6999999999999999999999999999999998766655443
No 120
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=8.6e-46 Score=359.61 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=224.4
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..-.....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 33455678999999999999999999999999999999999765432 246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...|+||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998653321
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~ 245 (417)
........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.... ...|...++.+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 1223345789999999999877664 89999999999999999999998877644333333222 23455678899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+||.+||..||++|||+.+++.||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999864
No 121
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=9e-47 Score=382.63 Aligned_cols=253 Identities=31% Similarity=0.476 Sum_probs=217.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-C-----CCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-H-----PNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-H-----pnIv~l~~~~ 85 (417)
..+..||++.++||+|+||.|-+|.+..|++.||||+++... ....+...|+.+|..|+ | -|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 345669999999999999999999999999999999998754 34678889999999997 4 3899999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CeEEeeee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW--DLKISDFG 160 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~--~vkl~DFG 160 (417)
..++++|||+|... .+|.++++. .+++...++.+++||+.||.+||+.||||.|||||||||...+ .|||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999995 499999986 5689999999999999999999999999999999999996543 69999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------- 232 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------- 232 (417)
.|+... ....+++-+..|+||||+.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 337 SSc~~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 337 SSCFES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 998754 234488899999999999999997 889999999999999999999999887776665531
Q ss_pred --------------------------------------------CCCCCCC-----------CCChHHHHHHHHhccCCC
Q 014849 233 --------------------------------------------GEYRCPK-----------WTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 233 --------------------------------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP 257 (417)
.+...|. .....+.+||++||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0001120 012456889999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q 014849 258 ATRITVDEILRDPWFKKD 275 (417)
Q Consensus 258 ~~R~t~~eil~h~~f~~~ 275 (417)
.+|+|+.++|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999853
No 122
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.2e-45 Score=354.76 Aligned_cols=252 Identities=32% Similarity=0.526 Sum_probs=209.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999876432 23335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence 997 578887753 4689999999999999999999999999999999999999999999999999865432 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2334567899999999876554458999999999999999999999876543322221110
Q ss_pred -CC---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 -EY---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 -~~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. ......++++.++|++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 0122358899999999999999999999999999998
No 123
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=4.3e-46 Score=364.30 Aligned_cols=246 Identities=25% Similarity=0.465 Sum_probs=195.0
Q ss_pred eeEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014849 21 GKIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIYFVME 96 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E 96 (417)
++.||+|+||.||+|++. .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++.+ ...+|+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 477899999986543 23457789999999999999999999854 467899999
Q ss_pred ccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeeecc
Q 014849 97 FAKGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLS 162 (417)
Q Consensus 97 ~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFGls 162 (417)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777642 258999999999999999999999999999999999999 45678999999999
Q ss_pred eeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHhc
Q 014849 163 AVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AMYRKIYK 232 (417)
Q Consensus 163 ~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 232 (417)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 1223445789999999999987655568999999999999999999999643210 11111110
Q ss_pred ----------------------------CCCC----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 233 ----------------------------GEYR----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 233 ----------------------------~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.... .....++++.+||.+||++||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 001125678999999999999999999999999998
No 124
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.7e-45 Score=357.75 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=224.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++.+.....+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 3455789999999999999999999999999999999976432 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||++|++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 169 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--Q 169 (296)
T ss_pred EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--c
Confidence 99999999999999998888999999999999999999999999999999999999999999999999988654321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 248 (417)
......+|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+.......+.... ...|...++.+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 123345789999999999877764 89999999999999999999999887665544444332 23455678899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|.+||..||++|||+.+++.||||+...
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999998543
No 125
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=1.4e-45 Score=351.01 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=219.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc------cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR------GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
+|.+++.||+|+||.||.|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6889999999999999999999999999999987543321 1234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
.++|+||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 679999999999999999999999999999999999999999999999999987553211
Q ss_pred C----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 170 P----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 170 ~----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
. ........|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+......++... ....|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112345689999999999877765 8899999999999999999999887665555554443 33556677899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 126
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=1.5e-45 Score=360.36 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=226.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765544345667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC--
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~-- 170 (417)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 4699999999999999999999999999999999999999999999999999764322110
Q ss_pred -------------------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 014849 171 -------------------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA 225 (417)
Q Consensus 171 -------------------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~ 225 (417)
........||..|+|||++.+..+ +.++|||||||++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011123468999999999987776 489999999999999999999999888887
Q ss_pred HHHHHhcCCCCCCCC--CChHHHHHHHHhccCCCCCCCC----HHHHhcCcccccc
Q 014849 226 MYRKIYKGEYRCPKW--TSPDLKWFIGRLLDTDPATRIT----VDEILRDPWFKKD 275 (417)
Q Consensus 226 ~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~h~~f~~~ 275 (417)
.+.++.......|.. .++.+.++|.+||..||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666655554 5899999999999999999999 9999999999864
No 127
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.4e-45 Score=360.21 Aligned_cols=253 Identities=24% Similarity=0.441 Sum_probs=215.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|..+|+|.+.... ......++.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----~~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc----ccc
Confidence 99999999999976 789999999999999999999997 599999999999999999999999999986432 223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 234 (417)
..+.+|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 3456899999999998776664 89999999999999999999997665444333222110
Q ss_pred ------------------CCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ------------------YRCP-KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ------------------~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...| ...++++++|+.+||..||++|||+.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0111 1257789999999999999999999999999999864
No 128
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=1.9e-45 Score=355.74 Aligned_cols=263 Identities=30% Similarity=0.469 Sum_probs=224.7
Q ss_pred CccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 7 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.+++.....+.|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 45566677789999999999999999999999999999999987542 233567888999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..+.+|+||||++|++|...+.+ +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999887753 5789999999999999999999999999999999999999999999999998864
Q ss_pred ecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---C
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---R 236 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~ 236 (417)
... .........|++.|+|||++.+ ..+ +.++|||||||++|+|++|.+||...+....+.++..... .
T Consensus 160 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 160 NVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ccc--cccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 322 1122344568999999999853 233 4789999999999999999999988776666666654432 3
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|...+.++.++|++||..||++||+++++++||||...
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 355678899999999999999999999999999999754
No 129
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-48 Score=385.45 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=232.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+-|+|+-.||.|+||+||+|.+++++-..|.|+|.... .+..+...-||.||..|.||+||+|++.|.-.+++|
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 34566889999999999999999999999999999997653 445678889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|..|||.||-....+-. ..|+|.+++-+++|++.||.|||+++|||||||..|||++-+|.++|+|||.|+.... .
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999999887764 6799999999999999999999999999999999999999999999999999875332 3
Q ss_pred CCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---CCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---CPKWTS 242 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 242 (417)
-....+..|||+||||||+. ..+|+ .++||||||+.|.+|..+.+|-..-+++..+-+|.+.+++ -|..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 34556789999999999974 46776 9999999999999999999999999999999999988765 477889
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..+.+|+++||..||..||+++++++||||++...
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 99999999999999999999999999999995443
No 130
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.3e-45 Score=358.41 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=224.1
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
......++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3456679999999999999999999999999999999999764322 2466789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
..|+||||++|++|.+++.+..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~- 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~ 246 (417)
........|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+... ....|...++.+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 169 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred -ccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 1223445789999999999887764 8999999999999999999999876654332222222 1224556788899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+|+.+||..||++|||++++++||||+....
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999999999999986443
No 131
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.1e-45 Score=373.33 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=208.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345678999999999999999999764 456789999886532 3458999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+|||++. ++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 588888864 78999999999999999999999999999999999999999999999999998755433
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhc-------------
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL---MAMYRKIYK------------- 232 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~------------- 232 (417)
.........+||+.|+|||++....|+ .++|||||||++|+|++|..||.+.+. ...+..+.+
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222233456799999999999888875 899999999999999999999976432 111111111
Q ss_pred ----------------CCCCCCC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 233 ----------------GEYRCPK-----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 233 ----------------~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+..|. ..+.++.+||++||..||++|||+.|++.||||++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 235678899999999999999999999999999864
No 132
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.8e-45 Score=352.08 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=224.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|.+++..+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987654321 2234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCC-CChHHHHHHHHhc
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKW-TSPDLKWFIGRLL 253 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~~~L 253 (417)
...|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+.......+..... ..+.. .++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 45789999999999887765 999999999999999999999988776666555555433 23334 6889999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..||++|||++++++||||++...
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999999987543
No 133
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=6.4e-46 Score=356.76 Aligned_cols=252 Identities=30% Similarity=0.526 Sum_probs=209.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976532 23334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence 9975 77776653 6799999999999999999999999999999999999999999999999999865432 11223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCC-------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------- 234 (417)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+..+.+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877654468999999999999999998885 4454444444332110
Q ss_pred C----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 Y----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+ ...+..++++++||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112357889999999999999999999999999998
No 134
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=9.3e-46 Score=355.18 Aligned_cols=256 Identities=34% Similarity=0.498 Sum_probs=222.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999999899999999986542 22356788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 999999999999875 56999999999999999999999999999999999999999999999999987654321 22
Q ss_pred cccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 244 (417)
......||+.|+|||++.. ..+ +.++|+||+||++|+|++|.+||...+......++..+.. ..|..++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 2345678999999999853 233 4789999999999999999999998887777777766543 345667899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.++|.+||+.+|.+|||++++++||||.+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 99999999999999999999999999998653
No 135
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.7e-45 Score=350.63 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=212.8
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 4568999999999999999999999999999999997542 1224567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--ccc
Confidence 9999999999998865 6899999999999999999999999999999999999999999999999999875432 112
Q ss_pred cccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-----KWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 244 (417)
.....+|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...+.......+....+..| ..++..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 2344578999999999853 234 4789999999999999999999976554443333333333222 235789
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
+.+||++||+.||++|||+++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
No 136
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=3.9e-45 Score=356.09 Aligned_cols=259 Identities=30% Similarity=0.561 Sum_probs=223.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765433344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 779999999999999999999999999999999999999999999999999875311000
Q ss_pred --------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--
Q 014849 170 --------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK-- 239 (417)
Q Consensus 170 --------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-- 239 (417)
.........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123468889999999887776 49999999999999999999999988888888887766544433
Q ss_pred -CCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 240 -WTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 240 -~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
..++++.++|.+||++||++||| +.++++||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 46888999999999999999997 7999999999763
No 137
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=5.7e-45 Score=344.00 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=222.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|.+..+|+.|++|.+...... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998754432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
....+|++.|+|||++.+..++ .++|+|||||++++|++|..||...+......++..+..+ .+...+.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999887765 8999999999999999999999988877777777766543 3446788999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
No 138
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=9e-46 Score=350.82 Aligned_cols=252 Identities=32% Similarity=0.554 Sum_probs=223.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665454557789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|+.|++|.+.+.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 9999999999976 4899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+ ...............|...++++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999987776 489999999999999999999998776 344444443356677778899999999999
Q ss_pred ccCCCCCCCCH--HHHhcCccc
Q 014849 253 LDTDPATRITV--DEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~--~eil~h~~f 272 (417)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
No 139
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.8e-45 Score=376.64 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=206.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
....|.+.+.||+|+||.||+|.+..+++.||||... .....+|+.+|++++|||||++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4568999999999999999999999999999999532 2235689999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 588888764 56999999999999999999999999999999999999999999999999999765432222
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCC--------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--------PNLMAMYRKIYKGEY-------- 235 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~-------- 235 (417)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+.. .....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 233356799999999999888875 899999999999999998765432 112223333222211
Q ss_pred ---------------------CCCCC-----CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 236 ---------------------RCPKW-----TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 ---------------------~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+.| .++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01111 3568999999999999999999999999999974
No 140
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=4.2e-45 Score=350.78 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=215.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+ |++|.+.+.. +.+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999998864 579999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
....|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+..+...- .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998766555689999999999999999999998776655544433210 0
Q ss_pred C-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 R-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 ~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
. ..+..+..+.+||.+||+.||++|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123468889999999999999999999999999983
No 141
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=5.7e-45 Score=349.89 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=212.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999999999999999875432 2223456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.|...+.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999888887765 679999999999999999999999999999999999999999999999999987654321 122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------C----C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------E----Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------~----~ 235 (417)
....++..|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+... . .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567899999999876554458999999999999999999999876654433222110 0 0
Q ss_pred CCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RCP------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..| ...+..+.+||.+||++||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 1347789999999999999999999999999998
No 142
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=4.7e-45 Score=353.43 Aligned_cols=261 Identities=31% Similarity=0.455 Sum_probs=219.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999766533 123455677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+ +++|.+++... .+++..+..++.||++||.|||++||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 88999999763 6999999999999999999999999999999999999999999999999998765432 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------------- 235 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (417)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+..+.+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986654446899999999999999999999988776655555432100
Q ss_pred ------C-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccCC
Q 014849 236 ------R-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280 (417)
Q Consensus 236 ------~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 280 (417)
. .....+..+.++|.+||.+||++|||+.|++.||||++...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01223678899999999999999999999999999998776543
No 143
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=5.3e-45 Score=344.84 Aligned_cols=252 Identities=30% Similarity=0.561 Sum_probs=222.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||+||.+.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999765432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 9999999998864 358999999999999999999999999999999999999999999999999987543211 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+..+...++..+... .|...+.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2345689999999998877664 8999999999999999999999988888888777766653 5666789999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999998
No 144
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=5.5e-45 Score=345.90 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=219.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++++.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+|+.++||||+++++.+......|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998999999999997654322 4678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 96 EFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999864 46899999999999999999999999999999999999999999999999998754432221
Q ss_pred --CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-----CCCCh
Q 014849 172 --GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP-----KWTSP 243 (417)
Q Consensus 172 --~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 243 (417)
......+|++.|+|||++......+.++|+|||||++|+|++|+.||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 13345578999999999877633458999999999999999999999887776666665554322 11 24578
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+.+++.+||..||++|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 89999999999999999999999999998
No 145
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.8e-45 Score=350.47 Aligned_cols=251 Identities=31% Similarity=0.495 Sum_probs=212.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||.|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3589999999999999999999999999999999875431 2245678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence 999999999998865 7899999999999999999999999999999999999999999999999999865432 1122
Q ss_pred ccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCChHH
Q 014849 174 LHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-----KWTSPDL 245 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 245 (417)
.....|++.|+|||++. ...+ +.++|+||+||++|+|++|..||................+..+ ..++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 34457999999999974 3334 4899999999999999999999976554443333333333222 2356789
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
.++|.+||..||++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
No 146
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=2.3e-45 Score=361.56 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=207.7
Q ss_pred EEeeEEeee--CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 19 EVGKIIGCG--AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 19 ~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
++.++||+| +|++||++.++.+|+.||+|.++.+.. .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 356789999 789999999999999999999976543 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC---
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--- 170 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--- 170 (417)
|+++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999864 4589999999999999999999999999999999999999999999999986532211000
Q ss_pred --CCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 014849 171 --DGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---------- 236 (417)
Q Consensus 171 --~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 236 (417)
.......+++..|+|||++.+. +| +.++||||+||++|+|++|+.||..............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111234578889999998763 45 48999999999999999999999876544433332222111
Q ss_pred ------------------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ------------------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.....++.+.+||.+||+.||++|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 011236789999999999999999999999999999763
No 147
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=4.2e-45 Score=348.58 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=213.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT----- 87 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~----- 87 (417)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4578999999999999999999999999999999987543 2245788999999998 69999999999865
Q ss_pred -CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...+|+||||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3578999999999999998875 368999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--C
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--R 236 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~ 236 (417)
.... ......+.+|++.|+|||++.. ..| +.++||||+||++|+|++|..||...........+..... .
T Consensus 160 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 5432 1223455679999999999863 344 4789999999999999999999987665554444433322 1
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+...+.++.+|+.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 233467899999999999999999999999999998
No 148
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=4.1e-45 Score=351.37 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=218.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788999999999999999999999999999986543 2235677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+++++|...+.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence 9999999888754 6799999999999999999999999999999999999999999999999999865322 11223
Q ss_pred cccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHH
Q 014849 175 HTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLK 246 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 246 (417)
....||+.|+|||++. +..+ +.++||||+||++|+|++|.+||...+..+...++.... ...|..++.++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 4457899999999984 2334 478999999999999999999999887776666665443 234556788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+||.+||+.||.+|||++++++||||+...
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999998653
No 149
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-47 Score=374.62 Aligned_cols=257 Identities=33% Similarity=0.566 Sum_probs=240.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-....+++.+||-|+||.|-++........+|+|++++..+.+....+++..|-.||..++.|.||++|..|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45667889999999999999998766655799999999988888888999999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
.||-|-||+|+..+.. |.+++..++.|+.-+++|++|||++|||+|||||+|++|+.+|-+||.|||+|.... .+.
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cCC
Confidence 9999999999999986 899999999999999999999999999999999999999999999999999997654 567
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 250 (417)
...|.||||.|+|||++.+++++ .++|.||||+++||||+|.+||.+.+++..|..|.+|- +.+|..++..+.+||+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred ceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 78999999999999999999998 99999999999999999999999999999999999874 6789999999999999
Q ss_pred HhccCCCCCCCC-----HHHHhcCccccc
Q 014849 251 RLLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 251 ~~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
++...+|.+|.. +.+|.+|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999995 999999999975
No 150
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=5.4e-45 Score=346.84 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=216.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc---ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+|++++.||+|+||.||+|.+ .+|+.+|+|.+...... ......++.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999987 58899999998754321 12234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc----
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI---- 168 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~---- 168 (417)
|+||++|++|.+++.+ +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 78999999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 245 (417)
..........|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+... ....|...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 111223445789999999999887775 8999999999999999999999876655444444332 234566678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.++|++||.++|++|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 151
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=7.1e-45 Score=349.63 Aligned_cols=250 Identities=23% Similarity=0.415 Sum_probs=211.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+.+....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999997643 2223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|..+ +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998654 4578999999999999999999999999999999999999999999999999865432 2334
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCC-CC-CCCCChHHH
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-------MAMYRKIYKGEY-RC-PKWTSPDLK 246 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~ 246 (417)
..+||+.|+|||++.+..++ .++|+||+||++|+|++|..||..... ......+..... .. ....+++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56899999999999887774 899999999999999999999965221 122222222221 11 234678999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++|.+||+.||.+||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999754
No 152
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=4.5e-45 Score=346.80 Aligned_cols=247 Identities=38% Similarity=0.687 Sum_probs=219.9
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++...|+|+||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999999999999999876654445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 578999999999999999999999999999999999999999999999999987553321 2334578999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHh--cCCCCCCCCCChHHHHHHHHhccCCCC
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRKIY--KGEYRCPKWTSPDLKWFIGRLLDTDPA 258 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~ 258 (417)
|+|||.+....++ .++|+||+|+++|+|++|..||.... ....+.++. ......|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998877775 89999999999999999999998776 667777776 345566777789999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 014849 259 TRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 259 ~R~t-----~~eil~h~~f~~ 274 (417)
+||| +.|+++||||++
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999985
No 153
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=8.1e-45 Score=346.94 Aligned_cols=256 Identities=32% Similarity=0.530 Sum_probs=215.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-------cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-------GGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+|.+.+.||+|+||+||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6999999999999999999999999999999986432211 112456788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+++||||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC----CC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK----WT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~----~~ 241 (417)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...+......++.... ...+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234567899999999987654 23589999999999999999999998766554444433222 22222 34
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+.++.++|.+||.++|++|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 7899999999999999999999999999997
No 154
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=6.3e-45 Score=350.62 Aligned_cols=249 Identities=33% Similarity=0.461 Sum_probs=205.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS---RLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
.||+|+||.||+|.+..+|+.+|+|.+.+.............+|..+++ ..+||||+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433322333344544443 3479999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 100 GGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 100 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 9999998875 7899999999999999999999999999999999999999999999999999864432 1223457
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
||+.|+|||.+.+....+.++||||+||++|+|++|..||.... ...............|...++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333489999999999999999999997532 222222233334556777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~ 275 (417)
||++|| |+.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999873
No 155
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=1e-44 Score=353.58 Aligned_cols=260 Identities=32% Similarity=0.467 Sum_probs=216.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
-.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999976542 222334566899999999999999999998654 579
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.+ +|.+.+.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887764 679999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------- 233 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 233 (417)
.......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 22233446888999999876544458999999999999999999999988877766655431
Q ss_pred ---CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+..+ .+.++++.+||.+||++||++|||+++++.||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 11111 235888999999999999999999999999999986543
No 156
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=4.2e-45 Score=351.10 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=214.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998764332 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.|...... +.+++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999998887765 57999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
....|++.|+|||++.+....+.++||||+||++|+|++|.+||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445689999999998765555689999999999999999999998766544433332100 0
Q ss_pred C------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 R------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .++..+..+.+|+.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123457889999999999999999999999999998
No 157
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=6.8e-45 Score=351.53 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=209.1
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----KAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 97 (417)
..+|+|+++.||+|.. +|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999988 789999999987654444445778899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
++||+|.+++.. +.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 999999999976 6799999999999999999999984 999999999999999999999999999875432 123
Q ss_pred ccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHH
Q 014849 176 TLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 251 (417)
...||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+..+++..+... .+..|...++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999999976 455 49999999999999999999999998888888877544 345555678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.||++|||+.|+++.
T Consensus 258 cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HhcCCcccCcCHHHHHHH
Confidence 999999999999999864
No 158
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=6e-45 Score=393.78 Aligned_cols=265 Identities=31% Similarity=0.472 Sum_probs=219.1
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
......+.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+|+.++|||||++++++.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 344567789999999999999999999999999999999999765432 2335678899999999999999999998854
Q ss_pred --CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEecC---
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR-------GVFHRDLKLENLLLDE--- 150 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~-------givHrDlkp~NILl~~--- 150 (417)
...+|+||||+.+|+|.++|.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4679999999999999998864 5799999999999999999999995 4999999999999964
Q ss_pred --------------CCCeEEeeeecceeecccCCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCC
Q 014849 151 --------------NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGY 215 (417)
Q Consensus 151 --------------~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~ 215 (417)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23489999999875432 2234556899999999998643 22358999999999999999999
Q ss_pred CCCCCCCHH-HHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 216 LPFNDPNLM-AMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 216 ~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.||...+.. .+...+...........++++.+||.+||+.+|.+|||+.|+|.|||++...
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999865544 4444444333222245689999999999999999999999999999998543
No 159
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=1e-44 Score=358.25 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=213.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 5689999999999999999999999999999999986422 223456678899999999999999999987544
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
..+|+|+||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 368999999965 8888888889999999999999999999999999999999999999999999999999998754322
Q ss_pred CC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Q 014849 169 RP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--------------- 232 (417)
Q Consensus 169 ~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 232 (417)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223467899999999976544446899999999999999999999987654433222211
Q ss_pred CC-------C----C-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 GE-------Y----R-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 ~~-------~----~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.. . . ..+..++++.++|.+||+.||.+|||+.|+++||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 0 0 01235788999999999999999999999999999986543
No 160
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=3.7e-45 Score=349.41 Aligned_cols=256 Identities=38% Similarity=0.676 Sum_probs=228.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 94 (417)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544444577889999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC---
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--- 170 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--- 170 (417)
|||+.+++|.+.+.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999977 5899999999999999999999999999999999999999999999999999875443221
Q ss_pred ---------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Q 014849 171 ---------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 171 ---------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
........|++.|+|||++....+ +.++|||||||+++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 122334568899999999877665 4899999999999999999999998887777777777788
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCccc
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITV----DEILRDPWF 272 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~----~eil~h~~f 272 (417)
..|...++.+.++|.+||+.||++|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888889999999999999999999999 999999998
No 161
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=5e-45 Score=347.03 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=215.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+|+.++.||+|+||.||.|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4889999999999999999999999999999997543211 2235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCC-
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRP- 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~- 170 (417)
|+||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999876 7899999999999999999999999999999999999998876 599999999865433211
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---h--cCCCCCCCCCChH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI---Y--KGEYRCPKWTSPD 244 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 244 (417)
.......+||..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+ . ......|...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112345689999999999877765 8999999999999999999999765433222222 1 1234456667899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999995
No 162
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.9e-45 Score=351.22 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=217.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 2223467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999888764 79999999999999999999997 599999999999999999999999999986432
Q ss_pred CCcccccccCccccccccccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HhcCC-CCCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGY-----DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK---IYKGE-YRCPKWT 241 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y-----~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~-~~~p~~~ 241 (417)
.....+.+|++.|+|||.+.+... .+.++||||+||++|+|++|..||...+....... +..+. ...|...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345678999999999865432 25789999999999999999999977654443333 33333 3456668
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++.+||.+||+.+|++||++++++.||||.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999999986543
No 163
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=1.6e-44 Score=348.44 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999976432 12234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence 999985 89888864 57899999999999999999999999999999999999999999999999998643221 11
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKG------------------ 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~------------------ 233 (417)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+ ..+....+.+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 22234578899999998764434589999999999999999999997665 22322222110
Q ss_pred -C--CCC---------CCCCC--hHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 -E--YRC---------PKWTS--PDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 -~--~~~---------p~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ... ....+ .++.+++.+||++||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01223 788899999999999999999999999998
No 164
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=2e-44 Score=341.06 Aligned_cols=248 Identities=30% Similarity=0.558 Sum_probs=218.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||++.+..+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+++++|.+++.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999998864 45899999999999999999999999999999999999999999999999998755331 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+... .|...+..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2345789999999999877764 8999999999999999999999998887777777666543 5666789999999999
Q ss_pred ccCCCCCCCCHHHHhcC
Q 014849 253 LDTDPATRITVDEILRD 269 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h 269 (417)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
No 165
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=1.5e-44 Score=344.53 Aligned_cols=255 Identities=28% Similarity=0.509 Sum_probs=214.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIY 92 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 92 (417)
.|++++.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6899999999999999999999999999999987543211 1234578899999999999999999998865 46789
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-C
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR-P 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~-~ 170 (417)
+++||+++++|.+.+.. +.+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999999876 679999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 248 (417)
........|+..|+|||.+.+..++ .++||||+||++|+|++|+.||..........++... ....|...++.++++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1222345689999999999877764 8999999999999999999999877655544444322 234566778899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+ +||..+|++|||++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 67778999999999999999996
No 166
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=3.5e-44 Score=339.27 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=223.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||.+++..+++.+++|.+...... .....++.+|+.++++++||||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998765432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|++|++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999875 368999999999999999999999999999999999999999999999999987543322 13
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-PKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+..+....+..+.+.. +...+.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999998877664 88999999999999999999999988888888877766543 455789999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|.++|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
No 167
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=4.3e-45 Score=366.94 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=207.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|++..+| ..||+|++..... ......+.+|+.+|+.+ +||||+++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 457999999999999999999975444 5799999976532 22356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
...|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999988742
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 110 ------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 110 ------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+.
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 14788889999999999999999999999999999999999999999999998754322111112233
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHHhcc
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+++.|+|||++.+..|+ .++||||+||++|+|++ |..||........+.+.... ....|...++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 456789999999877775 89999999999999997 99999876544433333333 345667789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 014849 255 TDPATRITVDEILR 268 (417)
Q Consensus 255 ~dP~~R~t~~eil~ 268 (417)
.||++|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
No 168
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=6.1e-45 Score=363.43 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=199.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..+|++.+.||+|+||.||+|.+..+++.||+|+..+. ....|+.+++.++||||+++++++.+....|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999975432 234689999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 478887754 5799999999999999999999999999999999999999999999999999864321 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCH----------HHHHHHHhcC---CCCCC
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY-LPFNDPNL----------MAMYRKIYKG---EYRCP 238 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~-~Pf~~~~~----------~~~~~~i~~~---~~~~p 238 (417)
......||+.|+|||++.+..|+ .++||||+||++|+|+++. .+|..... ..+...+... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456799999999999888775 8999999999999999854 44443211 0111111100 00011
Q ss_pred ------------------------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 ------------------------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 123567788999999999999999999999999985
No 169
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=1.5e-44 Score=359.58 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=215.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999875432 223345677899999999999999999988644
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 788877654 9999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------ 234 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 234 (417)
. ........||+.|+|||.+.+..++ .++|||||||++|+|++|+.||...+....+.++...-
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445789999999999888875 89999999999999999999998776554444332100
Q ss_pred ----------C-----C---------C-------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccC
Q 014849 235 ----------Y-----R---------C-------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279 (417)
Q Consensus 235 ----------~-----~---------~-------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 279 (417)
. . . +...++.++++|.+||+.||++|||+.|++.||||+.++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~ 321 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence 0 0 0 112355689999999999999999999999999999777643
No 170
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=2.7e-44 Score=342.30 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=214.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 91 (417)
..|++++.||+|+||.||.|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998643211 12235678899999999999999999998866 3578
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR- 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~- 169 (417)
|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999876 678999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 247 (417)
........+|+..|+|||++.+..++ .++|||||||++|+|++|+.||..........++... ....|...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 11123445789999999999877764 8999999999999999999999876655544444432 23345667888999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+|++||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999984
No 171
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=3e-44 Score=340.22 Aligned_cols=251 Identities=33% Similarity=0.523 Sum_probs=217.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.+...+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976532 2467888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 999999999998865 58999999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccccCcccccccccccc---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAKK---GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-----PKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~---~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~ 244 (417)
.....+|+..|+|||.+.+. .++ .++|+|||||++|+|++|.+||...+.......+....+.. +...+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 23445789999999998766 565 89999999999999999999998877665555554443322 2234678
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
+.+++.+||..+|..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
No 172
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.3e-44 Score=348.10 Aligned_cols=250 Identities=33% Similarity=0.470 Sum_probs=209.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE---ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+||+|+||.||+|.+..+++.||+|++.+..............| +..++...||||+++++++.+...+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987644322222223333 344555689999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 100 GGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 100 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|++|.+++.. +.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999988865 6799999999999999999999999999999999999999999999999999864432 1234568
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
|++.|+|||++.+....+.++||||+||++|+|++|+.||... ........+.......|...++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433358899999999999999999999876 4444444455555667777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
+|.+|| ++.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999998743
No 173
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=9.4e-45 Score=348.46 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=216.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999986655 689999986543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998864 3578889999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222233445678899999998877765 89999999999999998 999999988888888776
Q ss_pred cCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.. ..|...++++.+|+.+||+.||.+|||+.||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6543 4566789999999999999999999999999875
No 174
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=1.5e-44 Score=351.54 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=205.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEcc----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVR----------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn 77 (417)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999998532 34579999987543 2223567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 014849 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKG--------------------RFSEQLSRRYFQQLISAVEYCHSRGVF 137 (417)
Q Consensus 78 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~i~~ql~~aL~ylH~~giv 137 (417)
|+++++++.+.+..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988542 356778899999999999999999999
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CC
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GY 215 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~ 215 (417)
||||||+|||++.++.+||+|||++................+++.|+|||++....++ .++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999998754322211222344568899999998877764 89999999999999986 67
Q ss_pred CCCCCCCHHHHHHHHhc---C-----CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 216 LPFNDPNLMAMYRKIYK---G-----EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 216 ~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.||...+..+....+.. . ....|...++.+.+|+.+||+.||.+|||+++|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887666555443321 1 1223456788999999999999999999999994
No 175
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=5e-44 Score=345.32 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=214.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK--- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~--- 88 (417)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 45789999999999999999999999999999999986532 2246678899999998 799999999998653
Q ss_pred --CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 89 --AKIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
...|+||||++|++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 46899999999999998875 25789999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY----DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y----~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 235 (417)
+....... ......+|++.|+|||++..... .+.++||||+||++|+|++|++||...+.......+.+...
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 175 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred chhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 87543211 12234578999999999864321 25899999999999999999999988766555555544422
Q ss_pred -CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
..|...+..+.+||.+||+.||++|||+.|+++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445678899999999999999999999999999995
No 176
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.5e-44 Score=352.96 Aligned_cols=247 Identities=25% Similarity=0.459 Sum_probs=193.9
Q ss_pred EeeEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKIYFVM 95 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~ 95 (417)
.++.||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++. +...+|+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 35789999999999999754 66899999986543 2345778999999999999999999884 456899999
Q ss_pred eccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeeec
Q 014849 96 EFAKGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGL 161 (417)
Q Consensus 96 E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFGl 161 (417)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 77776631 248899999999999999999999999999999999999 5667899999999
Q ss_pred ceeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHh
Q 014849 162 SAVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AMYRKIY 231 (417)
Q Consensus 162 s~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~ 231 (417)
+....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 97653321 1122345678999999999987655569999999999999999999999653211 0000000
Q ss_pred c----------------------------CCCC----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 232 K----------------------------GEYR----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 232 ~----------------------------~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .... .....+..+.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0000 011235668899999999999999999999999998
No 177
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=3.6e-44 Score=338.56 Aligned_cols=251 Identities=33% Similarity=0.547 Sum_probs=220.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999875432 2346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~~~ 172 (417)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999975 2489999999999999999999999999999999999998655 5799999998755322 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
......|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..+.. ..|...++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 23345789999999999877664 899999999999999999999998887777777765543 4566789999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||.+||++|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
No 178
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=1.8e-44 Score=345.50 Aligned_cols=257 Identities=31% Similarity=0.594 Sum_probs=219.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 93 (417)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ......++.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2233567889999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 94 VMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCC-CCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPK-WTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~-~~s~~~~~li~~ 251 (417)
.....|++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+..... .++. ..+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 34457899999999987544445899999999999999999999988776555444433322 2222 267899999999
Q ss_pred hccCCCCCCCCHHHHhcCcccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||+.||++|||+.+++.||||++...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999999987553
No 179
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=1.1e-44 Score=347.70 Aligned_cols=248 Identities=31% Similarity=0.476 Sum_probs=212.9
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999875543333455667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... ........|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 998865 3 699999999999999999999999999999999999999999999999999865432 2223345678
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHHHHhccCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 256 (417)
..|+|||++.+..++ .++||||+||++|+|++|+.||..... ..+...+.......|...++++.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 899999998877764 899999999999999999999977543 333344444455566778999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 014849 257 PATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 257 P~~R~-----t~~eil~h~~f~~~ 275 (417)
|.+|| ++.+++.||||++.
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88889999999753
No 180
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=2.5e-44 Score=345.80 Aligned_cols=255 Identities=33% Similarity=0.520 Sum_probs=215.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999999876432 3334578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.+.....+ ..+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777766654 5799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------------------- 233 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 233 (417)
....+++.|+|||++......+.++||||+|+++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678999999999987734459999999999999999999999877655443332210
Q ss_pred CC-----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 EY-----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 ~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+ ..|...++++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458889999999999999999999999999998
No 181
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=9.9e-45 Score=343.03 Aligned_cols=250 Identities=35% Similarity=0.637 Sum_probs=221.5
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++.+.+....|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776544444567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC------CCcccc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP------DGMLHT 176 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~------~~~~~~ 176 (417)
.+++.+ +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 7899999999999999999999999999999999999999999999999999865332211 112344
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--ChHHHHHHHHhcc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT--SPDLKWFIGRLLD 254 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~L~ 254 (417)
.++++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 578899999999887765 4899999999999999999999999988888888887777766665 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCccccc
Q 014849 255 TDPATRITV---DEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t~---~eil~h~~f~~ 274 (417)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
No 182
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=2.6e-44 Score=349.24 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=209.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-- 89 (417)
....++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3457789999999999999999999999999999999875432 2223445678999999999999999999986543
Q ss_pred ------EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 ------KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 ------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
..|+||||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 56999999965 78777765 3799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CC---
Q 014849 162 SAVKEQIRPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GE--- 234 (417)
Q Consensus 162 s~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~--- 234 (417)
+......... .......++..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+.. +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8754332211 1223456789999999987654345899999999999999999999988765543332221 10
Q ss_pred --------------CCC-------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 --------------YRC-------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 --------------~~~-------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
... +...++.+.+||.+||..||.+|||++|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 001 11235678899999999999999999999999998
No 183
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=1.5e-44 Score=346.69 Aligned_cols=258 Identities=30% Similarity=0.492 Sum_probs=222.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4578899999999999999999999999999999875432 22356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|||++|++|.+++..+++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986543221 122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 253 (417)
....++..|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..+. ...+...+.++.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 335688899999999877664 89999999999999999999998877665555443332 2334456788999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.+|++|||+.+++.||||.+...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcch
Confidence 999999999999999999976543
No 184
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-46 Score=368.26 Aligned_cols=257 Identities=33% Similarity=0.667 Sum_probs=226.2
Q ss_pred ccccCCeEE--eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEV--GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+..-|.| .++||+|.||+||-|.++.+|+.||||+|++.++.... ..++++|+.||+.+.||.||.+--.+++++
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPE 636 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence 344455655 68999999999999999999999999999998875543 589999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~ 164 (417)
++++|||.+.|.-|.-.+. +|+|+|...+.+..||+.||.|||-++|+|.|||||||||.+.. .+||||||+|++
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999997744444443 38999999999999999999999999999999999999997654 599999999998
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--C--
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--W-- 240 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~-- 240 (417)
... .....+.+|||.|.|||++.+++|. ...|+||.|||+|.-|.|..||... +++-.+|..+.+.+|+ |
T Consensus 717 IgE---ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 717 IGE---KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred cch---hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhh
Confidence 763 3456778999999999999999998 8899999999999999999999765 4566778888877764 3
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+++++.+||..+|+..-.+|.|++..+.|||+++.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 58999999999999999999999999999999864
No 185
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=2.3e-44 Score=342.75 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=213.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~--- 89 (417)
..++|++.+.||+|+||.||+|.+..+++.+++|++..... ...++.+|+.+++.+ .||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45899999999999999999999999999999999876532 246788999999999 6999999999986644
Q ss_pred ---EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
.+|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988753 5799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG----YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~----y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 235 (417)
+...... ........|++.|+|||++.... ..+.++|||||||++|+|++|+.||...+......++.....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 8754321 22334567899999999975422 224789999999999999999999987766665555554432
Q ss_pred -CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+...+.++++||.+||..||++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367889999999999999999999999999996
No 186
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=1.9e-44 Score=346.57 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=210.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||.|+||.||+|++..+|+.||||.+..+.. .......+.+|++++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999876532 22334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+. ++|..++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578887753 57899999999999999999999999999999999999999999999999998654321 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------C
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------Y 235 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------~ 235 (417)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......++.... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 3344678999999998776655689999999999999999999998766544333322100 0
Q ss_pred CC-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RC-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+ .+..+++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01 12357889999999999999999999999999998
No 187
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=2e-44 Score=340.25 Aligned_cols=249 Identities=29% Similarity=0.502 Sum_probs=216.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.+++|.+..... ..++.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999998999999999875532 578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999864 578999999999999999999999999999999999999999999999999987544321 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~ 250 (417)
.....|++.|+|||++.+..++ .++||||+||++|+|++|+.||...........+... ....+...+.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 3345588999999999888775 8999999999999999999999877655444333322 22334456789999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||+.||++|||+.|+++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 188
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=4.4e-44 Score=337.98 Aligned_cols=253 Identities=32% Similarity=0.559 Sum_probs=217.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
||+..+.||+|+||+||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999889999999998764321 122356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999876 569999999999999999999999999999999999999999999999999987643221 2
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 251 (417)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||..........++.. .....|...++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987665235899999999999999999999987765554444443 2234566778999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||+.+|++|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
No 189
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=7.1e-45 Score=352.69 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=222.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.....|.....||+|+||.||++.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 44566777888999999999999999999999999986543 223567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||+++++|.+++..+++++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~ 173 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVP 173 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999864332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li 249 (417)
.....+|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.... ...+...+..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 23456789999999999877765 89999999999999999999998877666555544322 222234688899999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.+||..||++|||++++++||||+....+
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999865543
No 190
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=3e-44 Score=342.90 Aligned_cols=250 Identities=19% Similarity=0.273 Sum_probs=211.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999865 4567899999976532 22345788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999998875 579999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
........+++.|+|||++.+..++ .++||||+||++|++++ |..||.+.+..+....+..+. .+.|...+..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1111123456789999999887775 89999999999999775 999999888877777776553 3556667899999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+||+.+|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999975
No 191
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=3.5e-44 Score=343.73 Aligned_cols=248 Identities=33% Similarity=0.509 Sum_probs=206.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK--AKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV 94 (417)
|++.+.||+|+||.||+|.+..+++.||+|.+.+.... .......+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 78999999999999999999999999999998754321 11233457888998885 99999999999887 899999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 78777764 56899999999999999999999999999999999999999 99999999998754321 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------C
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------E 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 234 (417)
......+++.|+|||++...++.+.++||||+||++|+|++|.+||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568999999998766566668999999999999999999999987766555444321 1
Q ss_pred CCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+..| ...+.++.++|.+||++||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2357899999999999999999999999999998
No 192
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=5.1e-44 Score=338.15 Aligned_cols=252 Identities=34% Similarity=0.594 Sum_probs=220.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV 94 (417)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... .....++.+|+.+++.++||||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999999765432 233567889999999999999999999775 34678999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCH-----SRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH-----~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
|||+++++|.+++.. +++++..++.++.||+.||.||| +.+++||||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999988853 57899999999999999999999 99999999999999999999999999999876
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCh
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSP 243 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 243 (417)
..... ....+..|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+...+...+..+.+ ..|...++
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54321 113455789999999999877764 899999999999999999999999887788777777665 35667789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
++.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
No 193
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=2.4e-44 Score=345.72 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=212.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA----- 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~----- 86 (417)
...++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 45689999999999999999999999999999999986643 2245678899999998 6999999999984
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 87 -TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 87 -~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
....+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 34689999999999999998864 45899999999999999999999999999999999999999999999999998
Q ss_pred eeecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 236 (417)
..... ........+|++.|+|||++.. ..++ .++|+|||||++|+|++|..||...........+......
T Consensus 169 ~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 169 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred hhhhc--cccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 64432 1123345679999999999863 3453 7899999999999999999999876655444444333221
Q ss_pred -CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 -CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+...+.++.+||.+||..||.+|||+.||++||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123468899999999999999999999999999997
No 194
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=7.3e-44 Score=344.16 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=205.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999976532 22344667899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI--PSQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC--CCC
Confidence 99996 567666543 5688999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhc--C--------------C-
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYK--G--------------E- 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~--------------~- 234 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++.. + .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2344567999999999876543358899999999999999999999765432 22222110 0 0
Q ss_pred ----C-CC-CC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ----Y-RC-PK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ----~-~~-p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+ +. ..++++.+++.+||+.||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 00 125688999999999999999999999999998
No 195
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=1.2e-44 Score=363.91 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||+||+|.+ ..++..||+|++..... ....+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 35677899999965432 22356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISKG---------------------------------------------------------- 110 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 110 (417)
...|+||||++||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999887531
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 111 ------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 111 ------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36788899999999999999999999999999999999999999999999987543222111
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+. ...|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 22233456789999999887775 89999999999999997 99999876544 3333343332 334566788999999
Q ss_pred HHhccCCCCCCCCHHHHhcC
Q 014849 250 GRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h 269 (417)
.+||++||++|||+.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
No 196
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=9.4e-44 Score=337.19 Aligned_cols=255 Identities=33% Similarity=0.581 Sum_probs=216.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
||.+.+.||+|+||.||.|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++...+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 799999999999999999999999999999999766432 3356789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-c-
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-M- 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~- 173 (417)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999976 468999999999999999999999999999999999999999999999999987653322111 1
Q ss_pred ccccccCccccccccccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC-CCCCCCCC--ChHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKG-EYRCPKWT--SPDLKW 247 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~--y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~--s~~~~~ 247 (417)
....++++.|+|||++.... ..+.++||||+||++|+|++|+.||.... .......+..+ ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 23467899999999987654 12489999999999999999999997653 22332223322 33455555 899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+|.+||+.+|++|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
No 197
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=5.8e-44 Score=342.68 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=222.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
-|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47888999999999999999999999999999865432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccc
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 176 (417)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999986543211 12234
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhccC
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 255 (417)
..|+..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..... ..+...+.++.+++.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 5689999999998876664 899999999999999999999988776666655544432 34566789999999999999
Q ss_pred CCCCCCCHHHHhcCcccccccc
Q 014849 256 DPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 256 dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+|.+||++.++++||||.+...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999987543
No 198
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=7e-44 Score=344.41 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=208.9
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 90 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876532 2233467788999999995 6999999999877665
Q ss_pred -EEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecc
Q 014849 91 -IYFVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLS 162 (417)
Q Consensus 91 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls 162 (417)
+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 889999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------- 235 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------- 235 (417)
..... .........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCC--CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 64422 112223346789999999987644445899999999999999999999988766554444332100
Q ss_pred ----------CCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 ----------RCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 ----------~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
..| +..++++.+||.+||.+||.+|||+.|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23678899999999999999999999999999995
No 199
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=6.2e-44 Score=343.30 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=213.6
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE--
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA-- 86 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~-- 86 (417)
.-....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 33567889999999999999999999999999999999886432 1245678899999999 6999999999873
Q ss_pred ---eCCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 87 ---TKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 87 ---~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+...+|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 45679999999999999987642 5689999999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...+......++...
T Consensus 168 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 168 FGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CCceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9998754321 122344579999999999853 234 48999999999999999999999887655544444332
Q ss_pred C---CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 E---YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 ~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ...|...+..+.+||.+||+.||++|||+.|+++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2 22345567889999999999999999999999999997
No 200
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-45 Score=362.88 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=211.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+.+++.||+|.||.||+|... ....||+|.+..... ..+.+.+|+++|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 455788999999999999994 335899999876432 246777999999999999999999999998899999999
Q ss_pred cCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 98 AKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 98 ~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
++.|+|.+++.. +.+...+...++.||++||+||+++++|||||.+.||||+++..+||+|||||+..... .....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999985 57899999999999999999999999999999999999999999999999999843321 11111
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHh
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 252 (417)
...--+..|.|||.+....++ .+|||||+||+|+||+| |+.||.+.+..+....+.+|. .+.|..+++++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 122224569999999988885 99999999999999987 999999999999999998874 788999999999999999
Q ss_pred ccCCCCCCCCHHHHh
Q 014849 253 LDTDPATRITVDEIL 267 (417)
Q Consensus 253 L~~dP~~R~t~~eil 267 (417)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998664
No 201
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=3e-44 Score=347.23 Aligned_cols=254 Identities=33% Similarity=0.469 Sum_probs=214.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 92 (417)
.+.|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45799999999999999999999999999999999765432 33345677899999999999999999998877 8999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|+||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999975 89888865 45899999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---------------- 234 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 234 (417)
........+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1223445678999999998766545689999999999999999999999877666555543210
Q ss_pred ---------------CCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ---------------YRCPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ---------------~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+|.. .++.+.++|++||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 47889999999999999999999999999998
No 202
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=8e-44 Score=353.30 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=217.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 36889999999999999999999999999999999986542 22233557889999999999999999999987654
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+++||||+ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 469999999 7799998888889999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---------- 236 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 236 (417)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+....+.++......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 2234567999999999876444468999999999999999999999887765555444321111
Q ss_pred ---------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ---------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++.+.++|.+||+.||++|||+.+++.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 11346788999999999999999999999999999986533
No 203
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=8.9e-44 Score=338.54 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=214.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765444444556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999988742 45899999999999999999999999999999999999999999999999998765422
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCCC-C-CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRKIYKGEYR-C-PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~ 245 (417)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+....++ . +...+..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1223345789999999999887775 89999999999999999999996543 34445554443322 2 23567889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999864
No 204
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=3.6e-44 Score=347.73 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=221.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 445689999999999999999999999999999999986542 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||+++++|.+++.+..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~ 169 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 169 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--c
Confidence 99999999999999998888999999999999999999999999999999999999999999999999988654321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 248 (417)
.......|++.|+|||.+.+..++ .++|+||+||++|++++|+.||...+.......+.... +..+...+..++++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 223345789999999998877664 89999999999999999999998776544433332221 22233457889999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|.+||+.+|++||++.+++.||||+....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999999999986553
No 205
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-47 Score=354.86 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=225.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..-|.++..||+|+||.||+|.++++|+.+|||.+..+. ....+.+||+||++++.|+||++|+.+-..+.+|+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 345788999999999999999999999999999887654 267788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||..|+..+.+.. ..|+|+++..+++.-+.||.|||...-+|||||..||||+.+|+.||+|||.+..... .-.
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999999999874 6799999999999999999999999999999999999999999999999999865432 334
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li 249 (417)
..++..|||.||||||+..-+|+ .++||||||+...||..|++||.+-.++...--|-... +.-|..+|+++.+|+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 56788999999999999999998 89999999999999999999999887765443333322 334666799999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++||..+|++|.|+-++++|||.++..
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 999999999999999999999998643
No 206
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=5e-44 Score=354.47 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=212.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 56899999999999999999999999999999999876543 3356788999999999999999999876544
Q ss_pred ---------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEee
Q 014849 89 ---------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISD 158 (417)
Q Consensus 89 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~D 158 (417)
...|+|+||+. ++|.+.+..+.+++..++.++.||++||.|||++||+||||||+||+++. ++.+|++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 48999888888999999999999999999999999999999999999974 55789999
Q ss_pred eecceeecccCC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---
Q 014849 159 FGLSAVKEQIRP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--- 234 (417)
Q Consensus 159 FGls~~~~~~~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 234 (417)
||++........ .+......|++.|+|||++......+.++|||||||++|+|++|..||...+..+....+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432111 1122334688999999987654444589999999999999999999998776655544433211
Q ss_pred ----------------------C-----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ----------------------Y-----RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ----------------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
. ...+..+.++.+||.+||++||.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0112467889999999999999999999999999999864
No 207
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=6.9e-44 Score=342.34 Aligned_cols=251 Identities=30% Similarity=0.504 Sum_probs=211.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|++|.||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 88887754 35899999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------ 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 234 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765545689999999999999999999999877665555443210
Q ss_pred CC-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YR-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112347788999999999999999999999999998
No 208
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=7.6e-45 Score=348.60 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=219.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 3467788899999999999999999999999999875432 22356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+||+++++|.+.+..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999999998888999999999999999999999999999999999999999999999999998654321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 253 (417)
....|+..|+|||++.+..++ .++|+||+||++|+|++|..||...........+..+.. ..+...+.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 334688999999999887765 899999999999999999999987665554444433322 233456788999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+|++|||+.++++||||++.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999754
No 209
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1.1e-43 Score=342.72 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=221.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|...+.||+|++|.||+|.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 3456677899999999999999999999999999864322 2245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+||+.|++|.+.+..+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~ 172 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR 172 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999987643321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC---CCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC---PKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~ 251 (417)
....|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+......++....... +...++.+.+++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 345689999999999877765 89999999999999999999998888777777766553322 22367899999999
Q ss_pred hccCCCCCCCCHHHHhcCcccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||+.+|++|||+.++++||||++...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999987543
No 210
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=8.3e-44 Score=336.24 Aligned_cols=252 Identities=31% Similarity=0.578 Sum_probs=218.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 699999999999999999999999999999999775432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-eEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-vkl~DFGls~~~~~~~~~~ 172 (417)
|+++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||++++++. +||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 9999999998865 25899999999999999999999999999999999999998865 69999998875432 112
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
......|++.|+|||++.+..++ .++|+||+||++++|++|..||...+.......+..+.. ..++..+.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998877765 899999999999999999999998887777776665543 2345568899999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
No 211
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.9e-44 Score=344.45 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=218.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 57999999999999999999999999999999987543 2334678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. +.+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..... ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----SI 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----hc
Confidence 99999999998876 679999999999999999999997 6999999999999999999999999999864322 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHhcCC-CCCCCC-
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-----------AMYRKIYKGE-YRCPKW- 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~- 240 (417)
....+|+..|+|||++.+..++ .++||||+||++|+|++|..||...+.. .....+.... ...+..
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 2346799999999998877664 8999999999999999999999865431 2333333322 222322
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 279 (417)
.+.++.+|+.+||++||++|||+.|+++|+||.+...+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 678899999999999999999999999999998765443
No 212
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=7.8e-44 Score=337.93 Aligned_cols=247 Identities=36% Similarity=0.593 Sum_probs=210.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+|||++++++++.+.+.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765432222233444555444 455899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6799999999999999999999999999999999999999999999999998864322 234568
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCChHHHHHHHHhccC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC----PKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~ 255 (417)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +...++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987775 589999999999999999999999988888877776654432 234689999999999999
Q ss_pred CCCCCC---CHHHHhcCcccccc
Q 014849 256 DPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~---t~~eil~h~~f~~~ 275 (417)
||++|| +++|++.||||++.
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcC
Confidence 999999 55899999999753
No 213
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.3e-43 Score=342.34 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=214.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4689999999999999999997652 355899998865432 222446778999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
..|+||||+++|+|.+++.. ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999999863 1245678889999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YR 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~ 236 (417)
||+++...............++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998754322111112223457789999998877764 89999999999999998 899999888888777776554 34
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhc------Cccccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILR------DPWFKK 274 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~------h~~f~~ 274 (417)
.|...++.+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 56667899999999999999999999999987 888864
No 214
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=5.7e-44 Score=342.19 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=215.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++|+.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 468899999875432 223578899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCe
Q 014849 90 KIYFVMEFAKGGELFAKISK---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~v 154 (417)
..|+||||++|++|.+++.. ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999863 247889999999999999999999999999999999999999999
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998654322111222344567899999999887775 89999999999999998 99999988888888888776
Q ss_pred CCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 234 EYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 234 ~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
... .|...+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 654 35567899999999999999999999999975
No 215
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=5.1e-44 Score=347.47 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=220.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.-|+....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......|+|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 346667789999999999999999999999999865432 23566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|...+....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 175 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccc
Confidence 9999999999888788999999999999999999999999999999999999999999999999998643321 12234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChHHHHHHHHh
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~ 252 (417)
..+|++.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+..... ..+...++.+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 56799999999999877764 899999999999999999999988776666655544322 22345678899999999
Q ss_pred ccCCCCCCCCHHHHhcCcccccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|+.+|++|||++++++||||.+...
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999986543
No 216
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=4.1e-44 Score=340.20 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=217.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....++.+|+.+++.++||||+++++.+.+....|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+.|++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 99999999999875 679999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCC-CCCCCC-CChHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGE-YRCPKW-TSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~ 245 (417)
......|++.|+|||.+.+..++ .++||||+||++|+|++|..||... ...+....+.... ...|.. .++++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11226789999999999887775 8999999999999999999999764 3334444444332 233443 78899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++|.+||..||.+|||+.+++.||||+..
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999753
No 217
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=3.4e-43 Score=330.84 Aligned_cols=252 Identities=38% Similarity=0.649 Sum_probs=223.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 69999999999999999999999999999999976543 22345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|++|++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 250 (417)
......+|++.|+|||.+....++ .++|+||+|+++++|++|..||...+.......+..... ..|...+..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 234556899999999998877765 889999999999999999999998887777777666543 455677899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 218
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1.1e-43 Score=346.21 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=207.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIY 92 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 92 (417)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999875433344456778999999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC----CCCeEEeeeecc
Q 014849 93 FVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE----NWDLKISDFGLS 162 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~----~~~vkl~DFGls 162 (417)
+||||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 67665531 36899999999999999999999999999999999999999 899999999998
Q ss_pred eeecccCC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHh-
Q 014849 163 AVKEQIRP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---------MYRKIY- 231 (417)
Q Consensus 163 ~~~~~~~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i~- 231 (417)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|++||.+.+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533221 1123345789999999998765444589999999999999999999997544221 000000
Q ss_pred -------------------------cCCCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 232 -------------------------KGEYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 232 -------------------------~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
......+ ...+.++.+++.+||++||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1456789999999999999999999999999998
No 219
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=1.4e-43 Score=339.89 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=211.3
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..++|++.+.||+|+||.||.|.+. .++..||+|.+..... .....++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4568999999999999999999864 2456899999864321 12245678999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 89 AKIYFVMEFAKGGELFAKISKG-----------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
+..++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999988641 25677889999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 235 (417)
|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998643321111112234567889999999877764 89999999999999998 799999888877777666554 3
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566778899999999999999999999999864
No 220
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=1.6e-43 Score=341.70 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=212.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999852 355679999886542 233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-C-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 90 KIYFVMEFAKGGELFAKISK-G-------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~-------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
..|+||||+++++|.+++.. + .+++..+..++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999998863 2 489999999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754322111122334467889999999877765 89999999999999998 999999888888888887766
Q ss_pred C-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 235 Y-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 235 ~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
. ..+...++++.+|+.+||++||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 445567899999999999999999999999954
No 221
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=8.5e-44 Score=352.97 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=218.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK- 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~- 90 (417)
..+.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3578899999999999999999999999999999999875432 22234667889999999999999999988766554
Q ss_pred -----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 91 -----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 91 -----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.|+|+||+ |++|.+++..+++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 99999999 669999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--------- 236 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--------- 236 (417)
.. ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 2344578999999999876544468999999999999999999999887766655554331100
Q ss_pred ----------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ----------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++.+.+||.+||++||++|||+.++++||||++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 01235888999999999999999999999999999987543
No 222
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=8.3e-44 Score=351.46 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=214.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA----TKA 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~----~~~ 89 (417)
+.++|++.+.||+|+||.||.|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999999976432 2234567788999999999999999998875 345
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7999999996 589888865 67999999999999999999999999999999999999999999999999998654321
Q ss_pred C--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 169 R--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 169 ~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
. ......+.+|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 112223557899999999987644446899999999999999999999987765433322111
Q ss_pred -----------C-CCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 -----------G-EYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 -----------~-~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. .... .+..++++.++|++||+.+|++|||+++++.||||++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 0 0000 12357889999999999999999999999999999865443
No 223
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-45 Score=341.54 Aligned_cols=258 Identities=31% Similarity=0.591 Sum_probs=234.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 93 (417)
.+.|++.++||+|+|++|.+++.+.|.+.+|+|+++++.+...+..+-+..|-.+..+. +||.+|-++..|.+++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 56799999999999999999999999999999999999887777778888888888776 69999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|.||++||+|.-.+.+ ++|+|+.|+.|..+|+.||.|||++||++||||..|+|||..|++||+|+|+.. ....+..
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck--e~l~~gd 406 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGLGPGD 406 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh--cCCCCCc
Confidence 9999999999777765 789999999999999999999999999999999999999999999999999875 3455677
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-------CCHH-HHHHHHhcCCCCCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-------PNLM-AMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-------~~~~-~~~~~i~~~~~~~p~~~s~~ 244 (417)
...|.||||+|+|||++.+..| |.++|+|+|||++|||++|+-||+- .|.+ -+++-|......+|...|-.
T Consensus 407 ~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvk 485 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVK 485 (593)
T ss_pred ccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehh
Confidence 8889999999999999999988 6999999999999999999999952 2333 35677778889999999999
Q ss_pred HHHHHHHhccCCCCCCC------CHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPATRI------TVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~------t~~eil~h~~f~~~ 275 (417)
+...++.-|++||.+|. .+.++..|+||+..
T Consensus 486 as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 99999999999999997 58999999999853
No 224
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.5e-43 Score=343.72 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=217.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34557799999999999999999999999999999999765433334456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|+||+.| +|.+.+. .+.+++..+..++.||+.||.|||+.||+||||+|.||+++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 6766664 36799999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CC-CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RC-PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~ 245 (417)
.....|++.|+|||++.. .+..+.++||||+||++|+|++|+.||...+.......+..... .. +..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 234568899999999742 22235899999999999999999999998876665555544332 22 23457889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.++|.+||..||++|||+.+++.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999998754
No 225
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=3.2e-43 Score=333.17 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=221.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++......|+|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765421 34678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. +.+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999999999976 789999999999999999999999 999999999999999999999999999987654321 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCC-CCCCCC-CChHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGE-YRCPKW-TSPDLKWF 248 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~-~~~p~~-~s~~~~~l 248 (417)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+.... ...+.. .+..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 235678999999999887765 48999999999999999999999876 4555566655433 334444 78899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999974
No 226
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.8e-43 Score=333.88 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=204.7
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999864 4689999999999999999999999999999999999999999999999999864321111000111123
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+.......+... ....|...+..+.+|+.+||++||
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4569999999877764 89999999999999997 99999877766655555443 345566678999999999999999
Q ss_pred CCCCCHHHHhc
Q 014849 258 ATRITVDEILR 268 (417)
Q Consensus 258 ~~R~t~~eil~ 268 (417)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
No 227
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=5.7e-43 Score=328.90 Aligned_cols=254 Identities=31% Similarity=0.566 Sum_probs=220.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 94 (417)
+|.+.+.||+|++|.||.|.+..+++.|++|++...... ......+.+|+.++++++||||+++++.+.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999999766432 33467888999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999876 5899999999999999999999999999999999999999999999999999876654322112
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhc--CCCCCCCCCChHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYK--GEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 250 (417)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+.. .....|...+..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999887765 489999999999999999999998765 3333333332 334556677899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..||++|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
No 228
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2e-43 Score=339.74 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=212.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 357999999999999999999853 456789999986532 22234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 91 IYFVMEFAKGGELFAKISK------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999998842 2378889999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................++..|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222223445567789999999877664 89999999999999998 999998877766666655
Q ss_pred cCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... ...|...++.+.+++.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45667789999999999999999999999999875
No 229
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=5.9e-43 Score=329.17 Aligned_cols=252 Identities=35% Similarity=0.629 Sum_probs=221.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|+++++.++|||++++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999999999999876432 2346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 7899999999999999999999999999999999999999999999999999876543222 234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCCCCCCCCChHHHHHHHHhcc
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......++. ......|...++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999877765 489999999999999999999998766554444433 33445666778999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 014849 255 TDPATRITVDEILRDPWF 272 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f 272 (417)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999998
No 230
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=2.2e-43 Score=350.39 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=213.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456899999999999999999999999999999999976432 222345678899999999999999999988543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|++++++ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3578888887 7799988887889999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
.......||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2234457899999999987644345899999999999999999999987665554443322110
Q ss_pred ------------CC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 ------------RC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 ------------~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.. ....++++.++|.+||++||.+|||+.+++.||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00 1124788999999999999999999999999999997543
No 231
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=2e-43 Score=339.27 Aligned_cols=251 Identities=31% Similarity=0.503 Sum_probs=209.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||.|++|.||+|.+..+|+.||+|++..+.. .......+.+|+.+++.++|||++++++++.+....|+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 7889999999999999999999999999999976542 223345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 98 AKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 98 ~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+. ++|.+++.. . .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 589988865 3 5899999999999999999999999999999999999999999999999998654321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------- 234 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------- 234 (417)
....+++.|+|||++.+....+.++||||+||++|+|++|++||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578999999998765444589999999999999999999998776544433332210
Q ss_pred ---C------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ---Y------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ---~------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ......++.+.++|.+||++||.+|||++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 1123456889999999999999999999999999998
No 232
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1e-43 Score=339.96 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred cccccCCeEEeeEE--eeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 014849 11 EVNLFGKYEVGKII--GCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~ 87 (417)
.....++|++.+.+ |+|+||.||++++..++..+|+|++....... .|+.....+ +||||+++++.+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34556788888777 99999999999999999999999987653211 122222222 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~ 165 (417)
.+..|+||||++|++|.+++.. +.+++.+++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999999976 5899999999999999999999999999999999999999998 9999999998654
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCCC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWT 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~ 241 (417)
.. .....|++.|+|||++.+..++ .++||||+||++|+|++|..||....... ............++..
T Consensus 161 ~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T PHA03390 161 GT------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233 (267)
T ss_pred CC------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccccc
Confidence 32 1234689999999999888875 89999999999999999999998654322 1222223444556678
Q ss_pred ChHHHHHHHHhccCCCCCCCC-HHHHhcCccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRIT-VDEILRDPWFKK 274 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t-~~eil~h~~f~~ 274 (417)
++.+.+||.+||++||.+||+ ++++++||||++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999999996 699999999973
No 233
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=3.4e-43 Score=334.94 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=213.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+.+....|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5799999999999999999998654 4579999986543 2333567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999865 5799999999999999999999999999999999999999999999999999876542111
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+ ..+.|...++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999999877775 89999999999999997 99999887777777777654 334566678999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||+.+|++|||+.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999875
No 234
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=1.8e-43 Score=346.23 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=210.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..+|++.+.||+|+||+||+|.+..+|+. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35799999999999999999998776664 8999986432 223456788999999999999999999998765 5
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++|+||+.+|+|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+..+ ..+.|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211111223456789999999887775 89999999999999997 99999987766655444433 2355677889999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999987
No 235
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=2.6e-43 Score=347.76 Aligned_cols=265 Identities=27% Similarity=0.362 Sum_probs=217.2
Q ss_pred cccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----------chHHHHHHHHHHHHhCCCCCcce
Q 014849 13 NLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----------GLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 13 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
.+.+||.. .+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46788975 6889999999999999999999999999875432211 01225778999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
+++++......|+||||+. |+|.+.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 589888865 67999999999999999999999999999999999999999999999999
Q ss_pred ecceeeccc------------CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 014849 160 GLSAVKEQI------------RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY 227 (417)
Q Consensus 160 Gls~~~~~~------------~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~ 227 (417)
|++...... ..........+++.|+|||.+.+....+.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754310 01112234467889999999876554568999999999999999999999988766655
Q ss_pred HHHhcCC--C--------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 228 RKIYKGE--Y--------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 228 ~~i~~~~--~--------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..+.... . ......+.++.++|.+||+++|++|||++|++.||||+.....
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 5443210 0 0012347889999999999999999999999999999876543
No 236
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-44 Score=314.17 Aligned_cols=256 Identities=30% Similarity=0.531 Sum_probs=220.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|.-.+.||+|++|+|++|++++|++.||+|.+..+. .+++......|||.+|+.++|.|||+++++..+..++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46778889999999999999999999999999998765 34556678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.|||+||+|+|++.||.+|++|||+++.+.- +-.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 99965 88887765 8899999999999999999999999999999999999999999999999999986543 2233
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcC-------CCC---------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKG-------EYR--------- 236 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~-------~~~--------- 236 (417)
....+-|.+|++|.++.+...++.+.|+||.|||+.|+. +|.+.|.+.+..+...+|.+- .++
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 445567999999999988776679999999999999997 589999999888888777541 110
Q ss_pred ----CCC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ----CPK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ----~p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+|. ..+..-++|++++|.-+|.+|+++++.++||||.+.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 111 123456899999999999999999999999999753
No 237
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=2.9e-43 Score=337.87 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=206.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI-MSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+.|++.+.||+|+||.||+|++..+|+.||+|.+....... ...++..|+.+ ++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46999999999999999999999999999999987653221 23445556664 6777999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
|||++ |+|.+.+.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 477666542 4689999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCCcccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC-CCCCC-CCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKG-EYRCP-KWT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~-~~~~p-~~~ 241 (417)
.......|+..|+|||++.+ .++ +.++|+||+||++|+|++|..||... +..+....+..+ ....| ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 11233568899999998864 334 48899999999999999999999753 222223333322 23333 346
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.++.++|.+||..+|++|||+.++++||||++...
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 889999999999999999999999999999997643
No 238
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=4.5e-43 Score=339.18 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=211.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999866532 223346778999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCC
Q 014849 95 MEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~ 170 (417)
|||+++ +|.+.+.. . .+++..+..++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 78777754 2 3688889999999999999999999999999999999985 456999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---------------- 234 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 234 (417)
........|++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+...++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345678999999998765444589999999999999999999998776655554432110
Q ss_pred -------CC------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 -------YR------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 -------~~------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+. ..+..++++.+++.+||+.||++||++.++++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 112357889999999999999999999999999999864
No 239
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=7.1e-43 Score=331.72 Aligned_cols=250 Identities=31% Similarity=0.556 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++.+.+....++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999997654444444678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999988853 45899999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCC-CCCC-CCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKGEY-RCPK-WTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~-~~p~-~~s~~~~ 246 (417)
........|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||... +.......+..+.+ +.|. ..+..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2223445789999999999887775 8999999999999999999999654 33445555554443 2343 5788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
No 240
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=2.5e-43 Score=348.61 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=212.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+..+|++.+.||+|+||.||.|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999999876432 222345677899999999999999999987644
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..+|+|+||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 588888865 7899999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------------- 233 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 233 (417)
. .....+..|+..|+|||++......+.++||||+||++|+|++|++||.+.+.......+...
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 123345678999999999876443468999999999999999999999876543332222110
Q ss_pred --------------CC---CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 234 --------------EY---RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 234 --------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.. ...+..++++.+||++||++||++|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0123468889999999999999999999999999999764
No 241
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=3.2e-43 Score=330.89 Aligned_cols=246 Identities=43% Similarity=0.736 Sum_probs=222.4
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||.|.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++++.++..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999989999999999887655555567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 579999999999999999999999999999999999999999999999999987653321 23345678999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t 262 (417)
|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....+..|...+..+.+++++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999887665 4899999999999999999999998887888888888888888888999999999999999999999
Q ss_pred H---HHHhcCccc
Q 014849 263 V---DEILRDPWF 272 (417)
Q Consensus 263 ~---~eil~h~~f 272 (417)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
No 242
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=4.2e-43 Score=330.95 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=214.8
Q ss_pred eEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654322 4678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 99 KGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 99 ~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999875 56899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........+++.|+|||.+....++ .++|||||||++|+|++ |..||...........+..+. ...|...++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 222233455678999999998877664 89999999999999998 699999988888888877543 456778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||+.||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
No 243
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=5.6e-43 Score=333.76 Aligned_cols=247 Identities=31% Similarity=0.500 Sum_probs=206.2
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
...||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+...+|+|+||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 4589999999999999999999999998865432 2356788999999999999999999999999999999999999
Q ss_pred CChHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCCCCccc
Q 014849 101 GELFAKISK--GRF--SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 101 g~L~~~i~~--~~l--~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
++|.+.+.. +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 999999875 455 88899999999999999999999999999999999976 678999999998654321 12233
Q ss_pred ccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH-HhcCCCCCCCCCChHHHHHHHH
Q 014849 176 TLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM--AMYRK-IYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~li~~ 251 (417)
...|++.|+|||++.+.. ..+.++|+||+||++|+|++|..||...... ..... ........|...++++.+|+++
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 346899999999986543 2358999999999999999999999754322 22221 1223345677788999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||+.+|++|||+.|++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
No 244
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=3.6e-43 Score=334.85 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=209.6
Q ss_pred eEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 90 (417)
|.+++.||+|+||.||.|.... ++..||+|.+..+... ......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999998765 4478999998765332 2235678899999999999999999998765443
Q ss_pred --EEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 91 --IYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 91 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
.++++||+++|+|...+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999888732 3589999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+................++..|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. ...|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8754332221122233456789999998777664 89999999999999998 999999888777777766553 45677
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999865
No 245
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=1.4e-43 Score=340.60 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=214.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+|++.+.||+|+||+||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 34688999999999999999987543 5789999997543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999998742 2478888999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................+++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222223344567899999998776664 89999999999999998 899999988888888887
Q ss_pred cCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.. ..|...+..+.+|+.+||+.+|.+|||+.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7654 4567788999999999999999999999999864
No 246
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=2.5e-43 Score=335.41 Aligned_cols=250 Identities=30% Similarity=0.539 Sum_probs=212.9
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.+|||.+............++.+|+.+++.++||||+++++++.+....+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999999999999999887654434444567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998752 46899999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCCCC--CCCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL--MAMYRKIYKGEYR--CPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~--~p~~~s~~~~ 246 (417)
.......+|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+... ......+....++ .+...++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 1223456799999999999887765 899999999999999999999976432 3444444443332 2245788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998864
No 247
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1e-42 Score=335.91 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=212.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIYF 93 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 93 (417)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....++.+|+++++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999976432 2345678899999999999999999998854 457999
Q ss_pred EEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 94 VMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
||||++|++|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887642 5689999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCCC-CCC----
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGEY-RCP---- 238 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~~-~~p---- 238 (417)
.......++..|+|||.+.+..++ .++|||||||++|+|++|.+||... ...+....+..... ..+
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 112245678899999999887775 8999999999999999999999865 22344444433211 111
Q ss_pred --CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 239 --KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 239 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
...++.+.++|.+||.+||++|||+.|++.||||++...+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1235789999999999999999999999999999765543
No 248
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=3.3e-43 Score=347.48 Aligned_cols=264 Identities=31% Similarity=0.445 Sum_probs=216.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe--C
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT--K 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~--~ 88 (417)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +||||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 4577899999999999999999999999999999999865322 122245577899999999 99999999998864 3
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...|+||||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 478999999975 9999988778899999999999999999999999999999999999999999999999998754332
Q ss_pred CC---CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Q 014849 169 RP---DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------- 234 (417)
Q Consensus 169 ~~---~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 234 (417)
.. ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 1233456789999999998765555689999999999999999999998766554433322110
Q ss_pred ----------------C----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 235 ----------------Y----RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 235 ----------------~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. ...+..+.++.++|.+||+.||++|||+.++++||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0 011225788999999999999999999999999999987543
No 249
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=5e-43 Score=335.17 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=214.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3568999999999999999999986544 789999986442 122345678999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 89 AKIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
...|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 999999999999999998853 236788999999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 235 (417)
|||++................+|..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99998754332222223445678899999998776664 89999999999999998 999999888777777766543 4
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...+.++.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5577778999999999999999999999999753
No 250
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=4.1e-43 Score=334.84 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=207.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------KA 89 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~ 89 (417)
|.+++.||+|+||.||+|.+..+++ .+|+|.+..... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999987776 699998876432 22335678899999999999999999997632 23
Q ss_pred EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
..+++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887731 34889999999999999999999999999999999999999999999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 240 (417)
................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+......+..+..+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 764322211112233567789999999877764 89999999999999998 8999998887787777776543 45566
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+.++|.+||++||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78899999999999999999999999864
No 251
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=6.7e-43 Score=335.01 Aligned_cols=252 Identities=33% Similarity=0.548 Sum_probs=212.5
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIYFVM 95 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 95 (417)
|++.+.||+|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.++|||++++++++.+. ...|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2334456788999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++ +|.+.+.. ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 4799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------------------ 235 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 235 (417)
.....++..|+|||.+.+....+.++||||+||++|+|++|+.||...+......++.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 33446788999999877654446899999999999999999999998876665555443110
Q ss_pred -----C-------CCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -----R-------CPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -----~-------~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .... .++.+.+++++||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 0011 27889999999999999999999999999998
No 252
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=4.2e-43 Score=336.74 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999987 78899999886443 2223456888999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEee
Q 014849 90 KIYFVMEFAKGGELFAKISKG--------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISD 158 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~D 158 (417)
..|+||||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999998642 488999999999999999999999999999999999998765 599999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYR 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~ 236 (417)
||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9998754221111111223345679999999877775 99999999999999996 99999988777766665543 345
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|...+..+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567788999999999999999999999999987
No 253
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=7.4e-43 Score=330.71 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=210.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|+||.||+|... .+..+|+|.+..... ...++.+|+.+|+.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999884 456899998864432 2457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++||+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eec
Confidence 99999999998864 568999999999999999999999999999999999999999999999999886432111 111
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||++....+. .++||||+||++|+|++ |+.||...+..+....+..+.. ..|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345679999999877775 89999999999999999 9999999888888888776543 3466678899999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 014849 252 LLDTDPATRITVDEILR 268 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~ 268 (417)
||+.||++|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
No 254
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=7.7e-43 Score=332.16 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=213.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++||||+++++++.....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 46999999999999999999999999999999986542 12467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|...++++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122346679999998877775 88999999999999998 99999988888877777654 34566778899999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 014849 251 RLLDTDPATRITVDEILRD 269 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h 269 (417)
+||+.||++|||+.++++.
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHccCCcccCCCHHHHHHH
Confidence 9999999999999999763
No 255
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=2.7e-43 Score=343.15 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=209.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcE--EEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQS--VAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
-.+.|++.+.||+|+||.||+|.+..+|.. +|+|.+... ........+.+|+.++.++ +||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 356899999999999999999999888865 466665432 2233456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 91 IYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999999999998863 14789999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||++...... .......+++.|+|||++....+ +.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999998532211 01111234667999999877766 489999999999999998 9999998887777776654
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+. ...|...++++.+|+.+||+.+|++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 42 33455578999999999999999999999999987
No 256
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=1.5e-42 Score=330.44 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=216.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
..|++++.||+|+||.||+|.+..+|+.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1223456788999999999999999999998664 568
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
++++||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999875 6799999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKW 247 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 247 (417)
........|++.|+|||.+.+..++ .++|+|||||++|+|++|..||..........++... ....|...++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345689999999999887764 8999999999999999999999887666555555433 23457778999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+|.+||+ +|..|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
No 257
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=6.1e-43 Score=340.97 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=213.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYE 83 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~ 83 (417)
....++|.+++.||+|+||.||+|.+.. ++..+|+|.+..+. .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3446899999999999999999998753 33579999997643 222346788899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
++.....+|+||||+++|+|.+++... .++..+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999998642 478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999998654321111111222345789999999877764 89999999999999998 999999888877
Q ss_pred HHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 226 MYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 226 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...+..+. ...|...+.++.+|+.+||..+|++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777776554 35566778999999999999999999999999876
No 258
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-44 Score=363.27 Aligned_cols=245 Identities=35% Similarity=0.523 Sum_probs=217.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.+...|++...+|.|+|+.|..+.+..+++..++|++.+.. .+..+|+.++... +||||+++++++.+...+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 46788999999999999999999999999999999998762 2334677666555 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe-cCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL-DENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl-~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 999999999999999987665558899999999999999999999999999999999 6899999999999865432
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
...+.|-|..|+|||++...+|+ +++||||||++||+||+|+.||..... .++...+..+.+. .+.|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 25677889999999999999997 999999999999999999999976544 4777777666655 88999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
++||++||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
No 259
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=1.7e-43 Score=350.48 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=205.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT-K 88 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~-~ 88 (417)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 58999999999999999999754 3567899999875432 22245677899999999 89999999998754 4
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
..+|++|||+++++|.+.+..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 678999999999999988742
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccc
Q 014849 110 ---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186 (417)
Q Consensus 110 ---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~AP 186 (417)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999998754322211122334567789999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 014849 187 EILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY-RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITV 263 (417)
Q Consensus 187 Evl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 263 (417)
|++.+..++ .++|||||||++|+|++ |..||.+....+.. ..+..+. ...|...++++.+++.+||+.+|++|||+
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999888876 89999999999999997 99999875543333 3333322 34456678999999999999999999999
Q ss_pred HHHhcC
Q 014849 264 DEILRD 269 (417)
Q Consensus 264 ~eil~h 269 (417)
.|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999876
No 260
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=5.5e-43 Score=340.11 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=208.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK------ 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------ 88 (417)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .........+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 6899999999999999999999999999999999876542 222234567899999999999999999887433
Q ss_pred --CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 89 --AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..+|+|+||+.+ +|...+.. ..+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 67666653 5799999999999999999999999999999999999999999999999999875
Q ss_pred ecccCCC---------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Q 014849 165 KEQIRPD---------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 165 ~~~~~~~---------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
....... .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4322111 1123346789999999987654445899999999999999999999998877665555432110
Q ss_pred -----------------------CCC-------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -----------------------RCP-------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -----------------------~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+ ...++.+.++|.+||..||.+|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1234678899999999999999999999999998
No 261
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=6.8e-43 Score=338.67 Aligned_cols=257 Identities=29% Similarity=0.508 Sum_probs=212.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 457889999999999999999999999999999999976532 2233456778999999999999999999987654
Q ss_pred -------EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 -------KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 -------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.+|+|+||+++ +|...+.. ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999987 67666654 479999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--C---
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--Y--- 235 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~--- 235 (417)
++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|++||...+..+....+.... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9876533211 122233568889999998765444689999999999999999999998877665554443310 0
Q ss_pred -------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
......++.+.+++.+||+.||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011357889999999999999999999999999997
No 262
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.1e-42 Score=335.72 Aligned_cols=259 Identities=35% Similarity=0.576 Sum_probs=219.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.|++.+.||.|+||.||.|.+. .+|+.||+|++....... .....++.+|+.+++.+ +||||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 488999999997654322 23356788999999999 589999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999875 679999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.......+|+..|+|||.+... ...+.++||||+||++|+|++|..||... ....+...+.....+.|...++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223456789999999998653 23358899999999999999999999743 234455555556666777789999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
.+++.+||+.||++|| ++++++.||||++..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998653
No 263
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=4.9e-43 Score=338.46 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=213.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++.+.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 468999999999999999999986543 7899999876432 22345688999999999 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 89 AKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
..+|++|||+.+|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999998842 458899999999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKI 230 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 230 (417)
+.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||...+..+.+..+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999998764432211112223356789999998877775 89999999999999997 99999998888877777
Q ss_pred hcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+. ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6554 34566678999999999999999999999999875
No 264
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=7.5e-44 Score=371.44 Aligned_cols=246 Identities=30% Similarity=0.486 Sum_probs=206.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEE-EE---e---
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEV-LA---T--- 87 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~-~~---~--- 87 (417)
.+++|.+.|.+|+|+.||+|++...|..||+|.+-.. ++.....+++||.+|++|+ |||||.+++. .. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4678899999999999999999988899999988654 4556788999999999997 9999999993 21 1
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.-.++|.||||.||.|-+++.+ .+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 1358899999999999999974 57999999999999999999999997 999999999999999999999999988
Q ss_pred eeecccC--CCCc--c---cccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Q 014849 163 AVKEQIR--PDGM--L---HTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 163 ~~~~~~~--~~~~--~---~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 232 (417)
+-.-... ..+. + -...-||.|+|||.+. +.+ .+.|+|||+|||+||-|+....||++... -.|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe
Confidence 6321111 0000 0 0123599999999864 444 46999999999999999999999998743 24678
Q ss_pred CCCCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 233 GEYRCPK--WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 233 ~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.|.+|+ .++..+++||+.||++||.+||+|.+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 8888776 579999999999999999999999999854
No 265
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=6.5e-43 Score=339.08 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=217.3
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|+-...||+|+||.||.|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 344578999999999999999999999999885432 22356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
+++++|.+.+..+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999998888889999999999999999999999999999999999999999999999999876443211 122345
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHHHHhcc
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~ 254 (417)
+|++.|+|||.+.+..+ +.++|+||+||++|+|++|.+||...........+.... .......++++.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999877666 489999999999999999999998877665555443322 22334468899999999999
Q ss_pred CCCCCCCCHHHHhcCccccccccc
Q 014849 255 TDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.||.+||++.+++.||||.+...+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999987643
No 266
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=4.6e-43 Score=355.11 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56788999999999999999987543 3479999996542 2233567889999999996 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
..+|+|||||++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999887743
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 110 --------------------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 110 --------------------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHH
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRK 229 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~ 229 (417)
+.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... ..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999998754332222222344577889999999887775 89999999999999996 99999876443 33444
Q ss_pred HhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 230 IYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 230 i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+..+ ....|...++++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433 23445667889999999999999999999998865
No 267
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.3e-42 Score=337.92 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=216.0
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEc-------cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNV-------RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKL 81 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l 81 (417)
.-....++|++++.||+|+||.||.|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 33456789999999999999999999753 234579999987542 222356788999999999 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~ 144 (417)
++++......|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999988642 3677888999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 014849 145 NLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNL 223 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~ 223 (417)
|||++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999998755432222223334567889999999887775 88999999999999998 8999999888
Q ss_pred HHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 224 MAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 224 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++...+..+. ...|...+..+.+|+.+||.++|++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88887776543 34456678999999999999999999999999875
No 268
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=5.9e-43 Score=344.05 Aligned_cols=259 Identities=31% Similarity=0.445 Sum_probs=218.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
||++.+.||+|+||.||+|++..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987643 12334567889999999999999999999987775 89
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 88888876 5899999999999999999999999999999999999999999999999999886543221
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR------------- 236 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 236 (417)
........+|+.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112344568999999999987733458999999999999999999999988877766665432110
Q ss_pred ------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++++.++|.+||+++|.+|||+++++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 01225788999999999999999999999999999987544
No 269
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=1.1e-42 Score=337.56 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=209.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 92 (417)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.+++++ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999987775 46888776322 222356788999999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 93 FVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
+|+||+++++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999999864 2488899999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++....... .......+..|+|||++....++ .++|||||||++|+|++ |.+||.+.+..+...++..+.
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999985322110 01112235579999999877775 89999999999999997 999999988888877776553
Q ss_pred -CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 235 -YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 235 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...|...++++.+|+.+||+.||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566688999999999999999999999999765
No 270
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=4.3e-43 Score=332.75 Aligned_cols=247 Identities=22% Similarity=0.399 Sum_probs=213.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++++.||.|+||.||+|.+.. ++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4569999999999999999999977 89999999876532 2255788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 999999999999975 46899999999999999999999999999999999999999999999999998654221 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.......+++.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+.+..+..+ ..+.|...++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 112233457789999999877765 88999999999999998 89999988877777777654 3455667889999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||+.||++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
No 271
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.5e-44 Score=354.23 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=211.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 93 (417)
...|++.+.||+|+.++||++...+. +.+|+|.+.... .+......+.+||..|.+|+ |.+||+|++|-.+++.+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45799999999999999999998544 456666554332 34556788999999999995 9999999999999999999
Q ss_pred EEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||-+- +|...+.++ -.+....+.|.+|++.|+.++|.+||||-||||.|+|+- .|.+||+|||+|.........
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9998754 999999873 345458999999999999999999999999999999984 468999999999876554445
Q ss_pred CcccccccCccccccccccccCCC----------CChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCC--CCCC
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYD----------GAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGE--YRCP 238 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~----------~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~~p 238 (417)
-...+.|||+.|||||.+....++ +.++||||||||||+|+.|++||..-. ...-+..|.... ..+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 566788999999999998654443 678999999999999999999997643 444445555543 3566
Q ss_pred CCCChH-HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 KWTSPD-LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ~~~s~~-~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+.. +.++++.||..||++|||+.++|+|||.+-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 555544 999999999999999999999999999974
No 272
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-44 Score=360.55 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=222.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|.=.+.||+|+||.||.|++..+.+.||||.++.+.-...+-...|.+|++.|++++|||+|.+-++|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35667889999999999999999999999999998877666566778999999999999999999999999999999999
Q ss_pred eccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||-| +-.|++. +.++.|.++..|+.+.+.||+|||+++.||||||..||||++.|.|||+|||.+.+.. +
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------P 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------P 178 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------c
Confidence 99966 6677765 4689999999999999999999999999999999999999999999999999987653 3
Q ss_pred ccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-CCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP-KWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li 249 (417)
..+.+|||+||||||+. ..|.++-++||||||+...+|...++|+-..|.+...--|...+.+ ++ ..+|..++.|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 46789999999999986 3343448899999999999999999999888888666666555433 22 33588899999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..||++-|..|||.++++.|+|......
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 9999999999999999999999875443
No 273
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=1e-42 Score=336.63 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=212.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 457999999999999999999864 3456799998865432 22456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999854 2378999999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.++|+|||++................|++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998654322111222345578899999999887765 89999999999999998 999998888877777776
Q ss_pred cCCCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66543 455568899999999999999999999999753
No 274
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=8.8e-43 Score=336.90 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=210.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC----------------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG----------------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 5689999876532 2346778899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhc-C-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-G-----------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~-----------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
+++++++......++||||+.+++|.+++.. . .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999865 2 589999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLM 224 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~ 224 (417)
+++.++.++|+|||++................+|+.|+|||.+....+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875433222222334556789999999887666 499999999999999987 78899887766
Q ss_pred HHHHHHhcC--------CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 AMYRKIYKG--------EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..+..+... ....|...+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666555432 12334556789999999999999999999999964
No 275
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=2.8e-42 Score=340.31 Aligned_cols=259 Identities=31% Similarity=0.490 Sum_probs=214.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 91 (417)
.+.++|++.+.||.|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 357899999999999999999999999999999999875432 22335678899999999999999999999865 5679
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||+ +++|...+..+.+++..+..++.|+++||.|||++||+||||+|.|||++.++.+||+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 9999999 5689988888889999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------------- 232 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 232 (417)
....+..+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2223456789999999986633335899999999999999999999987654332211110
Q ss_pred -------CCCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 -------GEYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 -------~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..... .+..++.+.++|++||+.+|++|||+++++.||||+....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00011 12357889999999999999999999999999999765443
No 276
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.3e-42 Score=374.13 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||.||+|++..+|+.||+|++..+.........++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765433344566788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 95 MEFAKGGELFAKISK------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
|||++||+|.+.+.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998753 23456678899999999999999999999999999999999999999999999
Q ss_pred eeecccCC----------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 014849 163 AVKEQIRP----------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM 226 (417)
Q Consensus 163 ~~~~~~~~----------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~ 226 (417)
........ .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521100 0111235799999999999887774 899999999999999999999987654433
Q ss_pred HHHH-hcCCCC--CCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 227 YRKI-YKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 227 ~~~i-~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.... ...... .....++.+.+++.+||..||++||+..+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2221 111111 1234678899999999999999998755544
No 277
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.9e-43 Score=365.43 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=198.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccC-CcEEEEEEe--------------ecccccccchHHHHHHHHHHHHhCCCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAV--------------SKQKILRGGLTAHVKREISIMSRLRHP 76 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i--------------~~~~~~~~~~~~~i~~Ei~il~~l~Hp 76 (417)
..+.++|++++.||+|+||+||+|..+.. +...+.|.+ .+..........++.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34568999999999999999999976543 222332211 111111122345688999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKG------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE 150 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~ 150 (417)
||+++++++.+....|+|+|++. ++|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 4777776432 2346778899999999999999999999999999999999
Q ss_pred CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCC-CCCCC--CHHHHH
Q 014849 151 NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYL-PFNDP--NLMAMY 227 (417)
Q Consensus 151 ~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~-Pf~~~--~~~~~~ 227 (417)
++.+||+|||++....... .......+||+.|+|||++.+.+|+ .++|||||||++|+|++|.. ||... +....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999997654321 1223356899999999999988875 89999999999999999875 44332 222222
Q ss_pred HHHhcC------CCC---------------------CC-----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 228 RKIYKG------EYR---------------------CP-----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 228 ~~i~~~------~~~---------------------~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++... +++ .+ ...+.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 221110 000 00 1235677888999999999999999999999999764
Q ss_pred c
Q 014849 276 Y 276 (417)
Q Consensus 276 ~ 276 (417)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
No 278
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=6e-44 Score=357.51 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=223.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|..++.||-|+||+|.+++..+|...+|+|.+.+..+.......+++.|-.||.....+.||+||..|.++..+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 45688999999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc-----
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI----- 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~----- 168 (417)
|+|++||++..++-+ |-|+|+.|+.|+.+|..|+++.|..|+|||||||+|||||.+|++||+||||++-+...
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999988765 89999999999999999999999999999999999999999999999999998743110
Q ss_pred -------CCC----------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc
Q 014849 169 -------RPD----------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 169 -------~~~----------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~ 213 (417)
+.+ -..+..+||++|+||||+...+|. ...|+||.|||||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhh
Confidence 000 012456899999999999999996 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhc--C--CCCCCCCCChHHHHHHHHhccCCCCCCC---CHHHHhcCccccc
Q 014849 214 GYLPFNDPNLMAMYRKIYK--G--EYRCPKWTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKK 274 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~--~--~~~~p~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~ 274 (417)
|++||.+.+..+...++.. . .+..-..+|+++.+||.++.+ +++.|. ..+++..||||+.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 9999988766554444332 1 122334579999999998764 788898 4778999999985
No 279
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=2.4e-42 Score=338.20 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=216.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....+.|...+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++|||++++++++.+....
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 34455688888999999999999999999999999999865443444456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.| +|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 999999965 77776653 578999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 245 (417)
......|+..|+|||++.. .+..+.++|||||||++|+|++|..||...+......++.....+. ...++..+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 2234678999999999852 2323588999999999999999999998877666555554443321 22356789
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++|+.+||+.+|.+|||+.+++.||||+...
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999998644
No 280
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=3.5e-42 Score=322.18 Aligned_cols=248 Identities=33% Similarity=0.578 Sum_probs=214.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999998999999999976543 235788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999999876 4799999999999999999999999999999999999999999999999999876543221 3
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCC--CCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCP--KWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p--~~~s~~~~~li~~ 251 (417)
....|+..|+|||.+....+ +.++|+||+|+++|+|++|..||...+............ ...+ ...+..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999887665 489999999999999999999998875444433333222 2222 2237889999999
Q ss_pred hccCCCCCCCCHHHHhcCcc
Q 014849 252 LLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~ 271 (417)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
No 281
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=3.5e-42 Score=326.99 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=209.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...++.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 357999999999999999999974 557899999865432 245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999999999875 25899999999999999999999999999999999999999999999999998765421111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
......++..|+|||++.+..++ .++|||||||++|+|++ |++||.+.+.......+... ....+...++.+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11112234579999998877764 89999999999999999 99999988877777776554 2345566789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||+.+|++||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999864
No 282
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-45 Score=391.23 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=228.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.-||.-+..+|.|.||+||-|.+..||...|+|.+..+... ......+.+|..++..++|||+|++|++-.+.+..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34566888999999999999999999999999999999776544 44567889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc--
Q 014849 92 YFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI-- 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~-- 168 (417)
||.||||.||+|.+.+..| -.+|...+.|..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|......
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999999999985 5788889999999999999999999999999999999999999999999988654332
Q ss_pred CCCCcccccccCccccccccccccC--CCCChhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCCCCCCCCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~--y~~~~sDIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
.-.+.+....|||.|||||++.+.. -.+.++|||||||+..||.||+.||.. .+-.-||+--....+++|...|++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 1234667789999999999997543 235789999999999999999999974 334455655555567889999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.++||.+||..||.+|+++.||++|-|-+.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999987654
No 283
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=1.5e-42 Score=334.15 Aligned_cols=258 Identities=31% Similarity=0.528 Sum_probs=223.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
......|++.+.||+|+||.||.|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++.+......
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 4567789999999999999999999988999999999976532 356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|+||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 169 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE- 169 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc-
Confidence 9999999999999999874 7999999999999999999999999999999999999999999999999987643321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-C--CCCCCChHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-R--CPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~ 246 (417)
........+++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..... . .+..++.++.
T Consensus 170 -~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 170 -KSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred -hhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 1122345688999999999877765 899999999999999999999998776655555543332 2 2233678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++|.+||+.+|.+|||+.+++.|+||++..
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 999999999999999999999999999843
No 284
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=2.5e-42 Score=331.48 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=210.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..+|++.+.||+|+||.||+|.+..+|+ .||+|++.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 4579999999999999999999887777 48999986543 223356788999999999999999999998754 4
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999865 57999999999999999999999999999999999999999999999999998765422
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+. .+.+...++++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 111111222346789999999887775 89999999999999998 999998877766666555543 344566789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||++|||+.++++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999853
No 285
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=1.7e-42 Score=343.49 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=210.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 457899999999999999999999999999999999876432 233355678999999999999999999998654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+|+||+.. +|...+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 357999999964 676655 3478999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------ 234 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 234 (417)
. ......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 1 22345688999999998764434589999999999999999999999877655544433210
Q ss_pred -----------CCC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 -----------YRC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 -----------~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
... .+..++++.+||.+||+.||.+|||+++++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12356789999999999999999999999999999864
No 286
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.1e-42 Score=338.41 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=211.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
.++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 4689999999999999999998643 34579999987542 222356788999999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD 149 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~ 149 (417)
+...+|+||||+++|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 99999999999999999998854 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 014849 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYR 228 (417)
Q Consensus 150 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 228 (417)
.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998754322221222223345789999999877764 89999999999999998 999999888888777
Q ss_pred HHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+. ...|...+.++.+++.+||..||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 776654 34566678899999999999999999999999864
No 287
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=1.7e-42 Score=328.48 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=209.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 35899999999999999999885 567899999865432 2356778999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 5689999999999999999999999999999999999999999999999999865432111 01
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..+ ....|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999999887775 89999999999999998 89999887777777776654 345566679999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
No 288
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=1.6e-42 Score=334.89 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=209.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... .....++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998754 335799998865432 12246788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 92 YFVMEFAKGGELFAKISK-------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
|+|+||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|+++++.+||+|||++...............+++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322211122334567889999998877765 89999999999999998 999999888777
Q ss_pred HHHHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+..+ ....|...+.++.+++.+||++||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76665543 34456678899999999999999999999999975
No 289
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=2.1e-42 Score=336.97 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=209.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
...++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3456899999999999999999975 3456689999987543 223356788999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.....|+||||+.+|+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+|++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999865 238999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE--YRCPKW 240 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 240 (417)
...............+++.|+|||.+....++ .++||||+||++|+|++ |..||.+.+..+.+.+..... ...|..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54322111112233467889999999877765 89999999999999998 999998877655444443332 234566
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.+++.+||.++|++|||+.|+++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999999999999999999975
No 290
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=6.5e-43 Score=344.25 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=205.3
Q ss_pred eEEeee--CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCG--AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
..||+| +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..+...|+|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345555 9999999999999999999999765432 2335788999999999999999999999999999999999999
Q ss_pred CCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC----
Q 014849 100 GGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG---- 172 (417)
Q Consensus 100 gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~---- 172 (417)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 358999999999999999999999999999999999999999999999998653221110000
Q ss_pred -cccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--------------
Q 014849 173 -MLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-------------- 236 (417)
Q Consensus 173 -~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 236 (417)
......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||..................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223567799999987642 1258999999999999999999999876655444333222110
Q ss_pred ---------------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 237 ---------------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 237 ---------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.+...++.+.+||++||+.||++|||+.|+++||||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 112246778999999999999999999999999999876553
No 291
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=3.8e-42 Score=337.19 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=218.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
....|+..+.||+|+||.||+|.+..+|+.||+|++............++.+|+.+++.++|||++++++++.+....|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34558899999999999999999999999999999986544444456688899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+.| +|.+.+. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~----- 176 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----- 176 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-----
Confidence 9999975 7777664 3679999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKW 247 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 247 (417)
......|++.|+|||++.. .+..+.++||||+||++|+|++|..||...+.......+....... +...++.+++
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred -CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 1234578999999999742 2233589999999999999999999998877666666665544322 2346788999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++.+||+.+|.+|||+.++++|+|+.....
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999999976543
No 292
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=2e-42 Score=332.83 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457889999999999999999743 456789999886542 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
..|++|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999998864 24789999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998654321111122234457889999999887775 89999999999999998 9999988877777766665
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+. ...|...++.+.++|.+||+.||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53 4556678899999999999999999999999974
No 293
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=2.8e-42 Score=370.15 Aligned_cols=149 Identities=33% Similarity=0.615 Sum_probs=139.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||+||+|.+..+++.||||++............++.+|+.+++.++||||++++.++.+...+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
|||+.|++|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999875 678999999999999999999999999999999999999999999999999875
No 294
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.6e-44 Score=358.80 Aligned_cols=247 Identities=31% Similarity=0.552 Sum_probs=216.0
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGE 102 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~ 102 (417)
+||+|+||+||.|+|..|...+|||.+.... ......+..||.+.+.|+|.|||++++.+..++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999996542 2336678899999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeEEeeeecceeecccCCCCccccc
Q 014849 103 LFAKISK--GRF--SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 103 L~~~i~~--~~l--~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
|.+++.. |++ .|...-.|-+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-+..... -+....|.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 888 8889999999999999999999999999999999995 578999999998875544 34456788
Q ss_pred ccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHH-HhcCCCCCCCCCChHHHHHHHHh
Q 014849 178 CGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRK-IYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 178 ~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~-i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
.||..|||||++.. .|| |.++|||||||.+.||.||++||..-. ...|++. ..+--++.|...|.+++.||.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 89999999999864 355 799999999999999999999997533 2344432 23445677888899999999999
Q ss_pred ccCCCCCCCCHHHHhcCcccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+||..||++.++|++||++.+
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999876
No 295
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=2.8e-42 Score=327.46 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=209.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||.|.+. .+..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 46999999999999999999874 345699998865432 2456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999875 4689999999999999999999999999999999999999999999999999865422111 01
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+..+.. ..|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1112345679999999877765 89999999999999998 9999998887777777766543 3455678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||.+||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999865
No 296
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.8e-42 Score=327.41 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=209.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+....|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 46899999999999999999997 4667899998865432 256788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999999998864 5688999999999999999999999999999999999999999999999999876432111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.......++..|+|||.+....++ .++|||||||++|+|++ |..||...+.......+..+. .+.+...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111223456789999998877664 89999999999999998 999999887777777666542 233445688999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..+|++|||++++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999864
No 297
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=2.6e-42 Score=325.52 Aligned_cols=250 Identities=34% Similarity=0.514 Sum_probs=220.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 599999999999999999999999999999999765432 2235567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 56899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~ 250 (417)
......|++.|+|||.+.+..++ .++|+||+|+++|+|++|+.||...+..+....+..+.++ .+...+.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33446789999999999887765 8999999999999999999999998887777777666543 45567899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..+|++|||+.++++||+.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
No 298
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=2.2e-42 Score=327.92 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=205.3
Q ss_pred EEeeeCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 23 IIGCGAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
.||+|+||.||+|.+ ..+++.+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 5678999999987543 23334677889999999999999999999875 4567999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-Ccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLC 178 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~~~~~ 178 (417)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999865 67999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 256 (417)
+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+.......+..+. .+.|...++++.++|.+||++|
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 46789999998776664 89999999999999997 999999888777777776654 4567778999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 014849 257 PATRITVDEILRD 269 (417)
Q Consensus 257 P~~R~t~~eil~h 269 (417)
|++|||+++|.+.
T Consensus 239 p~~Rp~~~~i~~~ 251 (257)
T cd05116 239 VDERPGFAVVELR 251 (257)
T ss_pred chhCcCHHHHHHH
Confidence 9999999999653
No 299
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=3.1e-42 Score=328.85 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.+.|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3569999999999999999999987765 59999987542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++||||+++++|.+++.. +.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998864 568999999999999999999999999999999999999999999999999986543222
Q ss_pred CCCcccccc---cCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 170 PDGMLHTLC---GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 170 ~~~~~~~~~---Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
......... ++..|+|||.+....++ .++||||+||++|+|++ |..||...+..+....+... ..+.|...++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111112 24579999999887775 89999999999999886 99999988877777776543 23445567889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+++.+||..+|++||++++++..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999753
No 300
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=2.4e-42 Score=333.06 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=212.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467999999999999999999874 367899999987543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
..|+|+||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999999999998863 1367888999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
+++.++.++|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998654322111122233456779999999887775 89999999999999997 889998888888
Q ss_pred HHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+..+.. ..|...++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777776654 456677899999999999999999999999875
No 301
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=1.1e-42 Score=345.14 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=204.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT- 87 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~- 87 (417)
.++|++++.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35899999999999999999985 35678999999975432 22356788999999999 68999999998754
Q ss_pred CCEEEEEEeccCCCChHHHHhc----------------------------------------------------------
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---------------------------------------------------------- 109 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---------------------------------------------------------- 109 (417)
...+++||||+++|+|.+++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999988753
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 110 ----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 110 ----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1357778889999999999999999999999999999999999999999999875432211112223345
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcC-CCCCCCCCChHHHHHHHHhccCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 256 (417)
++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999887775 89999999999999996 99999875433 233333333 34556778899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 014849 257 PATRITVDEILRD 269 (417)
Q Consensus 257 P~~R~t~~eil~h 269 (417)
|++|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999987
No 302
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=4.6e-42 Score=327.08 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=208.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+..+ ..||+|++..... ...++.+|+.+++.++||||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 357899999999999999999998655 4699999976432 24578899999999999999999998754 56899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999999875 3589999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
.......++..|+|||++.+..++ .++||||+||++|+|++ |.+||.+.........+..+. ...+...+..+.++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 112234467789999998877774 89999999999999999 899999887777777665542 34556678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999865
No 303
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=3.7e-42 Score=328.16 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=210.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++++.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3689999999999999999999875544 799999865432 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||++|++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 170 PDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
... ......+++.|+|||.+.+..++ .++|+|||||++|++++ |..||.+....+....+..+. .+.+...++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 11112235689999999877764 89999999999999886 999998887777776666542 334445688999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
No 304
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=4.4e-42 Score=330.46 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=207.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||+||+|.+..+|+. +++|.+.... .......+..|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46899999999999999999999888875 6666664321 12234567788889999999999999998754 45
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999964 57899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 246 (417)
..........|+..|+|||++.+..++ .++||||+||++|+|++ |..||.+.........+..+.. ..|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 222222345577889999999877775 99999999999999998 9999998776665555554443 34555678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||++|||+.|+++.
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999764
No 305
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.6e-42 Score=339.79 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=212.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRT-------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
...+|++++.||+|+||.||.|++... +..||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345899999999999999999987532 2369999887542 223356788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL 148 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl 148 (417)
.....+|+++||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 9999999999999999999988641 36778889999999999999999999999999999999
Q ss_pred cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 014849 149 DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY 227 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 227 (417)
+.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999998754332211122223345679999999887775 88999999999999998 89999998888888
Q ss_pred HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 228 RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 228 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+..+. ...|...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776653 34566678899999999999999999999999987
No 306
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=1.4e-42 Score=334.49 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=206.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 94 (417)
..|+..+.||+|+||.||++.+..+|+.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3567788999999999999999999999999998765422 33567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHH---Hh---cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 95 MEFAKGGELFAK---IS---KGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 95 ~E~~~gg~L~~~---i~---~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|||+.+ +|.++ +. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 44432 21 26799999999999999999999975 999999999999999999999999999864322
Q ss_pred cCCCCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCC-CC----CC
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEY-RC----PK 239 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~----p~ 239 (417)
........|++.|+|||++.+. ...+.++||||+||++|+|++|++||...+. .....++..+.. .. +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1222344689999999998766 2335899999999999999999999976542 223333333222 11 22
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..++++.+||.+||++||++|||+++++.||||+...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 3688999999999999999999999999999998643
No 307
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=2.5e-42 Score=334.59 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=205.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC--------------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcce
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG--------------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+++|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 359999987542 2234567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISKG-------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLL 147 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NIL 147 (417)
+++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 3678889999999999999999999999999999999
Q ss_pred ecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 014849 148 LDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLMA 225 (417)
Q Consensus 148 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~~ 225 (417)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999865432211112233445778999999887776 499999999999999987 778998877665
Q ss_pred HHHHHhc-----C---CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYK-----G---EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~-----~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+.. + ....+...++.+.+|+.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5544321 1 12234556889999999999999999999999965
No 308
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=1.2e-42 Score=331.06 Aligned_cols=247 Identities=32% Similarity=0.477 Sum_probs=205.6
Q ss_pred EEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
++.+.||.|+||.||.|... ..+..|+||++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 456789999995432 223367889999999999999999999999988889999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||+++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998765222122
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 249 (417)
.......+...|+|||.+....++ .++||||||+++|+|++ |+.||.+.+..+...++..+.. ..|...+..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 223345577889999999887764 99999999999999999 7899999888888888866553 45667899999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
No 309
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=4.4e-42 Score=331.28 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=217.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.|++.+.||+|+||.||+|++. .+++.||+|++.+.... ......++.+|+.+++.+ +||||+++++.+.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999765432 223356778999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.||+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999998875 67999999999999999999999999999999999999999999999999998654322 1
Q ss_pred CCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||... ...+....+.......|..+++++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223457899999999986543 2358999999999999999999999643 233445555666677788889999
Q ss_pred HHHHHHhccCCCCCCCC---HHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRIT---VDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t---~~eil~h~~f~~~~ 276 (417)
.++|.+||+.||++||| +.++++||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 57889999998643
No 310
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=1.9e-42 Score=328.45 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=215.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
||.+.+.||+|+||.||+|.+..++..+++|++...... ......++.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888888888887653321 222345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||+++++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999987742 56999999999999999999999999999999999999975 5699999999875432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+......++..+.. ..|...+.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12233455689999999998877775 889999999999999999999998877777777665543 3455678899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f 272 (417)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
No 311
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=4.7e-42 Score=325.94 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=208.8
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3568999999999999999999874 667899999876432 2456889999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 9999999999999864 458999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........++..|+|||.+.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+ ..+.|...+..+.+|
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 1111222356679999998776664 89999999999999999 99999988877777777654 445667788999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||.+||++|||+.++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999863
No 312
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=9.7e-42 Score=336.44 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=208.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccC--CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRT--GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT----KA 89 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~----~~ 89 (417)
+|++.+.||+|+||.||+|++..+ ++.||+|.+.... ........+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 599999999999999999999888 9999999987532 2223355678899999999 59999999987532 24
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+++||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589888865 68999999999999999999999999999999999999999999999999998754322
Q ss_pred CC--CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 169 RP--DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 169 ~~--~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112344679999999998765332358999999999999999999999876644433322210
Q ss_pred ------------C---CC---CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ------------E---YR---CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ------------~---~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .. .....+..+.+++.+||+.||++|||+.+++.||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0 00 01124788999999999999999999999999999987643
No 313
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=7.6e-42 Score=328.10 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=212.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4689999999999999999999877765 589998876532 2335678899999999999999999999887 78
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++|+||+.+|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999999875 46999999999999999999999999999999999999999999999999998764422
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 111111222345789999998777765 89999999999999998 999999988888777776654 455667789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||..||+.|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999865
No 314
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=2.6e-42 Score=330.57 Aligned_cols=251 Identities=33% Similarity=0.531 Sum_probs=212.1
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||+|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+|+.++||||+++++++.++...|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876543 223456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+.+ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88877765 589999999999999999999999999999999999999999999999999987654321 1233
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------CC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------YR 236 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~~ 236 (417)
...++..|+|||.+.+....+.++|+||+||++|+|++|+.||...+..+.+.++...- ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 35678899999998776334589999999999999999999998877666555443210 00
Q ss_pred C-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 C-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+..+.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 11257789999999999999999999999999997
No 315
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=6.6e-42 Score=328.47 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=207.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 90 (417)
|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988999999999975432 222344566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 91 -IYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+|++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888764 358999999999999999999999999999999999999999999999999987653
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----C-----
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-----R----- 236 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~----- 236 (417)
.. .......+++.|+|||++.+..+. .++|+||+||++|+|++|.+||.+.+..+.+.++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 223344688999999999877764 899999999999999999999998887776666543110 0
Q ss_pred ------C-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 ------C-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ------~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+..++.+.++|.+||+.||++||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01235778899999999999999999999999998
No 316
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=5.9e-42 Score=329.54 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=202.4
Q ss_pred cCCe-EEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 014849 15 FGKY-EVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-- 87 (417)
Q Consensus 15 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-- 87 (417)
.+|| ++.+.||+|+||+||++. ...+++.||+|++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998764 345788999999875431 2235667899999999999999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
...+|+||||+.+++|.+++....+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHH-------------HHHh
Q 014849 168 IRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM--AMY-------------RKIY 231 (417)
Q Consensus 168 ~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~--~~~-------------~~i~ 231 (417)
.... .......++..|+|||.+.+..++ .++|||||||++|+|++|..||...... ++. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 111223456779999998876664 8999999999999999999998653211 111 1111
Q ss_pred cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 232 KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 232 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+ ..+.|...+..+.+++.+||++||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12345567889999999999999999999999985
No 317
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=5.3e-42 Score=332.43 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=204.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR----------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... ......++.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987542 22335678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKG------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
+++++++.+....|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999988652 366778999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLM 224 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~ 224 (417)
|++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875432211112223445678999998877666 489999999999999998 78999877665
Q ss_pred HHHHHHh--------cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 AMYRKIY--------KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ~~~~~i~--------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+...... ....+.|...++.+.+|+.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5444321 1123345567899999999999999999999999865
No 318
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=9.2e-42 Score=323.95 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=208.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...++.+|+.+|+.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 456899999999999999999986 4678899999875432 2457889999999999999999999874 456899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+.+++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 9999999999998864 468999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
........++..|+|||++....+. .++||||+||++|+|++ |++||.+.+..+....+..+. ...|...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999998877664 89999999999999998 999999888777777665542 34556678899999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
No 319
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=1.6e-41 Score=321.88 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+. .++.||+|.+..... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3568999999999999999999975 568899999875432 24678899999999999999999999999899999
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999999865 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |+.||.+.+......++..+ ....|...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234568999999987666 489999999999999998 99999988877777777654 334566678899999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
No 320
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=4.5e-42 Score=328.76 Aligned_cols=251 Identities=32% Similarity=0.531 Sum_probs=212.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||+|+||.||.|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998754 2333456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+.+ +|.+.+... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 975 899999764 7999999999999999999999999999999999999999999999999998754321 11233
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------CCCC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------EYRC 237 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 237 (417)
...++..|+|||.+......+.++|+||+||++|+|++|.+||...+....+.++... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456888999999877634458999999999999999999999887766555444321 0001
Q ss_pred C-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 238 P-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 238 p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+ +..+.++.++|.+||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1236789999999999999999999999999998
No 321
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=1.4e-41 Score=322.17 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=204.2
Q ss_pred eEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+++.+.||||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876655 78999999766532 345678899999999999999999998764 4689999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-cccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHT 176 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~ 176 (417)
.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 569999999999999999999999999999999999999999999999999987553221110 0111
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhcc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 254 (417)
..++..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+.... ...|...++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999999877764 89999999999999998 999999888777777766554 35667788999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 014849 255 TDPATRITVDEILR 268 (417)
Q Consensus 255 ~dP~~R~t~~eil~ 268 (417)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
No 322
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.7e-41 Score=323.34 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=210.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.+.|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876665 79999886542 222356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 579999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcc-cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 170 PDGML-HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~-~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..... .....++.|+|||++....++ .++|||||||++|+|++ |..||...+.......+..+. .+.+...++++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 112234579999999877764 89999999999999987 999998887777777776542 233445688999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
No 323
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=5.1e-42 Score=347.48 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=207.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.++|.+++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.+|.++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 457889999999999999999964 355689999997543 2223457889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISKG---------------------------------------------------------- 110 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 110 (417)
+.+|+||||+.+|+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988531
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 014849 111 -----------------------------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD 149 (417)
Q Consensus 111 -----------------------------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~ 149 (417)
.++...++.++.||+.||.|||++||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256667888999999999999999999999999999999
Q ss_pred CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-
Q 014849 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY- 227 (417)
Q Consensus 150 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~- 227 (417)
.++.+||+|||++.............+.++++.|+|||.+.+..+. .++|||||||++|+|++ |..||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999998754322111122344678899999999877764 89999999999999998 89999875544443
Q ss_pred HHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 228 RKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 228 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+..+ ....|...+.++.+|+.+||..+|.+||++.+|++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333333 234566789999999999999999999999999864
No 324
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=1.8e-41 Score=322.16 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46899999999999999999998555 4699998865432 2456788999999999999999999875 4568999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 999999999999864 348899999999999999999999999999999999999999999999999987543221 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.......++..|+|||.+.+..++ .++||||+||++|+|++ |.+||.+.+..+....+... ....|...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 111223456789999998776664 89999999999999999 99999988877777776654 2345666789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
++||.+||++|||++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999864
No 325
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.4e-41 Score=321.98 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=206.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL-ATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~l 93 (417)
..+|++.+.||+|+||.||+|.. .|+.||+|.+.... ....+.+|+.++++++|||++++++++ .+.+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 35799999999999999999976 48899999986432 245688999999999999999999875 55678999
Q ss_pred EEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 99999999999998752 488999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
......++..|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+..+. ...+...++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11234456789999999877765 88999999999999997 999999888877777776543 34456678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
No 326
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=4.5e-42 Score=335.23 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=201.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+++.+|.| +.||.+++..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+....|++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 344444444 5566666667999999999986532 2334678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----C
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR-----P 170 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~-----~ 170 (417)
++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999999874 468999999999999999999999999999999999999999999999999876432111 1
Q ss_pred CCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------------- 235 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------- 235 (417)
........++..|+|||++... +| +.++|+||+||++|+|++|..||.+............+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1122344578889999998763 45 4889999999999999999999987654443322111110
Q ss_pred ---------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 ---------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+..+++++.+|+.+||+.||++|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00112246788999999999999999999999999998654
No 327
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=9.1e-42 Score=333.18 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=214.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
....+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34456888999999999999999999999999999987643333334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|+||+.| +|.+.+. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 99999974 7777664 35689999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 246 (417)
.....|++.|+|||++.+ .+..+.++|||||||++|+|++|..||...+.......+..+..+. +...+..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 234568999999999752 2223578999999999999999999998776555544444443322 335678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+||++||+.+|.+|||+++++.|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999999864
No 328
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=1.9e-41 Score=320.80 Aligned_cols=242 Identities=28% Similarity=0.469 Sum_probs=210.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++.+.||+|+||.||+|.. .|+.||+|.+..... ...++.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 45799999999999999999987 489999999976532 356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 999999999999875 2 6999999999999999999999999999999999999999999999999998754221
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+...+...+..+ ....|...++.+.++|
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred --cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 112334667999999877666 489999999999999997 99999988877776666544 3345666789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999975
No 329
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=9.1e-44 Score=331.76 Aligned_cols=265 Identities=28% Similarity=0.477 Sum_probs=214.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
+.-...|++...||+|+||+||+|....++. .+|||.+..++- ..+......||+.+++.++||||+.|..++.+
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 3456789999999999999999997665544 689999977643 33445667799999999999999999999877
Q ss_pred -CCEEEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC----CCeEE
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN----WDLKI 156 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~----~~vkl 156 (417)
...+|+++||++. +|...|.- ..++...++.++.||++|+.|||++-|+||||||.|||+..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 8899999999987 89888752 468999999999999999999999999999999999999887 89999
Q ss_pred eeeecceeeccc-CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HH
Q 014849 157 SDFGLSAVKEQI-RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AM 226 (417)
Q Consensus 157 ~DFGls~~~~~~-~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~ 226 (417)
+|||+++++... .+-......+-|.+|+|||.+.+...++.+.|+|+.|||+.||++-.+.|.+.... +.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999976532 22224456678999999999999887789999999999999999998888542111 11
Q ss_pred HHHHhc--C-----CC----CCCCC--------------------------CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 227 YRKIYK--G-----EY----RCPKW--------------------------TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 227 ~~~i~~--~-----~~----~~p~~--------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+|.. | .+ ..|.+ .++.+.+|+.+||+.||.+|+|+++.|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 122211 0 00 01111 25668999999999999999999999999
Q ss_pred ccccccccc
Q 014849 270 PWFKKDYKE 278 (417)
Q Consensus 270 ~~f~~~~~~ 278 (417)
+||.++..+
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 999987544
No 330
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=1.7e-41 Score=322.52 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred EEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 23 IIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999875 455679999986543 23345678899999999999999999998764 568999999999
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-ccccc
Q 014849 101 GELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTL 177 (417)
Q Consensus 101 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~~ 177 (417)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998863 579999999999999999999999999999999999999999999999999987543211111 11112
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 255 (417)
.+++.|+|||++....++ .++|||||||++|+|++ |..||.+....+....+..+. ..+|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 335789999998877764 89999999999999996 999999888777777776644 456777899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014849 256 DPATRITVDEILRD 269 (417)
Q Consensus 256 dP~~R~t~~eil~h 269 (417)
||++||++.+|++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999653
No 331
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=9.9e-42 Score=327.18 Aligned_cols=249 Identities=34% Similarity=0.493 Sum_probs=207.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 96 (417)
|++.+.||+|+||.||+|.+..+++.||||.+...... .......+|+..++.++ ||||+++++++.++...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78999999999999999999999999999998654321 11234457999999999 9999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+ +|+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 7789888865 26899999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------C
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------------------E 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 234 (417)
.....|+..|+|||++......+.++|+||+|+++++|++|++||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568999999999865443458999999999999999999999887665554443210 0
Q ss_pred CC-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YR-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. .....++++.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999998
No 332
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=3.1e-41 Score=319.09 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=211.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+. .++.+|+|.+..... ....+.+|+.+++.++||||+++++++......|+|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999884 577899998865432 2456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.+++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999998864 5689999999999999999999999999999999999999999999999999875432111 11
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |+.||.......+...+..+. ...|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1223356789999999877765 89999999999999998 999999888888887776653 33456678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.+|++|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
No 333
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=2e-41 Score=319.45 Aligned_cols=247 Identities=30% Similarity=0.428 Sum_probs=211.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTG----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+++.+.||+|+||.||.|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357899999999999999998776 8999999965532 1146788899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-C-C-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK-G-R-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~-~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+++++|.+.+.. . . +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999875 2 2 99999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
... ....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+..+.. ..+...+.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236789999999866666 489999999999999998 8999998888888777766543 4566678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999985
No 334
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=1.3e-41 Score=325.18 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=202.3
Q ss_pred eEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
++||+|+||.||+|++..+|. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988876 46888876432 223356788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 99 KGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 99 ~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+...... ......+.++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+.+..+..+. ...+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 8532211 111122346679999999877764 89999999999999997 999999888777777765542 34455
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.++.+++.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678899999999999999999999999763
No 335
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=1.6e-41 Score=320.06 Aligned_cols=244 Identities=30% Similarity=0.407 Sum_probs=206.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||.|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999864 5689999999999999999999999999999999999999999999999999865432111111122334
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|...+..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 667999999887666 489999999999999998 89999888777666666544 344566778999999999999999
Q ss_pred CCCCCHHHHhcC
Q 014849 258 ATRITVDEILRD 269 (417)
Q Consensus 258 ~~R~t~~eil~h 269 (417)
++|||+.|+++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
No 336
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=1.9e-41 Score=325.32 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=209.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~ 89 (417)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999876 36889999886432 23345678899999999999999999998655 57
Q ss_pred EEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK---------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 88999999999999998864 348899999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCP 238 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p 238 (417)
+++...............++..|+|||++.+..++ .++|||||||++|++++ |.+||...+..+....+..+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 98643221111111223456789999999877775 89999999999999998 999999888777776665542 2344
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
...++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 556889999999999999999999999975
No 337
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=3.6e-42 Score=326.86 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=198.8
Q ss_pred eEEeeeCceEEEEEEEccCCcE-------EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQS-------VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+.||+|+||.||+|.+..++.. +|+|.+.... ....+.+.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998766544 8888886543 23356778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--------eEEeeeeccee
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--------LKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--------vkl~DFGls~~ 164 (417)
|||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999975 35899999999999999999999999999999999999987765 69999998754
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCh
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
.. ......+++.|+|||++.+....+.++|||||||++|+|++| .+||...+..... .........|...+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 32 123456889999999998754445899999999999999998 5777665544433 334445566766788
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++.+|+.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
No 338
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.1e-43 Score=351.75 Aligned_cols=258 Identities=28% Similarity=0.565 Sum_probs=225.8
Q ss_pred cccccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 11 EVNLFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
++.-.||| +...+||+|+|-+||+|.|..+|-.||.-.+....+.+ ....+++..|+.+|+.|+|||||++|..+.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 35556777 56788999999999999999999999987776555433 34468899999999999999999999999776
Q ss_pred CE--EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEecCC-CCeEEeeeecc
Q 014849 89 AK--IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR--GVFHRDLKLENLLLDEN-WDLKISDFGLS 162 (417)
Q Consensus 89 ~~--~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~--givHrDlkp~NILl~~~-~~vkl~DFGls 162 (417)
.+ +.+|+|++..|+|+.++.+ ++++...++.|++||+.||.|||++ .|+|||||-+||+|+.+ |.|||+|.|||
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 65 9999999999999999987 8999999999999999999999998 49999999999999765 89999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC--CCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYR--CPK 239 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~ 239 (417)
++..... ....+|||.|||||.+. ..|+ ..+||||||+.+.||.|+..||.. .+..++|+++..|..+ +.+
T Consensus 194 tl~r~s~----aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 194 TLLRKSH----AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHhhccc----cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 9865422 23478999999999987 6787 999999999999999999999975 6788999999988654 233
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
--.|++++||.+||.. .+.|+|+.|+|.||||..+
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 4489999999999999 9999999999999999875
No 339
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=2.2e-41 Score=323.75 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=212.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.+|++.+.||+|+||+||+|+... +.+.||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 35679999886543 22245678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 91 IYFVMEFAKGGELFAKISK-G---------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.|+||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999875 3 58999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC--CC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY--RC 237 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 237 (417)
++...... .........+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.........+..+.. ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 97643211 11122344567889999998776664 88999999999999998 8999988777777777765543 34
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...+..+.+++.+||+.||++|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55678899999999999999999999999875
No 340
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=4.2e-41 Score=317.02 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=204.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
++||+|+||.||+|.. .+++.+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4789999999999986 478899999987543 2223456889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99998864 468999999999999999999999999999999999999999999999999986432211 111112244
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 257 (417)
++.|+|||++....+ +.++||||+||++|++++ |..||.+.+.......+..+. ...|...+..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999877666 489999999999999998 999999887777666665543 34566788999999999999999
Q ss_pred CCCCCHHHHhcC
Q 014849 258 ATRITVDEILRD 269 (417)
Q Consensus 258 ~~R~t~~eil~h 269 (417)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999753
No 341
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=2.6e-41 Score=319.72 Aligned_cols=243 Identities=29% Similarity=0.427 Sum_probs=205.8
Q ss_pred eEEeeeCceEEEEEEEcc-CCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVR-TGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|++|.||+|.+.. .++ .||+|.+...... .....+.+|+.++++++||||+++++++.+ ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 456788999999999999999999999988 8999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-Ccc
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GML 174 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~ 174 (417)
++++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999876 35899999999999999999999999999999999999999999999999998765331111 111
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 251 (417)
....++..|+|||.+....++ .++|||||||++|+|++ |..||...+..+....+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577889999999887775 88999999999999998 99999888877777666542 233455668899999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 014849 252 LLDTDPATRITVDEILR 268 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~ 268 (417)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
No 342
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=2.6e-41 Score=327.57 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=209.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.-.+.|++.+.||+|+||.||+|.+..+++.||+|.+.+... ......+.+|+.++..+. ||||+++++++.+....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 345789999999999999999999998999999999976432 122445667777776665 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
|+||||+.+ .|.+.+.. +.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999854 67776654 679999999999999999999997 59999999999999999999999999998654321
Q ss_pred CCCCcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCC-CCC--CCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEY-RCP--KWT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~p--~~~ 241 (417)
.......|++.|+|||.+.+.. ..+.++|||||||++|+|++|+.||..... .+.+..+..... ..+ ...
T Consensus 169 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 169 ---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred ---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 1123345788999999987543 224889999999999999999999976432 344445444432 222 235
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.++.+|+.+||..||++|||+++++.||||+...
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 78999999999999999999999999999998644
No 343
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=2.6e-41 Score=322.29 Aligned_cols=238 Identities=22% Similarity=0.335 Sum_probs=195.1
Q ss_pred eEEeeeCceEEEEEEEcc------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 22 KIIGCGAFAKVYHGRNVR------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23358999876542 233556788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-------eEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-------LKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-------vkl~DFG 160 (417)
..++||||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 56999999999999999999999999999999999999987664 8999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKGEYRCPK 239 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 239 (417)
++..... .....|+..|+|||++......+.++||||+||++|+|+ .|..||......+.. +..........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8854321 123467889999999875444458999999999999997 699999876654432 33334444444
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456889999999999999999999999875
No 344
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=9e-42 Score=320.74 Aligned_cols=228 Identities=25% Similarity=0.415 Sum_probs=193.6
Q ss_pred eCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHH
Q 014849 27 GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAK 106 (417)
Q Consensus 27 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 106 (417)
|.||+||+|++..+|+.||+|.+.+... ..+|...+....||||+++++++.+....|+||||++||+|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 22444555566799999999999999999999999999999998
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccc
Q 014849 107 ISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185 (417)
Q Consensus 107 i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~A 185 (417)
+.+ +.+++..+..++.|+++||.|||++||+||||||+||+++.++.++++|||.+..... ......+++.|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 6799999999999999999999999999999999999999999999999998754332 1233456788999
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCH--
Q 014849 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITV-- 263 (417)
Q Consensus 186 PEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-- 263 (417)
||.+....++ .++|+||+||++|+|++|+.||........ .......|.+.++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 9998777764 899999999999999999998865432110 112345788899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 014849 264 ---DEILRDPWF 272 (417)
Q Consensus 264 ---~eil~h~~f 272 (417)
++++.||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999998
No 345
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=5.3e-41 Score=320.49 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+|.+.+.||+|+||.||+|.+..+ ...||||.+..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-Cc
Confidence 35699999999999999999987554 35699998865431 23356788999999999999999999988764 57
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999975 358999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
.. ......+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...++.+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11 11122345679999998877764 89999999999999885 999999888777766666554 4556778899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 014849 248 FIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h 269 (417)
+|.+||.++|++|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999764
No 346
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-42 Score=348.63 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=216.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
+..+...++..||+|.||+||+|++.. .||||+++.+.... +..+.+++|+.+++.-+|.||+-+.+++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 456677899999999999999999854 59999998876543 367889999999999999999999999988876 9
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+.+|.|.+|..++.- -+|.....+.|++|++.||.|||.++|||||||..||+|++++.|||+||||+........
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999998864 5799999999999999999999999999999999999999999999999999987766556
Q ss_pred CCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CPKWTS 242 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s 242 (417)
...+...-|...|||||++.. .+| +..+||||+||++|||++|.+||...+...++-.+.+|... .-...+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 666777789999999999863 345 59999999999999999999999977776666555565322 112345
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++++|+..||..+|++||++.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 68999999999999999999999987
No 347
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=3.1e-41 Score=324.10 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=194.4
Q ss_pred EEeeeCceEEEEEEEccC------------------------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 23 IIGCGAFAKVYHGRNVRT------------------------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358999886543 2234567789999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---- 152 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---- 152 (417)
+++++++.+....|+||||+++|+|..++.. +++++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988864 6799999999999999999999999999999999999997654
Q ss_pred ---CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHH-HcCCCCCCCCCHHHHHH
Q 014849 153 ---DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL-NAGYLPFNDPNLMAMYR 228 (417)
Q Consensus 153 ---~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l-l~G~~Pf~~~~~~~~~~ 228 (417)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+| ++|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753221 12345788899999987644446999999999999998 57999998776554433
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
........|...++++.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333445555567889999999999999999999999875
No 348
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1e-40 Score=317.03 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=207.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35689999999999999999999864 56679999886532 124678899999999999999999999887 7789
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++|||+++++|.+++.+ ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999865 357888999999999999999999999999999999999999999999999986543211
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
. .......++..|+|||++....+ +.++|+|||||++|++++ |.+||...+.......+..+. .+.+...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 1 11122335677999999987666 489999999999999998 999999887777776665542 2345667889999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+||++||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
No 349
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=4.9e-41 Score=327.11 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=207.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4578999999999999999999988886 468888765432 22344678999999999999999999998765 4
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999875 36899999999999999999999999999999999999999999999999999754432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+. ++.+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221122234567789999999877764 89999999999999997 999998876655555444433 344556788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
No 350
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=4.6e-41 Score=320.76 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=192.8
Q ss_pred eEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996532 44578888775432 22234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 100 GGELFAKISKG------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 100 gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccccCcccccccccccc------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc-CCCC-----CCCC
Q 014849 174 LHTLCGTPAYVAPEILAKK------GYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK-GEYR-----CPKW 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~------~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~ 240 (417)
.....+++.|+|||++... ...+.++|||||||++|+|++ |.+||......+...++.. .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 2234467789999997532 223589999999999999998 8999988766655554433 2222 2334
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++.+..++..|+ .||++|||++++++-
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 6788899999998 599999999999753
No 351
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=3.2e-41 Score=321.32 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=203.9
Q ss_pred eEEeeeCceEEEEEEEccCC------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTG------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.||+|+||.||+|.+.... +.+|+|.+.+... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986544 7899998865421 223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CeEEeeeecc
Q 014849 96 EFAKGGELFAKISK--------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-----DLKISDFGLS 162 (417)
Q Consensus 96 E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-----~vkl~DFGls 162 (417)
||++|++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999998853 2378899999999999999999999999999999999999887 8999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 240 (417)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 64432211112223345788999999987776 599999999999999998 99999988777776666543 3455667
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.++|.+||.++|++|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7899999999999999999999999975
No 352
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=8.9e-41 Score=317.00 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred eEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-TKAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 97 (417)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999885432 2233567889999999999999999999764 45678999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC--CCc
Q 014849 98 AKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--DGM 173 (417)
Q Consensus 98 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--~~~ 173 (417)
+.+|+|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 4567888899999999999999999999999999999999999999999999864322110 011
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..+.. ..|...++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233457789999998877764 89999999999999999 5778888777777776665543 3455678899999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||.++|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
No 353
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=6.6e-41 Score=319.89 Aligned_cols=244 Identities=22% Similarity=0.235 Sum_probs=193.7
Q ss_pred eEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3567899998865532 2224578889999999999999999999999999999999999
Q ss_pred CCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 100 GGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 100 gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999998864 2456778889999999999999999999999999999999999999999999864322111112
Q ss_pred ccccccCccccccccccccC------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CC--CCC---CC
Q 014849 174 LHTLCGTPAYVAPEILAKKG------YDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EY--RCP---KW 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~------y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~--~~p---~~ 240 (417)
....+|++.|+|||++.+.. ..+.++||||+||++|+|++ |..||......+........ .. ..| ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 23456788999999986432 12578999999999999996 99999877655544332222 22 112 23
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.+++.+|+ .+|++|||++||..
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5778899999999 68999999999974
No 354
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.5e-42 Score=344.04 Aligned_cols=249 Identities=30% Similarity=0.451 Sum_probs=214.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc---E-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ---S-VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
++-.+.+.||+|+||.||+|..+..+. . ||+|....+..........+.+|+++|+.++|||||++||+...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445667999999999999998765433 3 899998764444555677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|||+|+||+|.+++.+. .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+|+.-..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-- 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-- 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--
Confidence 9999999999999999873 499999999999999999999999999999999999999999999999999875331
Q ss_pred CCCccccc-ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCChHH
Q 014849 170 PDGMLHTL-CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~-~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (417)
....... --+..|+|||.+....|+ .++||||+||++||+++ |..||.+.+..+...+|....+ +.|...+.++
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred -eeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 1111112 246779999999988775 99999999999999998 8999999999999999966554 4566678889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 014849 246 KWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..++.+||..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999964
No 355
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=3.4e-42 Score=366.29 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=213.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT---- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~---- 87 (417)
.+....|+..++||+|+||.||+++++-+|+.||||.|.... .......+.+|+..|.+|+|||||++|..+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 356777899999999999999999999999999999998765 34456789999999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 014849 88 -------------------------------------------------------------------------------- 87 (417)
Q Consensus 88 -------------------------------------------------------------------------------- 87 (417)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CEEEEEEeccCCCChHHHHhcCCCC--HHHHHHHHHHHHHHHHH
Q 014849 88 ---------------------------K--------AKIYFVMEFAKGGELFAKISKGRFS--EQLSRRYFQQLISAVEY 130 (417)
Q Consensus 88 ---------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~i~~ql~~aL~y 130 (417)
+ ..+||-||||+...|.+.+..+.+. .+.++++|+||++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 2489999999998888898887764 88999999999999999
Q ss_pred HHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec----------------ccCCCCcccccccCccccccccccccC-
Q 014849 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE----------------QIRPDGMLHTLCGTPAYVAPEILAKKG- 193 (417)
Q Consensus 131 lH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~----------------~~~~~~~~~~~~Gt~~y~APEvl~~~~- 193 (417)
+|+.|||||||||.||+|+++++|||+|||+++... .....+..+..+||-.|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999997611 011222456679999999999998766
Q ss_pred --CCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCCCCCC----ChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 194 --YDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRCPKWT----SPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 194 --y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
|+ .|+|+||||||||||+ .||.. ........++.++.++.|..+ -+....+|++||++||++|||+.|+
T Consensus 793 ~~Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 793 NKYN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 65 9999999999999998 45643 234456667777777766322 3556889999999999999999999
Q ss_pred hcCcccc
Q 014849 267 LRDPWFK 273 (417)
Q Consensus 267 l~h~~f~ 273 (417)
|++.||.
T Consensus 869 L~s~llp 875 (1351)
T KOG1035|consen 869 LNSELLP 875 (1351)
T ss_pred hhccCCC
Confidence 9999996
No 356
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=1.1e-40 Score=315.39 Aligned_cols=241 Identities=29% Similarity=0.459 Sum_probs=205.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999864 78899999986532 245788999999999999999999998665 47999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999864 35899999999999999999999999999999999999999999999999998653211
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
......+..|+|||.+.+..++ .++|+|||||++|+|++ |.+||...+..+....+.++. ...+...++.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 1223346779999998876664 89999999999999997 999999888877777766553 234455788999999
Q ss_pred HHhccCCCCCCCCHHHHhcC
Q 014849 250 GRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h 269 (417)
++||+.+|+.|||+.++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999753
No 357
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-42 Score=314.45 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=205.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-----TKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-----~~~ 89 (417)
..||++.+.||+|+|+.||++.+..+++.+|+|.+..... +..+...+||...++++||||++++++.. ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4699999999999999999999999999999999987652 34678899999999999999999988753 334
Q ss_pred EEEEEEeccCCCChHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK----G-RFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
..|++++|...|+|.+.+.. | -++|.++.+||.+|++||.+||+.. ++||||||.|||+++.+.+++.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998864 3 6999999999999999999999998 999999999999999999999999988
Q ss_pred eeecccCCCC-------cccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHh
Q 014849 163 AVKEQIRPDG-------MLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNL--MAMYRKIY 231 (417)
Q Consensus 163 ~~~~~~~~~~-------~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~ 231 (417)
+...-.-.+. .......|..|+|||.+.-+.+. +.++|||||||+||+|+.|.-||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7532111111 11122348889999998755443 6899999999999999999999963210 01111233
Q ss_pred cCCCCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYRCPK--WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.+.+|. .+|..+.++|+.||++||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 44554443 378999999999999999999999999865
No 358
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=7.4e-41 Score=322.28 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=201.3
Q ss_pred eEEeeEEeeeCceEEEEEEE----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRN----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
|++.+.||+|+||.||.|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999974 4678899999986543 223356788999999999999999999998775 678
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999987543221
Q ss_pred CC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHHHHhcC
Q 014849 170 PD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---------------LMAMYRKIYKG 233 (417)
Q Consensus 170 ~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i~~~ 233 (417)
.. .......|+..|+|||++.+..++ .++||||+||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 122345677889999998877764 89999999999999999877653321 11111112222
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 234 -EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 234 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.+...++.+.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 223455678999999999999999999999999864
No 359
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=7e-41 Score=319.63 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=206.7
Q ss_pred eEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
|++.++||+|+||.||+|.+. .+++.||||++..+.. .....+++.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678999999999999999864 3678999999976532 2233567889999999999999999999875432
Q ss_pred -EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 -KIYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887632 2478999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+................+++.|++||.+....++ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754322111122234456789999999877775 89999999999999998 999999888777777666543 34556
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++.+.+++.+||+.+|+.|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 778999999999999999999999999864
No 360
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=1.6e-40 Score=319.49 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=199.6
Q ss_pred CCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 014849 16 GKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KA 89 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~ 89 (417)
.+|++.+.||+|+||.||.|. +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 45678999999986543 2235678899999999999999999998643 45
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
.+|+|+||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999865 4689999999999999999999999999999999999999999999999999876432
Q ss_pred cCCCCc-ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Q 014849 168 IRPDGM-LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----------------MYRKI 230 (417)
Q Consensus 168 ~~~~~~-~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~i 230 (417)
...... .....++..|+|||++.+..++ .++|||||||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 211111 1112234569999999877764 89999999999999999987765432110 11111
Q ss_pred hcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... .++.+...+.++.+|+.+||.++|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 223455678899999999999999999999999763
No 361
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=8.5e-42 Score=354.81 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=219.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...-+..+.||+|+||+||+|+.. ...+.||||.++... ...+..+++||+.+|..++|||||+|++++..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345677899999999999999753 344679999997654 3335788999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCe
Q 014849 90 KIYFVMEFAKGGELFAKISK---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~v 154 (417)
.+|+|+|||..|||.+++.. +.|+..+-..++.||+.||.||-++.+|||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999999998842 127888999999999999999999999999999999999999999
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||+|||+++-....+.........-..+|||||.|....|+ .+|||||+||+|||+++ |..||.+-...+.+.-|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999876655544444344457889999999988885 89999999999999986 99999999999999999887
Q ss_pred C-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 234 E-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 234 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
. +.+|...+.++.+|+..||+.+|++||++.||
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 6 58899999999999999999999999999998
No 362
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-41 Score=312.26 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=212.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+...+|.+.+.++.... .|.||+.+++|.++..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455678999999999999999999999999998765 3344678888888887765 899999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|.|.. .+..++.. ++++|..+-++...+++||.||.. +||+|||+||.|||+|..|++|+||||+|...-.. .
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence 99843 44444443 789999999999999999999985 68999999999999999999999999999754321 1
Q ss_pred cccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCCCC-C--CCCChHH
Q 014849 173 MLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRC-P--KWTSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~-p--~~~s~~~ 245 (417)
......|.+.|||||.+.. ..|+ .++||||||+.|+||.||..||.+.+ ..++..++...++++ | ..+|+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2234578999999999863 3565 89999999999999999999999854 447778888766543 2 3489999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+|+..||+.|+.+||...++|+|||++..
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 999999999999999999999999999753
No 363
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=3e-40 Score=314.82 Aligned_cols=249 Identities=30% Similarity=0.530 Sum_probs=211.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccc-------cccchHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKI-------LRGGLTAHVKREISIMSR-LRHPNIVKLYEVLAT 87 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~ 87 (417)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38899999999999999999987 788999999864321 122234566788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
....|+||||+.|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887732 469999999999999999999996 7899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-C-C
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-P-K 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p-~ 239 (417)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.+.. + .
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8764432 13455678999999999987666 589999999999999999999999888777777776655432 2 2
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.++|.+||+.||++|||+.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 568999999999999999999999998654
No 364
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=1.9e-40 Score=313.61 Aligned_cols=236 Identities=25% Similarity=0.312 Sum_probs=194.2
Q ss_pred eEEeeeCceEEEEEEEccCC----------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTG----------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998777 3588887754431 15678899999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-------CeEEeeeecc
Q 014849 92 YFVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-------DLKISDFGLS 162 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-------~vkl~DFGls 162 (417)
++||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999875 3 689999999999999999999999999999999999999887 7999999998
Q ss_pred eeecccCCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 240 (417)
..... .....++..|+|||++... ...+.++|||||||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75432 2234577889999998776 234589999999999999998 688887765433333322 22223333
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+.++|.+||..+|.+|||+.++++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 35889999999999999999999999863
No 365
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=4.5e-40 Score=319.31 Aligned_cols=254 Identities=17% Similarity=0.192 Sum_probs=194.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccch--------HHHHHHHHHHHHhCCCCCcce
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGL--------TAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~HpnIv~ 80 (417)
....++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......++..++.+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34567999999999999999999999877 6778888754332110000 011223444566778999999
Q ss_pred EEEEEEeCC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 81 LYEVLATKA----KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 81 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
+++...... ..|+++|++.. ++.+.+.. ...++..++.++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 45788888744 66666655 4578899999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-H-----
Q 014849 156 ISDFGLSAVKEQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-M----- 224 (417)
Q Consensus 156 l~DFGls~~~~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~----- 224 (417)
|+|||+|+....... ........||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+. .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999976532111 1122335799999999999888774 999999999999999999999986521 1
Q ss_pred ---HHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 ---AMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ---~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+...++..+....+ ..++.+.+++..||..+|++||++++|++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22344444444333 35788999999999999999999999975
No 366
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=7e-42 Score=339.43 Aligned_cols=235 Identities=27% Similarity=0.467 Sum_probs=204.0
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.-++-||.|+.|.||+|+. .++.||||.++-- -..+|+-|+.|+||||+.|.+++...-.++||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 3456799999999999997 6789999966322 125788899999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
..|-|...++. +.+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-+...... ...-..
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99999999987 57888889999999999999999999999999999999999999999999988654322 334568
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHHhccC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 255 (417)
|||..|||||++.+.+.. .|+||||+||+|||||||..||.+-+...++--+... .++.|...++.++-||++||+-
T Consensus 272 aGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 999999999999999986 9999999999999999999999887655443222222 3567888899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014849 256 DPATRITVDEILRD 269 (417)
Q Consensus 256 dP~~R~t~~eil~h 269 (417)
.|..||++.+|+.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999988
No 367
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=9.3e-43 Score=316.93 Aligned_cols=266 Identities=28% Similarity=0.437 Sum_probs=221.0
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--- 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--- 87 (417)
.....+.|+-...+|+|.||.|++|+...+|+.||+|++--+. .+.++.....+|+.+|..++|+|++.+++++.+
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 3567889999999999999999999999999999998765432 245566677899999999999999999988743
Q ss_pred -----CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 88 -----KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 88 -----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
...+|+|+.+|.. +|+-++.. -+++..++.++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 3469999999976 89999876 479999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCC-
Q 014849 161 LSAVKEQIR--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GEY- 235 (417)
Q Consensus 161 ls~~~~~~~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~- 235 (417)
+++.+.... ........+-|.+|++||.+.+..-+|++.|||..|||+.+|+++.+-|.+.+......-|.. |.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997553321 222345567799999999999887778999999999999999999999988765554443321 110
Q ss_pred -------------------CCCC-------------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 236 -------------------RCPK-------------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 236 -------------------~~p~-------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+.|+ ..++++.+|+.+||..||.+|+++.+++.|.||.++..+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0111 125688999999999999999999999999999987665
No 368
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=8e-40 Score=312.68 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=193.0
Q ss_pred eEEeeeCceEEEEEEEccC--CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVRT--GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||+||+|..... ...+++|.+..... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999976433 23466776654322 2235678899999999999999999999999999999999999
Q ss_pred CCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 100 GGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 100 gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+|+|.+++.+ ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998864 23567788899999999999999999999999999999999999999999987532211111122
Q ss_pred cccccCccccccccccccC------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C-----CCCCCC
Q 014849 175 HTLCGTPAYVAPEILAKKG------YDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y-----RCPKWT 241 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~------y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~ 241 (417)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+..+. . ..+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3467899999999975321 12478999999999999986 688998877776666654432 1 223346
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+.+++.+|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 68999999999965
No 369
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=6e-40 Score=314.39 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=203.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KA 89 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~ 89 (417)
..|++.+.||+|+||.||+|... .+++.+|+|++...... .....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 35889999999765432 246788999999999999999999999877 66
Q ss_pred EEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..++||||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999763 599999999999999999999999999999999999999999999999999876542
Q ss_pred cCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHh
Q 014849 168 IRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---------------MYRKIY 231 (417)
Q Consensus 168 ~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---------------~~~~i~ 231 (417)
.... .......++..|+|||.+....+. .++|||||||++|+|++|..||....... +...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 111123445679999998877664 88999999999999999999987543211 122222
Q ss_pred cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 232 KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 232 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.. ..+.|...+.++.+++.+||+++|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 21 23344556789999999999999999999999975
No 370
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=9.5e-41 Score=340.13 Aligned_cols=242 Identities=34% Similarity=0.530 Sum_probs=200.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
.+-|+..+.||+|+||.||++++++||+.||||.+.+....+ ..+..-+|+++|++++|||||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 477899999999999999999999999999999998865333 3677889999999999999999999865544
Q ss_pred -EEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCC--CeEEeeee
Q 014849 90 -KIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD--ENW--DLKISDFG 160 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~--~~~--~vkl~DFG 160 (417)
.-.+|||||.||+|+..+.+ .+|+|.+.+.++..+..||.|||++||+||||||.||++- .+| ..||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 46789999999999999975 5799999999999999999999999999999999999983 334 37999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcC--
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKG-- 233 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~-- 233 (417)
.|+-.+ .+....+.+||+.|.+||.+..+.+++..+|.||+||++|+..||.+||... +..-++..+.+.
T Consensus 170 ~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 998655 4557889999999999999987666679999999999999999999999542 222334333221
Q ss_pred ------------------CCCCCCCCChHH----HHHHHHhccCCCCCCC
Q 014849 234 ------------------EYRCPKWTSPDL----KWFIGRLLDTDPATRI 261 (417)
Q Consensus 234 ------------------~~~~p~~~s~~~----~~li~~~L~~dP~~R~ 261 (417)
.++.|...++.+ ..++..+|..+|.+|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123344444443 3467789999999998
No 371
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-40 Score=351.32 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..-++.+.||+|+||.||.|.-..... .||||.+.+.. +......+.+|..+|+.++|||||++++++-+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 456889999999999999998765332 38888886643 45567889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISKG--------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.++++|||.||+|..+|.+. .++......++.||+.|+.||+++++|||||...|+||+....|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999753 4888899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH-HHhcCCCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYR-KIYKGEYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~p~~ 240 (417)
+..........-....-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+... -...+..+.|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 84332222211111122467999999998777 499999999999999987 999999998888777 445567888999
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
++..+.++|..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
No 372
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-41 Score=321.32 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=208.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CC----cceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PN----IVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pn----Iv~l~~~~ 85 (417)
-.+.+||++..+||+|+||+|-.+.+.+++..||+|+++.-.. ..+..+-|+.+|.++.+ |+ +|++.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 3568899999999999999999999999999999999965321 23445568999999842 33 77888889
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-------------
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD------------- 149 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~------------- 149 (417)
.-.+++++|+|.+ |.++++++.. .+++-..++.+..||+.+++|||+.+++|-||||||||+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 7799999987 3689999999999999999999999999999999999983
Q ss_pred -------CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 014849 150 -------ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN 222 (417)
Q Consensus 150 -------~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~ 222 (417)
.+..++|+|||.|+...+. -.+.+.|..|+||||+.+-|++ .+.||||+||||+||.+|...|....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCC
Confidence 1346899999998864432 2567789999999999999996 89999999999999999999998765
Q ss_pred HHH---HHHHHhcC------------------CCCCCCC-------------------------CChHHHHHHHHhccCC
Q 014849 223 LMA---MYRKIYKG------------------EYRCPKW-------------------------TSPDLKWFIGRLLDTD 256 (417)
Q Consensus 223 ~~~---~~~~i~~~------------------~~~~p~~-------------------------~s~~~~~li~~~L~~d 256 (417)
..+ |.+.|... ....|.. ...++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 443 44444321 1111110 0234678999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 014849 257 PATRITVDEILRDPWFKKD 275 (417)
Q Consensus 257 P~~R~t~~eil~h~~f~~~ 275 (417)
|.+|+|+.|+|.||||...
T Consensus 394 P~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARL 412 (415)
T ss_pred ccccccHHHHhcCHHhhcC
Confidence 9999999999999999864
No 373
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-39 Score=321.89 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=196.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-KIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 93 (417)
.+.|.-...||+|+||.||+|... .|+.||||.+....... ..++.+|+.+|.+++|||+|+|+++|.+.+ ..++
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 467788899999999999999984 44899999876654321 345999999999999999999999999988 5999
Q ss_pred EEeccCCCChHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 94 VMEFAKGGELFAKISK--G-RFSEQLSRRYFQQLISAVEYCHSRG---VFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~-~l~e~~~~~i~~ql~~aL~ylH~~g---ivHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|+||++.|+|.+.+.. + .+++..+.+|+.+++.||+|||... |+||||||.|||||++.+.||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999875 3 7899999999999999999999854 99999999999999999999999999954332
Q ss_pred cCCCCccccc-ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC------HHHHHH-HHhcCC---CC
Q 014849 168 IRPDGMLHTL-CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN------LMAMYR-KIYKGE---YR 236 (417)
Q Consensus 168 ~~~~~~~~~~-~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~------~~~~~~-~i~~~~---~~ 236 (417)
. .....+. .||..|+|||.+..... +.++||||+||+|.||++|+.|.+... ..+... .+..+. +-
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 0 2222222 89999999999877444 599999999999999999998887532 222211 222221 11
Q ss_pred CCC----CCC--hH---HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 CPK----WTS--PD---LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~p~----~~s--~~---~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|. ..+ .. +..+..+|++.+|..||++.|+.+.
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111 122 23 3456789999999999999997543
No 374
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-39 Score=335.21 Aligned_cols=257 Identities=30% Similarity=0.528 Sum_probs=225.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT--- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~--- 87 (417)
....+.|++.+++|.|.+|+||+++++.+|+..|+|+.+... ...+.+.-|..||+.. .|||++.+|+++.-
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345678999999999999999999999999999999987653 2356777889999887 59999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.+.+|||||||.||+.-|+++. +++.|..+..|++.++.|+.+||.+.++|||||-.||||+.+|.||++|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 4689999999999999999875 68999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCcccccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKK-----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-----~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 236 (417)
+..+. .-+...|..|||.||||||+... .|+ ..+|+||||++..||-.|.+|+-+..++..+-+|-+...+
T Consensus 171 aQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 87765 44667889999999999998643 344 8899999999999999999999999888777676655432
Q ss_pred --CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 --CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
-|..++.++.++|..||..|-.+||+..++++|||.+..
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 355678999999999999999999999999999999843
No 375
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=3.3e-39 Score=339.34 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=179.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccC----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRT----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV----- 84 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~----- 84 (417)
-.++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+...+| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467899999999999999999999988 99999998754321 1111111 1122222233222211
Q ss_pred -EEeCCEEEEEEeccCCCChHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 014849 85 -LATKAKIYFVMEFAKGGELFAKISKGRF---------------------SEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142 (417)
Q Consensus 85 -~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~i~~ql~~aL~ylH~~givHrDlk 142 (417)
......+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456689999999999999998865321 234567899999999999999999999999
Q ss_pred CCcEEecC-CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCC---------------------CChhh
Q 014849 143 LENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD---------------------GAKVD 200 (417)
Q Consensus 143 p~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~---------------------~~~sD 200 (417)
|+|||++. ++.+||+|||+|+..... ......+.+||+.|+|||.+....+. +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999754321 12234567899999999976432221 24569
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-------C--------------CCCChHHHHHHHHhccCCCCC
Q 014849 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-------P--------------KWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 201 IwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------p--------------~~~s~~~~~li~~~L~~dP~~ 259 (417)
|||+||+||+|+++..|++.. .......+....... + ...+....+||.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999988776542 222222222211111 0 111233458999999999999
Q ss_pred CCCHHHHhcCcccccc
Q 014849 260 RITVDEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~~eil~h~~f~~~ 275 (417)
|||+.|+|+||||+..
T Consensus 441 R~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 441 RISAKAALAHPYFDRE 456 (566)
T ss_pred CCCHHHHhCCcCcCCC
Confidence 9999999999999864
No 376
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=4.4e-38 Score=292.03 Aligned_cols=239 Identities=46% Similarity=0.809 Sum_probs=208.2
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHH
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI 107 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 107 (417)
+||.||+|.+..+|+.+|+|++........ ...+.+|+..+++++||||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976543221 578889999999999999999999999999999999999999999998
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccc
Q 014849 108 SKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186 (417)
Q Consensus 108 ~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~AP 186 (417)
... .+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......|++.|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 764 4899999999999999999999999999999999999999999999999998765432 134456789999999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCCCCC---CChHHHHHHHHhccCCCCCCCC
Q 014849 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRCPKW---TSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 187 Evl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~t 262 (417)
|.+....++ .++||||+|+++++|++|..||.. .+.......+.......+.. .+.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999877775 799999999999999999999988 56666666665555443322 7789999999999999999999
Q ss_pred HHHHhcCccc
Q 014849 263 VDEILRDPWF 272 (417)
Q Consensus 263 ~~eil~h~~f 272 (417)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
No 377
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-39 Score=301.70 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=216.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
....||.-.+.+|.|+- .|..|.|..++++||+|.+..... ......+..+|...|..++|+||++++++|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 899999999999999999987733 334467888999999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+|||+++. +|...+. -.++-.....++.|++.|+.|+|+.||+||||||+||++..++.+||.|||+|+..+
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 368999999965 7877765 467788899999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
.+-..+.++.|..|.|||++.+.+|. +.+||||+|||+.||++|+..|.+.+..+.+.++...
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 33456678899999999999999975 9999999999999999999999987766666655320
Q ss_pred -----------C---CC----CCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 234 -----------E---YR----CPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 234 -----------~---~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+ +. +|. .-+..+++|+.+||..||++|.|++++|.||||+-++.+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 0 00 111 124568999999999999999999999999999955443
No 378
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=3.8e-39 Score=289.81 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--EE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA--KI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 91 (417)
.+.|++.+.+|+|-++.|+.|.+..+++.++||++..-+ ...|+||+.||+.|+ ||||++++++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568999999999999999999999999999999997654 578999999999997 999999999987653 57
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~~~~~ 170 (417)
.+|+||+...+...+-. .|+...++.|+.||+.||+||||.||.|||+||+|+++|.. ..++|+|+|+|.+.. +
T Consensus 111 aLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH---p 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---P 185 (338)
T ss_pred hhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC---C
Confidence 79999998876554433 58888999999999999999999999999999999999865 469999999997654 4
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHhc-------------CCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN-DPNLMAMYRKIYK-------------GEYR 236 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~~-------------~~~~ 236 (417)
....+-.+.+..|--||.+..-.+...+.|+||+||+|..|...+-||- +.+..+..-+|.+ -...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 4455666778889999999876655699999999999999999988873 4443343333321 0011
Q ss_pred CC-------------C-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 237 CP-------------K-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 237 ~p-------------~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+ . ..++++.+|+.++|..|.++|+|+.|+|.||||....
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 11 1 1379999999999999999999999999999998544
No 379
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.8e-39 Score=311.02 Aligned_cols=265 Identities=29% Similarity=0.435 Sum_probs=219.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc----ccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL----RGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
-..+..||-++.+||+|+|+.||+|.+....+.||+|+-...+.. +.+...+..||..|.+.|.||.||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 356788999999999999999999999999999999987554432 2334567889999999999999999999985
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEec---CCCCeEEeee
Q 014849 87 -TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR--GVFHRDLKLENLLLD---ENWDLKISDF 159 (417)
Q Consensus 87 -~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~--givHrDlkp~NILl~---~~~~vkl~DF 159 (417)
+...++-|+|||+|.+|.-+++. ..++|.+|+.|+.||+.||.||... .|+|-||||.||||- .-|.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 55678999999999999999987 5689999999999999999999976 699999999999994 3478999999
Q ss_pred ecceeecccCCC-----CcccccccCcccccccccc-c--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH
Q 014849 160 GLSAVKEQIRPD-----GMLHTLCGTPAYVAPEILA-K--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---MYR 228 (417)
Q Consensus 160 Gls~~~~~~~~~-----~~~~~~~Gt~~y~APEvl~-~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---~~~ 228 (417)
|||.+.+....+ .+.....||-+|++||.+. + .+-.+.++||||.|||+|..+.|+-||....... .+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999987654332 2334567999999999864 2 2344789999999999999999999997653322 122
Q ss_pred HHhcC-C--CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 229 KIYKG-E--YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 229 ~i~~~-~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|.++ + ++..+-.++++++||++||+..-+.|+.+.++-.||+|.-.
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 33333 2 34445679999999999999999999999999999999753
No 380
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=6.7e-39 Score=315.65 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=213.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC------CCCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR------HPNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~------HpnIv~l~~~~ 85 (417)
..+-+||++.-..|+|-|++|..|.+..-|+.||||+|....+ |...=.+|++||+.|+ --|+++|+.+|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3567899999999999999999999999999999999987543 3344468999999996 35899999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-G---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFG 160 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFG 160 (417)
...+++|||+|... ..|.+.+.+ | +|....++.|++||+.||..|-..||+|.||||.|||+++.. .+||||||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 99999999999884 489999986 3 588899999999999999999999999999999999998765 48999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 240 (417)
.|.... ......+.-+..|.|||++.+.+|+ ...|+||.||.||||.||+..|++.+...|++-.+...-++|..
T Consensus 583 SA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 583 SASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 987654 3445556667789999999999998 89999999999999999999999988887775543221111110
Q ss_pred -----------------------------------------------------C-------ChHHHHHHHHhccCCCCCC
Q 014849 241 -----------------------------------------------------T-------SPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 241 -----------------------------------------------------~-------s~~~~~li~~~L~~dP~~R 260 (417)
+ -..+++|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0 1346789999999999999
Q ss_pred CCHHHHhcCccccc
Q 014849 261 ITVDEILRDPWFKK 274 (417)
Q Consensus 261 ~t~~eil~h~~f~~ 274 (417)
+|+.++|.||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999974
No 381
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-38 Score=314.49 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=206.8
Q ss_pred eEEeeEEeeeCceEEEEEEEcc--CC--cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVR--TG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~--~g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..+.+.||.|.||.||.|.... .| -.||||.++.+. ..+..+.+..|..+|+.++|||||++++++.+. .+|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 3456789999999999998643 23 359999998754 333478899999999999999999999998755 6899
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++-|+|..++.. ..|+......|+.||+.||.|||+..+|||||...|||+.+.--|||+|||+|+..+.....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999999986 57888889999999999999999999999999999999999999999999999876532221
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
... ...-+.-|||||.++-..++ .+||||.|||.+||++ .|.-||.+-...+.+..|-+|+ .++|+.+++.+..|+
T Consensus 548 kaS-~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hcc-ccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 111 11224559999999877775 8899999999999976 5999999987777777777765 789999999999999
Q ss_pred HHhccCCCCCCCCHHHHh
Q 014849 250 GRLLDTDPATRITVDEIL 267 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil 267 (417)
.+||..+|.+||.+.+|.
T Consensus 626 skcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHhccCcccCCcHHHHH
Confidence 999999999999887764
No 382
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-38 Score=318.50 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=220.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC-Cc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+-.++.+++++||+|+||.|+.|.+... |+ .||||.+....... ....+.+|+.+|..|+|||+|+||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3456778899999999999999998653 33 58999997765432 47889999999999999999999999988 6
Q ss_pred EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 KIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+.+|+|++++|+|.+.+.+ +.|.......|+.||+.||.||.+++.|||||-..||||-....|||+||||.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999975 568888999999999999999999999999999999999999899999999998665
Q ss_pred ccCCCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCh
Q 014849 167 QIRPDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSP 243 (417)
Q Consensus 167 ~~~~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 243 (417)
..+... +.....-...|+|||.+....+. .++|+|++||.+|||++ |..||.+.+...++++|-.++ ++-|+.++.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 432211 11112234569999999998885 99999999999999997 799999999999999988654 567889999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
++.++++.||..+|++|||+..|.++-+.+
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999999998665544
No 383
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.7e-36 Score=312.62 Aligned_cols=260 Identities=19% Similarity=0.277 Sum_probs=189.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc----------------cCCcEEEEEEeecccccc-----------cchHHHHHHH
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV----------------RTGQSVAIKAVSKQKILR-----------GGLTAHVKRE 66 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~-----------~~~~~~i~~E 66 (417)
-.++|++.+.||+|+||.||+|... ..++.||||.+....... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999753 345679999986532110 0111223357
Q ss_pred HHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCChHHHHhc--C---------------------
Q 014849 67 ISIMSRLRHPNI-----VKLYEVLAT--------KAKIYFVMEFAKGGELFAKISK--G--------------------- 110 (417)
Q Consensus 67 i~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~--~--------------------- 110 (417)
+.++.+++|.++ +++++++.. +...|+|+||+.+++|.+++.. +
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 566666542 4568999999999999887753 1
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccc
Q 014849 111 --RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188 (417)
Q Consensus 111 --~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEv 188 (417)
.++...++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....... ........+||.|+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhh
Confidence 23556788999999999999999999999999999999999999999999986533211 111112334899999999
Q ss_pred ccccC--------------------CC-CChhhHHHHHHHHHHHHcCCC-CCCCCC-----------HHHHHHHHhcCCC
Q 014849 189 LAKKG--------------------YD-GAKVDMWSCGVVLFVLNAGYL-PFNDPN-----------LMAMYRKIYKGEY 235 (417)
Q Consensus 189 l~~~~--------------------y~-~~~sDIwSlGvil~~ll~G~~-Pf~~~~-----------~~~~~~~i~~~~~ 235 (417)
+.... |. ..+.||||+|||+|+|++|.+ ||.+.. ....++.+....+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75432 11 124799999999999999986 775421 1111222233333
Q ss_pred CCC--CCCChHHHHHHHHhccCCC---CCCCCHHHHhcCccccc
Q 014849 236 RCP--KWTSPDLKWFIGRLLDTDP---ATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 ~~p--~~~s~~~~~li~~~L~~dP---~~R~t~~eil~h~~f~~ 274 (417)
.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 333 3468899999999999766 68999999999999964
No 384
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-38 Score=290.69 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=210.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
..+-.|.||.|+||.||.+.|..+|+.||+|.+..-. .+-....++-+|+++|...+|.|++..+++..... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3456789999999999999999999999999886532 23334678889999999999999999999876654 47
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+++|++.. +|...|.. ..++.+.++-+++||+.||.|||+.||.||||||.|+|+++|+.+||||||+++..+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 889999854 88887765 7899999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY------------------- 231 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~------------------- 231 (417)
..+ ...+-|.+|+|||++.+...++.++||||.|||+.|||..+..|...++.+...-|.
T Consensus 212 ~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 222 334669999999999988777799999999999999999999998776665444432
Q ss_pred ----cCCCCCCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 232 ----KGEYRCPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 232 ----~~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++....|. ....+...++.++|.+||++|++.++.+.|++..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22222221 223567789999999999999999999999988654
No 385
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=6.2e-38 Score=287.37 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=205.3
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
-...||.|+||+|++-.++.+|+..|||.|..... +....++..|.... +.-+.||||++|+..-.++.-|+.||+|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34578999999999999999999999999987654 23356777777654 4456899999999999999999999999
Q ss_pred CCCChHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 99 KGGELFAKI------SKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 99 ~gg~L~~~i------~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+- +|..+- .+.+++|+..-.+.--.+.||+||-. ..|+|||+||.||||+..|.+||||||++..... .
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence 54 554322 23689999999999999999999985 5899999999999999999999999999864321 1
Q ss_pred CcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCC---CC---CCC
Q 014849 172 GMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRC---PK---WTS 242 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~---p~---~~s 242 (417)
-..+.-.|...|||||.+.. .||+ .+||+||||+.|||+.||..||.. .+..+...++..+.++. +. ..|
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 12233468889999999864 4677 999999999999999999999975 44556666777776643 22 268
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..+.++|.-||.+|-+.||+..+++++||++....
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 89999999999999999999999999999986443
No 386
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-36 Score=303.11 Aligned_cols=240 Identities=27% Similarity=0.467 Sum_probs=210.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+...||.|.||.||.+.++.-.-.||||.++-+.. ..+.+..|..+|+.++|||+|+|+++|..+-.+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345679999999999999999888999999865542 3678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
..|+|.+++.. ..++.-....++.||.+||.||..+++|||||...|+|+.++..|||+||||+++... ....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 99999999975 3577778889999999999999999999999999999999999999999999998642 1122
Q ss_pred cccc---CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 176 TLCG---TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 176 ~~~G---t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
...| ..-|.|||.+.-..+. .++|||+|||+|||+.| |--||.+-+..+.|.-+-++ ...-|..+++.+.+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2223 4569999999877775 89999999999999976 89999999999888877665 35678999999999999
Q ss_pred HhccCCCCCCCCHHHHh
Q 014849 251 RLLDTDPATRITVDEIL 267 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil 267 (417)
.||+++|.+||++.||-
T Consensus 501 aCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHhcCCcccCccHHHHH
Confidence 99999999999999983
No 387
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-36 Score=301.97 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=209.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
-++..+++.||+|-||.|.+|.- ..+..||+|.++.... ......+.+||++|.+|+|||||++++++...+.+++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35678899999999999999987 4478999999987653 33467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKGRF---SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l---~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||++.|+|..++.+... ......+++.||++||+||.+.+++||||.|.|+|++.++++||+|||+|+-.......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999987432 44556679999999999999999999999999999999999999999999855433333
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHH--HcCCCCCCCCCHHHHHHHHhc---C-----CCCCCCCC
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL--NAGYLPFNDPNLMAMYRKIYK---G-----EYRCPKWT 241 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l--l~G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~ 241 (417)
......+-+.+|||||.+....++ .++|+|++|+.+||+ ++...||...+.++..++... . -+.-|.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 333334456889999999887775 899999999999986 568899998877776665432 1 13457778
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+..+..||.+||..+-.+|||++++-
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 89999999999999999999999993
No 388
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-37 Score=314.35 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=218.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
....|.++||.|.||.||.|+.+..|+ .||||.++.-.. +.....+..|+.||-+..||||++|-++......+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345789999999999999999987774 699999975432 233567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+|||+.|+|..++.. |+++..+..-+++-|++||.||.+.|+|||||...|||++.|-..|++|||+|++.+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999999975 889999999999999999999999999999999999999999999999999999775432
Q ss_pred CCccccccc--CccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHH
Q 014849 171 DGMLHTLCG--TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~G--t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 246 (417)
.....+..| ..+|.|||.+....++ .+|||||+||++||.+ .|..||.+....+.++.|..+ .++.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 333333333 4679999999988885 8999999999999755 699999999989999888766 4566778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|+..||++|-..||++.||..+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999875
No 389
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=2.6e-36 Score=337.30 Aligned_cols=238 Identities=22% Similarity=0.346 Sum_probs=189.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|...+.||+|+||.||+|++..+|..||+|.+..... ...+|+.+|++++|||||++++++.+....|+|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3456777899999999999999999999999998864321 113568899999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH---SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH---~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++||+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred EeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999996 4889999999999999999999 6699999999999999999888876 665533211
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHhc---------CCC--
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-----LMAMYRKIYK---------GEY-- 235 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~---------~~~-- 235 (417)
..+..||+.|+|||++.+..|+ .++||||+||++|||++|+.||+... ..+....... ...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1234689999999999887775 89999999999999999999996421 1111111110 000
Q ss_pred --CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 --RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.....++.+++.+||+.||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011112346789999999999999999999875
No 390
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=5e-37 Score=317.02 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=199.7
Q ss_pred EeeEEeeeCceE-EEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014849 20 VGKIIGCGAFAK-VYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 20 i~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
--+++|.|+-|+ ||+|.. .|+.||||.+-.+. .+-+.|||..|+.. .|||||++|..-.+++.+||++|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 346789999986 799987 78899999875443 45678999999988 599999999999999999999999
Q ss_pred cCCCChHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CC--CeEEeeeecceeecc
Q 014849 98 AKGGELFAKISKG-R----FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NW--DLKISDFGLSAVKEQ 167 (417)
Q Consensus 98 ~~gg~L~~~i~~~-~----l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~--~vkl~DFGls~~~~~ 167 (417)
|.. +|.++++.. . ......+..+.|+++||++||+.+|+||||||+||||+. ++ .++|+|||++.....
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 976 899999862 1 111345789999999999999999999999999999976 34 589999999976543
Q ss_pred cC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCCCCCCCC---CC
Q 014849 168 IR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGEYRCPKW---TS 242 (417)
Q Consensus 168 ~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s 242 (417)
.. .-....+..||-.|+|||++...... .++||||+||++|..++| ..||.+.- +...+|..+.+..-.. ..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCch
Confidence 22 22245677899999999999876654 789999999999987775 99998764 3334677776543221 12
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.++.+||.+||.++|..||++.++|.||+|+...+.
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 289999999999999999999999999999876554
No 391
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-36 Score=302.82 Aligned_cols=206 Identities=31% Similarity=0.526 Sum_probs=186.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHH-----HHHHHHHHHHhCC---CCCcceE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-----HVKREISIMSRLR---HPNIVKL 81 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~-----~i~~Ei~il~~l~---HpnIv~l 81 (417)
+...-+..|...+.||.|+||+|++|.+++....|+||.|.++++.-..+.+ .+-.||+||..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3344566799999999999999999999999999999999999886554433 2457999999998 9999999
Q ss_pred EEEEEeCCEEEEEEec-cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 82 YEVLATKAKIYFVMEF-AKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
+++|++++.+|++||- -+|.+||++|+. .+++|.++..+|+|++.|+++||+.||+|||||-+|+.++.+|-+||+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9999999999999996 467899999986 78999999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN 219 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~ 219 (417)
|.|+.. ..++..+.+||..|.|||++.+..|-|..-|||+||++||.+.....||.
T Consensus 715 gsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998764 45778899999999999999999999999999999999999988888875
No 392
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-37 Score=309.72 Aligned_cols=266 Identities=30% Similarity=0.500 Sum_probs=229.9
Q ss_pred CCCCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEE
Q 014849 3 DNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82 (417)
Q Consensus 3 ~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~ 82 (417)
.-++.++++ .-.++|++.+.+|.|++|.||+|+++.+++..|+|+++.+-- ....-+..||-+++.++|||||.++
T Consensus 3 ~~~~disrr-nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~ 78 (829)
T KOG0576|consen 3 SPKSDISRR-NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYF 78 (829)
T ss_pred Cccchhhhc-CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHH
Confidence 345566666 778899999999999999999999999999999999987642 2356678899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 83 EVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 83 ~~~~~~~~~~lV~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
+-+.....+|++||||.||+|.+.-. .|.++|.++...++..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.
T Consensus 79 gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 79 GSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCc
Confidence 99999999999999999999988665 49999999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 238 (417)
++.... .-.......|||.|||||+-. ..+|. ..+|||++|+...++-.-++|..+...+....-..+..+..|
T Consensus 159 saqita--ti~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 159 SAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhhhhh--hhhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 875432 223445678999999999952 44564 999999999999999888888877777766666666666554
Q ss_pred -----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 -----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+++-+.+|++.+|..+|++|||++.+|.|||....
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3458889999999999999999999999999998754
No 393
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-35 Score=288.17 Aligned_cols=132 Identities=26% Similarity=0.466 Sum_probs=114.9
Q ss_pred ccc-CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----C---CCcceEEE
Q 014849 13 NLF-GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----H---PNIVKLYE 83 (417)
Q Consensus 13 ~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----H---pnIv~l~~ 83 (417)
.+. +||-+.+.||.|-|++||+|.|..+.+.||+|+.+... ...+....||.+|++++ | .+||+|++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 455 89999999999999999999999999999999987543 23556678999999984 3 36999999
Q ss_pred EEEe----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEec
Q 014849 84 VLAT----KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLD 149 (417)
Q Consensus 84 ~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~ 149 (417)
.|.. ..+++||+|+. |-.|..+|.. +.++...++.|++||+.||+|||.+ ||||-||||+||||.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9854 46899999999 6688888875 6799999999999999999999965 999999999999983
No 394
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-33 Score=299.89 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=207.4
Q ss_pred EEeeEEeeeCceEEEEEEEc---c----CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 19 EVGKIIGCGAFAKVYHGRNV---R----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~---~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
.+.+.||+|+||+|++|.-. . ....||||.+...... .....+..|+.+|+.+ +||||+.+++.+..++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 56779999999999999743 1 1457999998765432 4467889999999998 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 91 IYFVMEFAKGGELFAKISKGR-----------------FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
+++|+||+..|+|.+++...+ ++..+...++.||+.|++||++..++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998766 899999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCccccccc--CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC-HHHHHHH
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCG--TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPN-LMAMYRK 229 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~G--t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~-~~~~~~~ 229 (417)
+||+|||+|+.......... ....| ...|||||.+....|+ .++||||+||+|||+++ |..||.+-. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999985432221111 11122 3349999999997775 99999999999999987 899998854 5667777
Q ss_pred HhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 230 IYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 230 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+..|. ...|...++++.++++.||+.+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 77765 4778999999999999999999999999999965
No 395
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=100.00 E-value=1.2e-32 Score=248.82 Aligned_cols=212 Identities=44% Similarity=0.772 Sum_probs=187.0
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|++|.||++.+..+|+.+++|++....... ....+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 356789999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+++... .++...+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999864 7999999999999999999999999999999999999999 89999999999876543211 23345678
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987762345899999999999999 678999999999999999
Q ss_pred CCHHHHhcCc
Q 014849 261 ITVDEILRDP 270 (417)
Q Consensus 261 ~t~~eil~h~ 270 (417)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
No 396
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-33 Score=272.75 Aligned_cols=248 Identities=25% Similarity=0.445 Sum_probs=199.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEeC--
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLATK-- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~-- 88 (417)
.+..+..+.+.+|+|.||.||+|.+ -|+.||||++.... .....||.+|.+. |+|+||+.+++.-...
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3466789999999999999999999 58899999996542 4566778877765 5999999999874322
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCeEEee
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR--------GVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~--------givHrDlkp~NILl~~~~~vkl~D 158 (417)
+.+|+|++|-+.|+|+|++....++.+...+++..+++||++||.. .|+|||||..|||+..||..-|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 4799999999999999999999999999999999999999999954 599999999999999999999999
Q ss_pred eecceeeccc--CCCCcccccccCcccccccccccc----CCC-CChhhHHHHHHHHHHHHc----------CCCCCC--
Q 014849 159 FGLSAVKEQI--RPDGMLHTLCGTPAYVAPEILAKK----GYD-GAKVDMWSCGVVLFVLNA----------GYLPFN-- 219 (417)
Q Consensus 159 FGls~~~~~~--~~~~~~~~~~Gt~~y~APEvl~~~----~y~-~~~sDIwSlGvil~~ll~----------G~~Pf~-- 219 (417)
+|||-...+. .-+-..+..+||.+|||||++... -++ -..+||||+|.|+||+.. -++||.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999765443 123355778999999999998542 111 146899999999999864 258885
Q ss_pred ---CCCHHHHHHHHhcCCC--CCC-CCCChH----HHHHHHHhccCCCCCCCCHHHHhc
Q 014849 220 ---DPNLMAMYRKIYKGEY--RCP-KWTSPD----LKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 220 ---~~~~~~~~~~i~~~~~--~~p-~~~s~~----~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.++|.+-+.-.++ ..| .|.|.+ +..+++.||..||.-|.|+--|.+
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4677777666554433 334 455544 356889999999999999877754
No 397
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1e-33 Score=277.13 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 89 (417)
.....+.+++|+|.||.||+|.. +++.||||++.... .+.+.+|-.|.+. ++|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 44567889999999999999997 66999999997654 4566677777665 57999999998865444
Q ss_pred -EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCeEEeee
Q 014849 90 -KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR---------GVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~---------givHrDlkp~NILl~~~~~vkl~DF 159 (417)
.+++|+||-+.|+|.+++....++.....+++..++.||+|||+. +|+|||||..||||.+|++.-|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999999999999999999999999999999964 6999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCC-----CChhhHHHHHHHHHHHHcCC------------CCCC---
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD-----GAKVDMWSCGVVLFVLNAGY------------LPFN--- 219 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~-----~~~sDIwSlGvil~~ll~G~------------~Pf~--- 219 (417)
|+|..+....+.+..+..+||.+|||||++.+.--- -.+.||||+|.+||||++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988877777888889999999999999754221 13689999999999997642 4453
Q ss_pred --CCCHHHHHHHHhcC--CCCCCCCC-----ChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 220 --DPNLMAMYRKIYKG--EYRCPKWT-----SPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 220 --~~~~~~~~~~i~~~--~~~~p~~~-----s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
.+...+|.....+. ++.+|..+ -..+.+.+..||+.||+-|.|+.=+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 35666666655543 34444322 3456788999999999999997544
No 398
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-34 Score=265.88 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=205.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEV-LATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~-~~~~~ 89 (417)
..+.+.|.|.+.||+|.||++.+|+++.+.+.+++|.+.+.... ...+.+|..-=-.| .|.||+.-|++ |++.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 56789999999999999999999999999999999999876532 45667776543334 48999999987 68888
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CC-CCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-EN-WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~-~~vkl~DFGls~~~~~ 167 (417)
.+++++||++-|+|.+-+...++-|....+++.||++|+.|+|++++||||||.+||||- .| -.+||||||+++..+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g- 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG- 174 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence 999999999999999999998999999999999999999999999999999999999993 22 369999999987533
Q ss_pred cCCCCcccccccCcccccccccccc---CC-CCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCC-CCCC
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKK---GY-DGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGE-YRCP 238 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~---~y-~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~-~~~p 238 (417)
...+..--+..|.|||++... .+ ..+.+|||.+|+|+|..|+|.+||..... -..+.+...+. ...|
T Consensus 175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 222333346779999986432 11 14778999999999999999999974322 22333444333 3344
Q ss_pred ---CCCChHHHHHHHHhccCCCCCC---CCHHHHhcCcccccccc
Q 014849 239 ---KWTSPDLKWFIGRLLDTDPATR---ITVDEILRDPWFKKDYK 277 (417)
Q Consensus 239 ---~~~s~~~~~li~~~L~~dP~~R---~t~~eil~h~~f~~~~~ 277 (417)
..+|+.+.++.++-|.++|++| .++...+...|......
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 3469999999999999999999 56667777777765444
No 399
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-33 Score=289.95 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=210.6
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
.+.+++||+|+||+||+|.+...|+ +||||++..... ......+.+|+-+|.+|+|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4557899999999999999876665 588888876543 334678899999999999999999999998776 889
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|++|+++|.|.+++.. +.+--+....|..||++||.|||.++++||||-..|+|+..-.++||+|||++.+.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999874 67888899999999999999999999999999999999999999999999999876543222
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
-......-.+.|||=|.+....|. .++||||+||.+||++| |.-|+.+....++-.-+..++ ...|+..+-++..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 111222235669999999988885 99999999999999987 999999988887777666654 678999999999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||-.|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999988754
No 400
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=100.00 E-value=3.1e-32 Score=250.94 Aligned_cols=219 Identities=43% Similarity=0.702 Sum_probs=187.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++++.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999989999999999875432 2467888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc-CC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK-GR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~-~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+++++|.+.+.. .. +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999999999976 34 89999999999999999999999999999999999999999999999999876543221 1334
Q ss_pred ccccCccccccccc-cccCCCCChhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCCCCCCC
Q 014849 176 TLCGTPAYVAPEIL-AKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 176 ~~~Gt~~y~APEvl-~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 240 (417)
..+++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.....+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788999999998 455554 699999999999999999999987 44447778887776554443
No 401
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=1.1e-33 Score=273.96 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=203.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.+...|.+...+|+|+|+.||+|.+.. ..+.||+|.+.... ...++.+|+++|..+. +.||+.+.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 456789999999999999999999887 78899999987653 2567899999999995 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~~ 167 (417)
+...+|+||++.-+-.++... ++-.+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|.|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888887764 6788899999999999999999999999999999999754 5689999999862110
Q ss_pred cC--------------C-----------------CC-----------cccccccCccccccccccccCCCCChhhHHHHH
Q 014849 168 IR--------------P-----------------DG-----------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCG 205 (417)
Q Consensus 168 ~~--------------~-----------------~~-----------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlG 205 (417)
.. + .+ ......|||+|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00 001246999999999999888888999999999
Q ss_pred HHHHHHHcCCCCCCCC-CHHHHHHHHh--------------cCC---------------------------CCCC-----
Q 014849 206 VVLFVLNAGYLPFNDP-NLMAMYRKIY--------------KGE---------------------------YRCP----- 238 (417)
Q Consensus 206 vil~~ll~G~~Pf~~~-~~~~~~~~i~--------------~~~---------------------------~~~p----- 238 (417)
||+.-++++..||-.. +.......|. -|. .++.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999999321 0000000000 000 0000
Q ss_pred -----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 -----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..++..+.+|+.+||..||.+|+|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 112457899999999999999999999999999983
No 402
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=5e-33 Score=246.99 Aligned_cols=210 Identities=25% Similarity=0.450 Sum_probs=173.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 94 (417)
+...-+..||+|++|.|-+-++..+|+..|+|.+...- .....+++.+|+.+..+. .+|.+|.+|+.+.....+|+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34455778999999999999999999999999997543 233456777888876654 689999999999999999999
Q ss_pred EeccCCCChHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 95 MEFAKGGELFAKI----SK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i----~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
||.|+. +|..+- .+ +..+|...-+++..++.||.|||++ .|+|||+||.|||++.+|++|+||||+|....
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 999964 675543 33 6799999999999999999999987 79999999999999999999999999997543
Q ss_pred CCCCcccc-cccCcccccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC
Q 014849 169 RPDGMLHT-LCGTPAYVAPEILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKG 233 (417)
Q Consensus 169 ~~~~~~~~-~~Gt~~y~APEvl~----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~ 233 (417)
+....+ -.|...|||||.+. .++|+ .+|||||||+.++||.+++.||+. .++.+.++++...
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 222233 56888999999975 34776 999999999999999999999974 5666777776654
No 403
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.97 E-value=2.3e-32 Score=299.41 Aligned_cols=200 Identities=17% Similarity=0.187 Sum_probs=148.7
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 014849 72 RLRH-PNIVKLYEVL-------ATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141 (417)
Q Consensus 72 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl 141 (417)
.++| +||+++++.+ .....+++++|++ +++|.+++.. +.+++.+++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777788776 2334678889987 5699999975 46999999999999999999999999999999
Q ss_pred CCCcEEecC-------------------CCCeEEeeeecceeecccCC--------------CCcccccccCcccccccc
Q 014849 142 KLENLLLDE-------------------NWDLKISDFGLSAVKEQIRP--------------DGMLHTLCGTPAYVAPEI 188 (417)
Q Consensus 142 kp~NILl~~-------------------~~~vkl~DFGls~~~~~~~~--------------~~~~~~~~Gt~~y~APEv 188 (417)
||+||||+. ++.+|++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965 34566666666643211000 000112468999999999
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 189 l~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+.+..| +.++|||||||+||||++|.+|+.... .....+.....+ .+....+....++.+||++||.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 998888 499999999999999999999976432 122222211111 1112356678999999999999999999999
Q ss_pred cCcccccc
Q 014849 268 RDPWFKKD 275 (417)
Q Consensus 268 ~h~~f~~~ 275 (417)
+||||.+.
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999753
No 404
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=3.5e-33 Score=293.65 Aligned_cols=263 Identities=31% Similarity=0.518 Sum_probs=211.4
Q ss_pred ccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecc---cccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 14 LFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ---KILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 14 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+..+| .-.+++|.|++|.|+.+.........+.|..... ..........+..|..+-..++|||++.....+....
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 5688999999999999988877777777765421 1111122233667888888899999988777776666
Q ss_pred EEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++.+||||++ +|+.++... .++..++..+|+||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66777999999 999999884 9999999999999999999999999999999999999999999999999999876554
Q ss_pred CCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-H--------HHhcCCCCC
Q 014849 169 RPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY-R--------KIYKGEYRC 237 (417)
Q Consensus 169 ~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~-~--------~i~~~~~~~ 237 (417)
... ......||+..|+|||++.+..|+...+||||+|+|++.|.+|+.||.-....+.. . ++..+..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 444 46677899999999999999999999999999999999999999999754433211 1 111111222
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
-..++...+.+|.+||++||.+|+|+++|++++||+....
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 2334677889999999999999999999999999997544
No 405
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.97 E-value=1.3e-28 Score=234.70 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=214.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP-NIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E 96 (417)
|++.+.||.|+|+.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999997 88999999887654444577889999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~~ 171 (417)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777763 699999999999999999999999999999999999999998 6999999998754332221
Q ss_pred ----CcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCC-CCCC
Q 014849 172 ----GMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYR-CPKW 240 (417)
Q Consensus 172 ----~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~-~p~~ 240 (417)
......+||+.|+|||.+... .+.....|+||+|++++++++|..||.... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 135778999999999999874 455689999999999999999999998776 34555555554433 2222
Q ss_pred CC--------hHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TS--------PDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s--------~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 468999999999999999999999988766543
No 406
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.96 E-value=3e-31 Score=268.73 Aligned_cols=240 Identities=34% Similarity=0.564 Sum_probs=211.3
Q ss_pred EEeeeCceEEEEEE---EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014849 23 IIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~---~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
++|+|+||+|++++ ..+.|+.+|+|+..+......... +-..|-.++..++ ||.+|+++..++++++.|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999998764 446888999999988765443323 5566888888887 999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.||+|+..+.. ..+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||++...-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999887 67888899999999999999999999999999999999999999999999998754221 122
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
|||..|||||+++ ++. ..+|.||+|+++|+|++|..||.. +....|.+.++..|...+..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 554 889999999999999999999988 777888999999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccccc
Q 014849 258 ATRIT-----VDEILRDPWFKKDY 276 (417)
Q Consensus 258 ~~R~t-----~~eil~h~~f~~~~ 276 (417)
..|.- +.||++|+||+...
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred HHHhccCcchhHHHhccchheeee
Confidence 99984 68999999998643
No 407
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.96 E-value=1.4e-29 Score=226.55 Aligned_cols=158 Identities=22% Similarity=0.206 Sum_probs=129.1
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 101 GELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 101 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|+|.+++.. +.+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ..+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 46999999999999999999999999 999999999999999 9998765431 236
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCCC-------CCCCCh--HHHHH
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRC-------PKWTSP--DLKWF 248 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~l 248 (417)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||..... ......+....... +...+. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999988885 899999999999999999999976543 23333333222111 122233 68999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
|.+||..||.+|||+.|+++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999863
No 408
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.96 E-value=6.7e-29 Score=238.29 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=206.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE-EeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL-ATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~ 88 (417)
..|+++.-++-+|+||.||.|.+++... .|-+|.+.... .+-....+..|--.+..+.|||+.+..++. ++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 4578888899999999999998765433 35555443221 112245566788888888999999999986 556
Q ss_pred CEEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
...++++.+..-|+|..++.. +.++..+...++.|++.|++|||++||+|.||...|.+||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678888999999999888862 24677788899999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRC 237 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~ 237 (417)
.+|+..-..+..-.-...-.+..||+||.+.+..|. .++|+|||||+||||++ |+.|+-+-++.+++.-+.+|. ..-
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999865443333333334456779999999999986 88999999999999986 999999999999999988874 566
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
|-.+++++...+.-||..+|++||+++|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8888999999999999999999999999854
No 409
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.96 E-value=1.1e-28 Score=244.93 Aligned_cols=172 Identities=20% Similarity=0.231 Sum_probs=137.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCcce-EEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHPNIVK-LYEVL 85 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~HpnIv~-l~~~~ 85 (417)
....+.++|++++.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+|++. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 446789999999999999999999999876 788889998753311 12234567899999999999999985 5442
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCeEEeeeeccee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL-KLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl-kp~NILl~~~~~vkl~DFGls~~ 164 (417)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 458999999999999732 21 11 2578899999999999999999999 99999999999999999999986
Q ss_pred ecccCCCC------cccccccCccccccccccc
Q 014849 165 KEQIRPDG------MLHTLCGTPAYVAPEILAK 191 (417)
Q Consensus 165 ~~~~~~~~------~~~~~~Gt~~y~APEvl~~ 191 (417)
........ ...+.++++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 54332222 2357789999999999864
No 410
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=6.9e-26 Score=223.22 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=194.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH----PNIVKLYEVL-ATKAK 90 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H----pnIv~l~~~~-~~~~~ 90 (417)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+........ ...+..|+.+|..+.. +++.++++.. .+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997775 689999887653222 1267789999998873 6899999999 58888
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----CCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-----WDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-----~~vkl~DFGls 162 (417)
-|+||+.+ |.+|.++... ++++...+..++.|++.+|.++|+.|++||||||.|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 7799997743 689999999999999999999999999999999999999765 35999999999
Q ss_pred eeecccCC-------CCc-ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHh
Q 014849 163 AVKEQIRP-------DGM-LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---AMYRKIY 231 (417)
Q Consensus 163 ~~~~~~~~-------~~~-~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~ 231 (417)
+....... ... .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 83221111 111 233459999999999887776 59999999999999999999999765432 2222222
Q ss_pred cCCCC--CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 223345677777777777899999988877655
No 411
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.94 E-value=9.5e-27 Score=246.35 Aligned_cols=226 Identities=31% Similarity=0.574 Sum_probs=184.1
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
+........|+.+|++..|++|.||+.+++.|.+.+|+| ++++... .|- ++.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee---------
Confidence 366777889999999999999999999999999999994 5544321 111 44445566555
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|+-...++. |.++.+. +.+++|+|+.||+|||+||+|+||..=|++|++|||++..--.
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 566666655 6677655 7899999999999999999999999999999999999864211
Q ss_pred cCCC----C---------cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Q 014849 168 IRPD----G---------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 168 ~~~~----~---------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
.... + .-...||||.|+||||+..+|| |..+|+|++|+|+|+++-|..||.+.+.++++.+.....
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1110 0 1123599999999999999999 699999999999999999999999999999999998877
Q ss_pred CCCCCC---CChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccc
Q 014849 235 YRCPKW---TSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 235 ~~~p~~---~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~ 275 (417)
...|.. ..++++++|.++|+.+|..|. .+-++++|+||+..
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 666543 578999999999999999998 58899999999863
No 412
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.93 E-value=1.2e-26 Score=245.74 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=194.1
Q ss_pred CCCCCCCcccc-------ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-cccchHHHHHHHHHHHHh
Q 014849 1 MGDNTGDISRE-------VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREISIMSR 72 (417)
Q Consensus 1 ~~~~~~~~~~~-------~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~ 72 (417)
||+|...-+.. ..+...|...+.||.+.|=+|.+|++. .|. |+||++-+... ..-....+..+|++ ...
T Consensus 1 MGnqls~~sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l 77 (1431)
T KOG1240|consen 1 MGNQLSLPSQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FAL 77 (1431)
T ss_pred CCcccccccccchHHHHhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHh
Confidence 78876642221 234457899999999999999999994 444 99999977652 12222344455666 677
Q ss_pred CCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 73 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
++|||.+.+.-+..+...-|+|-+|+.. +|+|.+..++ +..-+.+.|+.||+.||..||..||+|||||.|||||+.-
T Consensus 78 ~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW 156 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW 156 (1431)
T ss_pred hcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee
Confidence 8999999999888888899999999976 8999999865 6777889999999999999999999999999999999999
Q ss_pred CCeEEeeeecceee--cccCCCC---cccccccCccccccccccccC-C---------CCChhhHHHHHHHHHHHHc-CC
Q 014849 152 WDLKISDFGLSAVK--EQIRPDG---MLHTLCGTPAYVAPEILAKKG-Y---------DGAKVDMWSCGVVLFVLNA-GY 215 (417)
Q Consensus 152 ~~vkl~DFGls~~~--~~~~~~~---~~~~~~Gt~~y~APEvl~~~~-y---------~~~~sDIwSlGvil~~ll~-G~ 215 (417)
..+.|+||..-... ...++.. ...|..--.+|.|||.+...+ + -+++.||||+||+++||++ |+
T Consensus 157 NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 157 NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 99999999743211 1111111 223444456799999986532 1 1467899999999999976 79
Q ss_pred CCCCCCC-----------HHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 216 LPFNDPN-----------LMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 216 ~Pf~~~~-----------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+||.-.. .....++| .+..++.||..|++.||++|.++++.|+.
T Consensus 237 PlF~LSQL~aYr~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 237 PLFTLSQLLAYRSGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CcccHHHHHhHhccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 9995322 22222222 35679999999999999999999999986
No 413
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=6.2e-25 Score=199.56 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=193.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~ 90 (417)
-...++|++++.||+|+||.+|+|....+|..||||+-+... --.++..|..+.+.|++ ..|..+..+..++..
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 356789999999999999999999999999999999865432 14577789999999986 778888888888889
Q ss_pred EEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~~ 165 (417)
-.+||++. |.+|.++.. .++++...+.-++-|++.-++|+|.++++||||||+|+|+.-+- .+.++|||+|...
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 779998875 47899999999999999999999999999999999999986443 5899999999765
Q ss_pred cccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCC
Q 014849 166 EQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRC 237 (417)
Q Consensus 166 ~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~ 237 (417)
..... ...-....||..|.+--...+... +..-|+-|+|.+|..+..|.+||.+-. ..+-+++|...+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 43322 223344679999998766555444 478899999999999999999998743 345566776655544
Q ss_pred C-----CCCChHHHHHHHHhccCCCCCCCC
Q 014849 238 P-----KWTSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 238 p-----~~~s~~~~~li~~~L~~dP~~R~t 262 (417)
| ..++.++.-.+.-|=..--.+-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 3 345777777776665544455554
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.92 E-value=3.3e-25 Score=206.02 Aligned_cols=174 Identities=17% Similarity=0.161 Sum_probs=137.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH------VKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.+.++|++.++||.|+||.||++.+ ++..+|+|++..+....+..... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4689999999999999999999765 57789999997665444333333 579999999999999999998865
Q ss_pred eC--------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 87 TK--------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 87 ~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
.. +..++||||++|.+|.+... +++ ....+++.+|..||++|++|||+||.||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 43 35899999999999987732 333 2456999999999999999999999999999998 99999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHH
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL 211 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l 211 (417)
||.+....... ....++....|+ .++||||||+.+..+
T Consensus 178 fg~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~ 215 (232)
T PRK10359 178 LSGKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIY 215 (232)
T ss_pred CCCcccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHH
Confidence 99875332110 011134555676 789999999988755
No 415
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.92 E-value=6.9e-24 Score=200.47 Aligned_cols=241 Identities=22% Similarity=0.326 Sum_probs=192.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
..-.|++++.||+|+||..+.|.+.-++++||||.-.... ...+++.|....+.|. .++|...|.+.....+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3448999999999999999999999999999999765432 2678999999999986 699999998888888888
Q ss_pred EEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CeEEeeeecceee
Q 014849 93 FVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-----DLKISDFGLSAVK 165 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-----~vkl~DFGls~~~ 165 (417)
+|+|+. |.+|.|+.. .++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|||+|...
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 779988875 47899999999999999999999999999999999999997544 4899999999754
Q ss_pred cccC-----CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCCC
Q 014849 166 EQIR-----PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---PNLMAMYRKIYKGEYRC 237 (417)
Q Consensus 166 ~~~~-----~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~ 237 (417)
.... +........||-.||+--...+...+ .+-|+-|||-+++.+|.|.+||.+ .+..+-|++|...+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 3322 23344456799999998877777664 889999999999999999999976 56778888886554433
Q ss_pred C-----CCCChHHHHHHHHhccCCCCCCC
Q 014849 238 P-----KWTSPDLKWFIGRLLDTDPATRI 261 (417)
Q Consensus 238 p-----~~~s~~~~~li~~~L~~dP~~R~ 261 (417)
| ..++.++...++-.=..+-.+-|
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 3 23444554444333333333334
No 416
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.92 E-value=8.2e-25 Score=199.51 Aligned_cols=141 Identities=25% Similarity=0.299 Sum_probs=112.9
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCCC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----------------------LTAHVKREISIMSRLRHPN 77 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~Hpn 77 (417)
...||+|+||.||+|.+. +|+.||+|++......... ......+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 9999999999765321111 0123346999999998888
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCeE
Q 014849 78 IVKLYEVLATKAKIYFVMEFAKGGELFAK-ISKGRFSEQLSRRYFQQLISAVEYC-HSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 78 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~i~~ql~~aL~yl-H~~givHrDlkp~NILl~~~~~vk 155 (417)
+.....+.... .++||||++|+++... +..+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75444332222 3899999999887655 4457899999999999999999999 799999999999999998 47899
Q ss_pred Eeeeecceee
Q 014849 156 ISDFGLSAVK 165 (417)
Q Consensus 156 l~DFGls~~~ 165 (417)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998643
No 417
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.92 E-value=2.1e-24 Score=206.37 Aligned_cols=232 Identities=24% Similarity=0.348 Sum_probs=152.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH----------PNIVKLYEVLA 86 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H----------pnIv~l~~~~~ 86 (417)
.+..++.||.|+|+.||.+++.+||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999999976653334456777777755555432 12232233321
Q ss_pred e------------CC-----EEEEEEeccCCCChHHHHhc----CCC----CHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 014849 87 T------------KA-----KIYFVMEFAKGGELFAKISK----GRF----SEQLSRRYFQQLISAVEYCHSRGVFHRDL 141 (417)
Q Consensus 87 ~------------~~-----~~~lV~E~~~gg~L~~~i~~----~~l----~e~~~~~i~~ql~~aL~ylH~~givHrDl 141 (417)
- .+ +.+++|+-+. ++|.+.+.. ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 11 2356777774 488777542 222 22233445599999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc--------CCCCChhhHHHHHHHHHHHHc
Q 014849 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK--------GYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 142 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~--------~y~~~~sDIwSlGvil~~ll~ 213 (417)
+|+|++++.+|.++|+||+.....+. .......+..|.|||..... .+ +.+.|.|+||+++|.|+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence 99999999999999999987654322 11113346779999987543 23 588999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCC
Q 014849 214 GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
|.+||........... .+ .|. ..+..++.||+++|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999987643322111 22 344 678899999999999999988
No 418
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.91 E-value=2.8e-26 Score=241.53 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=221.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
...|++.+.||+|+|+.|-.+.+.. +...+|.|.+.... .......++..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6789999999999999999988743 44567888776553 33445677888999988887 999999999999999999
Q ss_pred EEEeccCCCChHHHH-hc-C-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCC-CeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKI-SK-G-RFSEQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i-~~-~-~l~e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~ 167 (417)
++++|..|+++++.+ .. . ..+...+..++.|+..++.|+| ..++.|||+||+|.+++.++ +++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 55 3 6788889999999999999999 99999999999999999999 999999999987766
Q ss_pred -cCCCCccccccc-CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcC--C--CCCCCC
Q 014849 168 -IRPDGMLHTLCG-TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM-YRKIYKG--E--YRCPKW 240 (417)
Q Consensus 168 -~~~~~~~~~~~G-t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~--~--~~~p~~ 240 (417)
......+...|| ++.|+|||...+..|.+...|+||+|+++..+++|..|+........ +...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 556677888999 99999999999988999999999999999999999999976544321 1222221 1 233345
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.+..+.+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 6888999999999999999999999999999987
No 419
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.91 E-value=1e-23 Score=192.24 Aligned_cols=143 Identities=22% Similarity=0.287 Sum_probs=115.8
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCC
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----------------------LTAHVKREISIMSRLRHP 76 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~Hp 76 (417)
+.+.||+|+||.||+|.+. +|+.||||++......... ......+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 9999999999875321000 022346899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCe
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~v 154 (417)
++.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555443333 489999999886543 4556788999999999999999999999 9999999999999999 7899
Q ss_pred EEeeeecceeec
Q 014849 155 KISDFGLSAVKE 166 (417)
Q Consensus 155 kl~DFGls~~~~ 166 (417)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
No 420
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.90 E-value=4.9e-24 Score=205.55 Aligned_cols=188 Identities=28% Similarity=0.418 Sum_probs=146.0
Q ss_pred CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHH
Q 014849 74 RHPNIVKLYEVLAT---------------------------KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126 (417)
Q Consensus 74 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~ 126 (417)
+|||||++...|.+ +..+|+||.-.+. +|..++..+..+...++-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999877643 3479999998866 8999999888999999999999999
Q ss_pred HHHHHHHcCCeecCCCCCcEEe--cCCC--CeEEeeeecceeecccC-----CCCcccccccCccccccccccccCC---
Q 014849 127 AVEYCHSRGVFHRDLKLENLLL--DENW--DLKISDFGLSAVKEQIR-----PDGMLHTLCGTPAYVAPEILAKKGY--- 194 (417)
Q Consensus 127 aL~ylH~~givHrDlkp~NILl--~~~~--~vkl~DFGls~~~~~~~-----~~~~~~~~~Gt~~y~APEvl~~~~y--- 194 (417)
|+.|||++||.|||+|.+|||+ |+++ .+.|+|||.+- .+... ...-.....|.-.-||||+....+-
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL-Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL-ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee-eccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999998 3443 48999999653 22211 1111123457888999999764321
Q ss_pred --CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 014849 195 --DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITV 263 (417)
Q Consensus 195 --~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 263 (417)
+-.++|.|++|.+.||++....||.+...+.+-..-. .. -+..|...++.+++|+..+|+.||++|++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 1368999999999999999999998855443222111 12 245678889999999999999999999984
No 421
>PRK10345 hypothetical protein; Provisional
Probab=99.89 E-value=1.4e-22 Score=187.13 Aligned_cols=135 Identities=21% Similarity=0.294 Sum_probs=110.1
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-----RHPNIVKLYEVLATKA---KI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~ 91 (417)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 7777666 6999876432 2356789999999999 5799999999998874 44
Q ss_pred E-EEEec--cCCCChHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEecC----CCCeEEeeeecc
Q 014849 92 Y-FVMEF--AKGGELFAKISKGRFSEQLSRRYFQQLISAV-EYCHSRGVFHRDLKLENLLLDE----NWDLKISDFGLS 162 (417)
Q Consensus 92 ~-lV~E~--~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL-~ylH~~givHrDlkp~NILl~~----~~~vkl~DFGls 162 (417)
+ +|+|| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999988777777 35677888777 9999999999999999999974 347999995543
No 422
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.89 E-value=2.4e-22 Score=183.60 Aligned_cols=192 Identities=17% Similarity=0.182 Sum_probs=143.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-LTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..+...|++|+||+||.+.. .+..++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998776 7778887777554321111 1225789999999995 5889999886 3479999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCeEEeeeecceeecccCCC---
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL-KLENLLLDENWDLKISDFGLSAVKEQIRPD--- 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl-kp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 171 (417)
||+.|.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 78 SYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999999987654321 2357899999999999999999999 799999999999999999999754321110
Q ss_pred ---C-----cccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 172 ---G-----MLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 172 ---~-----~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
. ..+-...++.|++|+.-.-- ..+-...+.++.|+-+|.+.|+.+|+-+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01122368888988864322 11125679999999999999999987554
No 423
>smart00090 RIO RIO-like kinase.
Probab=99.85 E-value=3.8e-21 Score=181.32 Aligned_cols=143 Identities=22% Similarity=0.246 Sum_probs=114.8
Q ss_pred CeEEeeEEeeeCceEEEEEE-EccCCcEEEEEEeecccccc---------------------cchHHHHHHHHHHHHhCC
Q 014849 17 KYEVGKIIGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILR---------------------GGLTAHVKREISIMSRLR 74 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~ 74 (417)
-|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 66899999999997643110 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeccCCCChHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecC
Q 014849 75 HPN--IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG-VFHRDLKLENLLLDE 150 (417)
Q Consensus 75 Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~i~~ql~~aL~ylH~~g-ivHrDlkp~NILl~~ 150 (417)
+.+ +.+.++. . ..|+||||+.|++|.... ....+.+..+..++.|++.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444432 2 358999999998887655 3456777778899999999999999999 99999999999999
Q ss_pred CCCeEEeeeeccee
Q 014849 151 NWDLKISDFGLSAV 164 (417)
Q Consensus 151 ~~~vkl~DFGls~~ 164 (417)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998864
No 424
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.84 E-value=2e-20 Score=172.55 Aligned_cols=137 Identities=26% Similarity=0.330 Sum_probs=116.0
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+.||+|++|.||+|.+ .|..+++|+......... ....++.+|+.++..+.|++|.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 778899998654332111 113467789999999999999887777777788999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875322 7889999999999999999999999999999999 78999999998864
No 425
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.83 E-value=5.5e-21 Score=176.56 Aligned_cols=241 Identities=20% Similarity=0.334 Sum_probs=193.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
++...+...|.+.-.|..|++++ .|..++.|++...... ......+..|.-.|+...||||+.+++.+.++.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 44556777888999999999999 4556777887654432 22234566788889999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEe--eeecceeecc
Q 014849 95 MEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKIS--DFGLSAVKEQ 167 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~--DFGls~~~~~ 167 (417)
..|++.|+|+..+..+ ..+..++.+++.+++.|+.|||+.. |----|....+++|++-+.+|+ |--+|..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 9999999999999763 3678899999999999999999874 4444588899999999877664 3333211
Q ss_pred cCCCCcccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~ 243 (417)
. ....-+|.||+||.+..++-+ -.++|+||+.++++||.|...||.+-.+++.--+|.-. ...+|+.+++
T Consensus 343 --e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 --E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred --c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 1 112347899999999887665 35799999999999999999999998888776666543 4568999999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHh
Q 014849 244 DLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.+..|+.-|++.||.+||.+..|.
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987663
No 426
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.82 E-value=1.6e-19 Score=165.09 Aligned_cols=133 Identities=24% Similarity=0.307 Sum_probs=108.7
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+||+|+||.||+|.. +|..+++|+......... ....++.+|+.+++.++|+++....-+.......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 678999998654322111 1235677899999999998766555555566678999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 78999999999865
No 427
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.81 E-value=8.5e-20 Score=197.01 Aligned_cols=234 Identities=22% Similarity=0.304 Sum_probs=175.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 91 (417)
..+|.|-+.+|+|+||+||.|.+.. |+.||+|+=.......--...+++ .+|+ -+.|..++..+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~------~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVM------ERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHH------HhhchhhhcchHHHHHHHccCCcc
Confidence 4589999999999999999999976 999999987665443332333333 3333 23455555444445566
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-------CCCCeEEeeeecce
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-------ENWDLKISDFGLSA 163 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-------~~~~vkl~DFGls~ 163 (417)
++|+||.+.|+|.+++.. +.+++..+..+..|++..|+.||..+|||+||||+|+||. .+--++|+|||-|.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999986 6799999999999999999999999999999999999993 23359999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CP 238 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p 238 (417)
...-..........++|..+-.+|...++++. ..+|.|.+..+++.||.|+.- +...|... ++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-----------q~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-----------EVKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-----------HhcCCcceeccccch
Confidence 55433344577788999999999999999996 999999999999999999632 12222211 22
Q ss_pred CCC-ChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 239 KWT-SPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 239 ~~~-s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
..+ -+-..+++..+|++|-..=|.+.+|.
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 222 23346678888885555545555543
No 428
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.81 E-value=1.6e-19 Score=165.40 Aligned_cols=138 Identities=20% Similarity=0.273 Sum_probs=109.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-------------------chHHHHHHHHHHHHhCCCCC-
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-------------------GLTAHVKREISIMSRLRHPN- 77 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------~~~~~i~~Ei~il~~l~Hpn- 77 (417)
|.+.+.||+|+||.||+|.+ .+|+.||||++......-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999988 4899999999865431000 01123568999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 78 -IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 78 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
++..+. ....++||||++|++|...... ..+..++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2456899999999998765431 345678899999999999999999999999999999999999
Q ss_pred eeeecceee
Q 014849 157 SDFGLSAVK 165 (417)
Q Consensus 157 ~DFGls~~~ 165 (417)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999998543
No 429
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.80 E-value=2.4e-20 Score=186.49 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=169.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEE------
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE------ 83 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~------ 83 (417)
...+.+.+.+..+..+++.+...+-... ..-+.-+..+.+ +........+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~ 317 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLF 317 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchh
Confidence 3344556666666666666655443222 222333322221 1122334455665555554433332222
Q ss_pred -EE-----EeCCEEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 84 -VL-----ATKAKIYFVMEFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 84 -~~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
.+ .....+||.|++|.-.+|.++|..+ ..+......++.|+..|++| +|.+|||+||.||+...++.
T Consensus 318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh
Confidence 11 1133689999999999999999742 46677889999999999999 99999999999999999999
Q ss_pred eEEeeeecceeecccC----CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHH
Q 014849 154 LKISDFGLSAVKEQIR----PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYR 228 (417)
Q Consensus 154 vkl~DFGls~~~~~~~----~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~ 228 (417)
+||.|||+.+...... .........||++||+||.+.+..|. .++||||||+|||||+.- ..+|.. .....
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~ 470 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLT 470 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhh
Confidence 9999999987554332 12244567899999999999999985 999999999999999862 222221 22333
Q ss_pred HHhcCCCCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 229 KIYKGEYRCPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 229 ~i~~~~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+..+.++.-.+ -.|.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 471 d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 344444441122 24566799999999999999988777777664
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.79 E-value=6.8e-19 Score=184.99 Aligned_cols=140 Identities=21% Similarity=0.267 Sum_probs=113.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----GGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...|...+.||+|+||+||+|... +..+++|+........ .....++.+|+.+|+.++|++++....+..+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567899999999999999874 3445555433221111 112356789999999999999998887777777
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..++||||++|++|.+.+. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999998875 357899999999999999999999999999999 677899999999865
No 431
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.77 E-value=1.3e-18 Score=176.67 Aligned_cols=200 Identities=22% Similarity=0.399 Sum_probs=157.5
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcE
Q 014849 70 MSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGV-FHRDLKLENL 146 (417)
Q Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~gi-vHrDlkp~NI 146 (417)
|+.+.|.|+.++++...+...++.|.+||.-|+|.|.+.. -+++..-...+.++|+.||.|+|...| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 467777788889999999999998877 9999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCC------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY------DGAKVDMWSCGVVLFVLNAGYLPFND 220 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y------~~~~sDIwSlGvil~~ll~G~~Pf~~ 220 (417)
+++....+||+|||+..+..........+...-...|.|||.+..... -+.+.||||+|+|++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876542111111122223456999999876422 24679999999999999999999976
Q ss_pred C----CHHHHHHHHhc-CCCCC-CC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 P----NLMAMYRKIYK-GEYRC-PK-----WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
. ...+....+.+ +...+ |. ...+++..++.+||..+|..||+++++...
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 3 22345555555 22111 21 234568899999999999999999998543
No 432
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.77 E-value=1.5e-18 Score=156.93 Aligned_cols=139 Identities=24% Similarity=0.319 Sum_probs=101.4
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHH---------------------HHHHHHHHHHhCCCCC-
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA---------------------HVKREISIMSRLRHPN- 77 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~---------------------~i~~Ei~il~~l~Hpn- 77 (417)
+++.||+|+||.||.|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 8999999998764321111111 1135666666665443
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCe
Q 014849 78 -IVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 78 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~v 154 (417)
+.+.+.. ...++||||++|+.+.. .+...... .+++.++.|++.++.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4455543 23589999999954422 12211111 6788999999999999999 9999999999999999 8899
Q ss_pred EEeeeecceee
Q 014849 155 KISDFGLSAVK 165 (417)
Q Consensus 155 kl~DFGls~~~ 165 (417)
+++|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.75 E-value=1.1e-17 Score=157.92 Aligned_cols=138 Identities=17% Similarity=0.337 Sum_probs=107.6
Q ss_pred eeEEe-eeCceEEEEEEEccCCcEEEEEEeecccc----cc------cchHHHHHHHHHHHHhCCCCCc--ceEEEEEEe
Q 014849 21 GKIIG-CGAFAKVYHGRNVRTGQSVAIKAVSKQKI----LR------GGLTAHVKREISIMSRLRHPNI--VKLYEVLAT 87 (417)
Q Consensus 21 ~~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~------~~~~~~i~~Ei~il~~l~HpnI--v~l~~~~~~ 87 (417)
+..|| .|+.|+||.+.. .+..+++|.+..... .. .....++.+|+.++..++|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45676 777777887776 378899998865322 11 1224567899999999998875 677766433
Q ss_pred C-C---EEEEEEeccCC-CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 K-A---KIYFVMEFAKG-GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 ~-~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
. . ..++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 23599999997 6899888877777654 578999999999999999999999999999999999999987
Q ss_pred ee
Q 014849 163 AV 164 (417)
Q Consensus 163 ~~ 164 (417)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
No 434
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.74 E-value=1.3e-18 Score=185.06 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=213.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.+.+.+-+-+|+|+.+..+.-..+|...++|+..+...........++++-.++-..++|-+++..-.+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45678888899999999999999999988888877554333332344444554444445667777666555667789999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc-----
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI----- 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~----- 168 (417)
++|..|++|...+.. +..+++-++.+...+..+.+|||+..+.|||++|.|+|...+|+.+++|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999999999987 77899999999999999999999999999999999999999999999999832211100
Q ss_pred ----------------------CCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 014849 169 ----------------------RPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM 224 (417)
Q Consensus 169 ----------------------~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~ 224 (417)
..+ ...+...||+.|.|||.+.+... +..+|+|+.|+++++.++|.+||......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 000 12345679999999999988776 58899999999999999999999999999
Q ss_pred HHHHHHhcCCCCCC---CCCChHHHHHHHHhccCCCCCCCCHH---HHhcCcccccccc
Q 014849 225 AMYRKIYKGEYRCP---KWTSPDLKWFIGRLLDTDPATRITVD---EILRDPWFKKDYK 277 (417)
Q Consensus 225 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~---eil~h~~f~~~~~ 277 (417)
..+++|..+..+.| ...++++++++.++|..+|.+|..+. +...|+||+..-.
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 99999998877654 45689999999999999999999887 9999999986544
No 435
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.72 E-value=2e-17 Score=142.22 Aligned_cols=132 Identities=23% Similarity=0.263 Sum_probs=113.3
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999984 37899999865432 4578899999999987 5899999988888899999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR---GVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~---givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++.++.++++|||.+..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566778899999999999984 799999999999999989999999998753
No 436
>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs). Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.
Probab=99.66 E-value=8.2e-17 Score=117.56 Aligned_cols=62 Identities=50% Similarity=0.741 Sum_probs=48.5
Q ss_pred CCccCcchhhccCCCCCCCCCCccCCCCCCCccccceeecCCHHHHHHHHHHHHHhhcCCCceEEEE
Q 014849 299 EKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTK 365 (417)
Q Consensus 299 ~~~~~~~~~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 365 (417)
|..+|||||||+|+|||||+||+..... ...+++||+|++||++|+++||++|+.+ ||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~-~~~~~~RF~S~~~~~~Ii~klEe~a~~~----~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKS-SVKRETRFTSKEPASEIIEKLEEIAKKL----GFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S--SS---EEEEESS-HHHHHHHHHHHHHHT----TEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccc-cccccceEecCCCHHHHHHHHHHHHHhc----CceeeC
Confidence 5679999999999999999999876541 1126899999999999999999999999 999975
No 437
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.60 E-value=6.8e-16 Score=160.28 Aligned_cols=146 Identities=21% Similarity=0.335 Sum_probs=102.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--------------------------c-----cchHH
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--------------------------R-----GGLTA 61 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------------~-----~~~~~ 61 (417)
.++..|+. +.||+|++|.||.|+.+.+|+.||||+..+.-.. + .+...
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34667887 8999999999999999888999999999754200 0 01222
Q ss_pred HHHHH------HHHHHhCC----CCCcceEEEEEEe-CCEEEEEEeccCCCChHHH--Hhc-C----CCCHHHHHHHHHH
Q 014849 62 HVKRE------ISIMSRLR----HPNIVKLYEVLAT-KAKIYFVMEFAKGGELFAK--ISK-G----RFSEQLSRRYFQQ 123 (417)
Q Consensus 62 ~i~~E------i~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~i~~q 123 (417)
.+.+| +..+.+++ +.+.+.+-.++.+ .+..++||||+.|+.+.+. +.. + .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33333 33333332 3333443344432 4456899999999999764 333 3 3556666667777
Q ss_pred HHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecceeec
Q 014849 124 LISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLSAVKE 166 (417)
Q Consensus 124 l~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls~~~~ 166 (417)
++ ..|++|+|+||.||+++.+| .+++.|||++...+
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 65 59999999999999999988 89999999987553
No 438
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.59 E-value=5.4e-15 Score=151.31 Aligned_cols=140 Identities=21% Similarity=0.281 Sum_probs=96.9
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-------------------------------cchHH------HHH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-------------------------------GGLTA------HVK 64 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------------------------------~~~~~------~i~ 64 (417)
+.||.|++|.||+|+. .+|+.||||+....-... .+... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999997 589999999985431000 00001 233
Q ss_pred HHHHHHHhCC-----CCCcceEEEEE-EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 014849 65 REISIMSRLR-----HPNIVKLYEVL-ATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLIS-AVEYCHSRG 135 (417)
Q Consensus 65 ~Ei~il~~l~-----HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~-aL~ylH~~g 135 (417)
+|...+.+++ +|+|. +-.++ .-.+..++||||++|++|.+.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 4555555542 34332 22222 223456899999999999887643 2222 3445666665 478899999
Q ss_pred CeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 136 ivHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
++|+|+||.||+++.+|.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
No 439
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.56 E-value=2e-15 Score=153.77 Aligned_cols=255 Identities=19% Similarity=0.192 Sum_probs=189.7
Q ss_pred cCCeEEeeEEee--eCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGC--GAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~ 89 (417)
..++-+...+|. |.+|.||.+.. ..+++.+|+|.=..... ......+=.+|+...+.++ |+|.++.+..+++.+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCC
Confidence 446677888999 99999999998 99999999997322111 0111122235666666664 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLIS----AVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~----aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls 162 (417)
..|+-+|+|. .+|..+... . -+++..++.++.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999995 678777765 3 4899999999999999 9999999999999999999999999 88999999998
Q ss_pred eeecccCCCC---cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCC
Q 014849 163 AVKEQIRPDG---MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKGEYRC 237 (417)
Q Consensus 163 ~~~~~~~~~~---~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~ 237 (417)
.......-.. .....-|...|++||+..+- .+...||+++|.+..+-.+|..+.... +.....+++. ....+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~ 347 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEF 347 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhh
Confidence 7654322111 11122567789999997653 368999999999988877776554332 1111111111 01111
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
-...+.++...+..|++.+|-.|++.+.++.|++...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2233667777999999999999999999999999874
No 440
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.56 E-value=6.8e-14 Score=144.08 Aligned_cols=171 Identities=18% Similarity=0.317 Sum_probs=135.7
Q ss_pred EEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCC
Q 014849 34 HGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFS 113 (417)
Q Consensus 34 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 113 (417)
.|..+.++.+|.|.+.+...- .....+.+-++.|+.++||||+++++.+++.+.+|+|+|-+.- |..+++. +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 467778999999999977642 4567788999999999999999999999999999999999863 6666664 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc
Q 014849 114 EQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192 (417)
Q Consensus 114 e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~ 192 (417)
+.....-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ +.+...--..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6677788899999999997 67899999999999999999999999998865443222 12222223346777765433
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCC
Q 014849 193 GYDGAKVDMWSCGVVLFVLNAGYL 216 (417)
Q Consensus 193 ~y~~~~sDIwSlGvil~~ll~G~~ 216 (417)
. -..|.|.|||++++++.|.+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c---cchhhhhHHHHHHHHhCccc
Confidence 3 34799999999999999943
No 441
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.49 E-value=4e-13 Score=122.44 Aligned_cols=140 Identities=16% Similarity=0.201 Sum_probs=104.4
Q ss_pred eEEeeeCceEEEEEEEcc------CCcEEEEEEeeccccc-------------------ccchHHHHH----HHHHHHHh
Q 014849 22 KIIGCGAFAKVYHGRNVR------TGQSVAIKAVSKQKIL-------------------RGGLTAHVK----REISIMSR 72 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~-------------------~~~~~~~i~----~Ei~il~~ 72 (417)
-.||.|--+.||.|.... .+..+|||+....... +......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 3579999998542210 011122333 89999999
Q ss_pred CCC--CCcceEEEEEEeCCEEEEEEeccCCCChH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEe
Q 014849 73 LRH--PNIVKLYEVLATKAKIYFVMEFAKGGELF-AKISKGRFSEQLSRRYFQQLISAVEYC-HSRGVFHRDLKLENLLL 148 (417)
Q Consensus 73 l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~i~~~~l~e~~~~~i~~ql~~aL~yl-H~~givHrDlkp~NILl 148 (417)
+.. -++.+++.+ ..-++||||+.+..+. ..+....+++.++..++.|++.+|..+ |+.||+|+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 864 456666654 4568999999876553 234444566777888899999999999 89999999999999999
Q ss_pred cCCCCeEEeeeecceeec
Q 014849 149 DENWDLKISDFGLSAVKE 166 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~ 166 (417)
+ ++.+.|+|||.+...+
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4689999999886543
No 442
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.47 E-value=1.9e-13 Score=121.24 Aligned_cols=127 Identities=20% Similarity=0.230 Sum_probs=97.4
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 99 (417)
.+.|+.|.++.||.++. .|+.|++|+...... ......+|+.+++.+.+.++ .+++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478999998755421 12345789999998876554 45555433 33589999999
Q ss_pred CCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEecCCCCeEEeeeecce
Q 014849 100 GGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV-----FHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 100 gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~gi-----vHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11124567899999999999985 9999999999999 6689999999874
No 443
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.41 E-value=9.8e-14 Score=141.49 Aligned_cols=254 Identities=18% Similarity=0.152 Sum_probs=189.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEc-cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNV-RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.....++|-.+..||.|.|+.|+...-+ .++..+++|...+......... .-..|+.+...+ .|.++++.+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3456788999999999999999988755 7888999998865543221111 112455555555 499999999888888
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~ 166 (417)
...|+-.|||.|+++...+.- ..+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..+++|||..+...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 889999999999988766643 578899999999999999999999999999999999999886 788999999875321
Q ss_pred ccCCCCcccccccCcccc-ccccccccCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhcCCCCCCCCCChH
Q 014849 167 QIRPDGMLHTLCGTPAYV-APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~-APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
. .. ....+.-++. .+|++........++|++|||.-+.+..+|... .... ....|..+..+........
T Consensus 419 ~--~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 F--SS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred e--ec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHh
Confidence 1 00 1111233444 355555444446999999999999999888643 2222 2334555656555555588
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+..+.+.++.+++..|+.+.++..|.=|-.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 899999999999999999999988865543
No 444
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.39 E-value=4.3e-13 Score=127.61 Aligned_cols=201 Identities=17% Similarity=0.271 Sum_probs=143.1
Q ss_pred HHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc--CCe
Q 014849 70 MSRLRHPNIVKLYEVLATK-----AKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR--GVF 137 (417)
Q Consensus 70 l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~--giv 137 (417)
|-.+-|.|||++|.++.+. ....+++||+..|+|..++++ ..+......+|+-||++||.|||+. .|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4445699999999998654 458899999999999998864 3588888999999999999999987 499
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeecccCCCC--cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCC
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG--MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~--~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~ 215 (417)
|+.+...-|++..+|-+|+.---............ ......|-+.|.|||.=....- +.++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 99999999999999988886433222211111111 1112346788999997443333 46799999999999998775
Q ss_pred CC-CCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 216 LP-FNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 216 ~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.- -.+.........+.+.-+-. ..+--+.++++||+..|+.||++.+++.||-.-+
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 43 23322222222222211111 1233467899999999999999999999987643
No 445
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.32 E-value=1.7e-11 Score=109.08 Aligned_cols=135 Identities=21% Similarity=0.300 Sum_probs=105.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccch-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL-----TAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
..+++|+-+.+|.+.. -|..+.+|.=.++....+.. ..+..+|..+|..++--.|....-+..++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999966 34457777654433333332 3455679999999987677666666677788889999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
|+.|-.|.+.+... ...++..+=.-+.-||..||+|+||.+.||++...+ +.++||||+.+.
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998888888765 256777788888899999999999999999998775 999999998653
No 446
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.29 E-value=2.2e-11 Score=112.34 Aligned_cols=139 Identities=19% Similarity=0.295 Sum_probs=108.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATK---AKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E 96 (417)
+.||.|.++.||++... .|+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3689999997654321 134567899999999976 4467777776554 26789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS------------------------------------------- 133 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~------------------------------------------- 133 (417)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776543567777777888888888888873
Q ss_pred -------------cCCeecCCCCCcEEecC--CCCeEEeeeecce
Q 014849 134 -------------RGVFHRDLKLENLLLDE--NWDLKISDFGLSA 163 (417)
Q Consensus 134 -------------~givHrDlkp~NILl~~--~~~vkl~DFGls~ 163 (417)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5668999999875
No 447
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.22 E-value=1.6e-10 Score=102.54 Aligned_cols=143 Identities=22% Similarity=0.252 Sum_probs=109.6
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----LTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...++-||+-+.|+.+.. .|+...||.=.......+. ...+.++|+++|.+++--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677899999999999987 7888888865444333322 245677899999998766666555566677777899
Q ss_pred EeccCC-CChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeeccee
Q 014849 95 MEFAKG-GELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~g-g~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGls~~ 164 (417)
|||++| .++.+++.. ....+.....++++|=+.+.-||..+|+|+||..+||+|..+|+ +.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999988 466666653 22333333789999999999999999999999999999976653 58999999864
No 448
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.19 E-value=6.4e-10 Score=111.99 Aligned_cols=210 Identities=20% Similarity=0.268 Sum_probs=155.9
Q ss_pred ceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCC-CCh
Q 014849 29 FAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----KAKIYFVMEFAKG-GEL 103 (417)
Q Consensus 29 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L 103 (417)
-.+.|+|....+|..|++|.+...+.... .....-+++.+++.|+|||.+.+++.+ ...+.+|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999955443322 223345678899999999999999874 3479999999875 567
Q ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 104 FAKIS----------------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 104 ~~~i~----------------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
.++.- ..+.+|...+.|+.||..||.++|+.|+.-+-|.|.+||++.+-.++|+..|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 66431 13578999999999999999999999999999999999999998999998887765442
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHH-HHHHhcCCCCCCCCCChHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN-DPNLMAM-YRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~-~~~~~~~-~~~i~~~~~~~p~~~s~~~ 245 (417)
.. + |-+... .+-|.=.||.+++.|.+|..--. ....... ...| ....|.++
T Consensus 446 d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL 498 (655)
T ss_pred CC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence 11 0 112211 45688899999999999964411 1111111 1222 23468899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++|.-+...+++. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999887 678888765
No 449
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.12 E-value=6.1e-10 Score=101.07 Aligned_cols=127 Identities=25% Similarity=0.409 Sum_probs=85.6
Q ss_pred EEEEEEEccCCcEEEEEEeecccc-----------------------cccchHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 014849 31 KVYHGRNVRTGQSVAIKAVSKQKI-----------------------LRGGLTAHVKREISIMSRLRHP--NIVKLYEVL 85 (417)
Q Consensus 31 ~Vy~a~~~~~g~~vAiK~i~~~~~-----------------------~~~~~~~~i~~Ei~il~~l~Hp--nIv~l~~~~ 85 (417)
.||.|.. ..|..+|+|+...... ..........+|.+.|+++..- ++.+++.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899998 6788999999854210 0011134567899999999876 46677654
Q ss_pred EeCCEEEEEEeccC--CCChHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 86 ATKAKIYFVMEFAK--GGELFAKISKGRFSEQLSRRYFQQLISAVEY-CHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 86 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~y-lH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
++ -.+||||++ |..+.. +....++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.+
T Consensus 79 -~~--~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred -eC--CEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 33 369999998 655543 333333355677888899986665 579999999999999999988 8999999987
Q ss_pred ee
Q 014849 163 AV 164 (417)
Q Consensus 163 ~~ 164 (417)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 64
No 450
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.07 E-value=3e-09 Score=101.97 Aligned_cols=140 Identities=15% Similarity=0.133 Sum_probs=97.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc---ccc-----chHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI---LRG-----GLTAHVKREISIMSRLRHPNI--VKLYEVLAT----- 87 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~-----~~~~~i~~Ei~il~~l~HpnI--v~l~~~~~~----- 87 (417)
.+-......|..... .|+.+.||....... .+. .-.....+|...+..|..-+| +.++.+.+.
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 333333344555443 677899996643221 000 011246789888888853333 233444432
Q ss_pred CCEEEEEEeccCCC-ChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-------CCCeEE
Q 014849 88 KAKIYFVMEFAKGG-ELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-------NWDLKI 156 (417)
Q Consensus 88 ~~~~~lV~E~~~gg-~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-------~~~vkl 156 (417)
...-++|||+++|. +|.+++.. ...++.....++.+++..+.-||..||+|+|++|.|||++. ++.+.+
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999886 78888753 45677788899999999999999999999999999999975 467999
Q ss_pred eeeeccee
Q 014849 157 SDFGLSAV 164 (417)
Q Consensus 157 ~DFGls~~ 164 (417)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998753
No 451
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.02 E-value=9.4e-11 Score=121.60 Aligned_cols=155 Identities=21% Similarity=0.322 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccC------CCCcc-cccccCccccccccccccC
Q 014849 122 QQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR------PDGML-HTLCGTPAYVAPEILAKKG 193 (417)
Q Consensus 122 ~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~------~~~~~-~~~~Gt~~y~APEvl~~~~ 193 (417)
.+.+.|+.|+|.. ++||+.|.|++|.++.+|.+||+.|+++.-..... .+... .-..-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444999999965 89999999999999999999999999875433211 01111 1122356799999998844
Q ss_pred CCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHh----cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 194 YDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIY----KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 194 y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++++|++|+||++|.+. .|+.-+...+....+..-. .+.+..+..+++++++=+.++|..++..||++.+++.
T Consensus 186 -~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 -NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred -ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 469999999999999998 5666565543333222211 1223345677899999999999999999999999999
Q ss_pred Ccccccccc
Q 014849 269 DPWFKKDYK 277 (417)
Q Consensus 269 h~~f~~~~~ 277 (417)
.|||.+...
T Consensus 265 ~~ff~D~~~ 273 (700)
T KOG2137|consen 265 IPFFSDPGL 273 (700)
T ss_pred ccccCCchh
Confidence 999987543
No 452
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.97 E-value=1.3e-08 Score=100.53 Aligned_cols=233 Identities=18% Similarity=0.227 Sum_probs=152.8
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEE------EEeCC-E
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEV------LATKA-K 90 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~------~~~~~-~ 90 (417)
..++.||+|+-+.+|-.-.. +. .+-|++.+... ..+. .....|... .||-+-.-+.+ ..+.+ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp-----a~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP-----AAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCc-----hHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 45788999999999965432 22 34477765432 1111 122233333 46644331111 12233 3
Q ss_pred EEEEEeccCCCChHHHH-hc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKI-SK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i-~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+-+.|..++|..--..+ .. .....+-+.+..+.|+.+.+.||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 88999999886443322 21 13567788899999999999999999999999999999999999999885543
Q ss_pred eeecccCCCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcC-CCCCCCC-------CHHHHHHH
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDP-------NLMAMYRK 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~-------~~~~~~~~ 229 (417)
.+. ..+......+|.+.|.+||... +.+- ++..|.|.|||++|+||.| +.||.+- +..+ ..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 222 2333445678999999999864 2233 4789999999999998876 9999652 2111 12
Q ss_pred HhcCCC-----------CCC---CC--CChHHHHHHHHhccC--CCCCCCCHHHH
Q 014849 230 IYKGEY-----------RCP---KW--TSPDLKWFIGRLLDT--DPATRITVDEI 266 (417)
Q Consensus 230 i~~~~~-----------~~p---~~--~s~~~~~li~~~L~~--dP~~R~t~~ei 266 (417)
|..+.+ +.| +| .++++..|..+|+.. +|.-|||++.-
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 322211 122 11 478899999999853 36789987543
No 453
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.93 E-value=6.3e-09 Score=97.90 Aligned_cols=137 Identities=25% Similarity=0.327 Sum_probs=105.2
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecc-------cccc------------cchHHHHHHHHHHHHhCCCC--
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ-------KILR------------GGLTAHVKREISIMSRLRHP-- 76 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-------~~~~------------~~~~~~i~~Ei~il~~l~Hp-- 76 (417)
+.++..||-|--+.||.|.+ ..|..+|||.=..- +..+ .-......+|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 46789999999999999999 48899999963210 0000 01123467899999999765
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
.|.+.+++ +...+||||++|-.|...- ++...+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 67777664 4568999999997775442 245556677788888888788999999999999999999999999
Q ss_pred eeeecce
Q 014849 157 SDFGLSA 163 (417)
Q Consensus 157 ~DFGls~ 163 (417)
+||-.+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9997654
No 454
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.82 E-value=5.5e-08 Score=89.77 Aligned_cols=105 Identities=20% Similarity=0.326 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 014849 60 TAHVKREISIMSRLRHPN--IVKLYEVLATK----AKIYFVMEFAKGG-ELFAKISK-GRFSEQLSRRYFQQLISAVEYC 131 (417)
Q Consensus 60 ~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yl 131 (417)
.....+|...+..|..-+ +.+.+.+.... ..-++|+|+++|. +|.+++.. ..++......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 446778888888775332 34455554442 2468999999884 78888876 4577788899999999999999
Q ss_pred HHcCCeecCCCCCcEEecCCC---CeEEeeeeccee
Q 014849 132 HSRGVFHRDLKLENLLLDENW---DLKISDFGLSAV 164 (417)
Q Consensus 132 H~~givHrDlkp~NILl~~~~---~vkl~DFGls~~ 164 (417)
|.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999997754
No 455
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.77 E-value=1.8e-07 Score=86.34 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=94.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchH------HHHHHHHHHHHhCC---CCCcceEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT------AHVKREISIMSRLR---HPNIVKLYE 83 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~------~~i~~Ei~il~~l~---HpnIv~l~~ 83 (417)
.+.+.|++.+++-......|.+..- .|+.+++|............. ....+++..+..++ -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4578899999999988888877664 778999998865432111100 11223444444443 223333222
Q ss_pred EEE-----eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 84 VLA-----TKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 84 ~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+.+ -....+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|..|.|++++.++ +++.|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 221 1234568999999988876543 333 3446778889999999999999999999999665 99999
Q ss_pred eecc
Q 014849 159 FGLS 162 (417)
Q Consensus 159 FGls 162 (417)
|+-.
T Consensus 178 ~~~k 181 (229)
T PF06176_consen 178 TQGK 181 (229)
T ss_pred Cccc
Confidence 9854
No 456
>PRK09902 hypothetical protein; Provisional
Probab=98.66 E-value=4.6e-07 Score=83.27 Aligned_cols=137 Identities=14% Similarity=0.148 Sum_probs=98.8
Q ss_pred eeeCceEEEEEEEccCCcEEEEEEeecccc--cc-cchHHHHHHHHHHHHhCCCCC--cceEEEEEEe----CCEEEEEE
Q 014849 25 GCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LR-GGLTAHVKREISIMSRLRHPN--IVKLYEVLAT----KAKIYFVM 95 (417)
Q Consensus 25 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~----~~~~~lV~ 95 (417)
|+|+-+.|+.... .|+.+-+|.-..... .. +.-...+.+|+..|+.|..-+ +.+....-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4588888888664 444677776541111 11 223567889999999886322 4444422111 12478999
Q ss_pred eccCC-CChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--eEEeeeecce
Q 014849 96 EFAKG-GELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--LKISDFGLSA 163 (417)
Q Consensus 96 E~~~g-g~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--vkl~DFGls~ 163 (417)
|-+.| .+|.+.+..+ +.++.....++.++...+.-||+.|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 5888888663 4578888899999999999999999999999999999987777 9999998664
No 457
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.61 E-value=4.7e-07 Score=84.53 Aligned_cols=148 Identities=18% Similarity=0.256 Sum_probs=103.5
Q ss_pred cccCCeEEeeEEee---eCceEEEEEEEccCCcEEEEEEeecccccccch---------------------HHHHHHHHH
Q 014849 13 NLFGKYEVGKIIGC---GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL---------------------TAHVKREIS 68 (417)
Q Consensus 13 ~~~~~y~i~~~LG~---G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~---------------------~~~i~~Ei~ 68 (417)
.+..+..+....|. |--++||+|.. .++..+|+|++......-... ..-..+|..
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~ 120 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR 120 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence 45666666666665 55557999987 678999999996543321110 112346888
Q ss_pred HHHhCCC--CCcceEEEEEEeCCEEEEEEeccCCCC-hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCC
Q 014849 69 IMSRLRH--PNIVKLYEVLATKAKIYFVMEFAKGGE-LFAKISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLE 144 (417)
Q Consensus 69 il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~-L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~ 144 (417)
-|+++.. =.+.+.+.+.. -.+||||+.... -.-.+..-++...++..++.+++..+.-|-. .|+||+||+.=
T Consensus 121 NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy 196 (268)
T COG1718 121 NLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY 196 (268)
T ss_pred HHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence 8887753 34555555432 468999996531 1223333344455899999999999999988 89999999999
Q ss_pred cEEecCCCCeEEeeeecceeec
Q 014849 145 NLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~ 166 (417)
|||+. ++.+.|+|||.|....
T Consensus 197 NiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 197 NILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred heEEE-CCeEEEEECccccccC
Confidence 99999 7789999999886544
No 458
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.60 E-value=1.9e-09 Score=110.96 Aligned_cols=239 Identities=20% Similarity=0.188 Sum_probs=167.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV 94 (417)
..|+...-+++|+.+++++++...+...+ .+.+... ..++-++++|.+++||| .+..++-+..+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34556667889999999999987665444 5554332 34456888999999999 77777777778889999
Q ss_pred EeccCCC-ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGG-ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg-~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
++++.++ +-...+.. -.+.+.+.....+.-..+++++|+.-=+||| ||+..+ +..|..||+....... .
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---T 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---c
Confidence 9999887 22222111 2244444555666778899999998778999 888766 5799999998764432 2
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCC---CCCCChHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRC---PKWTSPDLK 246 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~---p~~~s~~~~ 246 (417)
....+..+|+.++|||+.....++ ...|.|++|+-..++--|-+|-..+- .....+..+. +.. ..|....-+
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCccccc
Confidence 245677899999999999988887 88999999987777878877754421 1000011010 000 112222223
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
++...|+..-|..|+...+.+.|.+|..
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 4778899999999999999999988864
No 459
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.55 E-value=1.1e-06 Score=82.31 Aligned_cols=132 Identities=13% Similarity=0.152 Sum_probs=84.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ 99 (417)
..+|+|..+.||+. .|..+++|...... ....+.+|.++|+.+..-+ +.+.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 25567888875422 2456789999999986433 4677888778888899999999
Q ss_pred CCC-hHH--------------HH-------hc---CCCCHH-HHHHHHHHH----------HH-HHHHHH----HcCCee
Q 014849 100 GGE-LFA--------------KI-------SK---GRFSEQ-LSRRYFQQL----------IS-AVEYCH----SRGVFH 138 (417)
Q Consensus 100 gg~-L~~--------------~i-------~~---~~l~e~-~~~~i~~ql----------~~-aL~ylH----~~givH 138 (417)
|.. +.. .+ .. ...+.. ....+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 111 11 10 001100 001111111 11 112222 124789
Q ss_pred cCCCCCcEEecCCCCeEEeeeecce
Q 014849 139 RDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 139 rDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999988 9999999774
No 460
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.53 E-value=4.1e-07 Score=94.48 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=91.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---------------------------c----chHH------HHH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---------------------------G----GLTA------HVK 64 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------------~----~~~~------~i~ 64 (417)
+-++.++-|.||.|+.. +|+.||||+....-... . +... .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999984 59999999975421000 0 0011 233
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCChHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 014849 65 REISIMSRLR-----HPNIVKLYEVLATKAKIYFVMEFAKGGELFAK--ISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137 (417)
Q Consensus 65 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~~~~i~~ql~~aL~ylH~~giv 137 (417)
+|...+.+++ .|++.=..-+++-.+.-.++|||++|-.+.+. +.....+.......+.++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4555555542 24333222233334556899999999998877 4445555333322222221 2223348999
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|.|.+|.||+++.+|.+-+.|||+....+
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999986543
No 461
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.42 E-value=3.7e-06 Score=77.66 Aligned_cols=136 Identities=18% Similarity=0.252 Sum_probs=83.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP--NIVKLYEVL---ATKAKIYFVM 95 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp--nIv~l~~~~---~~~~~~~lV~ 95 (417)
++.|+.|..+.||...... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999844 59999987554 2356788899998888533 355666643 3344689999
Q ss_pred eccCCCChHH----------------HHhc---C-----CCCHHH------HHH---------------HHHHHHH-HHH
Q 014849 96 EFAKGGELFA----------------KISK---G-----RFSEQL------SRR---------------YFQQLIS-AVE 129 (417)
Q Consensus 96 E~~~gg~L~~----------------~i~~---~-----~l~e~~------~~~---------------i~~ql~~-aL~ 129 (417)
++++|..+.. .+.. - .+.... ... ....+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 1110 0 001000 000 0112222 334
Q ss_pred HHHH-------cCCeecCCCCCcEEec-CCCCeEEeeeecce
Q 014849 130 YCHS-------RGVFHRDLKLENLLLD-ENWDLKISDFGLSA 163 (417)
Q Consensus 130 ylH~-------~givHrDlkp~NILl~-~~~~vkl~DFGls~ 163 (417)
.+++ ..++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4442 4599999999999999 66667899999765
No 462
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.41 E-value=2.8e-06 Score=93.33 Aligned_cols=202 Identities=20% Similarity=0.221 Sum_probs=142.8
Q ss_pred HHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 014849 64 KREISIMSRLRHPNIVKLYEVLATKA----KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFH 138 (417)
Q Consensus 64 ~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givH 138 (417)
.-|+..+....|+|+++++.+-.... .+.+..|+|++-++...+.. +..+....+.+..++++|+.|+|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 34666777789999999998864433 23345678999999998887 88999999999999999999999996666
Q ss_pred cCCCCC---cEEecCCCCeEEe--eeecceeecccCCCCcccccccCccccccccccccCCC-CChhhHHHHHHHHHHHH
Q 014849 139 RDLKLE---NLLLDENWDLKIS--DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLN 212 (417)
Q Consensus 139 rDlkp~---NILl~~~~~vkl~--DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~-~~~sDIwSlGvil~~ll 212 (417)
.-+... +-..+..+.+.++ ||+.+........ .....-+..+.|||......+. +...|+|.+|..+..+.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 655554 4444566677777 8887765443221 1222335668888887766654 22369999999999988
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 213 AGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 213 ~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.|..+-.-. .....+. +........+++.+|+..++++|+++.+++.|+|.+....
T Consensus 387 ~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 387 QGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 875442111 1111111 1112226788999999999999999999999999875443
No 463
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=98.34 E-value=3.6e-08 Score=109.61 Aligned_cols=207 Identities=16% Similarity=0.089 Sum_probs=153.5
Q ss_pred HHHHHHHhCCCCCcceEEEEE--EeCCEEEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--
Q 014849 65 REISIMSRLRHPNIVKLYEVL--ATKAKIYFVMEFAKGGELFAKISKG-----RFSEQLSRRYFQQLISAVEYCHSRG-- 135 (417)
Q Consensus 65 ~Ei~il~~l~HpnIv~l~~~~--~~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~aL~ylH~~g-- 135 (417)
.|..-++...|+++...+.-. .+....|.+++|+.+|.+++.|.+| .+.+.-+....++.+.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 344455667899888766544 3345688999999999999999763 2444445455556588888888652
Q ss_pred ---CeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH
Q 014849 136 ---VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN 212 (417)
Q Consensus 136 ---ivHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll 212 (417)
.+|+++|+-|-+|..+-++|++++|+.+...+ .........++|.|++|++.+.-.+. .++|+|+.|+-+|++.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHh
Confidence 79999999999999999999999999874322 22344567789999999999888875 6699999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 213 AGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 213 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.|..||.......+...+..+. +..+...+.++-.....+|-+.-..||.-..++.-+.|.-
T Consensus 1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9998875544444444444333 2344555666667777777788889999999988877753
No 464
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.33 E-value=4.7e-06 Score=78.57 Aligned_cols=130 Identities=15% Similarity=0.129 Sum_probs=81.7
Q ss_pred eeCc-eEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 26 CGAF-AKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 26 ~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
.|.. +.||.... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|..|
T Consensus 8 ~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 8 EGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred CCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444 78999875 34688888875432 345678999988884 34466777777776778999999999776
Q ss_pred HHHH----------------hc-CCC-------CHH------HHHHHHH----------------HHHHHHHHHH-----
Q 014849 104 FAKI----------------SK-GRF-------SEQ------LSRRYFQ----------------QLISAVEYCH----- 132 (417)
Q Consensus 104 ~~~i----------------~~-~~l-------~e~------~~~~i~~----------------ql~~aL~ylH----- 132 (417)
.... .. ..+ ... .....+. ++...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5321 00 001 100 0000000 0111122221
Q ss_pred --HcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 133 --SRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 133 --~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
No 465
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.31 E-value=1.4e-05 Score=73.24 Aligned_cols=131 Identities=19% Similarity=0.271 Sum_probs=96.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-------------cccchHHHHHHHHHHHHhCC------CCCcceE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-------------LRGGLTAHVKREISIMSRLR------HPNIVKL 81 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------HpnIv~l 81 (417)
...||+|+.-.||. + .......||+...... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999996 3 3445688999977650 01122456667777666665 7889999
Q ss_pred EEEEEeCCEEEEEEeccCC------CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---
Q 014849 82 YEVLATKAKIYFVMEFAKG------GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW--- 152 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~--- 152 (417)
+++.+|+.-.-+|+|.+.. -+|.+++..+.+++ . +...|-+-..||-+++|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998743 36788888788877 3 334555666788999999999999999996442
Q ss_pred -CeEEee
Q 014849 153 -DLKISD 158 (417)
Q Consensus 153 -~vkl~D 158 (417)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 366665
No 466
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.28 E-value=4.4e-06 Score=86.79 Aligned_cols=138 Identities=22% Similarity=0.271 Sum_probs=89.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----------------------------cchHHHHH------HH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----------------------------GGLTAHVK------RE 66 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------------------------~~~~~~i~------~E 66 (417)
+.||.-+.|.||.|+.+. |+.||||+=...- .+ .+....+. +|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 578999999999999965 9999999853311 00 01111222 22
Q ss_pred HHHH----HhCCCCC------cceEEEEEEeCCEEEEEEeccCCCChHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 014849 67 ISIM----SRLRHPN------IVKLYEVLATKAKIYFVMEFAKGGELFA--KISKGRFSEQLSRRYFQQLISAVEYCHSR 134 (417)
Q Consensus 67 i~il----~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~l~e~~~~~i~~ql~~aL~ylH~~ 134 (417)
.+-. +.+.|-+ |.++|-.+ .+...++||||+|..+.| .|.+.+++...+...+.+...-+ +-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 2222 2233544 33433322 345689999999987755 45566677765555444444333 3356
Q ss_pred CCeecCCCCCcEEecC----CCCeEEeeeecceee
Q 014849 135 GVFHRDLKLENLLLDE----NWDLKISDFGLSAVK 165 (417)
Q Consensus 135 givHrDlkp~NILl~~----~~~vkl~DFGls~~~ 165 (417)
|++|.|=+|.||++.. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 7999999999999984 667999999997644
No 467
>PLN02876 acyl-CoA dehydrogenase
Probab=98.24 E-value=1.4e-05 Score=88.56 Aligned_cols=81 Identities=19% Similarity=0.329 Sum_probs=58.0
Q ss_pred EeeEEeeeCceEEEEEEEccCC--cEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNI--VKLYEVLATK---AKI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~ 91 (417)
-.+.++.|.+..+|+......+ ..+++|........ .....+.+|+.+|+.+. |+++ .+.+.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764332 46777765443221 12457889999999996 6665 7778777664 467
Q ss_pred EEEEeccCCCC
Q 014849 92 YFVMEFAKGGE 102 (417)
Q Consensus 92 ~lV~E~~~gg~ 102 (417)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 99999999864
No 468
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.15 E-value=1.5e-05 Score=70.86 Aligned_cols=138 Identities=23% Similarity=0.283 Sum_probs=96.7
Q ss_pred cccccCCe--EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcc-eEEEEEEe
Q 014849 11 EVNLFGKY--EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV-KLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y--~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv-~l~~~~~~ 87 (417)
-....+.| ++.+.||+|.+|.||++.+ .|..+|+|+=..+. ....+..|.++|..+.-.++- ++|.+.
T Consensus 15 ~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg-- 85 (201)
T COG2112 15 LNVEEGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG-- 85 (201)
T ss_pred eeeeccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec--
Confidence 33444555 4578899999999999998 56699999876554 256788999999998865554 444443
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC-CCcEEecCCCCeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK-LENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlk-p~NILl~~~~~vkl~DFGls~~~ 165 (417)
..++.|||+.|-.|.+.-..+ + ++-...++++---|-..||-|..|. |...+|-.++.+.|+||..|++.
T Consensus 86 --~~~i~me~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 86 --EDFIRMEYIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred --hhhhhhhhhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 234569999998887664432 1 2333455566555667899999997 44444445558999999988743
No 469
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.08 E-value=7.2e-05 Score=68.39 Aligned_cols=130 Identities=21% Similarity=0.232 Sum_probs=91.9
Q ss_pred ccCCeEEeeEEeeeCc-eEEEEEEEccCCcEEEEEEeec---c-------ccccc--------chHHHHHHHHHHHHhC-
Q 014849 14 LFGKYEVGKIIGCGAF-AKVYHGRNVRTGQSVAIKAVSK---Q-------KILRG--------GLTAHVKREISIMSRL- 73 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~-------~~~~~--------~~~~~i~~Ei~il~~l- 73 (417)
....++..+.||.|+- |.||+++- .|+.+|+|++.. . ..... .....+..|.++..+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3478999999999999 99999987 788999999321 1 01000 1123455676666555
Q ss_pred --CCCCc--ceEEEEEEeC------------------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 014849 74 --RHPNI--VKLYEVLATK------------------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131 (417)
Q Consensus 74 --~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yl 131 (417)
.+.++ |+.|+++.-. ...-||.||++... .+. ..=+.++.+-|..+
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHH
Confidence 45666 9999987221 13457888776643 222 33456778888899
Q ss_pred HHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 132 H~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 4589999854
No 470
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=97.99 E-value=3e-05 Score=72.79 Aligned_cols=73 Identities=11% Similarity=0.140 Sum_probs=46.0
Q ss_pred eEEeeeCce-EEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 014849 22 KIIGCGAFA-KVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP---NIVKLYEVLATK---AKIYFV 94 (417)
Q Consensus 22 ~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lV 94 (417)
+.++.|+.. .||... ..+.+|+..... ....+.+|..+|+.+... .+.+.+...... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456766666 588752 357778654321 245788999999888532 344555443332 235889
Q ss_pred EeccCCCChH
Q 014849 95 MEFAKGGELF 104 (417)
Q Consensus 95 ~E~~~gg~L~ 104 (417)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997663
No 471
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=97.76 E-value=0.00011 Score=66.85 Aligned_cols=97 Identities=19% Similarity=0.238 Sum_probs=80.0
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCChHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHHH---cCC
Q 014849 65 REISIMSRLRH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAK---ISK-GRFSEQLSRRYFQQLISAVEYCHS---RGV 136 (417)
Q Consensus 65 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~~-~~l~e~~~~~i~~ql~~aL~ylH~---~gi 136 (417)
.|.-+|+.+++ +++++++|.+- .++|.||...+++... +.. ...++..+.+++.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999986 69999999884 2678999987766532 111 346888999999999999999997 458
Q ss_pred eecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 137 FHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 137 vHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
...|++|+|+-++++|++|+.|.......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999999976543
No 472
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.74 E-value=0.00056 Score=69.28 Aligned_cols=80 Identities=18% Similarity=0.150 Sum_probs=56.2
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-c-c--cchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-L-R--GGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~-~--~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 93 (417)
.+.||.|.+..||.+.+...++.++||.-..... . . ....++...|...|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999854446899998542111 0 1 123567778888888863 3467777776 4456789
Q ss_pred EEeccCCCC
Q 014849 94 VMEFAKGGE 102 (417)
Q Consensus 94 V~E~~~gg~ 102 (417)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
No 473
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.73 E-value=0.00038 Score=64.99 Aligned_cols=75 Identities=23% Similarity=0.267 Sum_probs=48.9
Q ss_pred eeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEecc
Q 014849 21 GKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+ .++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4667888888999987643 367899997754321 1123457888998885433 344444332 2 4799999
Q ss_pred CCCCh
Q 014849 99 KGGEL 103 (417)
Q Consensus 99 ~gg~L 103 (417)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
No 474
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=97.67 E-value=0.00036 Score=67.66 Aligned_cols=135 Identities=18% Similarity=0.192 Sum_probs=83.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEV------LATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 92 (417)
.+.+..|....+|+... .+..+++|+.... ....+..|+.++..+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56677888889998865 3457888987541 2456778888888875332 4444431 23345678
Q ss_pred EEEeccCCCChHH-----------HHh---c--CCCCH------------HHHH--------HHHHHHHHHHHHHHH---
Q 014849 93 FVMEFAKGGELFA-----------KIS---K--GRFSE------------QLSR--------RYFQQLISAVEYCHS--- 133 (417)
Q Consensus 93 lV~E~~~gg~L~~-----------~i~---~--~~l~e------------~~~~--------~i~~ql~~aL~ylH~--- 133 (417)
+|+++++|..+.. .+. . ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876521 010 0 00000 0000 011122334444443
Q ss_pred ----cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 ----RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 ----~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.|.|||+++++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999764
No 475
>PRK10593 hypothetical protein; Provisional
Probab=97.64 E-value=0.00092 Score=65.25 Aligned_cols=79 Identities=11% Similarity=0.093 Sum_probs=55.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH---PNIVKLYEVLAT---KAKI 91 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~ 91 (417)
-.-.+.||.|..+.||.... ++..+.+|... .. .....+.+|...|+.|.. -.+.+.++++.. .+.-
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD--SQGNPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEc--CCCCEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 34467899999999999865 22357777742 21 013467789999988853 357788877654 3668
Q ss_pred EEEEeccCCCCh
Q 014849 92 YFVMEFAKGGEL 103 (417)
Q Consensus 92 ~lV~E~~~gg~L 103 (417)
++|||+++|+.+
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998754
No 476
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.59 E-value=0.00032 Score=66.71 Aligned_cols=132 Identities=18% Similarity=0.214 Sum_probs=78.1
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg 101 (417)
.+..|-...+|+.. .+|+.+++|+...... ...-...+|..+++.+....+ .+++... . -++|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 34567778899887 3567888887644321 111134678899998864333 3444432 2 26899999987
Q ss_pred ChHH--------------HHh---cC-----CCC-HHHHHHHHHHHH---------HHHHHHHH--------cCCeecCC
Q 014849 102 ELFA--------------KIS---KG-----RFS-EQLSRRYFQQLI---------SAVEYCHS--------RGVFHRDL 141 (417)
Q Consensus 102 ~L~~--------------~i~---~~-----~l~-e~~~~~i~~ql~---------~aL~ylH~--------~givHrDl 141 (417)
.+.. .+. .- +++ ......+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111 10 111 122223332221 11222222 24899999
Q ss_pred CCCcEEecCCCCeEEeeeeccee
Q 014849 142 KLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 142 kp~NILl~~~~~vkl~DFGls~~ 164 (417)
.|.||++++++ +.|.||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999887 89999998753
No 477
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.45 E-value=0.0011 Score=65.43 Aligned_cols=139 Identities=27% Similarity=0.336 Sum_probs=96.8
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc--------ccc--------------chH-HHHHHHHHHHHhCCCCCcc
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--------LRG--------------GLT-AHVKREISIMSRLRHPNIV 79 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~--------------~~~-~~i~~Ei~il~~l~HpnIv 79 (417)
.|..|--+.||+|.. .+|..+|||++..+-. ... .+. --...|++-|++|+...|.
T Consensus 151 CiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred ccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456688888999988 6788899999854321 110 011 1234678888888765544
Q ss_pred eEEEEEEeCCEEEEEEeccCC-CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCeEEe
Q 014849 80 KLYEVLATKAKIYFVMEFAKG-GELFAKISKGRFSEQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 80 ~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
-.--+.. + ...|||+++.+ |--.-.+..-.++...++.+.+|++.-|.-|- ..++||.||.-=|+|+.+ |.+.|+
T Consensus 230 ~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiI 306 (520)
T KOG2270|consen 230 CPEPILL-K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYII 306 (520)
T ss_pred CCCceee-e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEE
Confidence 2222211 2 24689999953 22334555567888999999999999998885 679999999999999965 479999
Q ss_pred eeecceee
Q 014849 158 DFGLSAVK 165 (417)
Q Consensus 158 DFGls~~~ 165 (417)
|.+.|.-.
T Consensus 307 DVSQSVE~ 314 (520)
T KOG2270|consen 307 DVSQSVEH 314 (520)
T ss_pred EccccccC
Confidence 99877543
No 478
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.45 E-value=0.00096 Score=65.25 Aligned_cols=136 Identities=19% Similarity=0.205 Sum_probs=81.1
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEV------LATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 92 (417)
.+.++.|.-..+|.+.. .+| .+++|+..... ..+.+..|+.++..|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998864 344 67788765421 1345566777777774322 3343331 12245678
Q ss_pred EEEeccCCCChH-----------HHH---hc--CCCC--------HHH-----HH----------HHHHHHHHHHHHHHH
Q 014849 93 FVMEFAKGGELF-----------AKI---SK--GRFS--------EQL-----SR----------RYFQQLISAVEYCHS 133 (417)
Q Consensus 93 lV~E~~~gg~L~-----------~~i---~~--~~l~--------e~~-----~~----------~i~~ql~~aL~ylH~ 133 (417)
++++|++|.++. ..+ .. ..++ ... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999986531 011 00 1110 000 00 011123334555542
Q ss_pred -------cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 -------RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 -------~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.+.||+++.++.+.|.||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998877899999764
No 479
>PRK05231 homoserine kinase; Provisional
Probab=97.36 E-value=0.0021 Score=63.06 Aligned_cols=135 Identities=16% Similarity=0.195 Sum_probs=75.1
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYE------VLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~ 92 (417)
.+.++.|....+|.... .+| .+++|++... ....+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 34566777788999875 233 6888987511 1234445666666653211 333332 123356789
Q ss_pred EEEeccCCCChH-----------HHHhc-----CCCC----------H--HHHH-----------HHHHH-HHHHHHHHH
Q 014849 93 FVMEFAKGGELF-----------AKISK-----GRFS----------E--QLSR-----------RYFQQ-LISAVEYCH 132 (417)
Q Consensus 93 lV~E~~~gg~L~-----------~~i~~-----~~l~----------e--~~~~-----------~i~~q-l~~aL~ylH 132 (417)
++++|++|..+. ..+.+ ..++ . .... ..+.+ +-..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999997531 11110 0010 0 0000 11111 111122222
Q ss_pred -------HcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 133 -------SRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 133 -------~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
..|+||+|+.|.|||++.+...-|.||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999976556899999874
No 480
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.36 E-value=0.00015 Score=70.37 Aligned_cols=136 Identities=18% Similarity=0.278 Sum_probs=99.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc------------c---ccch----HHHHHHHHHHHHhCCCC-
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI------------L---RGGL----TAHVKREISIMSRLRHP- 76 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------------~---~~~~----~~~i~~Ei~il~~l~Hp- 76 (417)
=|.+|..||-|--+.||.+-+ ..|++.++|.=..-+. . ...+ .-...+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367899999999999999998 6788999985321100 0 0001 11344788888888531
Q ss_pred -CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 77 -NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 77 -nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
-|.+.++ .+..++|||++.|-.|...-. ...+..++..++.-+--|..+|+||+|+.-=||++++++.++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2444443 356789999999987754431 123557778888888999999999999999999999999999
Q ss_pred Eeeeecc
Q 014849 156 ISDFGLS 162 (417)
Q Consensus 156 l~DFGls 162 (417)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999743
No 481
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.35 E-value=0.0017 Score=63.21 Aligned_cols=76 Identities=22% Similarity=0.281 Sum_probs=49.0
Q ss_pred eeEEeeeCceEEEEEEEcc------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYF 93 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 93 (417)
++.|..|-...+|++.... +++.+++|+..... .......+|..+++.+...++ .+++..+. . .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3556667777899887533 36889999965432 112456788888888864333 34555443 2 35
Q ss_pred EEeccCCCChH
Q 014849 94 VMEFAKGGELF 104 (417)
Q Consensus 94 V~E~~~gg~L~ 104 (417)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
No 482
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=97.21 E-value=0.0013 Score=67.56 Aligned_cols=164 Identities=20% Similarity=0.277 Sum_probs=105.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 014849 60 TAHVKREISIMSRLRHPNIVKLYEVLATK-AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138 (417)
Q Consensus 60 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givH 138 (417)
..++.-...+++.+.|+|..+.+.+.... ....+|+|++ +.+|.+.+..+.+-... +. .+|+.|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s---~~-----------~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDES---LL-----------AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhh---hc-----------ccccce
Confidence 34566778899999999999999886543 3577899999 55899988765432111 11 222222
Q ss_pred cCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC
Q 014849 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218 (417)
Q Consensus 139 rDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf 218 (417)
.|+ ++.+| -+. . . | |- ..++++||||+|.|+.++.-|...+
T Consensus 91 -----~~~-------~~~td-~~~---t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFL---T----K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred -----ehh-------hhccc-ccc---c----c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 222 33333 010 0 0 0 11 1135999999999999999998777
Q ss_pred CCCCHHHHHHHHhcCCCCCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 219 NDPNLMAMYRKIYKGEYRCP------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 219 ~~~~~~~~~~~i~~~~~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
......+....+.+-....- ...+.....+..+|+-..|..||...++++++-|...+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 66554444444432211100 112445667889999999999999999999999876543
No 483
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.14 E-value=0.0038 Score=62.22 Aligned_cols=85 Identities=14% Similarity=0.112 Sum_probs=54.5
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc-cc---cchHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LR---GGLTAHVKREISIMSRLR--HP-NIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~---~~~~~~i~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 95 (417)
.+|.|...-||++.+...++.|+||.-..--. .. +-...+...|..+|+... -| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57899999999999854447899997542211 11 223566778888887764 24 46666554 555567999
Q ss_pred eccCCCC-hHHHHhc
Q 014849 96 EFAKGGE-LFAKISK 109 (417)
Q Consensus 96 E~~~gg~-L~~~i~~ 109 (417)
|+++... |...+.+
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 9985533 3344433
No 484
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=96.84 E-value=0.0094 Score=58.54 Aligned_cols=141 Identities=14% Similarity=0.244 Sum_probs=82.2
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKA--KIYFVM 95 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~lV~ 95 (417)
+++....|.--.+|...+. ++.+++. ... ............+|..+|+.+.- --+..-+.++.+.. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444433444445665553 7788887 332 12223346677889999888753 22334455555544 779999
Q ss_pred eccCCCChHHHHhcCCCC---------------------------------HHHHHHHHHH--------------HHHHH
Q 014849 96 EFAKGGELFAKISKGRFS---------------------------------EQLSRRYFQQ--------------LISAV 128 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~---------------------------------e~~~~~i~~q--------------l~~aL 128 (417)
+|+.|..+.+.......+ ..+...+..+ ...-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999984332221111111 0111111111 12233
Q ss_pred HHHHHc--------CCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 129 EYCHSR--------GVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 129 ~ylH~~--------givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
.|++.+ .++|+|+.+.||+++.++.+-|.||+++.+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 444433 489999999999999999999999999875
No 485
>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.
Probab=96.84 E-value=0.0016 Score=45.12 Aligned_cols=34 Identities=15% Similarity=0.076 Sum_probs=29.4
Q ss_pred cceEEEEEEEEec-CceEEEEEEecCCc---hhhhhcc
Q 014849 377 GNFTMVIGIDRLT-DDLVVVEIKKSMRR---GEENWKD 410 (417)
Q Consensus 377 ~~~~~~~~~~~~~-~~~~~v~~~~~~g~---~~~~~~~ 410 (417)
-.+.+.+||+.+. ++++.|.|+|.+|| |+++|.+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~ 40 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK 40 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH
Confidence 4578999999998 89999999999999 9999983
No 486
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=96.81 E-value=0.014 Score=56.90 Aligned_cols=29 Identities=31% Similarity=0.612 Sum_probs=25.5
Q ss_pred cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 ~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999999653
No 487
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=96.80 E-value=0.0095 Score=57.52 Aligned_cols=30 Identities=27% Similarity=0.382 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEecCCCC-eEEeeeeccee
Q 014849 135 GVFHRDLKLENLLLDENWD-LKISDFGLSAV 164 (417)
Q Consensus 135 givHrDlkp~NILl~~~~~-vkl~DFGls~~ 164 (417)
.++|+|++|.|||++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998753
No 488
>PLN02756 S-methyl-5-thioribose kinase
Probab=96.80 E-value=0.02 Score=58.11 Aligned_cols=77 Identities=16% Similarity=0.091 Sum_probs=53.6
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-ccc---chHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRG---GLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 92 (417)
..+.+|.|....||+..+ .++.++||.-..... ... ....+...|...|+.+. ..++.+++.+..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 477889999999999887 355799997652221 111 13456667788887764 2478888887664 357
Q ss_pred EEEeccCC
Q 014849 93 FVMEFAKG 100 (417)
Q Consensus 93 lV~E~~~g 100 (417)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
No 489
>PLN02236 choline kinase
Probab=96.58 E-value=0.023 Score=56.58 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=79.2
Q ss_pred eeEEeeeCceEEEEEEEcc----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV-KLYEVLATKAKIYFVM 95 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~ 95 (417)
.+.|-.|-.-.+|++.... +++.|.+|+..... ....+ ..+|..+++.+..-++- ++++.+.. . .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3445557788899986432 34789999876542 22233 26788998888643333 45555532 2 589
Q ss_pred eccCCCChHHH--------------Hh---cCC------C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 014849 96 EFAKGGELFAK--------------IS---KGR------F-SEQLSRRYFQQL-----------------ISAVEYC--- 131 (417)
Q Consensus 96 E~~~gg~L~~~--------------i~---~~~------l-~e~~~~~i~~ql-----------------~~aL~yl--- 131 (417)
+|++|.+|... +. +.. . .......++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 11 100 1 112232333222 1111122
Q ss_pred -H----HcCCeecCCCCCcEEecC-CCCeEEeeeecce
Q 014849 132 -H----SRGVFHRDLKLENLLLDE-NWDLKISDFGLSA 163 (417)
Q Consensus 132 -H----~~givHrDlkp~NILl~~-~~~vkl~DFGls~ 163 (417)
. ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4679999999875
No 490
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.52 E-value=0.016 Score=58.61 Aligned_cols=78 Identities=21% Similarity=0.199 Sum_probs=54.0
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---GGLTAHVKREISIMSRLR--HP-NIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV 94 (417)
.+.||.|.-.-||++.+...++.|+||.-..--... +-..++..-|..+|+... -| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999984346789998653221111 223567788999998774 34 56666654 55556789
Q ss_pred EeccCC
Q 014849 95 MEFAKG 100 (417)
Q Consensus 95 ~E~~~g 100 (417)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
No 491
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=96.49 E-value=0.0084 Score=60.20 Aligned_cols=124 Identities=21% Similarity=0.238 Sum_probs=83.3
Q ss_pred eEEeeeCceEEEEEEE---------------ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 014849 22 KIIGCGAFAKVYHGRN---------------VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVL 85 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~---------------~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~ 85 (417)
..+|.|+-+.||.|.- +...+.+|||+.++. ...++++...||.-.. -+|+|.-..+.
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~------V~~~ir~Dl~Il~f~Akl~~~vP~l~wL 268 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN------VEKQIRLDLGILGFGAKLINNVPDLSWL 268 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc------HHHHHHHHHHHHhhhhhhhhhcCccccc
Confidence 4589999999999852 234567999998654 2455666666654432 22222111110
Q ss_pred ----------------------------------------------EeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHH
Q 014849 86 ----------------------------------------------ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRR 119 (417)
Q Consensus 86 ----------------------------------------------~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~ 119 (417)
.--+...++-+|..|-++..+++....+|...++
T Consensus 269 ~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kk 348 (565)
T KOG1236|consen 269 SLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKK 348 (565)
T ss_pred cCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHH
Confidence 0113456777899999999999877778877777
Q ss_pred HHHHHHHHHHHHH-HcCCeecCCCCCcEEecCC
Q 014849 120 YFQQLISAVEYCH-SRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 120 i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~ 151 (417)
++.--+.|+.-+- -.+++|.|+.|.||++-.+
T Consensus 349 va~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 349 VAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 7776677665544 5689999999999999544
No 492
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.21 E-value=0.042 Score=54.41 Aligned_cols=134 Identities=18% Similarity=0.185 Sum_probs=77.0
Q ss_pred eEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~ 97 (417)
+.|..|---.+|+...... +..|.+++...... . .-.-.+|..+++.+..-++ .+++.++. .+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 4444477778898865432 34789998754321 1 1223578888888865444 35555543 22 58999
Q ss_pred cCCCChHH----------HH----h---cCC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q 014849 98 AKGGELFA----------KI----S---KGR------F-SEQLSRRYFQQL----------------------ISAVEYC 131 (417)
Q Consensus 98 ~~gg~L~~----------~i----~---~~~------l-~e~~~~~i~~ql----------------------~~aL~yl 131 (417)
++|..|.. .+ . ... . ....+..++.++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98765521 11 1 111 1 112233333332 1112222
Q ss_pred H----HcC----CeecCCCCCcEEecC-CCCeEEeeeecce
Q 014849 132 H----SRG----VFHRDLKLENLLLDE-NWDLKISDFGLSA 163 (417)
Q Consensus 132 H----~~g----ivHrDlkp~NILl~~-~~~vkl~DFGls~ 163 (417)
. +.+ .||.|+.|.|||+++ ++.++++||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 122 799999999999975 4689999999875
No 493
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.13 E-value=0.054 Score=52.97 Aligned_cols=29 Identities=24% Similarity=0.325 Sum_probs=27.0
Q ss_pred CCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 135 GVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 135 givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
++||+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999764
No 494
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=95.89 E-value=0.024 Score=52.08 Aligned_cols=30 Identities=27% Similarity=0.488 Sum_probs=21.6
Q ss_pred CCeecCCCCCcEEe-cCCCCeEEeeeeccee
Q 014849 135 GVFHRDLKLENLLL-DENWDLKISDFGLSAV 164 (417)
Q Consensus 135 givHrDlkp~NILl-~~~~~vkl~DFGls~~ 164 (417)
.++|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998864
No 495
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=95.88 E-value=0.063 Score=52.13 Aligned_cols=76 Identities=16% Similarity=0.169 Sum_probs=47.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 94 (417)
-+-.+.++.|....+|... .+++.+.+|+-.... ...+..|..-|+.|. --.+++.+.+....+.-|+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3456778999999999977 688899999876322 234556777777773 44577888888777777999
Q ss_pred EeccCCC
Q 014849 95 MEFAKGG 101 (417)
Q Consensus 95 ~E~~~gg 101 (417)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
No 496
>PTZ00384 choline kinase; Provisional
Probab=95.39 E-value=0.12 Score=52.29 Aligned_cols=76 Identities=21% Similarity=0.246 Sum_probs=45.0
Q ss_pred EeeEEeeeCceEEEEEEEccC-CcE-----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRT-GQS-----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIY 92 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~-g~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 92 (417)
..+.|..|-...+|++..... +.. |.+.+... .....-.-.+|+.+++.+...++ .++++.+. -+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 344555588889999875332 222 44433211 11112233578999999875444 45666554 26
Q ss_pred EEEeccCCCCh
Q 014849 93 FVMEFAKGGEL 103 (417)
Q Consensus 93 lV~E~~~gg~L 103 (417)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998766
No 497
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=95.38 E-value=0.19 Score=49.73 Aligned_cols=129 Identities=19% Similarity=0.277 Sum_probs=79.0
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC------cce----EEEEEEeCCEEEEEEec
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN------IVK----LYEVLATKAKIYFVMEF 97 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn------Iv~----l~~~~~~~~~~~lV~E~ 97 (417)
.--.||+... ..|+. ++|+.... ....++.-|+..|..|.-.. +.. .+.....+.+.+-+.+|
T Consensus 37 ~eN~~f~~~~-~~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 37 EENSNFRVQT-EDGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccCceEEEEe-cCCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 4456888877 34444 89988764 12567778888888874221 221 12222333488889999
Q ss_pred cCCCChHH------------H---Hh--cCCC-----------CHH----H---------HHHHHHHHHHHHHHHHHc--
Q 014849 98 AKGGELFA------------K---IS--KGRF-----------SEQ----L---------SRRYFQQLISAVEYCHSR-- 134 (417)
Q Consensus 98 ~~gg~L~~------------~---i~--~~~l-----------~e~----~---------~~~i~~ql~~aL~ylH~~-- 134 (417)
++|..+.. . +. ...+ ... . ......++...++.+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987762 0 00 0011 111 0 011334445555555543
Q ss_pred ------C--CeecCCCCCcEEecCCCC-eEEeeeecce
Q 014849 135 ------G--VFHRDLKLENLLLDENWD-LKISDFGLSA 163 (417)
Q Consensus 135 ------g--ivHrDlkp~NILl~~~~~-vkl~DFGls~ 163 (417)
+ +||+|+.|.||+++.+.. .-+.||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999999885 8999999763
No 498
>PRK11768 serine/threonine protein kinase; Provisional
Probab=94.82 E-value=0.74 Score=45.42 Aligned_cols=70 Identities=14% Similarity=0.142 Sum_probs=43.2
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccCC
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLY---E--VLATKAKIYFVMEFAKG 100 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~---~--~~~~~~~~~lV~E~~~g 100 (417)
.-..||.... .+|..+++|+..... ....++..|+..+..|.... ++... + +..-++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4456888775 566789999875432 12566777888887664211 22211 1 12335678889999988
Q ss_pred CC
Q 014849 101 GE 102 (417)
Q Consensus 101 g~ 102 (417)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
No 499
>PRK06148 hypothetical protein; Provisional
Probab=94.58 E-value=0.63 Score=53.10 Aligned_cols=135 Identities=13% Similarity=0.222 Sum_probs=76.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-------CCCcceE-----EEEEEe-C
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-------HPNIVKL-----YEVLAT-K 88 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-------HpnIv~l-----~~~~~~-~ 88 (417)
+.|+. ..-.+|+... .+|+.+++|+.+... ....+..|...|..|. -|.+++. +..... .
T Consensus 31 ~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLDG-ERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecCC-cCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 56643 4567888765 567789999987642 1233445555665442 2333321 112221 2
Q ss_pred C--EEEEEEeccCCCChHHH-----------------H----hc-------CCCC-----------------HHHHHHHH
Q 014849 89 A--KIYFVMEFAKGGELFAK-----------------I----SK-------GRFS-----------------EQLSRRYF 121 (417)
Q Consensus 89 ~--~~~lV~E~~~gg~L~~~-----------------i----~~-------~~l~-----------------e~~~~~i~ 121 (417)
+ ..+.+++|++|..|.+. + .. ..+. ....+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56778999999776541 0 00 0000 01122333
Q ss_pred HHHHHHHHH-----HH--HcCCeecCCCCCcEEecCCC--CeE-Eeeeecce
Q 014849 122 QQLISAVEY-----CH--SRGVFHRDLKLENLLLDENW--DLK-ISDFGLSA 163 (417)
Q Consensus 122 ~ql~~aL~y-----lH--~~givHrDlkp~NILl~~~~--~vk-l~DFGls~ 163 (417)
.+++....- +. .+++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333333221 11 25799999999999999875 555 99999875
No 500
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=93.53 E-value=0.31 Score=48.63 Aligned_cols=87 Identities=22% Similarity=0.301 Sum_probs=59.4
Q ss_pred CCCCcceEEEEEEe-CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCC
Q 014849 74 RHPNIVKLYEVLAT-KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDEN 151 (417)
Q Consensus 74 ~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~ 151 (417)
.-++..+++-+-.+ ....|++|++- |+.| ..+.. -..+++..+|.+.+..++-+..+ ..=|||+.-.||||+ +
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Ccee-eeeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34555555544422 33456666654 3333 33322 23456778888888877777655 689999999999999 9
Q ss_pred CCeEEeeeecceee
Q 014849 152 WDLKISDFGLSAVK 165 (417)
Q Consensus 152 ~~vkl~DFGls~~~ 165 (417)
|+|-|+||-++++.
T Consensus 358 GnvtLIDfklsRl~ 371 (488)
T COG5072 358 GNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEeeeeecc
Confidence 99999999999853
Done!